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Abstract 
Phosphorylases are interesting enzymes with regard to both their role in metabolism 
and their use in the in vitro synthesis of carbohydrates. The disaccharide 
phosphorylases have attracted attention because of their strict stereo- and 
regiospecificity and their tractability. The polymerising phosphorylases have 
received less attention due to heterogeneous product formation, requiring more 
complex analyses. In this work three polymerising carbohydrate phosphorylases 
have been studied.  
The plant α-1,4-glucan phosphorylase PHS2 is closely related to the well 
characterised mammalian glycogen phosphorylase. We present the first crystal 
structures of the plant enzyme which reveals a unique surface binding site.  
PHS2 allowed the production of novel starch like surface, both in two and three 
dimensions, which show some of the same properties as a native starch granule. 
This can now be used to study starch-active enzymes on an insoluble glucan 
surface which is analogous to the native starch granule. 
The bacterial β-1,4-glucan phosphorylase CDP is involved in degradation of 
cellulose. In the reverse direction this enzyme allows the rapid synthesis of cellulose 
polymers in solution and also allows the synthesis of hemicellulose-like materials. 
The substrate specificity can in part be probed in the crystal structure presented 
here, which represents the first structure of a polymerising, inverting phosphorylase. 
Together these data provide the foundation for further work with this enzyme in the 
synthesis of plant cell wall related glycans. 
The third enzyme studied was the β-1,3-glucan from the unsequenced alga  
Euglena gracilis, which was used for the facile enzymatic synthesis of  
β-glucosyl glycerols. In order to identify the sequence of this enzyme we obtained  
de novo transcriptome sequencing data from this alga, which has revealed 
unexpected metabolic diversity. Aside from complex carbohydrate metabolism, 
there are also many surprising features, including novel enzyme architectures, 
antioxidants only previously noted in human parasites and complex natural product 
synthases.  
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Chapter 1 – Introduction 
1.1 The significance of carbohydrates 
Carbohydrates are the most abundant organic molecules on earth, and are key 
components in virtually every aspect of life from respiration to reproduction. 
Formed during photosynthesis and metabolised during respiration, 
carbohydrates are central to energy transduction within cells as well as acting 
as structural support, ligands and protein modifications.1 All cells are coated in 
a surface layer of carbohydrates which can be protective, such as the 
peptidoglycan coat of bacteria, as well as supportive, such as the 
glycosaminoglycans of animal tissues. Despite the vast range of uses and the 
ubiquitous presence of carbohydrates in Nature, we still know very little about 
the structure and function of natural polysaccharides. In this age  
of next-generation DNA sequencing and whole cell proteomics this is 
principally because the structure of carbohydrates is not directly encoded in the 
genome. Instead they are synthesised by a set of specific transferases which 
can be affected by a number of different factors, including stress, disease, diet 
and environment.2 
The structure of carbohydrates is extremely complex and difficult to analyse, 
with many sugars being isomers of each other. Great progress has been made 
in structural elucidation of mammalian N-glycans, based on knowledge of their 
biosynthesis.3  However, for many other systems entire research programs are 
required to characterise a single structure, such as the core carbohydrate  
of the pear glycosylphosphatidylinositol anchor,4 and well characterised 
synthetic analogues are often necessary to confirm the correct identification, 
for example in the identification of the enzymatic reactions during pectin 
biosynthesis.5 
Carbohydrates also find diverse and important applications including in 
biomedicine,6 materials science7 and the growing field of nanotechnology.8 
Pure sources of well-defined carbohydrates are required for these 
technologies, and to some extent they can be obtained from natural sources. 
However, isolated polysaccharides are often produced as small quantities of 
impure and ill-defined material, which can have disastrous side effects. For 
example, over sulfation of chondroitin in clinical heparan resulted in hundreds 
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of cases of adverse side effects and many deaths. The impurities turned out to 
be a minor modification of one of the carbohydrate structures that make up the 
active components of the drug.9 It is clearly desirable to synthesise defined 
polysaccharides to prevent contamination and to ensure precise control over 
the nature of the compounds. 
1.2 The structures of polysaccharides 
Carbohydrates are formed from the joining of diverse monosaccharide building 
blocks through different positions on the sugar rings, giving an extremely 
diverse class of compounds. These structural complications can be highlighted 
by comparison with short oligomers of the other biopolymers. There are four 
nucleotides, twenty amino acids and, considering just the most common sugars 
in mammals, ten monosaccharides each with two anomeric forms. This means 
for a simple pentanucleic acid there are 45 (1024) possible structures, and 
there are 205, about 3.2 million, pentapeptides; however there are over  
1.5 billion possible five member polysaccharides,10 unrestrained by simple 
geometric progression. There are many more monosaccharides present in 
Nature, vastly increasing this number to an unimaginably complex sample 
space, although only a few structures are actually utilised. 
1.2.1 Structural complexity in monosaccharides 
Monosaccharides are composed of polyhydroxylated carbon chains with 
multiple stereocentres and the different diastereomers can have vastly different 
properties. For example, the ricin toxin recognises and binds to β-galactose, 
but will not recognise β-glucose, with a single difference in stereochemistry at 
the 4 position (Fig 1.1).11  
 
 
 
Figure 1.1: Comparison of D-galactose (1) and D-glucose (2)  
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Under physiological conditions the monosaccharides undergo reversible 
intramolecular cyclisation, by nucleophilic attack by an hydroxyl on to the 
carbonyl group, resulting in ring formation. This ring can vary in size, normally 
five-membered (furanose) or six-membered (pyranose) rings, both of which are 
utilised in Nature (Fig 1.2). For instance, mammalian carbohydrates exclusively 
contain the more stable pyranose form of galactose,12 whilst the furanose form 
is a key component of various polysaccharides and glycoconjugates in a range 
of bacteria, protozoa and fungi.13  
 
 
 
Figure 1.2: Comparison of D-galactofuranose (3) and D-galactopyranose (1) 
 
 
Cyclisation also introduces a new stereocentre, the anomeric centre, as the 
planar C=O bond is converted into an hemi-acetal (Fig 1.3). The two isomers, 
known as anomers, are rapidly interconverted in solution, but when a 
substituent is added to the anomeric oxygen, the structure becomes fixed. 
 
 
 
Figure 1.3: Comparison of α-D-glucopyranose (4) and β-D-glucopyranose (2)  
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1.2.2 Structural complexity in linear polysaccharides 
The sugars can be linked on to each other through any of the hydroxyls, giving 
radically different properties. Cellulose (5) is a long linear polymer of  
β-1,4-glucose and forms a ribbon with the glucose residues alternately flipping 
(Fig 1.4).14 These ribbons then stack to form large bundles of hydrogen-bonded 
structural polymers. If residues are instead linked by α-1,4 bonds, as in 
amylose (6), the polymer twists such that it takes six residues to form a 
complete turn, which can assemble to form double helices.15 Alternatively, if 
the residues are joined by β-1,3 linkages, as in paramylon (7),  the polymer 
chains assemble to form triple helices with six residues per turn (Fig 1.4). 16  
 
 
     
 
Figure 1.4: Comparison of glucan polymers  
Three homo-polymers of glucose are common in nature and have remarkably 
different structures based on their linkage. Cellulose (5), a β-1,4-glucan, forms flat 
ribbons with the residues alternating orientation.17 Amylose (6), an α-1,4-glucan, 
forms double helices with six residues per turn.15 Paramylon (7), a β-1,3-glucan, 
forms triple helices with six residues per turn.18  Structures obtained from 
PolySac3DB.19 
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1.2.3 Structural complexity provided by mixed linkages 
Each of the different hydroxyl groups on monosaccharides can be linked to 
other sugars, potentially on more than one position, forming branched chains, 
as opposed to the exclusively linear chains of the other biopolymers, nucleic 
acids and proteins. β-1,3-Glucans are found throughout nature as linear 
chains, such as bacterial extracellular curdlan,20 or the paramylon storage 
granules in Euglena (7).21 They can also have various degrees of other 
linkages, which impart different molecular architectures (Fig 1.5). Kinks in the 
chains, such as the mixed linkage β-glucans from oat (8),22 prevent the 
formation of the triple helices and branches, for example in laminarin (9), 23 
ensure the polysaccharide remains soluble. One of the Streptococcus capsules 
has a β-1,2 linked glucose on every residue (10), giving a crowded, comb-like 
structure.24 
 
 
 
Figure 1.5: Examples of mixed linkage β-glucans 
Paramylon (7), is a linear β-1,3-glucan.21 Oat glucan (8) is a linear β-1,3-glucan  
which contains some β-1,4 linkages.22 Laminarin (9) is a β-1,3-glucan which 
has β-1,6 branches.23 Streptococcus pneumonia type S37 capsule (10) is 
composed of a β-1,3-backbone with β-1,2-glucoses on every residue.24   
 Represents a glucose residue. 
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1.3 Natural synthesis and degradation of carbohydrates 
The enzymes utilised in the natural synthesis and degradation of carbohydrates 
are categorised into families in the CAZy database.25 They tend to have high 
specificity for their substrates, regulating the sugar and the linkage, though 
there are also some relatively promiscuous enzymes, such as the macrolide 
glycosyl transferases.26 
 
1.3.1 Glycosyltransferases (GTs) 
Glycosyltransferases catalyse the transfer of sugars from activated donor 
molecules to specific acceptor molecules (Fig 1.6). The sugars are typically 
activated as nucleotide phosphosugars, sugar phosphates or lipid 
diphosphosugars and the energy of the phospho-sugar bond is used to drive 
the reaction.27 The acceptor molecule can be a carbohydrate or other 
molecules can accept the sugar to form glycoconjugates, including 
glycoproteins,28 glycolipids,29 and small molecules.30 
 
 
Figure 1.6: General scheme of glycosyl transfer 
Glycosyltransferases catalyse the transfer of sugars from activated sugar 
donors, which are typically sugar phosphoesters (R1), on to acceptor molecules 
(R2), which maybe proteins, lipids, small molecules or other sugars. Often this 
transfer is on to oxygen, but transfer on to nitrogen, sulphur and carbon are 
also known. 
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1.3.2 Glycoside hydrolases (GHs) 
Glycoside hydrolases hydrolyse the glycosidic bond between carbohydrate 
moieties (Fig 1.7).31 If a molecule other than water can intercept the 
intermediate a transglycosidation reaction can take place. For example 
xyloglucan endotransferase shows no glycosidase activity, and instead 
transfers an oligosaccharide on to another polymer to form a new glycosidic 
linkage.32 
 
Figure 1.7: General scheme of glycoside hydrolysis 
Glycoside hydrolases cleave glycosidic linkages between sugars and another 
molecule (R1), transferring the sugar on to water (R2=H) resulting in hydrolysis. 
If a molecule other than water (R2≠H) can intercept the reaction then 
transglycosylation occurs. 
 
1.3.3 Polysaccharide lyases 
Polysaccharide lyases cleave sugars by deprotonation of glycosides, resulting 
in unsaturated sugars (Fig 1.8). This is particularly important in plants,  
since pectin, a major plant cell wall component, is composed of galacturonic 
acid, and is susceptible to these enzymes.33,34 
 
Figure 1.8: General scheme of polysaccharide lyases 
Polysaccharide lyases cleave the glycosidic bond between sugars, releasing 
unsaturated sugars. 
 
1.3.4 Auxiliary activities 
Recently auxiliary activities, a new category of enzymes acting on 
carbohydrates was added to the CAZy categories.35 It includes polysaccharide 
mono-oxygenases and lignin degrading enzymes.  
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1.4 Carbohydrate space 
A huge diversity of carbohydrates is made in nature, with different properties 
and structures.  
1.4.1 Storage polysaccharides 
Energy is stored in mammalian and bacterial cells in the form of glycogen, a 
highly branched, soluble α-1,4/1,6-glucan.36 The random distribution and high 
degree of branching ensures both energy storage capacity and accessibility to 
degradative enzymes. Plants also store energy in the form of α-1,4-glucans, 
but the highly regulated spacing of the α-1,6-branching gives an ordered, 
insoluble starch granule.15  
In certain species of alga β-1,3-glucans are used as the major energy storage 
molecules, which can be strictly linear, as in paramylon, or branched as in 
laminarin.37 Instead of polymers of glucose, some plants instead store other 
polysaccharides, such as polymers of fructose, including the fructans produced 
by Agave,38 or glucomannan produced by the Voodoo Lily.39 
1.4.2 Extra-cellular carbohydrates 
Mammalian cells have flexible surfaces, which contact each other via 
carbohydrates, allowing communication and control of cellular shapes.40 These 
surface glycans are highly specific for cell type and can be used as biomarkers 
for disease states such as cancer.2 Beyond this surface layer is a region of 
amorphous polysaccharide, mostly composed of negatively charged 
glycosaminoglycans, often with specific modifications such as addition of 
sulphate on heparans.41  
Plants, on the other hand, have a rigid cell wall which provides structural 
integrity and strength. Cellulose makes up the largest proportion of most cell 
walls, composed of crystalline linear β-1,4-glucan chains.42 Insect 
exoskeletons, crustacean shells and some fungal cell walls are also made of a 
crystalline β-1,4 polymer, although this chitin is made of GlcNAc.43  
The cellulose in plant cell walls is cross linked with hemicelluloses, which are 
complex polysaccharides, including xylans, mannans and arabinans.44  
These can be used industrially, including Guar Gum,45 a galactomannan, and 
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pectin, containing a mixture of substituted poly-galacturonic acids,46 for 
example as food additives, in pharmaceutical manufacture and in the oil 
industry. Plant cell walls also contain charged pectins, based on a 
polygalacturonic acid backbone, which bind calcium, causing cross-linking and 
aggregation that hold the molecules in a gel.47 When the carboxyl groups are 
methyl esterified, which occur during fruit ripening, they are not able to form 
these calcium bridges and the cell wall loses some of its structure. These 
pectins also have complex branching such as in Rhamnogalacturonan II,  
an extremely intricate, highly conserved structure, which forms borate cross 
links, holding the plant cell wall together (Fig 1.9).  
 
Figure 1.9: Schematic structure of pectin from plant cell wall 
Pectin is composed of four different polymers which are not in equal ratios and 
may not actually be covalently linked. Reproduced with permission from the 
American Society of Plant Biologists. Copyright (2010).46 
 
1.5 Conclusions  
Carbohydrates are extremely complex in their structure, with various building 
blocks, linkages and covalent modifications. Their structure is not encoded 
directly in the genome, making analysis challenging. Polysaccharides are used 
in diverse industries from oil drilling to food manufacture.48 In order to make the 
greatest use of this class of macromolecule further research is needed, both to 
study natural compounds and to engineer specific new materials.  
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Chapter 2 – In vitro synthesis of polysaccharides 
Polysaccharides are very complex in structure and their synthesis, for use in 
industry and in the understanding of Natural materials, is highly challenging. 
Over the years a number of chemical, enzymatic and chemoenzymatic 
strategies have been developed to synthesise defined oligosaccharides,1  
which will be summarised in this chapter. 
2.1 Chemical synthesis 
It is possible to synthesise short oligosaccharide sequences chemically but this 
requires a great deal of time, effort and skill. Rarely is there integration of the 
synthesis and application of oligosaccharides to a biological system. It is very 
difficult to synthesise longer oligosaccharides. Instead of stepwise syntheses, 
polymerisation type reactions are generally performed, to create repeating 
motifs.  
2.1.1 Polycondensation 
Polycondensation reactions, in which the alcohol promoted loss of two leaving 
groups unveils another alcohol, can be used to make long, polydisperse 
carbohydrate chains. However it is difficult to produce the desired control over 
stereochemistry. For example the condensation of 1,2,5-orthobenzoylacetal 
arabinose produced a linear arabinan with 92% 1,5- and 8% 1,2-linkages  
(Fig 2.1).2   
 
Figure 2.1: Polycondensation 
The polycondensation of 1,2,5-orthobenzoylarabinofuranose (11) is initiated by  
the hydroxyl of the glucose tetraacetate (12) and produces predominantly  
1,5-linkages (13).2   
 
Chapter 2 – In vitro synthesis of polysaccharides 
 
~ 14 ~ 
 
2.1.2 Ring-opening polymerisation 
Ring opening polymerisation, with attack into the back of an activated ring, can 
be difficult to make specific for linkage and ring forms. With extensive work,  
it can be refined to produce both natural and unnatural polysaccharides. For 
example 1,6-anhydroglucose can be stereospecifically opened by phosphorous 
pentafluoride to form an artificial dextran, with exclusively α-linkages and an 
average DP of 200-225 glucose residues (Fig 2.2).3 
 
Figure 2.2: Ring-opening polymerisation 
The 1,6-anhydro ring of glucose-tribenzoate (14) is held in the β-position by the 
axial positioning of C6. The ring is then opened by attack into the back of the 
anomeric carbon by the anhydro ring, forming the α-1,6-glucan (15).3  
2.1.3 Solid phase synthesis 
Historically the synthesis of peptides and oligonucleotides faced similar 
problems of yield and specificity as is faced in carbohydrate synthesis; 
however these problems have been ameliorated by the use of automated solid-
phase synthesis. An analogous approach has been developed to make 
oligosaccharide synthesis as routine as DNA synthesis.4 This is achievable, 
despite the huge range of potential carbohydrates possible from the  
10 monosaccharides present in mammalian cells, as it has been calculated that 
to synthesise 80% of mammalian oligosaccharides just 13 modified sugar 
donors are necessary.5 However, when plant and bacterial carbohydrates are 
considered the number of linkages, and hence required building blocks, 
dramatically increases. Seeberger has constructed the first experimental 
oligosaccharide synthesizer able to create more complex oligosaccharides, 
with a larger variety of linkages, much faster than standard synthesis. 6 There 
has been criticism from the synthetic community as the system uses a brute 
force approach to the reactions, without allowing some key linkages or 
functional groups. Most importantly the methods fail to provide the complete 
anomeric control desired, one of the key aspects of carbohydrate structure.5 
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2.2. In vitro enzymatic synthesis of polysaccharides 
In nature glycoside synthesis is carried out by glycosyltransferases and 
transglycosidase, and the cleavage of glycosidic bonds is performed by 
glycoside hydrolases and polysaccharide lyases. These have been thoroughly 
categorised in the CAZy database.7 Theoretically, all the enzymes necessary to 
make all naturally occurring glycans are available from Nature, and could be 
exploited in vitro. However, polysaccharide synthesis is highly complicated and 
uses an enormous array of enzymes. Carbohydrate active enzymes make up 
3% of the Arabidopsis genome8 and all 1167 of these enzymes are needed to 
make the structures in just this one organism. 
Carbohydrate active enzymes have exquisite control over the anomeric 
configuration of the monosaccharides and the linkages involved, providing an 
alternative to synthetic chemistry for precise carbohydrate synthesis. 
Enzymatic reactions are in principle reversible, though this is often not seen in 
Nature.  For example, hydrolases act in such an abundance of water that no 
reverse reaction occurs in nature. This bi-directionality could potentially foil 
attempts to use enzymes, as any synthesis is offset by the degradation of the 
product. The equilibrium must be forced into the direction of synthesis,  
which can be inefficient and wasteful of starting material. Wild-type enzymes 
can be used under artificial conditions to force the synthetic reaction, or 
enzymes can be modified to prevent the undesired reaction.9 
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2.2.1 Glycoside hydrolases 
Glycoside hydrolases hydrolyse the glycosidic bond between carbohydrate 
moieties in an acid/base attack, which can be inverting, if direct attack is by 
water, or retaining, if proceeding via double displacement and a covalent 
sugar-enzyme intermediate (Fig 2.3).10  
 
 
Figure 2.3: Mechanisms of glycoside hydrolases 
A. The catalytic base of inverting hydrolases deprotonates a water molecule and 
the hydroxyl attacks the anomeric carbon. B. In retaining hydrolases the enzyme 
nucleophile attacks the anomeric carbon, forming an acyl-enzyme intermediate. 
The catalytic base deprotonates a water molecule, which then attacks the  
acyl-enzyme bond, inverting the anomeric centre back to the original 
conformation. C. In transglycosidases an enzyme-sugar intermediate is attacked 
by another sugar to form a glycosidic bond.  
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Glycosidases can be used to synthesise polysaccharides by preventing 
hydrolysis, either using very high concentrations of the donor saccharide, so 
that water is outcompeted, or by using activated sugar donors so that the 
glycosyl enzyme intermediate may react with the acceptor molecule faster than 
with water. Cellulase, for example, can be used to form artificial cellulose by 
condensation of β-cellobiosyl fluoride in organic solvent buffer (Fig 2.4.A).11 
The fluorine can readily leave the molecule, making the reaction proceed in the 
synthetic direction. The β-configuration of the fluorine is essential for activity 
and the linkage of the product is precisely controlled by the retaining 
mechanism of the enzyme. The organic solvent is used to exclude water and 
thus to prevent the possibility of the hydrolysis reaction. The purity of the 
cellulase used had a marked effect on the structure of the cel lulose 
macromolecular structure.12 A two enzyme strategy can be  used to control the 
length pf the polymer formed. For example, repeated extension with β-lactosyl 
fluoride followed by de-galactosylation using β-galactosidase, allows only one 
glucose addition per cycle (Fig 2.4.B).13 
 
 
Figure 2.4: Chemoenzymatic syntheses of cellulose 
A. Cellulase can readily remove the fluorine from cellobiosyl fluoride (16) and 
allow attack by the 4OH of a β-glucoside (R= (β-1,4-Glc)n) of the enzyme-sugar 
intermediate to form the β-1,4-glucan product (17). B. Cellulase can also transfer 
lactose from lactosyl fluoride (18). The product (19) is not an acceptor for a 
further transfer, until it has been de-galactosylated using β-galactosidase to 
uncover the glucosyl residue (20), allowing complete control of the product 
length. 
  
 
β 
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For the polymerisation of sugars which have an N-acetyl group at the  
2-position, oxazoline rings can be used as the leaving group, with the opening 
of the ring forming the N-acetyl group.14 For example, artificial chitin was 
synthesised using chitinase to open an oxazoline derivative of the 
disaccharide, controlling formation of the β-anomer (Fig 2.5).15 Crucially the 
reaction proceeded well at pH 10.6, whilst the hydrolysis reaction was 
prevented.  
 
Figure 2.5: Chemoenzymatic synthesis of chitin 
Chitin, a polymer of N-acetyl glucosamine, can be made by the opening of 
chitobiose oxazoline derivative (21) by hydrolytic enzymes, followed by attack of 
the polymer chain to form artificial chitin (22).15   
 
To overcome the problems of hydrolysis using natural enzymes Withers 
introduced the concept of artificial “glycosynthases” (Fig 2.6).16 A 
glycosynthase is a hydrolase in which the catalytic nucleophile is mutated to 
prevent the hydrolytic degradation of the transglycosidation products. The 
activated glycosyl donors are fluorinated compounds, which are readily 
synthesised using standard procedures. This technique uses cheaper starting 
materials and absolutely controls the configuration of the bond formed, whilst 
preventing product degradation.   
 
 
Figure 2.6: Glycosynthases   
If the catalytic nucleophile of a hydrolase is mutated then the enzyme cannot 
attack the sugar. Instead another sugar can be deprotonated by the catalytic 
base and then attack the activated sugar, causing release of the stable leaving 
group (F-) and formation of a new glycosidic bond. 16 
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2.2.2 Glycosyltransferases  
Glycosyltransferases catalyse the transfer of sugars from activated nucleotide 
phosphosugar, sugar phosphate or lipid diphosphosugar donor molecules to 
specific acceptor molecules.17 The reactions are well characterised as either 
retaining or inverting (Fig 2.7).7 
 
Figure 2.7: Mechanisms of glycosyltransferases 
A. In inverting glycosyltransferases, direct attack by the deprotonated acceptor 
on the sugar nucleotide leads to inversion of the anomeric centre.  
B. Nucleophilic attack by retaining glycosyltransferases on the sugar 
phophoester-bond forms an acyl-enzyme intermediate. The acceptor is then 
activated by the catalytic base and attacks the sugar-enzyme bond forming a 
new glycosidic linkage. R = phosphoester such as a nucleotide diphosphate or a 
lipid phosphate. 
 
Nucleotide phosphosugar cleavage, during glycosyltransferase activity,  
is strongly favoured, such that these enzymes show very little reverse 
reaction.18 However, if a high energy glycoside is used the enzymes can be 
driven in reverse to efficiently synthesise sugar nucleotides.19  
Unfortunately, glycosyltransferases are mostly integral membrane proteins 
(>70% in Arabidopsis and >85% in humans) and so are not accessible for in 
vitro reactions. Additionally, the activated glycosyl donors are often expensive 
and unstable, and the glycosyltransferases have a tendency towards product 
inhibition. To combat inhibition by the nucleotide released from glycosyl 
transfer, a phosphatase can be used to hydrolyse the nucleotide, which 
provides a large increase in yield (Fig 2.8.A).20 
  
 
 
 
Figure 2.8: Enhancing the yields of glycosyltransferases 
A. Addition of a phosphatase to the transfer of Gal from UDP-Gal (23) on to 
GlcNAc (24) improved the overall yield of LacNAc (25) from below 60% to over 
90%.20 B. Catalytic amounts of UDP can be used to drive the transfer of 
galactose from galactosyl fluoride (26) on to a galactose acceptor (27) to form 
the α-1,4-galactan (28).21 C. Hyaluronic acid (34) was made by generating the 
sugar nucleotides in situ. The UDP-GlcNAc (32) was generated from UTP and  
GlcNAc-1-P (33), using GlcNAc pyrophosphatase (GlcNAcPPAse), driven by the 
degradation of the released pyrophosphate, by inorganic pyrophosphatase 
(PPAse). The UDP-GlcA (31) was made by first generating UDP-Glc (30) from 
Glc-1-P (29) and UTP, using UDP-Glc pyrophosphatase (UDPGlcPPAse), and 
then oxidising, using NAD and UDP-Glc dehydrogenase (UDPGlcDH). The NAD 
was regenerated using lactate dehydrogenase (LacDH) and pyruvate, and the 
UTP was regenerated by pyruvate kinase (PK), converting phosphoenolpyruvate 
into pyruvate. 22 
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Alternatively catalytic quantities of UDP can be used to prevent the product 
inhibition, and also to reduce the use of expensive substrates. This technique 
has been used to enhance the transfer of galactose form the anomeric fluoride 
on to galactosides by α-galactosyltransferase, with decreased use of 
nucleotide and reduced inhibition (Fig 2.8.B).21 Hyaluronic acid has been 
prepared using hyaluronic acid synthase and a series of other enzymes to 
regenerate sugar nucleotides, using energy derived from phosphoenolpyruvate 
(Fig 2.8.C).22 These regenerative enzymes reduce the requirement for 
expensive starting materials and greatly increased the yield from 20% to 90%. 
Although some glycosyltransferases can be relatively non-specific towards 
donor and substrate, such as the natural product glycosyltransferases,23 many 
have strict donor specificity which limits the carbohydrates that can be 
synthesised. The human ABO blood group antigen is a carbohydrate found on 
the surface of many cells, notably red blood cells. The A antigen terminates in 
an N-acetyl-galactosamine, whilst the B type terminates in a galactose, both 
linked α-1,3 to the same core antigen (Fig 2.9). This difference in specificity is 
determined by four amino acids in the glycosyltransferase and exchange of 
these converted the antigen produced.24 Glycosyltransferase specificity can 
readily be altered or relaxed using molecular biology, opening up the range of 
potential oligosaccharides that can be synthesised.25 Further studies of these 
enzymes should enhance their use in the chemoenzymatic synthesis of 
carbohydrates. 
 
Figure 2.9: Human ABO blood group antigens 
The A antigen (35) has GalNAc, whilst the B antigen (36) has Gal, and the  
O antigen (37) has no additional monosaccharide, on the 3 hydroxyl of the  
H antigen core. 
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2.2.3 Polysaccharide lyases 
Polysaccharide lyases cleave sugars by deprotonation of glycosides, resulting 
in unsaturated sugars. The most common mode of action is the β-elimination 
reaction on the C5 of a six carbon carboxylate sugar, releasing a  
4,5-unsaturated sugar (Fig 2.10.A). A neutral polysaccharide lyase has also 
been characterised, which acts on α-1,4-glucans with a similar mechanism to 
the inverting hydrolases (Fig 2.10.B).26 Instead of deprotonating a water 
molecule to attack the sugar-enzyme intermediate, it is proposed that H2’ is 
removed and a double bond formed which eliminates the enzyme-sugar bond, 
forming 1,5-anhydro-fructose. 
 
Figure 2.10: Mechanisms of polysaccharide lyases 
A. In uronic acid lyases the catalytic base removes the proton alpha to the 
carboxyl, forming an enolate. When this reverts to the carbonyl a double bond is 
formed between carbons four and five, and the glycosidic bond is eliminated in 
an E1cB type reaction. B. In α-1,4-glucan lyases a sugar-enzyme bond is 
formed, in a similar way to retaining hydrolases, and the bond is eliminated by 
the formation of a double bond, with loss of the proton on C2. 
 
Polysaccharide lyases are used in biotechnology to remove or remodel 
polysaccharides and to release specific oligosaccharides.27 There is no current 
use in the synthesis of polysaccharide by reversing the enzyme reaction, 
though in principle this is possible. 
 
  
Linkage Name CAZy 
Family  
Type Polymer 
length 
EC Ref Ref 
α,α-1,1 Trehalose GH65 I 2 2.4.1.64 28 28 
α,α-1,1 Trehalose-6-P GH65 I 2 2.4.1.216 29 29 
α,α-1,1 Trehalose GT4 R 2 2.4.1.231 30 30 
α-1,2 Kojibiose GH65 I 2+ 2.4.1.230 31 31 
α,α-1,2 Sucrose GH13 R 2 2.4.1.7 32 32 
β-1,2 β-1,2-Glucan GH94 I NA 2.4.1.- 33 33 
α-1,3 Nigerose GH65 I 2 2.4.1.279 34 34 
α-1,3 Glucosyl-
rhamnose 
GH65 I 2 2.4.1.282 35 35 
β-1,3 Laminaribiose GH94 I 2 2.4.1.31 36,37 36,37 
β-1,3 Laminarin ??? I 2+ 2.4.1.30 38 38 
β-1,3 β-1,3-Glucan ??? I 2+ 2.4.1.97 39,40 39,40 
β-1,3 Galactosyl-
HexNAc 
GH112 I 2 2.4.1.211 41,42 41,42 
β-1,3 Galactosyl-
rhamnose 
GH112 I 2 2.4.1.- 43 43 
α-1,4 Glycogen/ starch GT35 R 4+ 2.4.1.1 44,45 44,45 
α-1,4 Maltose GH65 I 2 2.4.1.8 46 46 
α-1,4 Maltosyl GH13 R 6+ 2.4.1.169 47 47 
β-1,4 Cellobiose GH94 I 2 2.4.1.20 48 48 
β-1,4 Cellodextrin GH94 I 2+ 2.4.1.49 49 49 
β-1,4 Mannosyl-glucose GH130 I 2 2.4.1.281 50 50 
β-1,4 Mannan  GH130 I 2+ 2.4.1.- 51 51 
β-1,4 Chitobiose GH94 I 2 2.4.1.280 52 52 
Table 2.1: Classification of phosphorylases so far characterised  
Type R = retaining, I = Inverting. NA = has not been defined  
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2.3 The natural role of phosphorylases 
Of particular interest in the context of this thesis are the glycoside 
phosphorylases. Phosphorylases have the required stereo- and 
regioselectivities to allow their use in synthesising specific glycosyl linkages. 
Exploiting the reverse reaction of phosphorylases can be utilised to synthesise 
polysaccharides53 and the sugar-phosphates are both more stable and more 
readily attained than nucleotide phosphosugars.  
The currently characterised phosphorylases are soluble glycosyltransferases 
which catalyse the reversible addition of phosphate across the glycosidic bond 
(phosphorolysis), in the following reaction:54  
(Glycose)n+1 + Orthophosphate  (Glycose)n + Glycose-1-P 
Phosphorylases have been found for many diverse linkages but most act on 
glucosyl residues (Table 2.1). Replacement of the inorganic phosphate with 
arsenate releases an unstable sugar-arsenate, which readily decomposes to 
the free monosaccharide.55  
The mechanism can be inverting or retaining, which is determined by the 
enzyme’s reaction mechanism and CAZy family. The configurations of the 
linkage and sugar phosphate produced are related by this interconversion. A 
range of specific phosphorylases have been identified54 and there is now a 
characterised diglucose phosphorylase for every linkage except β-1,1 and α- or 
β-1,6 (Fig 2.11). 
 
Figure 2.11: Diglucose linkages for which phosphorylases are found in Nature 
Trehalose (α,α-1,1-glucosyl-glucose) (38). Kojibiose (α-1,2-glucosyl-glucose) (39). 
Sophorose (β-1,2-glucosyl-glucose) (40). Nigerose (α-1,3-glucosyl-glucose) (41). 
Laminaribiose (β-1,3-glucosyl-glucose) (42). Maltose (α-1,4-glucosyl-glucose) (43). 
Cellobiose (β-1,4-glucosyl-glucose) (44). 
  
 
 
Figure 2.12: Trehalose metabolism using phosphorylases 
A. Trehalose (38) is phosphorolysed by inverting phosphorylases from GH65 to form β-Glc-1-P (45) and Glc (2) which are converted into  
Glc-6-P (47) by β-phosphoglucomutase and hexokinase respectively.56 B. Trehalose (38) can be phosphorylated to trehalose-6-phosphate (46) 
by trehalose kinase before being phosphorolysed by an inverting phosphorylase yielding Glc-6-P (47) and β-Glc-1-P (45), which is converted 
into Glc-6-P (47) by β-phosphoglucomutase.29 C. Retaining trehalose phosphorylase from family GT4 can convert trehalose (38) to α-Glc-1-P 
(29) and Glc (2), which are converted to Glc-6-P (47) by phosphoglucomutase and hexokinase respectively.57  
β 
β 
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2.3.1 α-1,1-Glucan phosphorylases 
2.3.1.1 Inverting trehalose phosphorylase 
Trehalose is used in a variety of different roles including energy storage,58  
in abiotic stress responses59 and for osmoregulation60 and can accumulate  
to very high levels in a variety of organisms.61 Euglena gracilis has an enzyme 
which shows phosphorolytic activity towards trehalose56 and promiscuity 
towards the 6 position in the reverse reaction (Fig 2.12.A).62 No sequencing 
data is available but the activity was also identified in bacteria, including plant 
symbionts63 and thermophiles,28 and assayed for the production of a variety  
of disaccharides.28  
2.3.1.2 Trehalose-6-phosphate phosphorylase 
Many acid bacteria phosphorylate the trehalose and then use  
trehalose-6-phosphate phosphorylase29 to release β-Glc-1-P and Glc-6-P into 
the hexose phosphate pool (Fig 2.12.B).64 
2.3.1.3 Retaining trehalose phosphorylase 
An alternative trehalose phosphorylase was identified in Flammulina velutipes 
which is retaining, and thus produces α-Glc-1-P (Fig 2.12.C).30 This enzyme 
has since been found in many other fungi.57 
2.3.2 α-1,2-Glucan phosphorylases 
2.3.2.1 Kojibiose phosphorylase 
In nature kojibiose is found in honey65 and in Leuconostoc dextran,66 whilst the 
oligomer is produced by Rhizobium.67 It is also part of the core antigen  
of Moraxella catarrhalis, currently under investigation as a vaccine candidate.68  
A phosphorylase was isolated from Thermoanaerobium brockii which was 
capable of degrading kojibiose to yield β-Glc-1-P.31 Kojibiose phosphorylase 
was also capable of the reverse reaction transferring more than one glucose 
moiety to make kojioligosaccharides,69 and the enzyme from 
Caldicellulosiruptor can be used for the synthesis of longer oligosaccharides.70 
Mutagenesis and chimerisation with the trehalose phosphorylase from the 
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same organism allowed even longer polymers to be formed.71 The enzyme 
strictly transferred on to glucose configured sugars but allowed either anomeric 
configuration and any glucoside tested.31 This allowed the enzyme to be used 
in the addition of glucose to a cyclic α-glucan.72  
2.3.2.2 Sucrose phosphorylase 
Sucrose is a common plant sugar  and a specific phosphorylase is found in diverse 
bacteria, such as Leuconostoc mesenteroides,73 where it catalyses the 
phosphorolysis of sucrose, releasing α-Glc-1-P and fructose.32 This enzyme is a 
member of GH13 and has been used for the in vitro transfer of glucose on to 
various sugars74 and phenolics.75  
2.3.3 β-1,2-Glucan phosphorylases 
Certain bacteria including Rhizobia76 and Brucella77 synthesise cyclic  
β-1,2-glucans as osmoregulators in their cell walls, which are necessary for 
virulence.78 The synthesis of these compounds proceeds at the cell membrane 
by initial autoglucosylation of the enzyme,79 extension of the growing chain and 
cyclisation once the chain reaches the appropriate length. This length control is 
mediated by the C-terminal of the protein, which is an inverting phosphorylase 
in the GH94 family.33 To date, this domain has not been explored for the 
synthesis of oligosaccharides. 
2.3.4 α-1,3-Glucan phosphorylases 
2.3.4.1 Nigerose phosphorylase 
Recently an enzyme which degrades α-1,3-glucosyl glucose was identified in 
Clostridium phytofermentans and has been characterised as nigerose 
phosphorylase.34 α-1,3-Glucan polymers are found in fungal cell walls80 and 
this is presumably the source of the natural substrate for this enzyme. The 
enzyme shows some activity towards kojibiose and can transfer on to some 
other monosaccharides, though only transfers one glucose residue.   
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2.3.4.2 Glucosyl-rhamnose phosphorylase 
α-1,3-Glucosyl rhamnose phosphorylase was58 identified in Clostridium 
phytofermentans.35 This structure is found in plant and bacterial cell walls and, 
based on the presence of this enzyme, is postulated to be in this organism’s 
capsule, with the phosphorylase having some role in cell wall recycling. 
2.3.5 β-1,3-Glycan phosphorylases 
2.3.5.1 β-1,3-Glucan phosphorylases 
β-1,3-Glucans are used in some algae, including Euglena and brown algae, as 
the major storage carbohydrate81 and make up the cell walls of certain fungi, 
including yeasts and Basidiomycetes.82 β-1,3-Oligoglucan phosphorylases are 
categorised in three sub groups based on substrate preferences. Laminaribiose 
phosphorylases (EC 2.4.1.31) were first discovered in Euglena gracilis36 and 
related algae83 and strict disaccharide phosphorylases have recently been 
identified in  bacteria and assigned to GH94.37,84 Laminarin phosphorylase  
(EC 2.4.1.30)38 and β-1,3-glucan phosphorylase (EC 2.4.1.97) have also been 
identified with preferences for longer glucans.39,40 The Euglena enzyme has 
been purified and analysed,85 though no sequence data is available.  
This enzyme has proved useful in the synthesis of cell wall related 
oligosaccharides, including mixed linkage β-glucans,86 and for the extension of 
other sugars, such as galactose and glucosamine.38 
2.3.5.2 Galactosyl-HexNAc phosphorylase 
Human mucin87 and milk88 contains complex oligosaccharides which are 
degraded by intestinal bacteria, in part by hydrolysis, but also by 
phosphorolysis.41 These enzymes release Gal-1-P from Gal-β-1,3-GlcNAc or 
Gal-β-1,3-GalNAc42 and belong to GH112.89 An additional enzyme has been 
identified which, in the reverse reaction, transfers galactose on to rhamnose more 
efficiently, leading to its proposed identification as galactosyl-rhamnose 
phosphorylase.43 This carbohydrate structure is found in the cell walls of plants, 
such as Tanacetum vulgare,90 and bacteria, including certain Klebsiella,91 and these 
may represent the natural substrates. 
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2.3.6 α-1,4-Glucan phosphorylases  
2.3.6.1 α-1,4-Glucan phosphorylases 
α-1,4-Glucan phosphorylases are present in all classes of organism from 
bacteria (maltodextrin phosphorylase) to animals (glycogen phosphorylase) 
and plants (starch phosphorylase). Structural studies of the mammalian,92 
bacterial93 and yeast94 glycogen phosphorylases identify them as members of 
GT35 family of retaining phosphorylase. Uniquely among the phosphorylases, 
they require a pyridoxal phosphate prosthetic group to stabilise the inorganic 
phosphate.95  
Their function in nature appears to be in metabolism of glucose storage 
molecules, though they all have slightly different specificity for chain length and 
branching frequency, as expected for their different substrate specificities.  
The mammalian enzyme is used in the release of energy stored as glycogen 
and, thus, is implicated in diabetes. As such, many inhibitors have been 
studied.96  
All plants have at least two forms of starch phosphorylase, localised in the 
chloroplast (PHS1) and the cytoplasm (PHS2). In the plastid the phosphorylase 
has been ascribed to starch degradation, although there is no direct in vivo 
evidence. Mutations in rice results in severely reduced starch content and 
altered amylopectin structure, suggesting a role in starch synthesis. 97 
2.3.6.2 Maltose phosphorylase 
Maltose phosphorylase (EC 2.4.1.8) was initially identified from Neisseria as an 
enzyme which degrades maltose to β-Glc-1-P and Glc.46 It was found to act 
exclusively on the disaccharide98 and was reasonably promiscuous towards the 
acceptor monosaccharide.99 The disaccharide formed during reverse 
phosphorolysis can be altered to kojibiose and trehalose by the engineering of a 
specific loop.100 
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2.3.6.3 Maltosyl phosphorylase 
An enzyme was identified in Mycobacterium which catalysed the transfer of maltose 
from α-maltose-1-P on to glycogen.47 Maltosyl phosphorylase is the only known 
naturally synthetic phosphorylase and mutations are lethal in Mycobacterium, 
suggesting this as a potential therapeutic target.101 The structure of this enzyme 
shows a large carbohydrate binding cleft, indicating limited substrate flexibility.102 
2.3.7 β-1,4-Glycan phosphorylases 
2.3.7.1 β-1,4-Glucan phosphorylases 
Cellulose represents an enormous source of energy but is exceptionally difficult to 
access. Many microbes have developed sophisticated capabilities for degrading this 
recalcitrant compound, including direct oxidation103 and the bacterial multi-
component cellulosomes.104 The cellodextrins released by cellulose hydrolases can 
be imported directly into cells,105 where they are further broken down, either by 
hydrolysis to glucose and cellobiose, or by phosphorolysis to α-Glc-1-P.49 The 
cellobiose can be phosphorolysed by cellobiose phosphorylase, releasing Glc and 
α-Glc-1-P.48 Alternatively cellobiose can be epimerised, by cellobiose 2’-epimerase, 
to glucosyl-mannose before hydrolysis, releasing Glc and Man.106  
2.3.7.2 β-1,4-Mannan phosphorylases 
Plant cell walls also contain large amounts of hemicellulose including  
β-1,4-mannan. This is structurally related to cellulose and can be hydrolysed to 
mannodextrins and mannobiose. These can be directly phosphorolysed by 
mannan phosphorylase or mannobiose phosphorylase, respectively.51 
Mannobiose can also be epimerised, by cellobiose 2-epimerase, to mannosyl-
glucose which can subsequently be phosphorolysed, releasing α-Man-1-P and 
Glc.50  
2.3.7.1 Chitobiose phosphorylase 
Chitin has the same linkage as cellulose, composed of a homopolymer of  
β-1,4-GlcNAc. Vibrio degrades chitin extracellularly to GlcNAc and chitobiose,  
which is imported into the cell,107 where it can be degraded by hydrolysis or by 
phosphorolysis to release GlcNAc-1-P.52  
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2.4 Conclusions on the in vitro synthesis of 
polysaccharides 
Polysaccharides are incredibly complex in structure and do not yield to modern 
sequencing technologies. Modern mass spectrometry based techniques, 
including cross ring fragmentation and MSn,108 are facilitating structural 
analysis, but are restricted to highly skilled specialists working on dedicated 
analytical projects. This has left glycomics somewhat out in the cold in the 
modern genomics era. However, we now understand the basis of natural 
carbohydrate synthesis and the exquisite control imposed on the structures. 
The unexpected requirement for degradative enzymes during synthesis, for 
example in starch biosynthesis109 and glycoprotein processing,110 adds another 
aspect to the complexity.  
The heterogeneity of polysaccharides purified from natural sources makes 
them unsuited to use in advanced technologies, such as pharmaceuticals and 
nanotechnology. With the knowledge of natural structures and biosynthesis, 
well defined carbohydrates have begun to be synthesised in vitro. Various 
chemical methods have been utilised to produce carbohydrates of well 
characterised structure and with the stereochemistry required. Natural 
enzymes have also been used to synthesise polysaccharides from natural 
substrates, although the cost of the substrates and the low yields currently 
limits their use. Modified enzymes and modified substrates have reduced these 
drawbacks and allowed the production of a wider range of oligosaccharides.  
Phosphorylases can avoid some of these drawbacks and are beginning to be 
employed in the production of polysaccharides with defined structures and 
sizes. With the application of molecular biology to the enzymes involved, the 
potential structures available are almost unlimited. As synthetic 
oligosaccharides become available new drugs, medical tests and materials can 
be developed.  
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Chapter 3 – PHS2 – an α-1,4-glucan phosphorylase 
3.1. Introduction 
3.1.1 α-1,4-Glucans 
Starch is the highest single calorie contribution to the human diet with a global 
requirement, for both food and industrial uses, running at several billions of tonnes. 
Production needs to double by 2050 when the global population is predicted to be 
over 9 billion. There is also increasing demand for starch as a renewable feedstock 
in industry, particularly for the production of biofuels.1 The volatility in grain prices 
continues to cause unrest around the world and, with climate change producing 
unpredictable effects, this volatility is only likely to worsen. Increases in agricultural 
land will not be able to provide stable growth in production, so substantial 
improvements in crop yield are required.2 
 
 
 
Figure 3.1: Structure of the starch granule 
The α-1,4-glucans contain some α-1,6-branches (48) which place them parallel to 
each other, allowing double helix formation. The branches are specifically placed to 
give regions of branching, known as amorphous lamella, and regions of exclusively 
linear chains which form crystalline lamella, and these lamella form specific growth 
rings. Adapted from, Food, The Chemistry of its Components, Tom Coultate with 
permission from the Royal Society of Chemistry. Copyright (2002).3 
48 
  
 
 
 
Figure 3.2: Starch granule metabolism 
Glc-6-P from photosynthesis or metabolism is converted to Glc-1-P  
by Phosphoglucomutase (PGM) and AMP is added by ADP-Glucose 
Pyrophosphorylase (AGPase). The glucose is transferred on to the growing chain  
of the starch granules by soluble Starch Synthase (sSS) and Granule Bound Starch 
Synthase (GBSS) and branches are added by Starch Branching Enzyme (SBE). 
Degradation of the starch granule in the transitory starch granules is by initial 
phosphorylation, catalysed by Glucan Water Dikinase (GWD) and Phosphoglucan 
Water Dikinase (PWD), allowing attack of the granule, though amylases are not 
necessary. The storage granule is directly attacked by α-amylases (AMY) which 
releases branched chains, although mutants in all three isoforms have normal 
starch metabolism.4 These branched glucans are debranched by Isoamylases (ISA) 
and Limit Dextrinase (LD). Linear glucans are degraded to release: Glc-1-P  
by phosphorylase (PHS1); maltose by β-amylase (BAM); and glucose, either by  
α-Glucosidases (α-Glcase) or by disproportionation of maltotriose by DPE1. The 
number of isoforms of each enzyme in Arabidopsis is indicated in the transitory 
starch diagram.5 
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Starch granules are made of α-1,4-glucans with α-1,6-branches to give long chains 
stacked side by side, which form alternating layers of highly ordered liquid 
crystalline lamella interspersed with amorphous regions (Fig 3.1).6 This makes the 
surface of a starch granule highly resistant to enzymatic attack, requiring 
specialised enzymes, such as α-amylase, to initiate degradation.  
The source of starch can have marked effects on the properties important for 
industrial uses. For instance, cereal starch is virtually phosphate free, whilst potato 
starch has high phosphate content, with increased viscosity and decreased 
retrogradation, factors important in the paper industry.7 Starches may also need to 
be modified in a number of ways, including degradation, esterification and oxidation, 
although this is costly and potentially hazardous. Production of modified starches  
in planta is therefore an attractive alternative.8 For example, the gelatinisation 
properties of the starch can be altered by changing the ratio of linear amylose to 
branched amylopectin using genetic engineering.9,10 
In order to engineer precisely controlled starches we need to understand the 
biosynthetic enzymes involved, and insights are provided by continued research in 
the model plant Arabidopsis.5 There are multiple enzymes needed to form the 
correct morphology of the starch granule, and the precise role of many isoforms is 
poorly understood (Fig 3.2).11,12 For example, the synthesis of correct starch 
granules counter intuitively requires two paralogues of the degradative isoamylases, 
which form a complex.13 Storage starch is stored in the amyloplasts of specialised 
storage organs, such as the grain or tuber, whilst transitory starch is stored in the 
leaf chloroplasts, as a carbon source for photosynthetic cells at night. The two 
plastids use different suites of enzymes to attack the starch granule.14 In the storage 
organs the granule is enzymatically hydrolysed,15 ultimately releasing glucose.  
In photosynthetic organs the transitory starch granule is initially phosphorylated by 
specific glucan kinases, before being broken down into short 
maltooligosaccharides.16 There are many isoforms of each enzyme involved in 
starch synthesis and breakdown, but to date the differences in enzymology are 
interpreted based upon their gene and protein expression, rather than enzyme 
activity.  
. 
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The enzymology of the starch granule actually takes place at a solid-liquid interface, 
rather than the solution phase used in most experiments. This can have profound 
effects on the reaction; for example the reaction rate of granule-bound starch 
synthase is enhanced on crystalline amylopectin.17 There are few studies involving 
crystalline maltodextrins18 or purified starch granules,19 but even these measured 
discreet product formation, not breakdown of the starch granule. Electron 
microscopy clearly shows that the initial attack on the surface alters the granule  
(Fig 3.3),20 undermining endpoint kinetic assessments. Direct monitoring of purified 
starch granules during degradation, either using electron microscopy21 or 
synchrotron radiation,22 provides snapshots of these processes during the 
degradation of the granule. 
 
Figure 3.3: Surface changes upon enzymatic degradation of starch granules 
Scanning electron micrographs of maize starch granules after hydrolysis by 
Aspergillus fumigatus alpha-amylase. A. High-amylose. B. Normal. C. Waxy.  
Bars correspond to 1 µm. Reproduced from the Journal of Cereal Science with 
permission from Elsevier. Copyright (1995).21 
 
To study starch surface biochemistry, it is necessary to monitor what is happening 
to the starch substrate, rather than the released product, in real time. In order to do 
this a well-defined starch-like surface, with continuous measurement, is required. 
  
Figure 3.4: Proposed products formed using α-1,4-glucan phosphorylases 
A. Phosphorylases were used to extend various maltooligosaccharide grafted 
compounds to form, for example, amylose grafted chitosan (49),23 polystyrene (50)24 
and HPLC matrix (51).25 B. Phosphorylase could transfer various sugars from their 
respective anomeric phosphates on to acceptors. 2-Deoxyglucans were synthesised 
from D-glucal (52),26 which can then be phosphorolysed to synthesise  
2-deoxy-α-Glc-1-P,27 and 3- and 4-deoxy and fluoro-D-glucose were transferred on 
to glycogen (53-56) by rabbit muscle enzyme.28 Potato phosphorylase has been 
used to transfer D-xylose (57),29 D-mannose (58),30 D-glucosamine (59)31 and  
N-formyl-D-glucosamine32 (60) from their respective phosphates on to 
maltotetraose.  Thermostable phosphorylase catalysed the transfer of D-glucuronic 
acid on to maltotriose(61).33 
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3.1.2 The in vitro use of α-1,4-glucan phosphorylases 
α-1,4-glucan phosphorylases represent a readily controllable system for the 
synthesis of extended amylose chains. Mammalian glycogen phosphorylases (GP) 
have been heavily studied, particularly with reference to their role in  
type II diabetes34 and cancer35 in humans, and a wide range of inhibitors have been 
tested which bind to several different sites on the enzyme, including the catalytic 
site, the allosteric site and the caffeine binding site.36 They have proven less useful 
in biotechnology than plant phosphorylases because of the allosteric regulation, 
absent from the plant enzyme.37  
α-1,4-Glucan phosphorylases have been used to synthesise many different glucan 
based molecules38  both by extension of a covalent acceptor, such as 
maltoheptaose immobilised on chitosan23 or polystyrene24 (Fig 3.4.A), or by twining 
polysaccharides around a hydrophobic core to form a macromolecular complex, 
such as amylose-wrapped lipid.39 These enzymes have allowed the production of 
hybrid materials such as a novel HPLC matrix, based on extension of 
maltoheptaose immobilised on silica,25 and soluble single-walled carbon nano-
tubes, insulated by wrapping with amylose helices.40  
Phosphorylases also display some promiscuity towards the donor substrate.  
2-Deoxy-maltooligosaccharides26 have been synthesised from D-glucal in the 
presence of Pi, which can then be phosphorolysed to synthesise  
2-deoxy-α-glucose-1-phosphate (Fig 3.4.B). Deoxy- and fluoro-glucose could be 
transferred on to glycogen by phosphorylase, but with a very low yield.28 Alternative  
sugar-1-phosphates can be utilised including xylose,29 mannose,30 glucosamine,31 
N-formyl-glucosamine32 and glucuronic acid,33 although the products were all 
isolated after a single residue extension, indicating these sugars are not bound in 
the acceptor site of the enzyme for further extension. 
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3.1.3 Rationale 
Many physiologically important enzymatic reactions occur on surfaces and their 
analysis is not trivial. A range of techniques have been developed for monitoring 
enzymatic reactions on surfaces, including mass spectrometry, fluorescent and 
radioactivity based assays.41 Whilst it has been possible to detect glycosylation 
reactions on surfaces using surface plasmon resonance spectroscopy (SPR),  
this has typically been by alterations in lectin binding.42 Recently direct 
measurement of polysaccharide synthesis on SPR surfaces has been achieved.43,44 
All the enzymes to which these techniques have been applied naturally use soluble 
substrates and act in solution. Any kinetic analysis, therefore, has to take into 
account the unnatural nature of the surface immobilised substrates. Starch-active 
enzymes would benefit markedly from studies using immobilised substrates which 
mimic the insoluble surface upon which they naturally act. It was hoped that by 
combining techniques for monitoring enzymatic reactions on surfaces a quantifiable 
starch-like surface could be generated to study starch enzymology. 
Crystalline amylose is required to mimic the starch granule surface. It is known that 
when amylose is synthesised in solution a crystalline structure can be formed.45 
Working on surfaces, crystalline material could be seen by electron microscopy 
imaging of glycogen particles extended using amylosucrase46 and measurement of 
the kinetics of phosphorylase-catalysed amylose synthesis was achieved using 
quartz crystal microbalance.47 Gold nanoparticles can be used to simultaneously 
display and provide visual output of carbohydrate interactions,48,49  using the same 
physical and chemical properties as SPR. These techniques were used to provide 
the basis for the development of approaches based on glucan-coated SPR 
biosensors and gold nanoparticle surfaces for the generation of enzyme-extended 
glucan surfaces that may be deployed for the assessment of starch-active enzymes. 
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3.2 Cloning, expression and purification of PHS2 
PHS2, the cytosolic α-1,4-glucan phosphorylase, was cloned from Arabidopsis 
thaliana Col0 cDNA into pET151 using the TOPO cloning method. This inserts a 
hexahistidine tag and a V5 epitope beyond a TEV protease cleavage site on the N-
terminus of the protein. The protein was successfully expressed in E. coli Rosetta2 
cells and purified using nickel affinity chromatography and gel filtration (GF) to 
provide pure protein (Fig 3.5). SDS-PAGE and dynamic light scattering (DyLS) both 
demonstrated the monodispersity and purity of the protein and proteomic analysis of 
the purified protein confirmed it was indeed PHS2. The DyLS and GF gave a 
molecular weight in agreement for the calculated molecular weight for a dimer of 
PHS2 of 198 kDa.  
 
Figure 3.5: Purification of PHS2 from E. coli 
A. SDS-PAGE of protein purification. Lane 1:  Kaleidoscope protein standards (Bio-
Rad), Lane 2: total cell extract, Lane 3: insoluble cell material, Lane 4: soluble cell 
lysate, Lane 5: purified protein, showing a single band running just under 100 kDa. 
B. Gel filtration shows a single peak eluting around 108 ml, which on a Superdex 75 
gives a predicted Mw > 150 kDa when compared to standards shown (vitamin B12 – 
1.355 kDa, aprotinin – 6.5 kDa, cytochrome C – 12.4 kDa, ribonuclease A –  
13.7 kDa, myoglobin – 17.6 kDa, carbonic anhydrase 29 kDa, albumin 66 kDa and 
alcohol dehydrogenase – 150 kDa. C. Dynamic Light Scattering shows that protein 
is present as monodisperse species with a radius of 6.0 nm, correlating to a 
molecular weight of 221kDa. D. Sequence of PHS2, with artificial tag in blue, and 
peptides identified in MALDI-ToF spectrum after tryptic digestion in red. 
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3.3 PHS2 activity in solution 
3.3.1 Activity assays 
3.3.1.1 Optimal conditions for PHS2 activity 
To assay the enzyme kinetics of PHS2 the amount of phosphate (Pi) released upon 
transfer of Glc from Glc-1-P on to acceptor glucans was measured. The optimum 
conditions for the enzyme were assayed using standard reactions performed over a 
range of temperatures and pHs. The temperature optimum was found to be 50 °C 
and the optimum pH was found to be 6.0 for the synthetic reactions of PHS2  
(Fig 3.6). 
 
Figure 3.6: Optimum conditions for PHS2 activity  
All reactions measured the release of phosphate from Glc-1-P (10 mM) in the 
presence of maltopentaose (1 mM) by PHS2 (8 μg/ml). Maximum activity (∆) was at 
pH 6.0 (100 mM Tris, MES, citrate) at 37 °C, and at 50 °C in MES (20 mM, pH 6.0). 
No release of phosphate is observed in the absence of enzyme (◊) across the pH 
range tested and for the temperature experiments a no-enzyme control was 
subtracted from the values obtained with the enzyme. pH variation was performed in 
a mixed buffer (0.1 M Tris, MES, citrate) pH determined to 0.02 units at 21 °C. 
Temperature variation was performed in a thermocycler (GStorm) in MES (20 mM, 
pH 6.0 measured at 21 °C). 
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3.3.1.2 Inhibitors of PHS2 
Molybdate, a critical component of the activity assay, and acarbose, a known 
inhibitor of the E. coli α-1,4-glucan phosphorylase,50  were assessed for their ability 
to inhibit PHS2 by measuring release of Pi from Glc-1-P by PHS2 in the presence of 
(α-1,4-Glc)7 (Fig 3.7). Molybdate was a weak inhibitor for PHS2, with an IC50  
(1.4 ± 0.05 mM) well below the concentration used in the phosphorylase activity 
assay (200 mM), confirming this will stop the reaction. Acarbose was found to be a 
good inhibitor of PHS2 (IC50 = 1.3 ± 0.2 µM). 
 
 
Figure 3.7: Inhibition assays of PHS2  
Molybdate, a critical component of the activity assay, was first assessed for its 
ability to inhibit PHS2 by measuring release of Pi from Glc-1-P (10 mM)  
by PHS2 (2.5 µg/ml) in the presence of (α-1,4-Glc)7 (1 mM) in MES buffer  
(200 mM, pH 7.0) at 21 °C. Acarbose was then assessed as an inhibitor  
by measuring the release of Pi from Glc-1-P (1 mM) in the presence of (α-1,4-Glc)7  
(1 mM) in MES buffer (20 mM, pH 6.0) by PHS2 (5 µg/ml) at 21 °C. 
 
3.3.1.3 Kinetic parameters of PHS2 
To determine apparent KM values, reactions were performed under standard 
conditions, varying one substrate at a time (Fig 3.8). After 20 min the reactions were 
terminated by the addition of equal volumes of aqueous ammonium molybdate 
solution (400 mM), which had been confirmed to stop the reaction completely. Using 
maltoheptaose (1 mM) as the acceptor the KM
app
 for Glc-1-P was determined to be  
3.9 ± 0.5 mM.  
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Figure 3.8: Kinetic analysis of PHS2 
Experiments were conducted in 12.5 μl MES buffer (20 mM, pH 6.0) at 21 oC using 
8 μg/ml PHS2. Experiments were performed in triplicate in the range 0.1-10 mM 
Glc-1-P, using 1 mM (α-1,4-Glc)7.  
The specific activity for heterologously expressed PHS2 in the synthetic direction, 
measuring the phosphate released from Glc-1-P, under optimum conditions,  
was measured as 18 µmol/min/mg, giving a turnover number of 30 per second. This 
is similar to the rabbit muscle enzyme (25 µmol/min/mg)51 and an order of 
magnitude faster than starch synthases (0.1-3 µmol/min/mg),52,53 which have been 
considered for similar studies. This is also 2-3 times faster than the degradative 
reaction of Arabidopsis PHS2 measured by Lu et al. (6-8 µmol/min/mg).54  
The optimum acceptor length was assayed by measuring KM
app for different length 
maltooligosaccharides (Table 3.1). KM
app decreases as acceptor length increases, 
leading to faster turnover, despite the decrease in the Vmax. This indicates that for 
longer glucans there are more favourable binding sites along the active site cleft. 
The minimum acceptor length for glucosylation, as for most enzymes of this class, 
was found to be (α-1,4-Glc)4,
55 an important consideration when using this enzyme. 
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Acceptor KM
app
 (mM) kcat  (1/s) kcat /KM
 app
 (1/mM/s) 
maltotriose – (α-1,4-Glc)3 NA NA NA 
maltotetraose – (α-1,4-Glc)4 2.0 ± 0.94 25 ± 6.2 12.5 
maltopentaose – (α-1,4-Glc)5 1.1 ± 0.43 16 ± 2.8 14.5 
maltohexaose – (α-1,4-Glc)6 1.0 ± 0.26 18 ± 2.0 18.0 
maltoheptaose – (α-1,4-Glc)7 0.24 ± 0.05 15 ± 1.0 62.5 
Table 3.1: Acceptor length specificity of PHS2  
NA indicates less than 1% turnover in 20 min. See Section 8.2.3 for assay details. 
 
3.3.2 Carbohydrate electrophoresis 
Carbohydrate electrophoresis (CE) separates carbohydrates, which have been 
uniformly tagged with a charged and fluorescent label, on the basis of size.56,57 
Separation of amylose polymers up to 80 residues, released by the hydrolysis of 
starch, has been demonstrated using capillary electrophoresis.58 In this study  
8-aminopyrene-1,3,6-trisulfonic acid (APTS) was attached to carbohydrates by 
reductive amination (Fig 3.9)59 and enzymatic extension was monitored using CE. 
 
 
Figure 3.9: Attachment of APTS to carbohydrates 
APTS (62) was attached to reducing carbohydrates by reductive amination of the 
spontaneously formed aldimine with sodium cyanoborohydride.  
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The synthesis reaction used APTS-(α-1,4-Glc)5, which has four intact pyranose 
rings, as the acceptor for PHS2 and yielded a range of products with a degree of 
polymerisation (DP) up to 100 glucose residues (Fig 3.10).  All the maltopentaose 
was polymerised in the reaction, although the contaminating maltotriose remained, 
confirming the minimum acceptor length. Varying the Glc-1-P:acceptor ratio has 
been established as a way to control the length of the polymer formed.60 A coupled 
enzymatic reaction, to remove the inorganic phosphate released during the PHS2 
reaction, can also be used to promote the synthesis of longer polymers.61  
 
 
Figure 3.10: Carbohydrate electrophoresis of PHS2 catalysed extension of 
maltooligosaccharides 
A. The reaction contained APTS-(α-1,4-Glc)5 (2.2 μM), Glc-1-P (100 mM), MES  
(20 mM, pH 6.0) and PHS2 (5 μg/ml) in 100 μl at 30 °C for 24 hr, when it was 
stopped by heating to 95 °C in boiling water. PNPase rxn contained PNPase  
(1 U/ml, EC 2.4.2.1, Invitrogen) and amino-6-mercaptopurine riboside (63, 100 mM). 
Signals have been scaled appropriately. B. The PNPase catalysed removal of Pi 
from the reaction, by phosphorolysis of purine riboside (63) to purine (64) and 
ribose-1-phosphate (65).  
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In order to confirm the product formed is indeed amylose, the newly synthesised 
polymers were degraded. APTS-(α-1,4-Glc)5 was extended by PHS2 to DP>50  
(Fig 3.11). In the presence of excess inorganic phosphate PHS2 could 
phosphorolyse the polymer down to very short oligomers, mostly maltotetraose 
which is the minimum acceptor length. Amyloglucosidase (AG), a specific  
α-1,4-glucan hydrolase, could also degrade the newly synthesised polymer down to 
maltose and maltotriose, confirming the α-1,4-linkage of the PHS2-generated 
product. 
 
 
Figure 3.11: Degradation of the PHS2 synthesised polymers  
The synthetic reaction (purple) contained APTS-(α-1,4-Glc)5 (2.2 μM, black),  
Glc-1-P (10 mM), MES (20 mM, pH 6.0) and PHS2 (5 μg/ml) in 100 μl. For the 
phosphorolysis reaction (red) 50 µl was taken and made up to 100 μl containing 
extra Pi (100 mM) and fresh PHS2 (5 μg/ml)  For hydrolysis 50 μl sample was made 
up to 100 μl containing amyloglucosidase (5 μg/ml). All reactions were carried out at 
30 °C for 24 hr and terminated by heating to 95 °C in boiling water. Signals have 
been scaled appropriately. 
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3.3.3 Helical wrapping 
α-1,4-Glucans naturally form helices which stain strongly with iodine. The polymers 
formed by PHS2 stain very strongly, indicating that helical structures are indeed 
formed (Fig 3.12.A). Polyaniline is a long, electrically conducting polymer with a 
strong blue colour and is insoluble in water.62 The vine twining polymerisation of 
amylose around hydrophobic polymers has been performed with α-1,4-glucan 
phosphorylases to solubilise hydrophobic materials in water, including lipids39 and 
single walled carbon nano-tubes.40 When the PHS2 catalysed synthesis of amylose 
is performed in the presence of polyaniline the dye is solubilised (Fig 3.12.B), 
indicating the carbohydrate is wrapping around the hydrophobic polymer. This 
technique can be used to solubilise many hydrophobic polymers in aqueous 
solvents. 
 
 
 
 
Figure 3.12: Formation of amylose helices using PHS2 
PHS2 (50 µg/ml, right) polymerises amylose from (α-1,4-Glc)5 (1 mM) by the 
transfer of Glc from Glc-1-P (100 mM) at 21 °C in MES (20 mM, pH 6.5). 
A. 1% iodine saturated EtOH strongly stains the amylose helices synthesised by 
PHS2 in 2 hours (right). B. Polyaniline (1% saturated DMSO solution) can be 
solubilised after 16 hours by PHS2 catalysed synthesis (right). 
3.3.4 Conclusions on PHS2 activity in solution 
PHS2 can synthesise long polymers by transferring Glc from Glc-1-P on to 
maltooligosaccharide acceptors longer than four residues. This reaction is reversible 
and the polymers formed can be over 100 residues in length. The polymer is 
composed of α-1,4-glucans and forms helices that can include hydrophobic 
moieties, such as polyaniline, and stain with iodine. 
PHS2     -  + 
  
 
 
Figure 3.13: PHS2 crystals 
A. A crystal of PHS2 in crystallisation drop. PHS2 crystals were approximately  
100 µm rhomboids. B. A crystal of PHS2 in litho loop at DLS, showing beam 
centring on the middle of the crystal. C. An example diffraction pattern for PHS2. 
A B 
C 
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3.4 Crystal structure of PHS2 
The structure of mammalian glycogen phosphorylase (GP) has long been known, 
and the conformational changes associated with its allosteric and covalent control 
have been studied.63,64 The crystal structure of the plant enzyme will help to 
rationalise the substrate promiscuity and allow the future exploitation of  
α-1,4-glucan phosphorylases in biotransformations. 
3.4.1 Protein crystallisation 
After initial crystallisation trials PEG buffered to around pH 7.5 was found to induce 
crystallisation. Further optimisation was performed varying pH from 6.5-8.5 in MES, 
HEPES, Tris, citrate and phosphate buffers, and altering the concentration and 
average molecular weight of PEG. Finally the counter ion for citrate was altered 
before producing the optimised condition of approximately 20% (w/v) PEG3350,  
ammonium citrate (100 mM, pH 8.25), 10% (v/v) glycerol. PHS2 (1 μl, 10 mg/ml)  
in 25% GF buffer was mixed with 1 μl of well solution to give the final drop. Crystals 
appeared after 2 weeks of hanging drop vapour diffusion and at this point  
1 mM substrates in well solution were added to the drop (Fig 3.13). After a further 
week crystals were mounted in CryoLoops and flash cooled to -173 °C in liquid 
nitrogen; no additional cryoprotection was required due to the presence of glycerol 
in the crystallisation solution.   
3.4.2 Data collection and structure solution 
Data were collected at the Diamond Light Source (DLS) from an unsoaked crystal to 
1.7 Å resolution (Table 3.2). A molecular replacement monomer template was 
prepared from the structure of rabbit muscle glycogen phosphorylase  
(PDB accession code 1GPB) using CHAINSAW65  guided by an amino acid 
sequence alignment of GP and PHS2. A molecular replacement search with 
PHASER66 using the monomer template was successful in finding two copies of the 
subunit, which together yielded a dimer that was consistent with the biological units 
of both GP and MalP. A final model with Rwork and Rfree values of 0.153 and 0.183 
respectively, at 1.7 Å resolution, was produced to give the Apo structure.   
  
 
Data set Apo Acarbose Maltotriose 
Data collection    
Space Group P21 P21 P21 
Cell parameters (Å) 
a = 84.7, b = 117.1,  
c =  94.2, β = 
106.7° 
a = 84.3, b = 117.1,  
c =  95.0, β = 106.8° 
a = 83.7, b = 116.1,  
c =  94.3, β = 107.4° 
Beamline
a
 I03 I02 I02 
Wavelength  (Å) 0.971 0.980 0.980 
Resolution range
b
 (Å) 
49.11 - 1.70  
(1.79 - 1.70) 
66.42 - 2.35 
(2.48 - 2.35) 
65.81 - 1.90  
(2.00 - 1.90) 
Unique reflections
b
 190517 (26165) 73427 (10684) 132861 (17494) 
Completeness
b
 (%)
 
98.9 (93.5) 99.9 (99.8) 98.2 (88.8) 
Redundancy
b
 4.2 (3.2) 3.7 (3.7) 4.0 (3.4) 
Rmerge
b, c
 0.080 (0.433) 0.098 (0.791) 0.064 (0.558) 
Rmeas
b, d
 0.091 (0.523) 0.115 (0.926) 0.073 (0.661) 
Mean I/(I)
e
 11.8 (2.5) 8.7 (1.6) 12.9 (2.2) 
Wilson B value (Å
2
) 17.8 45.6 28.1 
Refinement    
Reflections: working/free
d
 180900/9587 69673/3670 126128/6643 
Rwork
f
 0.153 0.184 0.196 
Rfree
f 
0.183 0.240 0.241 
Ramachandran favoured/ 
allowed
g
 (%) 
98.0/99.9 96.4/99.8 97.6/99.9 
Ramachandran outliers
g
 2 3 1 
rmsd bond distances (Å) 0.016 0.014 0.014 
rmsd bond angles (º)  1.46 1.60 1.55 
Contents of model    
Protein residues  
824 (A chain)  
825 (B chain) 
824 (A chain)  
827 (B chain) 
824 (A chain) 
824 (B chain) 
Pyridoxal phosphate 2 2 2 
Ligands
h
  0 2 x ACR; 3 x GLC 2 x M3 
Precipitant/cryoprotectant 
molecules
h
 
2 x GOL; 4 x PEG 1 x GOL 1 x GOL; 1 x PEG 
Water molecules 1844 344 919 
Average atomic displacement 
parameters (Å
2
) 
   
Main chain atoms 17.2 45.4 31.9 
Side chain atoms 18.8 47.3 33.9 
Pyridoxal phosphate 15.9 44.1 31.0 
Ligands
h
 - 
ACR: 72.5; GLC: 
77.1 
M3: 39.4 
Precipitant/cryoprotectant 
molecules
h
 
GOL: 30.8; PEG: 
34.6 
GOL: 48.3 
GOL: 35.0; PEG: 
35.0 
Water molecules 27.8 39.7 37.5 
Overall 19.2 46.4 33.2 
PDB accession code 4BQE 4BQF 4BQI 
 
Table 3.2: Summary of PHS2 X-ray data and model parameters 
a
 I02, I03 = beamlines at the Diamond Light Source (Oxfordshire, UK).   
b
 The figures in brackets indicate the values for outer resolution shell. 
c
 Rmerge = ∑hkl ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl), where Ii(hkl) is the ith observation of reflection hkl and 
I(hkl) is the weighted average intensity for all observations i of reflection hkl. 
d
 Rmeas = ∑hkl [N/(N  1)]
½
 ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl),  where N is the number of observations of 
reflection hkl.  
e
 The data sets were split into "working" and "free" sets comprising 95% and 5% of the data, 
respectively. The free set was not used for refinement. 
f
 The R-factors Rwork and Rfree are calculated as follows: R = (| Fobs - Fcalc |)/| Fobs | x 100, where Fobs 
and Fcalc are the observed and calculated structure factor amplitudes, respectively. 
g
 As calculated using MOLPROBITY.
67
 
h
 Abbreviations: ACR = acarbose; GOL = glycerol; GLC = glucose; PEG = polyethylene glycol; M3 = 
maltotriose.  
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3.4.3 Apo structure of PHS2 
In the asymmetric unit of the crystal two copies of the protein were found, which 
together comprise the biologically relevant dimer (Fig 3.14). The dimer interface of 
PHS2 has about 2600 Å2 of solvent accessible surface buried per monomer, which 
is comparable in extent to that of the GP dimer (2500 Å2), with 24 H-bonds giving a 
calculated solvation free energy gain of 23.7 kcal/mol upon dimerisation.68 
 
 
Figure 3.14: Structure of the PHS2 dimer 
PHS2 forms a dimer, which has an interface of around 2600 Å2. The prosthetic 
group PLP is shown as spheres, indicating the position of the active site. 
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As expected there is a pyridoxal phosphate (PLP) covalently bound, about 20 Å 
from the surface, by formation of a Schiff base with Lys687 (Fig 3.15).  
The phosphate group acts as a catalytic acid/base in the reaction, and also has a 
role in coordinating the phosphate in the active site.69 
 
   
 
Figure 3.15: Pyridoxal phosphate in the active site of PHS2 
A. Pyridoxal phosphate is bound in the active site of PHS2 by formation of a Schiff 
base with the Lys687. B. The catalytic mechanism of α-1,4-glucan phosphorylases, 
showing the reversibility of these enzymes and the role of PLP in the reaction.69  
PL = Enzyme bound pyridoxal. R = (α-1,4-Glc)n. 
 
A 
B 
Lys687 
Lys687 
  
 
 
 
Figure 3.16: The sites of allosteric regulation in GP are not present in PHS2  
A. The tower helices, involved in inter-subunit interactions, in PHS2 and MalP adopt 
a similar conformation whereas the GP structure adopts a variable conformation, 
depending on state. Chain B surface in grey. B. PHS2 does not have the residues 
involved in AMP binding with the exception of two arginines involved in phosphate 
binding.63 AMP shown from GP structure. C. The 280s loop, which controls access 
to the active site and thus allosteric regulation in GP, adopts a more open 
conformation in PHS2 and MalP. D. The active site in PHS2 and MalP is 
substantially more open than in either conformation of GP. PHS2 in green.  
GP R state in magenta, T state in yellow. MalP in blue. 
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There are many close structural homologues of PHS2 in the PDB, with an RMSD 
less than 2.0,70 which come from just seven non-redundant proteins: mammalian63 
and yeast GP structures71 and the E. coli maltodextrin phosphorylase, MalP.72 At 
the subunit level, PHS2 most closely resembles the A form mammalian enzymes 
and the yeast enzyme, whilst at the dimer level, PHS2 most closely resembles the B 
form mammalian enzymes. The latter suggests that PHS2 has a quaternary 
structure that is closest to the non-phosphorylated, less active, state of the 
mammalian enzymes. However, the N-terminus of PHS2, the site of 
phosphorylation in the mammalian and yeast enzymes, takes up a unique 
conformation which does not impinge on the active site.  
In the inactive state of the mammalian enzyme, the so-called tower helices are 
almost anti-parallel, whilst they are almost perpendicular in the active form.63  
By contrast, in PHS2 the tower helices cross each other at an angle of roughly 55°, 
which is similar to the situation in yeast GP and MalP (Fig 3.16.A). In addition, there 
is no recognisable binding site for the allosteric activator AMP at the dimer interface 
(Fig 3.16.B), where binding of AMP changes the quaternary structure of the dimer 
such that the tower helices re-orient with respect to one another.63 This has the 
effect of drawing the 280’s loops away from the active sites. Thus PHS2 would be 
expected to be insensitive to inhibitors that target this site in the mammalian 
enzymes.  
The active site is more accessible in PHS2 than in the rabbit muscle enzyme, partly 
due to the 380's loop adopting a more open conformation, and the shorter  
280's loop (Fig 3.16.C), which would appear to be incapable of gating access to the 
active site or of binding allosteric inhibitors. The 730 helix and 770 loop are also 
further from the active site (Fig 3.16.D). Overall the structures indicate PHS2 is 
structurally more closely related to the less elaborately regulated mammalian liver 
and yeast GPs and the unregulated MalP, and it is not possible for PHS2 to be 
regulated in the same way as the rabbit muscle enzyme. 
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3.4.4 Substrate-bound structures of PHS2 
Crystals which had been soaked with acarbose (66, Acr), Glc-1-P, (α-1,4-Glc)3,  
1,4-dideoxy-1,4-imino-D-arabinitol, β-cyclodextrin (βCD), (α-1,4-Glc)4+Glc-1-P,  
(α-1,4-Glc)4+Pi, and (α-1,4-Glc)7+Pi all diffracted successfully and were solved from 
the Apo structure, with which they were isomorphous. Only the (α-1,4-Glc)3 and Acr 
showed sufficient unique additional density to merit full refinement.  
3.4.4.1 Oligosaccharide-bound structures 
Upon soaking with oligosaccharides the PHS2 protein crystals tended to crack, 
although this was likely attributable to ligands binding near crystal contacts, rather 
than to conformational changes. Nevertheless, useable X-ray data were collected 
for soaks with (α-1,4-Glc)3, (α-1,4-Glc)4 and β-cyclodextrin (βCD). All three 
oligosaccharides bound to the surface of the enzyme, although only three glucosyl 
moieties could be resolved in the electron density for the longer polymers. This is 
the first time this surface site has been seen to date, although it is adjacent, and 
almost contiguous with, the (α-1,4-Glc)5 site previously observed in rabbit muscle 
GP.73 The PHS2 site is roughly 40 Å from the PLP in a direct line, whilst the GP site 
borders the mouth of the active site channel. The GP surface binding site is almost 
identical in MalP, but all the interacting amino acids are different in PHS2  
(Fig 3.17.A). The presence of Asn435 across the binding site would appear to 
exclude the probability of binding in this site, and so the failure to find bound 
substrate is hardly surprising.  The unique PHS2 surface binding pocket is 
composed of amino acids identical to those in GP and MalP, with the exception of 
Leu361Met (Fig 3.17.B).  The fold is substantially the same although the loop  
210-216 is truncated in MalP. Indeed, the juxtaposition of the reducing end of the  
(α-1,4-Glc)3 in PHS2, and the non-reducing end of the (α-1,4-Glc)5 in GP, suggests 
that the latter could theoretically bind longer oligosaccharides that span both sites.  
It is therefore surprising that no carbohydrates have been observed in this site in GP 
or MalP.  
The enzymes may associate with their soluble substrates via this surface site, rather 
than remaining free in the cytosol. Theses alternative surface sites may determine 
the binding to the different substrates, SHG for PHS2 and glycogen for GP. GP also 
prefers branched acceptors whilst PHS2 prefers longer, unbranched acceptors,37 
which may be determined by the proximity of these surface sites to the active sites. 
  
 
 
Figure 3.18: Oligosaccharides binding to PHS2 
A. The structure of acarbose (66). B. Oligosaccharides (green) bind to the surface 
of PHS2 in a unique position compared to GP (magenta). In the active site only two 
glucosyl units from acarbose can be resolved (purple), neither of which is close 
enough to the active site pyridoxal phosphate (white) to act as an acceptor.  
C. Acarbose binds to the active site of PHS2 but can only be resolved as two 
glucosyl residues, adjacent to Tyr285 and 620, roughly corresponding to the  
4-amino-1,6-dideoxy glucose and reducing terminal glucoses of acarbose bound in 
MalP (D).74  
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Figure 3.17: Details of oligosaccharides binding to α-1,4-glucan phosphorylase 
surface sites 
A. The GP (magenta) surface binding site is not present in PHS2 (green) and the 
conformation of Asn435 would not allow substrates in this site. B. The PHS2 
surface binding site is conserved in GP except for the presence of Leu361 instead 
of Met. Maltooligosaccharides are shown as lines in the colour of the binding 
protein. 
Since no oligosaccharides were successfully bound in the active site, attempts were 
made to soak the pseudo-tetrasaccharide inhibitor acarbose into crystals of PHS2. 
Acarbose is a potent inhibitor of α-amylases, binding in the substrate binding site 
across the active site.75 In this study a structure was obtained with acarbose bound 
to the same surface site of PHS2 as the maltotriose, making very similar contacts to 
the protein (Fig 3.18). In one subunit, the whole of the inhibitor was resolved, 
whereas only the two central rings could be seen in the other subunit. This was, at 
least in part, due to the proximity of a symmetry related subunit, which effectively 
blocks the site for the cyclohexitol ring. There was, in addition, discontinuous 
residual density in the active site channel (Fig 3.18.C). In one subunit, it was 
possible to model two separate glucosyl moieties, although it was not clear if they 
were parts of the same or different acarbose molecules. In the second subunit of 
PHS2, only the inner site had sufficient density to model a glucosyl residue.  
A comparison with the acarbose complex of MalP74 showed that the ring closest to 
the PLP (some 9 Å distant) is between the 4-amino-4,6-dideoxy-D-glucopyranose 
and cyclohexitol of the acarbose in the MalP complex, whilst the ring further from 
the PLP (some 14 Å distant) roughly corresponded to the glucosyl moiety at the 
reducing end of the acarbose in the MalP structure. However the substrates do not 
directly overlay indicating there are differences in the substrate binding in the Active 
sites of these enzymes. 
 
A. B. 
Asn435 
Leu361 
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3.4.4.2 Glc-1-P-bound structures 
Addition of 1 µl of Glc-1-P (10 mM) to crystallisation drops resulted in precipitation of 
the PHS2, although when a 1 mM solution was added crystals could be grown 
which diffracted successfully. As this concentration is below the KM for Glc-1-P of 
this enzyme (see Section 3.3.1) the structure does not show complete occupancy 
and not enough extra density can be resolved to be reported as bound substrate. 
This extra density might equate to one Glc-1-P π-stacking to Tyr620 in one subunit 
and Tyr285 in the other subunit, making the same contacts as the glucose moieties 
in the acarbose bound structures (Fig 3.19). When Glc-1-P and (α-1,4-Glc)4 were 
soaked into the PHS2 crystals one subunit had additional density, adjacent to the 
PLP, which might equate to Glc-1-P and matches the binding site of Glc-1-P in the 
active site of MalP.76  
 
Figure 3.19: Additional density when Glc-1-P was soaked into in PHS2 crystals 
A. Density adjacent to Tyr620. B. Density adjacent to Tyr285. C. Density adjacent  
to PLP in active site when (α-1,4-Glc)4 is also soaked in to the crystal.  
D. Glc-1-P in MalP active site from 1L5V.76 
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3.4.5 Conclusions on the PHS2 structures 
The active site of PHS2 is substantially similar to that of GP and MalP. Whilst it has 
not been possible to resolve oligosaccharides bound in the active site,  
the structures show the importance of π-stacking for oligosaccharide binding.  
The fact that acarbose doesn’t directly overlay with related structures suggests that 
the PHS2 active site contains some important differences. The unprecedented 
surface binding site is consistent with the unusual substrate upon which PHS2 acts. 
With this range of structures we can see how the plant α-1,4-glucan phosphorylase 
has adapted for its substrate and lost the controls present in glycogen 
phosphorylase. 
  
 
 
Figure 3.20: Immobilisation of glucans on SPR surfaces 
A. The EDC (68)/NHS (69) promoted coupling of hydrazide glycosides (70) to the 
SAM linker (67). B. A schematic of the SAM composed of mixed spacer (72)  
and linker molecules (71). R = (α-1,4-Glc)n. 
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3.5 Surface glucan synthesis by PHS2  
In order to assay starch active enzymes quantifiable starch-like surfaces are 
required. PHS2 can rapidly synthesise α-1,4-glucans in solution and, by 
immobilising acceptors, insoluble glucan surfaces were developed. 
3.5.1   SPR analysis of surface glucan synthesis by PHS2 
Glucans for surface immobilisation were first functionalised with adipic acid 
dihydrazide (ADH) through their reducing termini.77 The SPR surfaces were made 
by peptide coupling of ADH-glucoside to alkane-thiol-carboxylates and the formation 
of self-assembled monolayers (SAM) on the gold surface of the SPR chips  
(Fig 3.20).78,79  This technique allowed the rapid assembly of different glucans at 
various concentrations, insulated from the SPR surface. 
3.5.1.1 Enzyme reactions on maltoheptaose surfaces  
In order to analyse PHS2 activity on a surface analogous to a starch granule,  
(α-1,4-Glc)7 was immobilised on an SPR chip. PHS2 binds well to the surface and 
the binding is enhanced by Glc-1-P, but no synthesis was observed upon  
co-injection with Glc-1-P on this surface (Fig 3.21). The crystallographic evidence 
would suggest the surface binding site might account for the donor free binding, 
whilst in the presence of Glc-1-P the active site binds more tightly to the surface. 
The lack of synthesis would suggest either the glucan structure on the surface 
cannot reach into the active site or the conformation of the surface prevents PHS2 
binding in an active mode, possibly mediated by the surface binding site elucidated 
in the crystal structures (see Section 3.4.4.1). 
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Figure 3.21: PHS2 activity on maltoheptaose SPR surface 
PHS2 (15 µg/ml) binds to the maltoheptaose surface and is almost completely 
removed by NaOH (10 mM) wash. When co-injected with Glc-1-P (4 mM) a larger 
response is seen over the course of the injection, but this is also removed by the 
NaOH wash. 
 
3.5.1.2 Fractionated glucan   
As an alternative to (α-1,4-Glc)7, fractionated glucan (FG), a partially degraded 
starch fragment, was immobilised on the SAM as this is likely to provide a more 
open and accessible surface. FG was obtained by removing low DP contaminants 
from the GlucidexTM, which would not act as acceptors for PHS2.  
This material has 3% branching, as judged by 1H NMR and an average molecular 
weight of 19 kDa (DP ~ 110) (Section 8.2.3.2). 80 
3.5.1.3 Enzyme reactions on low FG density SPR surfaces  
A SAM surface, containing 2% linker, was immobilised on the SPR surface and FG 
was coupled, using the same chemistry as for the (α-1,4-Glc)7 surface, and 
interrogated using SPR. PHS2 was able to bind rapidly to this surface, with the 
response showing typical surface binding kinetics and slow dissociation (Fig 3.2).  
It was not possible to extract surface binding kinetics from the data collected, due to 
the high Ka of this protein for the surface. 
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Figure 3.22: SPR analysis of PHS2 binding to the low FG density surface 
The low sugar density surface was interrogated by injecting 100 µl PHS2  
(0.5-10 µg/ml in running buffer) on to the surface, normalised 10 s after injection. 
When PHS2 (5 µg/ml) was co-injected with Glc-1-P a larger, stable response was 
observed indicating surface extension. After extension with PHS2 the surface could 
be repeatedly probed with enzymes showing consistent results. PHS2 further 
extended the surface by a similar amount and the response positively correlates 
with Glc-1-P concentration (Fig 3.23), confirming the response is due to synthesis, 
not protein-surface interactions.  
 
Figure 3.23: Kinetics of low FG density surface extension using PHS2 
As the concentration of Glc-1-P increases, co-injected with a constant concentration 
of PHS2 (5 µg/ml), the response increases. 
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Figure 3.24: PHS2-catalysed glucan synthesis on low FG density surface, as 
analysed by SPR and AFM 
A. Composite SPR sensogram and B. quantification of the final change in response, 
using the low sugar density surface. Green: When Glc-1-P (10 mM) was injected 
over the surface (20 µl injection) there was a bulk change that returns to baseline 
when the injection ends. Blue: When PHS2 (5 µg/ml) was injected alone there was 
around 250 RU signal increase, which did not decrease significantly when the 
injection ended, or with NaCl wash (100 mM, 20 µl). Purple: When PHS2  
(5 µg/ml) and Glc-1-P (10 mM) were co-injected, a large response (1200 RU) was 
seen, giving rise to an elevated and stable baseline after NaCl wash  
(100 mM, 20 µl). Yellow: When PHS2 (5 µg/ml) and Pi (10 mM) were co-injected a 
large decrease in signal (800 RU) was observed. Orange: Amyloglucosidase  
(1 mg/ml, Aspergillus niger, Sigma) caused a significant decrease in signal  
(500 RU) when injected over the surface. Red: Barley β-amylase (3 mg/ml, 
Megazyme) also gave a decrease (400 RU) in signal when injected over the 
extended surface. All enzyme reactions used 100 µl injections. C. AFM of SPR chip 
showing a gold sputtered surface, with a standard deviation, corresponding to 
surface roughness, of 536 pm. After addition of the 2% SAM layer the surface 
remains smooth (SD 563 pm). Coupling of FG to the surface caused an increase in 
roughness (SD 1.069 nm); when PHS2 (5 µg/m) and Glc-1-P (10 mM) were co-
injected, a large change in surface morphology was observed, with an increase in 
SD from the mean of the surface thickness to 2.8 nm. 
 
A. 
B. C. 
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After this initial extension the surface can then be enzymatically degraded: PHS2 
can phosphorolyse the surface when co-injected with Pi, showing a decrease of 
over 1000 RU, after initial protein binding to the surface; specific α-1,4-glucan 
hydrolases, amyloglucosidase (AG) and barley β-amylase (BBA), showing a 
decrease of approximately 450 and 400 RU respectively (Fig 3.24). These results 
confirm the increase in response is indeed caused by the PHS2 mediated synthesis 
of amylose. 
Previously it has been reported that atomic force microscopy (AFM) can be used to 
analyse soluble polysaccharides synthesised on SPR surfaces43 and this technique 
was used to measure the insoluble starch like surface in this study. The initial gold 
surface and the surface after immobilisation of the SAM were relatively smooth, with 
a standard deviation from the mean of 0.5-0.6 nm (Fig 3.24.C). Immobilisation of FG 
caused the surface to become rougher (SD = 1.1 nm) and after PHS2 injection the 
surface became much more uneven (SD = 2.8 nm). These results confirm that 
PHS2 catalyses the addition of substantial amounts of material to the glucan 
surface which can be removed by α-1,4-glucan hydrolases. 
3.5.1.3 Enzyme reactions on high FG density SPR surfaces  
A higher sugar density surface was prepared by coupling FG to the SAM linker in 
solution and then applying this to the surface, without dilution with the SAM spacer. 
Figure 3.25 shows a typical SPR trace of enzyme injections over this high FG 
density surface. When PHS2 alone is injected over the surface a much greater 
response is seen, compared to the low FG density surface, as there is more ligand 
immobilised on the surface. The co-injection of PHS2 and Glc-1-P gave an increase 
of around 5000 RU of polysaccharide synthesis. Hydrolases were then used to test 
this surface: amyloglucosidase, which cannot degrade granular starch, is unable to 
degrade this surface; α-amylase, which can readily degrade starch granules, is able 
to degrade the surface, removing nearly all the newly synthesised glucan.  
α-Amylase is able to hydrolyse both α-1,4 and α-1,6 glucosidic linkages, so can 
remove some of the branch points already present in the FG surface, rendering the 
surface unusable.  
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Figure 3.25: Typical SPR trace of enzyme reactions on the high FG density surface 
A. Composite SPR sensogram and B. quantification of the final change in response, 
using the high sugar density surface. Green: When Glc-1-P (10 mM) was injected 
over the surface (20 µl injection) there was a bulk change that returns to baseline 
when the injection ends. Blue: When PHS2 (5 µg/ml) was injected alone there was 
around 500 RU signal increase, which did not decrease significantly when the 
injection ended. Purple: When PHS2 (5 µg/ml) and Glc-1-P (10 mM) were  
co-injected, a large response (5000 RU) was seen, giving rise to an elevated and 
stable baseline. Orange: Amyloglucosidase (AG, 1 mg/ml) caused no decrease in 
signal when injected over the surface. Maroon: Porcine pancreatic α-amylase  
(PAA, 3 mg/ml, Megazyme) also gave a large decrease (>2000 RU) in signal when 
injected over the extended surface, and continued to degrade the surface after the 
end of the injection by a further 1500 RU, as the enzyme slowly dissociates and 
continues to degrade the glucans. All enzyme reactions used 100 µl injections.   
 
3.5.1.5 Conclusions on the SPR experiments 
The SPR surfaces behave differently depending on the density of the immobilised 
glucan. When relatively dilute the surface behaves in the same way as in solution, 
with all the tested hydrolases able to degrade the surface. This confirms that PHS2 
is synthesising large amounts of α-1,4-glucan on the surfaces. When a denser 
surface is used the material takes on the pattern of enzyme resistance seen  
in starch granules. These results indicate that the amylo-polymer created by PHS2 
on the high density surface, forms a macromolecular complex, which may be 
crystalline, preventing access by most enzymes to the surface. 
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3.5.2 Nanoparticles 
Whilst a quantifiable 2D system is relevant for the analysis of starch active enzymes 
a third spacial dimension is needed to represent a starch granule. As can be seen in 
Figure 3.3, enzymatic degradation of the starch granule remodels the surface in 
three dimensions.  The physical and chemical properties and uniform shape and 
size81 of gold nanoparticles make them excellent materials for the study of biological 
interactions.82 Uses include the rapid detection of DNA,83 as anticancer vaccines84 
and for the detection of carbohydrate binding proteins85,86 based upon the 
interactions between surface plasmons, altering the colour, upon aggregation. 
Citrate stabilised gold nanoparticles (AuNP) of approximately 15 nm provide  
an excellent carbohydrate display system49 and are simple to make according to the 
procedure of Turkevich.81  
3.5.2.1 Glycogen based nanoparticles 
Extension of glycogen particles using amylosucrase showed an increase in the 
particle size, when imaged using transmission electron microscopy (TEM), followed 
by a contraction of the material upon ageing of the material, leading to the proposal 
that the amylose chains are forming double helices and crystallites.45 In this study 
the extension of glycogen by PHS2 gives a similar pattern of behaviour.  
The material stained dark blue with iodine only after extension, indicating the 
formation of ordered amylose double helices (Fig 3.26). Particle size had also 
increased, when imaged using TEM. 
 
Figure 3.26: Extension of glycogen with PHS2 
Glycogen (1 mg/ml) does not stain with iodine (0.5% EtOH saturated with I2)  
but after extension with PHS2 (10 µg/ml, 10 mM Glc-1-P, 20 mM MES pH 6.5)  
the material stains very strongly, and is seen under TEM (50000x, 2% UA stained) 
as larger formations. 
  
 
 
  
 
Figure 3.27: Representative images of the glucan layer on the surface of the 
FGNPs 
Gold nanoparticles with FG immobilised on the surface were imaged with TEM, 
either stained with PATAg (A) or 2% uranyl acetate (B). Both staining methods 
show the carbohydrate on the nanoparticles increases from around 1 ± 0.09 nm (1) 
to around 4.0 ± 0.13 nm after treatment with PHS2 (10 µg/ml) and Glc-1-P  
(10 mM) (2). 24 hours after the reaction had been stopped a thinner layer of about  
2.3 ± 0.09 nm can be observed (3). See Fig 3.29 for quantification. C. 1. Five µl of 
ethanol saturated with iodine diluted into 1 ml water has a pale yellow colour.  
2. Gold nanoparticles with FG. 3. Iodine only weakly stains the FG nanoparticles.  
4. The extension of the immobilised carbohydrate on the surface of the 
nanoparticles by PHS2 does not change the colour of the gold nanoparticles.  
5. Iodine stains nanoparticles brown after treatment with PHS2. 
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3.5.2.2 Synthesis of gold nanoparticles with a glycan surface 
Gold nanoparticles were prepared by the citrate reduction of gold chloride81 and had 
a regular round shape and an average diameter of 14.7 ± 0.09 nm, according to 
TEM. The high FG density surface was immobilised on these AuNPs, using the 
same technique as for the SPR surface, to form FGNPs, which were probed with 
various enzymes. 
3.5.2.3 PHS2 catalysed synthesis on the FGNPs 
When imaged by TEM after negative staining with the carbohydrate-specific periodic 
acid/thiocarbhydrazide/silver (PATAg)87 or 2% uranyl acetate (UA), a narrow 
unstained zone was visible around the FG-NPs (0.9 ± 0.05 nm), indicating the 
thickness of the SAM and FG layer on the particles (Fig 3.27.A/B). When imaged 
immediately after a one hour incubation with PHS2 and Glc-1-P, a much larger 
unstained zone (4.0 ± 0.13 nm) was visible around the particles. After 24 hours of 
aging at 4 °C, this clear zone had collapsed to a much smaller size (2.3 ± 0.09 nm), 
suggesting that some reordering and packing of the newly synthesised glucan 
chains had occurred. 
The PHS2-mediated extension of FGNPs had no effect on the red colour of the 
AuNPs themselves (Fig 3.27.C.2 to 4), indicating that the particles had not been 
affected by the glucan extension. However the PHS2-extended FGNPs stained 
strongly with iodine (Fig 3.27.C.5), in contrast to the starting FGNPs (Fig 3.27.C.3) 
indicating that the material synthesised on the particles had arranged to form 
ordered amylose helices rather than a random unstructured arrangement of 
chains.88 
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With high enzyme concentrations and at extended time periods, a precipitate of 
nanoparticles in an entangled micron scale amylose matrix was formed, without 
causing a change in the colour (Fig 3.28). This indicates there is no aggregation, 
which would cause interaction between the gold plasmons. While some way short of 
the 0.5-100 µm length scale of the typical starch granules,89 these preliminary data 
show potential for the elaboration of micron scale carbohydrate architectures  
by PHS2-meditated synthesis. 
 
 
Figure 3.28: Extended reaction of PHS2 on FGNPs 
A. FGNPs show characteristic red colour.  B. PHS2 (5 µg/ml) and Glc-1-P (10 mM) 
were added to 75 ml of the FG-NPS for 16 hours at 21 °C. The red colour of the 
precipitant indicates that the nanoparticles had precipitated, but not aggregated.  
C. TEM (11500x magnification) shows extensive material has been synthesised 
when stained with UA. D. Positive staining with PATAg shows the material 
synthesised is carbohydrate. 
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3.5.2.4 Degradation of PHS2 synthesised glucan on FGNPs 
FGNPs that had been extended by PHS2 and aged for 24 hours were probed with 
α-1,4-glucan hydrolases. Amyloglucosidase, which cannot degrade starch granules, 
caused no significant change in the zone around the particles which did not stain 
with UA. Treatment with PPA, which can degrade starch granules, caused a modest 
reduction (0.7 ± 0.09 nm) in the extended surface.  
  
Figure 3.29: Changes in the glucan layer on FGNPs 
The glucan layer on the FG-nanoparticles (A) increased after treatment with PHS2 
(10 µg/ml, 10 mM Glc-1-P) (B). 24 hours after PHS2 was inactivated the thickness 
of the clear zone around the FG-NPs had decreased (C). After treatment with  
PAA (0.3 mg/ml) a further decrease was apparent (D), whilst AG (1 mg/ml) caused 
no decrease in the clear zone around the particles (E). Clear zones were measured 
using TEM with UA negative staining. Means and SE were determined with  
31-65 particles for each treatment and all conclusions are at the 5% confidence 
level (t-test). 
 
3.5.2.5 Conclusions on the use of PHS2 to extend glucan nanoparticles 
PHS2 is able to synthesise polymeric α-1,4-glucans from a fractionated glucan 
primer immobilised on gold nanoparticles. The resultant glycopolymer stains with 
iodine in a manner similar to amylose and has the same resistance to 
amyloglucosidase, and susceptibility to α-amylase, as native starch granules.  
These particles can be used to analyse starch active enzymes and as models for 
the synthesis and modification of biocompatible starch layers on inorganic surfaces. 
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3.6 Conclusions on the use of PHS2 for the synthesis of 
amylose in solution and on surfaces 
In order to study the surface enzymology of the starch granule we need new ways 
to investigate enzymatic reactions at solid-liquid interfaces. Due to its catalytic 
efficiency, we have explored the plant phosphorylase PHS2 for the rapid synthesis 
of linear amylose chains.  
In solution assays, linear amylose-like structures of up to 100 sugar units could be 
synthesised. Similar syntheses could also be achieved on gold sensor chip 
surfaces: on its own, the phosphorylase enzyme bound tightly to the glucan-coated 
sensor surface, presumably using the surface binding site elucidated in these 
crystal structures of PHS2. When co-injected with the donor substrate PHS2 was 
able to synthesise glucans, which could be monitored conveniently in real time by 
SPR. The resulting extended surfaces were responsive to starch-active enzymes in 
a manner reminiscent of native starch granules, suggesting the potential for this 
approach to generate physiologically relevant starch-like surfaces.  
PHS2-catalysed glucan polymerisation could also be monitored on gold 
nanoparticles using TEM. These nanoparticle-based glucan surfaces were subject 
to aging, with the glucan layer appearing to reorganise and assemble into a much 
more tightly packed structure over time. This data is interpreted as glucan chains 
wrapping back on themselves to produce inter- or intra-chain hydrogen bonds, as 
proposed for crystalline material generated by the enzymatic debranching of 
starch90 or the amylosucrase-mediated extension of glycogen nanoparticles.45  
The 2D and 3D surfaces developed in this study represent novel tools for the study 
of surface enzymology, which will be explored further to investigate enzymes 
associated with starch granule metabolism and the industrial processing of this bulk 
commodity.   
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Chapter 4 – Cellodextrin phosphorylase – a β-1,4-glucan 
phosphorylase 
4.1 Introduction 
4.1.1 Cellulose 
Cellulose is the most abundant organic compound on Earth1 and is extremely strong 
and resistant to degradation. Composed of β-1,4-linked glucose, the residues 
alternate orientation and the structure should possibly be considered, at least in 
terms of molecular shape, as a polymer of cellobiose (Fig 4.1). Together with its 
structural homologue, chitin, this isoform is the main structural support in plants, 
insects, fungi and to a certain extent in bacteria2 and oomycetes.3 Cellulose and 
chitin are synthesised as parallel chains which form crystalline fibres.4-6 
Figure 4.1: Structure of β-1,4-glucans 
β-1,4-Glucans, such as cellulose (5), are composed of β-1,4-linked glucose 
residues, alternating in orientation, which gives a flat ribbon shape.  
The repeating motif in is the disaccharide cellobiose (44), or in the case of chitin is 
chitobiose (73). 
The global biofuel industry is beginning to utilise the structural sugars in plant 
biomass. Commercial usage of this lignocellulosic biomass is hampered by the 
relatively slow rate of sugar release from plant material,7 due to the fact that the 
cellulose is rarely found in a pure form, but is instead combined with hemicellulose 
and lignin. The future direction of work in this field is likely to involve modifying the 
cellulose chains, such that they are more easily attacked, and altering the 
hemicellulose and lignin content in planta, thus making the release of sugars more 
efficient.7 Bacterial cellulose is synthesised in a much purer form, requiring less 
processing before being incorporated into a range of products as diverse as wound 
dressings,8 food thickeners9 and composite materials.10 
  
 
Figure 4.2: Proposed products formed using cellobiose phosphorylases 
A. Glc can be transferred from Glc-1-P on to various monosaccharides including 
glucose (44), L-fucose (74), D-allose (75), D-altrose (76),11 D-arabinose (77),12  
D-glucosamine (78), D-mannose (79), D-xylose (80),13  D-glucuronamide (81)14 and  
L-galactose (82).15 B. Deoxy and fluoro-cellobioses could also be made using  
6-deoxy- (83), 6-fluoro- (84), 3-deoxy- (85), 3-fluoro- (86), 2-deoxy- (87) and  
2-fluoro- (88) D-glucose as acceptors.16 When glucal was used as the donor  
2’-deoxy-cellobiose (89), 2,2’-dideoxy-cellobiose (90), and 2’-deoxy-glucosyl-xylose 
(91) and mannose (92) were formed using appropriate acceptors.17  
1-Deoxy-D-glucose, known as 1,5-anhydroglucitol, also accepted glucose to form 
1,5-anhydrocellobiitol (93).18  C. Alkyl chains (94) were acceptors as were the  
6-glycsoylated glucoses gentiobiose (95), isomaltose (96) and melibiose (97).12  
D. Mutagenesis allowed formation of lactose phosphorylase which tolerated 
galactose at the non-reducing position (98)19 and allow addition of glucose to the 
reducing end of ethyl (99) or phenyl (100) glucosides.20 
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β-1,4-Linked polysaccharides, other than cellulose, are also used in many structural 
polymers. For example, β-1,4-linked mannan and xylan are used in plant secondary 
cell walls, while chitin (73) is used in the exoskeleton of insects and crustaceans. 
Research into the degradation of these materials, for fine chemical production21 and 
to enhance release of sugars from biomass,22 is on-going. 
A substantial amount of research effort has been spent studying the microbial 
degradation of cellulose for the identification of enzymes useful in the 
biotechnological conversion of biomass.23 For studying cellulases various substrates 
are used: delignified wood which contains some hemicellulose; microcrystalline 
cellulose, from which hemicellulose and amorphous cellulose have been removed 
by acid treatment; bacterial cellulose, which does not have the same crystalline 
form;24 carboxymethyl cellulose, which is soluble and can be degraded by  
non-cellulolytic enzymes. Thus a system allowing direct measurement of pure 
cellulose degradation is highly desirable.  
4.1.2 Cellobiose phosphorylases (CBP) 
Disaccharide β-1,4-glucan phosphorylases, which have been more thoroughly 
studied than oligosaccharide phosphorylases, include galactosyl-rhamnose,25 
mannosyl-glucose,26 mannobiose,27 chitobiose28 and cellobiose29 phosphorylases. 
The last of these has been particularly heavily studied with respect to substrate 
specificity (Fig 4.2). Whilst many assays utilise only phosphate release to indicate 
turnover,15 purification of the products is required to confirm product formation rather 
than hydrolysis of the donor.  3-Deoxy-, 3-deoxy-3-fluoro- and 3-epimers of glucose 
are acceptors for CBP, but 3-O-methyl glucose was not, suggesting steric hindrance 
at the 3OH.11 Detailed substrate interactions were studied with deoxy- and  
fluoro-sugars, all showing reasonable kinetics except the 3-deoxy-3-fluoro-
glucose.16 Glucosamine, mannose and xylose were also shown to be acceptors13 
and glucosyl-xylose (80) was produced, with a 60% yield, using the cell extract of 
Cellvibrio gilvus.30 A 28% yield of disaccharide (77) was achieved from the transfer 
from Glc-1-P on to arabinose.12 Glucal was also a substrate, in the presence of Pi, 
allowing formation of 2’-deoxyglucosyl disaccharides.17 In addition, trisaccharides 
could be synthesised using the 1,6-disaccharides gentiobiose, melibiose and 
isomaltose as acceptors for glucose12 and, whilst glucuronic acid was not an 
acceptor, glucuronamide was.14 Linear alcohols as small as methanol were utilised 
as acceptors,31 as was 1,5-anhydro-glucitol.18 
  
 
Figure 4.3: Proposed products formed using cellodextrin phosphorylase 
A. Cellodextrin phosphorylase can be used to extend deoxynojirimycin (DNJ) to 
form pseudo cellooligosaccharides for use as cellulase inhibitors (101-103).32  
Trisaccharides could be purified from the transfer of glucose on to the 4-hydroxyl of 
cellobiose (104), sophorose (105) and laminaribiose (106). B. Specific xyloglucan 
oligosaccharides can be made by using either Xyl-1-P or Glc-1-P as the sugar 
donors and the synthesised xylo- and cellooligosaccharides as acceptors.  
(107-110)33 and β-1,3/1,4 glucans can be made using laminarin phosphorylase and 
CDP (111-114).34 C. The enzymes were also capable of extending glucosides 
including p-nitophenol glucoside (115) and β-octyl glucoside (116).35 Novel 
glycolipids could be made by adding glucose to glucosyl (117) and sophorsyl (118) 
lipids and a single transfer from galactose-1-P on to the glucosyl lipid was achieved, 
yielding lactosyl lipid (119).36 D. Dendrimers were also made by extending 
cellobiose derivatised succinamide (120), tris(2-aminoethyl)amine (121) and 
polyamidoamine (122) with CDP.37 
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4.1.3 Cellodextrin phosphorylases (CDP) 
The most studied polymerising β-1,4-glucan phosphorylase is cellodextrin 
phosphorylase,38 closely related to the cellobiose phosphorylases. This enzyme has 
been used to synthesise cellooligosaccharide-DNJ (Fig 4.3.A),32 as cellulase 
inhibitors. β-Linked disaccharides acted as acceptors,12 showing that the enzyme is 
permissive for anomeric substitution of β-glucosyl acceptors. CDP was capable of 
transferring xylose from Xyl-1-P, and could also transfer Glc and Xyl on to β-linked 
xylose, facilitating the synthesis of a series of xylans related to hemicellulose  
(Fig 4.3.B).33 By alternating between CDP and laminarin phosphorylase, both of 
which will transfer on to any β-glucan, specific β-1,3/1,4-glucans related to plant cell 
walls were synthesised.34 Alkyl and PNP glycosides were also assessed as 
acceptors for CDP35 and novel glycolipids were produced (Fig 4.3.C).36 Dendrimers 
based on cellulose could readily be synthesised by the extension of cellobiose 
dendrimers (Fig 4.3.D).37 
4.1.4 Rationale 
β-1,4-Linked oligosaccharides have interesting properties, including structural 
strength and resistance to degradation. In order to better utilise these carbohydrates 
in new materials and in biomedicine, pure, well-defined material is required.  
In addition, well-characterised standards are needed for the study of the natural role 
of these compounds in Nature. 
In this study, cellodextrin phosphorylase was investigated for the production of 
cellulose oligomers and the possibility of synthesising β-1,4-oligosacchaides based 
on alternative sugars explored. This enzyme is flexible towards certain acceptors,  
but more inflexible with regard to the donor. Inhibition experiments were used to 
probe the interaction between the substrates and the enzyme. In order to study this 
further X-ray crystallography was used to characterise the structure of cellodextrin 
phosphorylase. The comparison between cellobiose phosphorylase and cellodextrin 
phosphorylase from the same organism shows the structural changes necessary for 
accommodation of longer polymers in the phosphorylase active site and rationalise 
the engineering of polymerising phosphorylases. 
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4.2 Expression and purification of CDP 
The E. coli codon optimised CDP gene from Clostridium thermocellum was 
synthesised and subcloned into the BamHI site of pET15b, which inserts a 
hexahistidine tag behind a thrombin cleavage site at the N-terminus of the protein. 
After optimisation the protein was successfully expressed in E.coli BL21 and purified 
using Ni-IMAC and GF to obtain >98% pure protein, as judged by SDS-PAGE  
(Fig 4.4). The elution from the GF column at 120 ml indicates the protein is 
approximately 111 kDa, comparable to the calculated MW of 114.3 for the monomer. 
Dynamic light scattering shows the protein is present as a monodisperse species 
with a molecular weight of 277 kDa, which is comparable to the MW of the dimer.  
A total yield of 10 mg of purified CDP per litre culture was obtained and 
concentrated to 40 mg/ml. 
 
Figure 4.4: Purification of CDP from E. coli 
A. Purification of CDP was by the standard protein purification protocol  
(Section 8.1.2). CDP was eluted from the Ni-IMAC by single step increase of 
imidazole at 220 ml. The whole peak was injected on the gel filtration column at 
260ml to give a single species (A2-B4) at 120 ml elution volume, as judged by A280 
(blue), with some low molecular weight contaminants eluting in the column volume, 
as indicated by the conductivity trace (green). B. SDS-PAGE of the fractions from 
GF show a major band, consistent with the calculated MW of 114 kDa.  
1:  Kaleidoscope protein standards (Bio-Rad). 2: total cell extract of uninduced cells.  
3: total cell extract of induced cells. 4: insoluble induced cell material. 5: soluble 
induced cell lysate. 6-12: fractions A2-B5 from GF. C. DyLS of CDP (0.1 mg/ml) 
shows the protein is present as a monodisperse species with a radius of 6.6 nm.  
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4.3 Activity of CDP 
4.3.1 Initial assays 
The activity of CDP was confirmed by synthesis of cellooligosaccharides, monitored 
using carbohydrate electrophoresis (Fig 4.5). CDP was able to extend  
APTS-labelled cellohexaose (APTS-(β-1,4-Glc)6) to long polymers by transferring 
glucose from Glc-1-P on to the acceptor, although most of the synthesised material 
was insoluble and removed during the sample preparation (Fig 8.14). CDP can also 
clearly phosphorolyse both the APTS-(β-1,4-Glc)6 and the CDP-synthesised 
polymers to cellobiose and cellotriose. Cellulase can degrade the CDP-synthesised 
polymers, confirming the material is indeed cellulose-based.  
 
Figure 4.5: Carbohydrate electrophoresis of CDP-synthesised polymers 
The activity of the phosphorylase was confirmed by assaying the ability of CDP  
(0.5 μg) to transfer Glc from Glc-1-P (10 mM) on to APTS-(β-1,4-Glc)6 (0.72 μM) in 
100 μl MES (20 mM, pH 7.5). After 1 hour at 37 °C the reactions were terminated by 
heating to 95 °C in a boiling water bath for 15 min and centrifuging at 16,000 g for  
5 min (CDP+G1P). 30 μl of this synthetic reaction was further probed by 
degradation with either cellulase (0.94 U) from T. longibrachum (Megazyme) in 
NaAc (100 mM, pH 4.5), or CDP (0.5 μg) in Pi (100 mM, pH 7.0), for 1 hour at 37 °C 
(CDP+Pi), before again heating to 95 °C and centrifuging as before.  
  
 
Figure 4.6: Donor specificity of CDP, analysed using carbohydrate electrophoresis 
A. Extension of APTS-cellobiose with various sugar-1-P donors. B. Extension of 
APTS-cellotriose with various sugar-1-P donors. C. Extension of APTS-cellotriose 
with GlcN-1-P. Assays were carried out using CDP (5 µg/ml) at 40 °C with  
APTS-labelled acceptor (2 µM) in HEPES (50 mM, pH 7.5) followed by heating to  
95 °C and centrifuging at 16,000 g.  
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4.3.2 Donor specificity of CDP 
4.3.2.1 Glucan extension 
In order to determine the capability of CDP for the synthesis of other β-1,4-glycan 
polymers the transfer of other sugars on to cellooligosaccharides was monitored 
using CE. APTS-(β-1,4-Glc)2 was initially used, even though this is a poor acceptor 
(Section 4.3.3), as this would reduce the chance of phosphorolysis of the acceptor, 
releasing the natural donor Glc-1-P (Fig 4.6). Glc-1-P is an excellent donor, rapidly 
extending the polymer. The other sugar-1-Ps showed no significant new peaks, 
which does not agree with the literature.33 
APTS-(β-1,4-Glc)3 was then used as a more efficent acceptor, which was confirmed 
by the faster extension when using Glc-1-P. There is very little material visible in the 
Glc-1-P reactions, as the long polymers formed are insoluble and so removed 
during sample preparation. In the presence of Gal-1-P disproportionation is the only 
reaction occurring, caused by hydrolytically released Pi, allowing phosphorolysis of 
one cellooligosaccharide and transfer of Glc on to another acceptor molecule. This 
is apparent from the equal amount of APTS-(β-1,4-Glc)2 and APTS-(β-1,4-Glc)4 
formed. In the reactions which has contained Man-1-P or Xyl-1-P there is a small 
additional peak which may correspond to the addition of one of these sugars to the 
acceptor. 
Most strikingly the reaction with GlcN-1-P shows a large new peak appearing, 
greatly retarded on the electrophoretogram. This is proposed to be caused by a 
single turnover adding one GlcN residue which, at the pH of the running buffer  
(pH 4.75), is protonated. This alters the charge on the molecule causing it to elute 
much later. With a much longer electrophoresis another peak is visible suggesting 
another addition, either of a further GlcN or of a Glc. 
We have been unable to confirm the identity of these or any other APTS-labelled 
products by mass-spectrometry. This has been a consistent drawback of this 
technique across numerous projects. 
 
  
 
 
 
  
 
Figure 4.7: Sugar-1-P binding inhibits CDP activity 
A. CE was performed with standard conditions varying Glc-1-P concentration with a 
range of Xyl-1-P or Man-1-P concentrations. B. The DP of the peak with the largest 
area was calculated and thus the average turnover of the enzyme, allowing a 
calculation of the approximate inhibition constants. Assays were carried out using 
CDP (5 µg/ml) at 40 °C with APTS-(β-1,4-Glc)6 (2 µM) in HEPES (50 mM, pH 7.5) 
followed by heating to 95 °C and centrifuging at 16 000 g.  
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4.3.2.3 Competitive inhibition by sugar-1-Ps 
Competition assays were performed in order to understand whether the lack of 
efficient activity is caused by failure to bind the substrates (KM) or inefficient 
catalysis (kcat) (Fig 4.7). Reaction mixtures, containing different concentrations of 
Glc-1-P, had competing substrates added, to assess the impact on polymerisation.  
Xyl-1-P decreased the average polymer length indicating binding to the active site, 
consistent with the ability for Xyl-1-P to act as a donor for CDP.33 Man-1-P causes a 
much greater decrease in polymer length, indicating tighter binding, but is a much 
poorer donor than Glc-1-P. This suggests that Man-1-P has a lower turnover, 
possibly because of the deactivation of the phosphate ester by the axial hydroxyl on 
C2. Repeating these experiments over a range of substrate and inhibitor 
concentrations it was possible to calculate the Ki of Xyl-1-P (6.2 ± 2.6 mM) and 
Man-1-P (1.2 ± 0.6 mM). As these are substrates this reduces the reliability of the 
values. These calculations are based on competitive inhibition as the Vmax is 
unchanged (13.4 ± 0.5 μmol/min/mg) and the KM
app changes with varying inhibitor 
concentration, to 0.4 mM ± 0.06 mM with no inhibitor. However the acceptor 
concentration (2 μM) is significantly below KM so these results do not match 
literature values (KM
app = 4.7 mM,39 Vmax = 64.2.
40). 
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4.3.3 Acceptor specificity of CDP 
4.3.3.1 β-1,4-Glucans 
The length specificity of CDP for unlabelled acceptors was determined by 
measurement of the phosphate released from 10 mM Glc-1-P over a range of 
acceptor concentrations. Using this assay the capability of CDP to use 
cellooligosaccharides as acceptors was assayed (Table 4.1). Glucose was found to 
be a poor acceptor, whilst the monosaccharide analogue phenyl  
β-D-glucopyranoside (BPG) was a better acceptor, probably because of its fixed 
anomeric configuration. The cellooligosaccharides had a decreasing KM up to DP5, 
indicating there are stabilising interactions with the sugars further from the catalytic 
site. Cellohexaose has a higher KM, which may be an effect of its limited solubility. 
The kcat also follows a similar pattern, with turnover decreasing as acceptor length 
increases, which may be an effect of the longer oligomers binding more tightly the 
active site. 
 
Acceptor KM
app
 (mM) kcat (1/s) kcat /KM
 app
 (1/mM/s) 
Glucose – (Glc) NA NA NA 
BPG  (24 ± 13) (15 ± 6.3) 0.63 
Cellobiose – (β-1,4-Glc)2 2.6 ± 0.18 17 ± 0.50 6.5 
Cellotriose – (β-1,4-Glc)3 0.68 ± 0.076 9.5 ± 0.35 14 
Cellotetraose – (β-1,4-Glc)4 0.54 ± 0.13 5.0 ± 0.25 9.3 
Cellopentaose – (β-1,4-Glc)5 0.36 ± 0.076 4.3 ± 0.47 12 
Cellohexaose – (β-1,4-Glc)6 1.9 ± 0.76 7.6 ± 1.8 4.0 
Table 4.1: Acceptor length specificity for CDP. 
Glucose is an acceptor, but the activity is too low for kinetic analysis. BPG is a poor 
acceptor and the values calculated are outside the range of the assay. 
  
 
Figure 4.8: CDP catalysed extension of APTS-labelled cellooligosaccharides 
A. Extension of APTS-cellobiose. B. Extension of APTS-cellotriose. C. Extension of 
APTS-cellohexaose. Assays were carried out using CDP (5 µg/ml) at 40 °C with  
Glc-1-P (10 mM) and APTS-labelled acceptor (2 µM) in HEPES (50 mM, pH 7.5) 
followed by heating to 95 °C and centrifuging at 16 000 g.  
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The ability of CDP to use APTS labelled (β-1,4-Glc)2, (β-1,4-Glc)3 and (β-1,4-Glc)6 
was monitored over time using CE (Fig 4.8).  
APTS-(β-1,4-Glc)2 is a poor acceptor and when a single glucose residue is added 
the formed APTS-(β-1,4-Glc)3 is a much better acceptor and is rapidly polymerised 
to insoluble cellooligosaccharides.  BPG is a poor acceptor in solution and the 
reductively-aminated cellobiose will have a similar Glc configuration. It is unclear 
whether the APTS itself prevents access of the acceptor to the active site,  
or whether this low activity is purely caused by the lack of a second pyranose ring.  
APTS-(β-1,4-Glc)3 is a much better acceptor, being completely consumed within  
10 min. Interestingly, after 5 min there is still some DP 3, 4 and a very little amount 
of 5 material, though there is apparently no DP 6 polymer. This suggests either, that 
DP 6 and 7 are much better acceptors than DP 3, 4 and 5, or that for short 
oligomers the reaction is processive and for longer oligomers is non-processive.  
APTS-(β-1,4-Glc)6 is a good acceptor for CDP forming long polymers rapidly.  
This can be seen in the CE as a non-processive reaction, with all oligomers 
extending continuously until they become insoluble at DP>25.  
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4.3.3.2 Other β-1,4-glycans 
Xylotriose ((β-1,4-Xyl)3) and mannotriose ((β-1,4-Man)3) were labelled with APTS 
and assessed as acceptors for CDP (Fig 4.9). CDP is not able to transfer glucose, 
or any other tested sugar, from the anomeric phosphates on to (β-1,4-Man)3-APTS 
and there is no apparent phosphorolysis. This indicates the -1 binding site of CDP 
cannot tolerate an axial 2OH. (β-1,4-Xyl)3-APTS on the other hand is a reasonable 
acceptor of Glc, forming long polymers. There may be some slight transfer of Xyl or 
Man from their respective phosphates (marked with arrows in Fig 4.9.B).  
This indicates the 6 hydroxyl is not required in the -1 binding site for CDP.  
 
 
Figure 4.9: CDP catalysed extension of APTS-labelled β-1,4-glycans 
A. Extension of APTS-(β-1,4-Man)3, which is not an acceptor for CDP. B. Extension 
of APTS-(β-1,4-Xyl)3, which is an acceptor for CDP catalysed transfer of glucose, 
and to a much lower extent xylose and mannose (arrows indicate new peaks 
formed). Assays were carried out using CDP (5 µg/ml) at 40 °C with Glc-1-P  
(10 mM) and APTS-labelled acceptor (13.5 µM) in HEPES (50 mM, pH 7.5) followed 
by heating to 95 °C and centrifuging at 16 000 g.  
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In order to probe this further, competition experiments were carried out using 
standard assay conditions (Fig 4.10). When a large excess of (β-1,4-Xyl)3 was  
added, there was a significant decrease in the average extension of the  
APTS-(β-1,4-Glc)6 acceptor indicating binding to the active site of the enzyme. 
Small additional shoulders on the peaks may indicate some Xyl-1-P is formed by 
phosphorolysis and this is then transferred on to the acceptor. This is consistent 
with xylans acting as acceptors for CDP.33 Addition of (β-1,4-Man)3 has no impact 
on the average extension indicating there is no binding to the active site.  
 
Figure 4.10: Inhibition of CDP catalysed cellulose polymerisation by β-1,4-glycans 
Standard reactions had unlabelled trisaccharides added to assess the impact on the 
CDP catalysed reaction. The average DP of glucose polymer was less when  
(β-1,4-Xyl)3 was added but not with (β-1,4-Man)3. Assays were carried out using 
CDP (5 µg/ml) at 40 °C with Glc-1-P (10 mM) and APTS-(β-1,4-Glc)6 (13.5 µM) in 
HEPES (50 mM, pH 7.5) followed by heating to 95 °C and centrifuging at 16 000 g. 
4.3.4 Conclusions on the activity of CDP 
Extensive work has previously been carried out on cellobiose phosphorylases to 
assess the substrate promiscuity and to synthesise disaccharides. Monitoring 
polymerisation reactions is less straightforward, but by utilising the combination of 
resolution and dynamic range provided by capillary electrophoresis the long 
polymers produced by this enzyme could be resolved. This technique shows that 
different polymers can be produced with mixed substrates and can resolve the 
relative impacts of binding and catalysis on the turnover of non-natural substrates, 
giving clues to the nature of enzyme-substrate interactions. 
  
 
Figure 4.11: CDP crystals 
A. A Crystal of CDP in the crystallisation drop. Crystals were clusters of 
approximately 50 x 200 µm rods which were separated before mounting in the loop.  
B. Crystal of CDP in litho loop at DLS, showing elliptical beam centred on the 
middle of the crystal. C. Example diffraction pattern of CDP crystal, showing 
diffraction to 3 Å. 
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4.4 Crystallisation of CDP 
In order to better understand substrate recognition by CDP and inform engineering 
strategies, structural studies were carried out. 
4.4.1 Protein crystallisation 
After screening crystallisation conditions CDP was crystallised from approximately 
20% (w/v) PEG3350, 100 mM HEPES (pH 7.5), KCl (300 mM) using the hanging 
drop vapour diffusion method at 20 °C. Crystals appeared after 2 days and were 
soaked in crystallisation solution containing 20% (v/v) glycerol, as cryoprotectant, 
and flash cooled to -173 °C in liquid nitrogen (Fig 4.11). 
4.4.2 Heavy atom derivatisation  
Attempts were made to soak the crystals with heavy metals to facilitate phasing by 
single-wavelength anomalous diffraction. Whilst mercury, gold and platinum 
derivatised crystals gave good diffraction and strong fluorescence (see Section 
8.3.3.2). However, the anomalous signals were too weak for structure solution and 
the selenomethionine (SeMet) strategy was adopted instead. Protein was 
expressed from the same cells as above using the metabolic inhibition strategy in 
the presence of exogenously supplied SeMet.41 The protein was purified from one 
litre of culture to give a final yield of 12 mg of purified protein, which was crystallised 
in the same conditions as the native enzyme. Crystals grown from the SeMet 
containing CDP showed a clear selenium K-edge in the X-ray energy scan  
(Fig 4.12) and diffracted to around 3.5 Å resolution.  
  
Data set SeMet peak Native 1 Native 2 
Data collection    
Space Group P21 P21 P21 
Cell parameters (Å) 
a = 84.68 b = 151.80, 
c = 91.97, β = 114.6 
a = 84.75 b = 151.50, 
c = 91.47, β = 114.7 
a = 84.64 b = 151.80, 
c = 91.97, β = 114.6 
Beamline
a
 I02 I04 I02 
Wavelength  (Å) 0.9795 0.9760 0.9795 
Resolution range
b
 (Å) 
83.62 - 3.50 (3.59 - 
3.50) 
73.93 - 2.55 (2.62 - 
2.55) 
50.60 - 2.30 (2.36 - 
2.30) 
Unique reflections
b
 26456 (1937) 68073 (4901) 93120 (6720) 
Completeness
b
 (%)
 99.0 (99.1) 99.7 (96.8) 99.6 (97.3) 
Redundancy
b
 3.5 (3.4) 5.2 (4.9) 5.6 (3.4) 
Rmerge
b, c
 0.043 (0.142) 0.097 (0.880) 0.084 (0.759) 
Rmeas
b, d
 0.078 (0.174) 0.120 (1.092) 0.102 (1.035) 
Mean I/(I)
e
 18.9 (7.1) 12.9 (2.0) 14.3 (2.0) 
Wilson B value (Å
2
) 72.9 63.9 57.9 
Refinement    
Reflections: working/free
d
 - - 88414/4668 
Rwork
f
 - - 0.191 (0.317) 
Rfree
f - - 0.223 (0.334) 
Ramachandran favoured/ 
allowed
g
 (%) 
- - 95.8/3.9 
Ramachandran outliers
g
 - - 6 
rmsd bond distances (Å) - - 0.008 
rmsd bond angles (º)  - - 1.18 
Contents of model    
Protein residues  - - 
984 (1-984)/978 (1-
694; 653-795; 799-
984) 
Ligands
h
  - - 6xCl 
Precipitant/cryoprotectant 
molecules
h
 
- - 0 
Water molecules   233 
Average atomic displacement 
parameters (Å
2
) 
   
Main chain atoms - - 66.7 
Ligands
h
 - - 59.6 
Water molecules - - 52.1 
Overall - - 66.5 
PDB accession code - -  
Table 4.2: Summary of CDP X-ray data and model parameters 
 
a
 I02, I04 = beamlines at the Diamond Light Source (Oxfordshire, UK).   
b
 The figures in brackets indicate the values for outer resolution shell. 
c
 Rmerge = ∑hkl ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl), where Ii(hkl) is the ith observation of reflection hkl and 
I(hkl) is the weighted average intensity for all observations i of reflection hkl. 
d
 Rmeas = ∑hkl [N/(N  1)]
½
 ∑i |Ii(hkl)  I(hkl)|/ ∑hkl ∑iIi(hkl),  where N is the number of observations of 
reflection hkl.  
e
 The data sets were split into "working" and "free" sets comprising 95% and 5% of the data, respectively. 
The free set was not used for refinement. 
f
 The R-factors Rwork and Rfree are calculated as follows: R = (| Fobs - Fcalc |)/| Fobs | x 100, where Fobs 
and Fcalc are the observed and calculated structure factor amplitudes, respectively. 
g
 As calculated using MOLPROBITY.
42
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Figure 4.12: X-ray energy scan at the Se K absorption edge of a crystal of SeMet 
derivatised CDP  
Crystals of SeMet derived CDP showed a good absorption edge near the expected  
12666 eV. 
 
4.4.3 Data collection and structure solution 
The structure was solved by Single Isomorphous Replacement with Anomalous 
Scattering (SIRAS) using Phenix43 by combining this data set with the native data to 
2.55 Å resolution. A homology model of CDP, based on the structure of cellobiose 
phosphorylase from Cellvibrio gilvus (2CQT), the closest homologue  
(16.3% identity) for which the structure has been solved,44 was manually docked 
into the resultant experimentally phased electron density map. A higher resolution 
native data set (2.3 Å resolution) was subsequently collected, allowing extension of 
the resolution of the model (Table 4.2). The protein backbone was automatically 
fitted into the electron density maps using the Buccaneer package,45 followed by 
several rounds of manual model building and refinement in the CCP4 software 
suite46 to give a final model with Rwork and Rfree values of 0.191 and 0.222 
respectively. 
  
  
 
 
 
Figure 4.14: Comparison of the structures of CDP and CBP  
A. CDP (green) has an N-terminal extension (blue box) over CBP (3QDE,47 
magenta), with clearly defined structure. Helix 630-660 (red box) has moved out of 
the active site compared to CBP. This structure was rotated through 90° and one 
subunit removed. B. CBP active site with cellobiose modelled form C. uda CBP 
(3S4A).  Loop 490-510 (yellow) caps the substrate binding site. C. Helix 630-660 in 
CDP does not cap the active site compared to loop 490-510 in CBP.  
The hydrophobic platform (Trp622) and the catalytic base (Asp424) are both 
apparent in the structure. For alignment of primary protein sequences see  
Appendix 2.3. 
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4.4.4 Apo structure of CDP 
The structure of the CDP is a dimer, which is consistent with the DyLS, but not GF. 
The dimer interface of CDP has about 4800 Å2 of solvent accessible surface buried 
per monomer, giving an overall solvation free energy gain ∆G = -37.0 kcal/mol upon 
dimerization, as well as 59 H-bonds and 26 salt bridges (Fig 4.13).48  
 
Figure 4.13: Structure of the CDP dimer 
CDP forms a dimer, coloured from the N-terminus (blue) to the C-terminus (red) of 
each monomer. 
There are few close structural homologues of CDP in the PDB: 17 entries give a 
DALI Z score of greater than 30,49 although these come from just four  
non-redundant proteins: cellobiose phosphorylases from Cellulomonas uda, 
Cellulomonas gilvus44 and Clostridium thermocellum (CBP)47 and chitobiose 
phosphorylase from Vibrio proteolyticus.50 Compared to these enzymes, CDP has 
an N-terminal extension of over 120 amino acids, which forms a well ordered 
globular domain with no known structural or sequence homologues (Fig 4.14.A) and 
might be involved in protein-protein interactions. The disaccharide phosphorylases 
have a relatively closed active site, with Loop 490-510 capping the substrate binding 
site (Fig 4.14.B). In CDP there is a 12 amino acid extension in the equivalent of this 
loop, Helix 630-660, which has moved away from the substrate binding site, with 
substantial remodelling of this side of the active site (Fig 4.14.C). This opens up the 
active site to accommodate the extended glucan substrate of this enzyme. 
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The residues identified in the CBP structure as the hydrophobic platform (Trp622) 
and the catalytic aspartate (Asp624)47 are both apparent in the active site of CDP  
(Fig 4.14.C). Previously, it has been noted that the lactose phosphorylase capability 
of cellobiose phosphorylase can be enhanced by two mutations,19 one of which 
(T→I) is in the highly altered region of the active site and the other (N→A) is already 
present in CDP. 
Three regions of extra density could be resolved in the active site of each monomer 
in the structure of CDP. These were all modelled as chloride ions, based on their 
local environments and the high concentration in the crystallisation solution. One of 
these sites directly overlays with the active site phosphate in the structure of CBP 
from the same organism (Fig 4.15), suggesting this site probably binds phosphate 
during catalysis. 
 
 
Figure 4.15: Proposed phosphate binding site of CDP 
Phosphate has been resolved in the active site of CBP (3QDE, magenta).47  
Extra density can be resolved in the same place in the CDP structure (green),  
which is modelled as a Cl-. Two other Cl- atoms are also resolved in the active site. 
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4.4.5 Conclusions on the structure of CDP 
The crystal structure of CDP is the first solved for an inverting polymerising 
phosphorylase. There is a large and unique N-terminal extension, which may be 
involved in making inter-protein contacts. The key difference between the relatively 
closed structure of the CBP and this structure rationalises the ability of CDP to 
accept the longer polymers. Work is on-going to achieve structures of CDP with 
oligosaccharides bound, which will help elucidate the substrate specificity of this 
enzyme. 
4.5 Conclusions on cellodextrin phosphorylase 
CDP can be used to synthesis long β-1,4-glucans which rapidly precipitate out of 
solution. There is a very slow transfer of other sugars, including mannose, xylose 
and glucosamine, and competition assays have helped to define the substrate 
recognition by CDP. Using CE xylotriose was also found to be a reasonable 
acceptor and to outcompete the APTS-labelled β-1,4-glucan, indicating it binds to 
the active site. 
The crystal structure shows substantial rearrangement of the active site compared 
to cellobiose phosphorylase, which allows activity on longer polymers. There is also 
some evidence that phosphate binds in the same position as in the cellobiose 
phosphorylase. Together with the substrate binding assays the crystal structures will 
help to inform the synthesis of plant cell wall related β-1,4-oligomers.  
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Chapter 5 – Laminarin phosphorylase – a β-1,3-glucan 
phosphorylase 
5.1 Introduction 
5.1.1 β-1,3-Glucans  
The chemistry, biochemistry and biology of β-1,3-glucans has been the focus 
of study for many years and has been extensively reviewed by Bacic et al.1 
This class of glycans is found throughout nature as exclusively β-1,3-linked 
chains, such as paramylon, the algal storage glucan,2 or the bacterial 
extracellular curdlan.3 They also contain various degrees of other linkages 
including β-1,4, as in oat glucan,4 β-1,6 as in laminarin5 or, in the case of a 
Streptococcus capsule, β-1,2.6 β-Glucans are used structurally in the cell walls 
of some fungi, such Aspergillus,7 and as cell wall reinforcing material in plants.8 
They are also used in some algae, including brown algae and diatoms, as the 
major storage carbohydrate,9 in preference to the α-1,4-glucans used in plants 
and animals. For example, the β-1,3-glucan storage polysaccharide in the 
Euglenoid algae, known as paramylon, is a cytosolic crystalline granule, with 
characteristic shape dependent upon the species of Euglena (Fig 5.1).10 
 
 
 
Figure 5.1: Freeze-etch scanning electron micrograph of a paramylon granule from 
Euglena gracilis 
The β-1,3-glucans form 4 nm ridges in the paramylon granule, which is the width of 
the glucan triple-helix (scale bar = 500 nm). Reprinted from Protoplasma, with 
permission from Springer-Verlag. Copyright (1988).11  
  
 
 
Figure 5.2: Proposed products formed using laminarin phosphorylases 
A. Proposed products formed when glucose was transferred by bacterial 
laminaribiose phosphorylases on to D-glucose (42), D-mannose (123),  
β-methyl-D-glucoside (124), 2-deoxy-D-glucose (125), D-xylose (126),  
6-deoxy-D-glucose (127),12 D-glucuronic acid (128) and 1,5-anhydroglucitol (129).13  
B. Phosphorylases from Euglena are capable of transferring glucose on to the same 
sugars as the bacterial phosphorylases and in addition D-galactose (130),  
D-glucosamine (131), α-phenyl (132), β-methyl (133) and β-phenyl (134)  
D-glucosides, salicin (135), arbutin (136)14 and o/m/p-nitrophenyl β-glucosides 
(137). C. Glucose can also be transferred on to laminaribiose (138),  
cellobiose (139), gentiobiose (140), sophorose (141)15 and β,β-trehalose (142).16 
These are only identified by the Pi released from Glc-1-P by the phosphorylase in 
the presence of these acceptors and their stereochemistry has not been confirmed.  
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β-1,3-Glucans are plant immune elicitors, acting as pathogen associated molecular 
patterns (PAMPs), indicating to the plant the likely presence of a fungal parasite.17 
By applying these to crops, and activating the plant immune response, the yield of 
defence compounds, such as capsaicin in pepper,18 increased and mildew could be 
controlled on strawberries.19 
The β-1,3-glucan curdlan has been extensively investigated in the food industry,20 
where it is used for its excellent thermal stability and resistance to freeze-thaw.21 
This has led to research into improvements in yield and purification of this material 
from the producing bacteria.22 There is a growing interest in biomedical applications 
of β-1,3-glucans, particularly with respect to immunological activity.23 β-1,3-Glucans 
from diverse sources, including curdlan, fungal cell walls24  and paramylon,25 have 
been shown to targeting vaccines to immune cells, enhancing their immunogenicity. 
They also trigger immune cells, including natural killers and monocytes, which 
protect against cancer.26  These glucans can lower cholesterol,27 protect against 
HIV28 and sulphated β-1,3-glucans can be used to prevent blood clots.29 In addition, 
the triple helical structure of β-1,3-glucans30 allows them to be used in diverse 
biotechnological applications, including as part of a chemosensor for acarbose31 
and for the co-complexation of DNA strands.32,33 
5.1.2 Laminarin phosphorylase 
Two laminaribiose phosphorylases have been cloned from β-1,3-glucan 
metabolising bacteria, Paenibacillus sp. YM-1 and Acholeoplasma laidlawii.12,13 
These have been well characterised and belong to the GH94 family, alongside 
CDP (see Chapter 4). These two enzymes show reasonable promiscuity 
towards substitution at the 2 and 6 positions of the acceptor and are strict 
disaccharide phosphorylases (Fig 5.2.A). The Euglena laminarin 
phosphorylases were partially purified and analysed in 1993, but no sequence 
data is available.15 They are able to form polymers, as opposed to the 
exclusively disaccharide phosphorylases found in bacteria, and allow large 
substituents on the reducing terminal of the acceptor, including other sugars 
(Fig 5.2.B+C). This has proved useful in the synthesis of cell wall related 
oligosaccharides, in combination with CDP, to form specific mixed  
β-1,3/1,4-glucan oligosaccharides.34  
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5.1.3 Rationale 
In order to exploit β-1,3-glucans, a source of defined and tractable material would 
be highly desirable. The ability to specifically modify parts of the molecule,  
by inserting or appending other chemical moieties, including sugars, would allow 
further understanding of the mode of action, and give advances in the 
biotechnological utilisation of this carbohydrate. 
In order to utilise the laminarin phosphorylase from Euglena (LDP) the enzyme was 
purified from cells and tested for activity. The utility of this enzyme for the 
glycosylation of small compounds was investigated. To obtain high purity enzymes 
heterologous expression is desirable, requiring a protein sequence. Sequencing of 
the transcriptome of Euglena gracilis var. saccharophila, which avoided the 
complications of genome sequencing,35 revealed the range of carbohydrate active 
enzymes used by this alga. It was hoped that combining this transcriptome with 
proteomic analysis of the purified enzyme would allow identification of the sequence 
of the LDP protein. 
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5.2 Synthesis of glucosyl glycerols 
5.2.1 Growth of Euglena cells 
Euglena gracilis var. saccharophila was obtained from the culture collection of algae 
and protozoa (www.ccap.ac.uk) and grown in the recommended EG:JM media with 
added glucose. Cells were grown for 7 days in the dark and collected  
by centrifugation at 800 g. These cells were then lysed using a cell disruptor and 
cleared by centrifugation at 30,000 g. 
5.2.2 Assay for phosphorylase activity 
Two assays were employed to confirm the activity of the phosphorylase. Initially the 
release of phosphate from Glc-1-P in the presence of Glc was measured using the 
method of De Groeve et al.36 In order to confirm the activity measured was indeed 
that of a laminarin phosphorylase, samples were then analysed for their ability to 
synthesise β-1,3-glucans using CE. Activity was confirmed by the extension of 
APTS-labelled laminaritriose to over 20 residues, in the presence of Glc-1-P,  
as analysed using capillary electrophoresis (Fig 5.3). 
 
Figure 5.3: Extension of APTS-laminaritriose using Euglena phosphorylase  
Cleared cell lysate (EgT, 5 μl) was used to extend APTS-(β-1,3-Glc)3 (9.2 μM) 
by transferring Glc from Glc-1-P (20 mM) in buffer (20 mM MES pH 7.0) at 30 °C  
in 20 min. 
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5.2.3 Acceptor specificities of Euglena laminarin phosphorylases 
The acceptor specificity of the Euglena phosphorylases was assayed by quantifying 
the amount of phosphate released from Glc-1-P in the presence of various 
acceptors (Fig 5.4). Euglena cell lysate was used with no further purification. 
Maltose was found to be a reasonable substrate, although the non-reducing 
terminal glucosyl moiety is held in the α-anomeric configuration, which is known to 
be non-permissive for the laminarin phosphorylases.14 This led to the hypothesis 
that there is some hydrolysis of maltose to glucose, which then acts as the acceptor. 
Glucosamine and xylose are reasonably good acceptors, presumably because  
of their close similarity in structure to glucose. There is some enhancement  
of phosphate release from Glc-1-P in the presence of all the tested sugars and 
sugar alcohols, but the precise structure of the products is unclear. 
 
 
 
 
 
Figure 5.4: Acceptor specificity of phosphorylases in cleared Euglena cell lysate 
Cleared Euglena cell lysate (1 mg/ml total protein) was used to transfer Glc from 
Glc-1-P (10 mM) on to various acceptors (10 mM) in reaction buffer  
(20 mM MES, pH 6.5) for 72 hr at 37 °C. The amount of phosphate released was 
measured using the phosphate release assay. 
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5.2.4 Glucosyl glycerols 
Glucosyl glycerols (Glc-gol) are found in many organisms including plants37 and 
bacteria.38 The α-anomers are produced in many species in response to stress,39 
where they act as potent osmolytes with high water solubility and no net charge. 
Mixtures of mono-glucosyl-α-D-glycerol are stable at 160 °C and have low 
hygroscopicity yet a high water holding capacity,40 making them attractive 
compounds for industry. Maltooligosaccharyl-α-D-glycerols have also been found to 
be inhibitors of digestive enzymes including pancreatic α-amylase41 and an 
intestinal enzyme mixture.42 The less studied β-glucosyl glycerols (β-Glc-gol), and 
derivatives, are also naturally occurring, for example found in the leaves of  
Lillium longiflorum.43  
The natural biosynthetic pathway for the formation of Glc-gol, which involves 
transfer of glucose from unstable ADP-Glucose on to glycerol-3-phosphate followed 
by dephosphorylation,44 is too complicated to be used industrially. Chemical 
syntheses are unsuitable for commercial production as they show low yields and a 
lack of stereo and regiospecificity.45 2-O-α-Glucosyl glycerol (146) has been 
prepared by Nidetzky’s group using an in vitro phosphorylase catalysed 
biotransformation (Fig 5.5).46 Sucrose phosphorylase (E.C 2.4.1.7) was used to 
transfer glucose from sucrose (143) on to glycerol (144), and the product was 
purified using simple column chromatography on a mixture of activated charcoal 
and calcined Celite. This method is currently used by bitop AG (www.bitop.de) to 
produce α-Glc-gol commercially, to be used as a cosmetic moisturiser, with further 
potential including use as a novel sweetener, as a biotechnological stabiliser and in 
cancer therapy.47  
 
Figure 5.5: Sucrose phosphorylase catalysed synthesis of 2-O-α-glucosyl glycerol 
Sucrose phosphorylase catalyses the transfer of glucose from sucrose (143) on to 
various acceptors, including glycerol (144), releasing fructose (145).46 This is used 
in the commercial synthesis of α-Glc-gol (146).  
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β-Glucosyl glycerol is also reported to have useful properties, such as in the 
suppression of the tumour promoting activity of Epstein-Barr Virus.48 The isomers of 
β-Glc-gol have been enzymatically synthesised using catalytically unfavourable 
transglycosylation or reverse hydrolysis. However these tended to yield a mixture of 
products which are difficult to separate.49 For example the almond  
β-glucosidase-catalysed reverse hydrolysis can achieve yields of up to 54%, but the 
mixture of isomers produced (147,148 and 149 in a 2:15:15 ratio) require separation  
(Fig 5.7).50 
 
Figure 5.6: Reverse hydrolysis to form β-glucosyl glycerols 
Almond β-glucosidase can be used to transfer glucose (2) on to glycerol (144), 
forming a mixture of 2-O-β-glucosyl glycerol (147), (2R)-1-O-β-glucosyl glycerol 
(148), (2S)-1-O-β-glucosyl glycerol (149).50 
 
β-glucosidase 
2-O-β-Glc-gol 
(6%) 
(2R)-1-O-β-Glc-gol 
(47%) 
(2S)-1-O-β-Glc-gol 
(47%) 
  
 
 
Figure 5.8: MALDI-ToF MS analysis of the peracetylated biotransformation of glucosyl glycerols using Euglena cell lysate 
Highlighted in green are the glucosylated glycerols, presumed to be β-1,3-glucans, terminating in glycerol. Highlighted in red are the 
oligoglucosides, presumed to be β-1,3-glucans, synthesised by the repeated transfer of Glc from Glc-1-P on to Glc. 
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5.2.5 Biotransformation and purification of β-Glucosyl glycerols 
When cleared Euglena lysate was incubated with Glc-1-P and glycerol, inorganic 
phosphate was released (see Section 5.2.3). To confirm that the product formed 
was the potentially valuable β-Glc-gol the reaction was repeated using 100 mg of 
Glc-1-P in a 10 ml reaction, with a yield of approximately 1.5% based on phosphate 
release, although the protocol has not been optimised (Fig 5.7). 
 
Figure 5.7: Proposed enzymatic synthesis of β-Glc-gol using cleared Euglena cell 
lysate 
Cleared Euglena cell lysate was used to transfer glucose from Glc-1-P (29) on to 
glycerol (144) to form glucosyl glycerol with undefined regio- and stereochemistry 
(150). 
 
After removing the protein, the reaction mixture was subject to anion exchange 
chromatography to remove the buffer, unreacted Glc-1-P and any released Pi.  
The unbound material was acetylated using acetic anhydride (Ac2O) in pyridine.  
MALDI-ToF MS indicated that poly-glucosylated glycerol had been produced  
(Fig 5.8, green). These are more likely to be β-1,3-glucan monosubstituted glycerol, 
rather than multisubstituted glycerol, although insufficient quantities of these 
products were produced for isolation and further characterisation (Fig 5.9). There 
was also a high proportion of glucose polymers produced (Fig 5.8, red), assumed to 
be β-1,3-glucans, formed by the reverse phosphorolysis, catalysed by LDP, on to 
Glc, which had been released by hydrolysis of Glc-1-P or the β-Glc-gol product. The 
acetylated mono-glucosylated products (150) could readily be isolated using silica 
gel chromatography, with a hexane:ethyl acetate gradient, to provide TLC 
homogenous material. The product identity was confirmed by MS and NMR analysis 
was consistent with literature data for peracetylated 2-O-β-glucosyl glycerol  
(Fig 5.11). 
  
 
 
Scheme 1: Chemical synthesis of peracetylated β-glucosyl glycerols 
 
Figure 5.10: MALDI-ToF MS analysis of the products of the chemical synthesis of 
peracetylated glucosyl glycerols 
The crude reaction mixture shows peaks consistent with the sodium and potassium 
adducts of peracetylated Glc-gol (166-167), Glc2-gol (168-169) and Glc3-gol (165). 
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Figure 5.9: Proposed products of the glucosylation of glycerol with Euglena cell 
lysate 
MALDI-ToF of the peracetylated products indicates that there are multiple products 
produced in the reaction. These are proposed to be β-1,3-glucans (42, 155-158), 
some of which terminate in glycerol (150-154). 
5.2.6 Chemical synthesis of β-Glucosyl glycerols 
In order to confirm that the product formed was indeed 2-O-β-glucosyl glycerol, the 
authentic compound was synthesised chemically. The chemical syntheses of all 
isomers of β-glucosyl glycerol have previously been described.51 In order to make 
authentic standards of the peracetylated compound a statistical glycosylation was 
performed (Scheme 1). β-D-Glucose pentaacetate (159) was reacted with HBr in 
AcOH for 3 hours at 0 °C in DCM. The product was recrystallised from diethyl ether 
to give 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide (160). Glucosyl bromide 
160 was then refluxed for one hour with glycerol in dry dichloroethane (DCE) in the 
presence of HgBr2 and Hg(CN)2, and the reaction was left to stir at room 
temperature over the weekend.52 The glycerol was barely soluble in DCE, forming a 
tar in the reaction vessel with the mercury salts and Drierite. After working up, the 
reaction was directly acetylated with acetic anhydride in pyridine, yielding 
peracetylated mono- (166-167), di- (168-169) and tri- glucosylated glycerol (165), as 
judged by MALDI-ToF MS (Fig 5.10). These three species were separated by silica 
gel chromatography to single spots on TLC, which were confirmed by MALDI-ToF 
MS.  
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The chemically synthesised mono-glucosylated glycerol contained three products by 
NMR, which match the previously reported (2R/2S)-1-O-β-glucosyl glycerol  
(167, δ: 4.51(d, J1,2 8 Hz) and 4.52 (d, J1,2 8 Hz)) and the 2-O-β-glucosyl glycerol 
(166, δ: 4.63(d, J1,2 8 Hz)),
51 which could not be separated (Fig 5.11). Integration 
indicates a 10:6 ratio of 167:166, and that the isomers of 1-O-glucosyl glycerol have 
a diastereomeric excess of 20%. The anomeric proton from the biologically 
synthesised product gave a doublet in 1H NMR spectrum which matched the signal 
allocated to the 2-O-β-glucosyl glycerol synthesised chemically. 
 
Figure 5.11: 1H NMR analysis of the peracetylated mono-glucosyl glycerols 
The purified peracetylated mono glucosyl glycerols formed from the chemical 
synthesis contains both 2-O-β-Glc-gol (166) and both (2R)- (149) and  
(2S)-1-O-β-Glc-gol (148), as judged by the chemical shift of the anomeric protons. 
The product of the biotransformation contains exclusively the 2-O-β-Glc-gol. 
5.2.7 Conclusions on the synthesis of glucosyl glycerols 
Glucosyl glycerols are attractive compounds, but the chemical synthesis is 
impractical and the natural biosynthesis too complicated. Using enzymatic 
biotransformation provides a commercially viable synthetic route for these 
compounds and the laminarin phosphorylase from Euglena has the potential for the 
production of large amounts of anomerically pure 2-O-β-glucosyl glycerol. 
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5.3 Partial purification of laminarin phosphorylase from 
Euglena 
5.3.1 Purification strategies 
In order to identify the laminarin phosphorylase form Euglena two purification 
strategies were developed (see Section 8.4.4) and proteomic analysis carried out on 
the most active fractions. 
5.3.1.1 Strategy one 
In strategy one (see Section 8.4.4.5), anion exchange chromatography (AIEX) was 
first performed on cleared Euglena cell lysate and two active fractions separated 
(Eg1.1/2, Table 5.1). There was very little recovery of the activity from the AIEX 
column, giving a very poor purification. The two active fractions were separately 
purified by hydrophobic interaction chromatography (HIC) which gave an increase in 
the purification, though again with loss of most of the activity (Eg2.1/2).  
After the final HIC purification Eg2.1 and Eg2.2 are both able to extend  
APTS-labelled laminaritriose, as judged by CE (Fig 5.12). These fractions were 
separately purified by gel filtration (GF). However no activity could be detected in 
the fractions. Instead the HIC fractions were precipitated with 5% TCA and run on 
SDS-PAGE. The region from 100-150 kDa was cut out, based on the previously 
identified size of LDP,15 and proteomic analysis performed. 
 
 
 
 
Specific activity  
(µM Pi/min/mg) 
% Recovery Fold purification 
Total (EgT) 0.056 100 1.0 
AIEX1 (Eg1.1) 0.18 2.0 3.3 
HIC on AIEX 1 (Eg2.1) 0.89 0.43 15.9 
AIEX2 (Eg1.2) 0.074 2.7 1.3 
HIC on AIEX2 (Eg2.2) 0.35 0. 37 6.2 
Table 5.1: Purification of LDP using strategy one 
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Figure 5.12: Activity of laminarin phosphorylase partially purified from Euglena 
The LDP activities in the eluants from the HIC chromatography were confirmed by 
extension of APTS-(β-1,3-Glc)3 (9.2 μM) by transferring Glc from Glc-1-P (20 mM)  
in buffer (20 mM MES pH 7.0) over 16 hours at 30 °C. 
5.3.1.2 Strategy two 
In strategy two (see Section 8.4.4.6) GF was performed (EgA), followed by HIC 
(EgB), both of which gave good purification and reasonable recovery (Table 5.2). 
The fraction with the highest relative activity was applied to the AIEX column.  
The activity at this point was only detectable after 16 hour incubation with the assay 
mixture, with the loss of activity possibly caused by inactivation of the enzyme under 
the high pH conditions (pH 8.5) of the AIEX. Proteomic analysis was performed on 
the most active fraction (EgD), as well as a fraction which showed no activity (EgC) 
but is expect to contain LDP, based on previous chromatographies. 
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Specific activity  
(µM Pi/min/mg) 
% Recovery Fold purification 
Total (EgT) 0.025 100 1.0 
GF (EgA) 0.080 79.8 3.2 
HIC (EgB) 0.297 3.1 12 
AIEX1 (EgC) NA NA NA 
AIEX2 (EgD) 0.018 0.028 0.72 
Table 5.2: Purification of LDP using strategy two 
NA indicates activity was too low to be detected. 
 
5.3.2 Proteomic analysis of partially purified laminarin phosphorylase 
The protein fractions which were thought to contain laminarin phosphorylases  
(Eg2.1 and Eg2.2 gel slices and EgC and EgD) were subjected to proteomic 
analysis by tryptic digestion and peptide mass-fingerprinting. These were initially 
compared to the limited Euglena genome, protein and EST sequences in the NCBI. 
There were many peptides identified, but there were no proteins with homology to 
carbohydrate active enzymes and thus no candidates for the LDP in these 
sequences. 
5.3.3 Conclusions on the purification of laminarin phosphorylases 
Whilst it was not possible to completely purify the laminarin phosphorylase, fractions 
which showed greatly enhanced purity were achieved. This was in part due to the 
low alkaline stability of the activity. However there were many peptides identified 
which matched candidate enzymes, when better sequencing was interrogated  
(see Section 5.5.1, Appendix 3). 
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5.4 Euglena transcriptome sequencing 
In order to identify candidate laminarin phosphorylases from the partially purified 
fractions good quality sequence data is needed. The genome of Euglena has not 
been sequenced due to its size and complexity. To assist in the identification of the 
laminarin phosphorylase a de novo transcriptome sequencing approach was 
utilised. 
5.4.1 Sequencing of the Euglena transcriptome 
5.4.1.1 Growth of Euglena 
To obtain a broad set of transcripts the RNA of Euglena gracilis var. saccharophila 
was extracted from cells which had been grown under two radically different growth 
conditions. 
The first growth condition was designed to force the cells to undergo photosynthesis 
and synthesis all the cellular components. This comprised a minimal media, solid 
agar containing no amino acids or carbon source. Cells were maintained at 21 °C 
with 12 hours light-dark cycle with ambient illumination. Cells from this condition are 
known as light grown cells. 
The second growth condition included high nutrient media which provides the cells 
with all the basic cellular building blocks. This media contained amino acids, yeast 
extract and extra glucose. Cells were maintained at 30 °C in liquid culture with 
shaking at 200 rpm and light was excluded and cells were collected in mid-log 
phase growth. These cells were designated dark grown cells. 
These growth conditions were chosen to give the widest diversity in growth types of 
Euglena in order to provide the broadest de novo transcriptome with which to 
understand the biosynthetic potential of this organism. Under both these conditions 
cells grew successfully and are expected to undergo paramylon synthesis, whereas 
under carbon starvation conditions heterotrophic cells rapidly degrade the 
paramylon granules.53 The dark grown cells were used for the purification of the 
laminarin phosphorylase (see Section 5.3) and so both cell types are expected to 
contain the transcript for this enzyme. 
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5.4.1.2 Sequencing 
mRNA was extracted from 106 cells grown under each of these conditions and equal 
amounts were pooled and sequenced using 100 base paired-end reads on one lane 
of Illumina HiSeq 2000, to give 26.5 Gbp and 11.9 Gbp of good quality reads, for 
light and dark grown cells respectively (Table 5.3). These sequences were 
assembled into contigs using the Trinity software package,54  with approximately 
290 and 140 fold read depth, for the light and dark samples. 
 
The coding sequences were identified, to give 32,128 non-redundant protein 
fragments. Approximately one third of these were unique to the light grown cells, 
one third unique to the dark grown cells and one third shared between them  
(Fig 5.13). 
 
Figure 5.13: Sequence distribution in the light and dark grown cells 
 Light Dark Total 
Total number of reads 264,808,150 118,608,486 383,414,636 
Total number of nucleotides 26.5Gbp 11.9Gbp 38.3Gbp 
Total number of contigs 233,748 231,176  
Mean length of contigs 391bp 364bp  
Total number of unique proteins 22,280 20,811 32,218 
Mean length of unique proteins 456aa 401aa  
Table 5.3: Summary of Euglena gracilis transcriptome sequencing 
  
 
Figure 5.14: Annotation of the Euglena transcriptome 
A. Top 25 GO ontology terms assigned to the transcriptome. B. Kingdom distribution of top hits of BLAST matches (>1 E-10) of E. gracilis 
unique sequences. C. Distribution of numbers of splice variants estimated from Trinity component and sequence designation. 
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5.4.2 Annotation of the Euglena transcriptome 
To annotate gene functions comparison of the proteins encoded on the contigs 
using BLASTP revealed 14,389 matches the UniRef100 database. Of these proteins 
12,020 were classified into 157 Gene Ontology classifications (Fig 5.14.A).  
The species distribution of the top hits shows the diversity of sources of genetic 
material present in the Euglena genome and highlights its complex genetic history 
(Fig 5.14.B). It should be noted that whilst around 30% of the Euglena sequences 
deposited in the bioinformatics databases match the transcripts presented here, the 
rest do not. For example there are sequences for the HSP70 protein in this 
transcriptome, from Simpson et al.55 and from the sequencing by the Mark C. Field 
laboratory, which only encodes 35 amino acids. These sequences only have  
46% identity at the protein level over these 35 amino acids (Fig 5.15). This is likely 
to be because the strains used in other studies are not related to the one used in 
this work: caution should be taken when comparing sequence data from different 
algal isolates.  
 
A               QLPANPENTIYAVKRLIGRKYEDKTVQSDKNLLAY  
B               QSAMNPENTVFDAKRLIGRKIMDPDVQADMKNWPF  
C               QVAMNPKNTVFDAKRLIGRKFTDATVQADMKHWPF  
                *   **:**::  *******  *  **:* :   : 
 
Figure 5.15: Comparison of the HSP70 protein sequence from different strains of 
Euglena  
The HSP70 protein sequence from this transcriptome (A, lm.7137) was aligned with 
that obtained by genome sequencing (B, E. gracilis genome data obtained from the 
Mark C. Field laboratory sequence database) and that obtained from direct 
sequencing of the mRNA (C)55 shows low identity (46%) between strains of this 
species. (: = homology, * = identity) 
  
 
  
 
Figure 5.16: Examples of splice variants amongst the Euglena transcripts  
lm.75841 and lm.75842 are identical for the first 354 amino acids, comprising a GT1 
domain, but lm.75841 has a further 421 amino acids including a domain related to 
Pex24p, an integral peroxisomal membrane protein.  Yellow indicates identity, green 
indicates similarity. Red box indicates GT1, blue box indicates Pex24p. 
GT1 Pex24p 
GT1 
lm.75841 
lm.75842 
Chapter 5 – Laminarin phosphorylase – a β-1,3-glucan phosphorylase 
 
~ 134 ~ 
 
5.4.3 Splice variants amongst the Euglena transcripts 
Many of the transcripts identified in the present study are alternative splice variants 
(Fig 5.14.C), information that would not be available from genome sequencing. For 
example, transcript lm.75841 and lm.75842 contain an identical N-terminus, coding 
for a glycosyltransferase, but the former has a C-terminal extension, encoding a 
peroxisomal protein which is not present in the latter (Fig 5.16). The splice variant 
abundance is at an approximately 11:1 ratio of long to short in the light sample, but 
in the dark sample no short sequence variant is detectable. This suggests that in the 
light the enzyme activity is required in both subcellular locations, but in the dark it is 
not required in the cytosol. Euglena appears to make use of alternative splicing to 
control sub-cellular targeting of a single gene product, as has been seen for many 
enzymes,56 including glycolytic enzymes in fungi57 and amino acid metabolic 
enzymes in plants.58  
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5.5 Carbohydrate-active enzymes in the Euglena 
transcriptome 
In an attempt to identify the laminarin phosphorylases, all Euglena transcripts 
annotated as encoding carbohydrate-active enzymes (CAZys) were identified and 
classified into families, with the assistance of Bernard Henrissat at the AFMB in 
Marseille (Appendix 4).59 The wealth of information provided by the transcriptome 
highlights many other aspects of carbohydrate metabolism carried out by this alga. 
Euglena is not reported to have a carbohydrate-based cell wall, although 
Trypanosomes, close relatives of Euglena, use sophisticated protein glycosylation 
machinery to achieve their highly flexible cell-surface glycoprotein coat, which is 
important for evasion of the immune system of infected hosts.60 There are many 
more CAZys in the Euglena transcriptome than in the sequenced Euglenozoa, the 
human pathogens Trypanosoma brucei and Leishmania braziliensis (Fig 5.17). 
There are also more CAZys than most other sequenced algae, but fewer than the 
land plants, which require complex cell walls to support their growth. 
Figure 5.17: Average numbers of carbohydrate-active enzymes in different Phyla  
The number of carbohydrate active enzymes annotated in the genomes of 
sequenced organisms was averaged amongst related organisms  
(Appendix 5). Most organisms have more glycosyltransferases then glycoside 
hydrolases, except amongst the saprophytic fungi and oomycetes. 
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5.5.1 Phosphorylases 
Euglena is known to possess both trehalose61 and laminarin62 phosphorylases.  
5.5.1.1 Trehalose phosphorylases 
Bacterial trehalose phosphorylases are in family GH65 and have been well 
characterised.63 There are sequences for four full length members of GH65 in the 
Euglena transcriptome (lm.12469, lm.41777, lm.50851 and lm.95741), which are 
related to the known bacterial trehalose phosphorylases. The first of these also 
encodes a β-phosphoglucomutase, which isomerises the β-Glc-1-P, released by the 
phosphorylase domain, into Glc-6-P, for general cellular metabolism (Fig 5.18). 
      
Figure 5.18: Trehalose phosphorylases encoded in the Euglena transcriptome 
Trehalose (38) can be phosphorolysed in Euglena to produce β-Glc-1-P (45) and 
Glc (2). One of the enzymes (lm.12469) also contains a C-terminal  
β-phosphoglucomutase for the conversion of the β-Glc-1-P (45) into Glc-6-P (47). 
5.5.1.2 Laminarin phosphorylases 
β-1,3-Glucan phosphorylases from bacteria belong to family GH94 and act 
exclusively upon the disaccharide, laminaribiose.12,13 No members of this family are 
present in the transcriptome, suggesting that Euglena utilises another enzyme 
family for this activity.  
The proteomic analysis of the purified laminarin phosphorylase (see Section 5.3) 
yielded two potential candidate enzymes for the laminarin phosphorylase  
(dm.25642 and lm.26257), belonging to GH81 family of endo β-1,3-glucanases  
(see Appendix 3).64  
β-phosphoglucomutase 
GH65 bPGM lm.12469 
GH65 
GH65 
GH65 
lm.41777 
lm.50851 
lm.95741 
Trehalose phosphorylase 
  
 
 
Figure 5.19: Comparison of glycosyltransferase family members in Euglena and humans 
There are a similar number of glycosyltransferases in the human genome as in the Euglena transcriptome, but they are in radically different 
families.
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5.5.2 Glycosyltransferase 
By comparing the distribution of the Euglena CAZys with those in humans, 
hypotheses about the likely glycome of Euglena can be developed. There are 
approximately as many GTs in the Euglena transcriptome as are found in humans, 
but their distribution is markedly different (Fig 5.19).  
5.5.2.1 Energy storage carbohydrates 
As would be expected for an organism that does not produce or utilise  
α-1,4-glucans as an energy storage molecule, there are no members of GT3 or 
GT5, for their synthesis, or GT35 family of α-1,4-glucan phosphorylases for their 
degradation. Instead there are members of GT48 and GT2 for β-1,3-glucan 
synthesis which are absent from the human genome (see Section 5.5.5). 
5.5.2.2 Glycolipids 
The thylakoid membranes of plants contain galactolipids and sulfoquinovosyl diacyl 
glycerol,  which are synthesised by members of CAZy families GT465 and GT28 
(see Section 5.5.6).66 These are absent from the human genome but present in the 
Euglena transcriptome, as would be expected for a photosynthetic organism. In 
addition there are two galactofuranosyl transferases (GT40) not present in humans. 
In Leishmania members of this family are involved in the biosynthesis of 
lipophosphoglycans.67 The Euglena transcriptome also encodes the UDP-Gal 
mutase (lm.28797), required for the synthesis of the substrate for this enzyme. This 
may suggest that Euglena contains galactofuranose residues on their lipids  
or possibly proteins.68 
5.5.2.3 Extra-cellular polysaccharides 
Enzymes in families GT7, GT14, GT43 and GT64, which are involved in the 
synthesis of the human extra-cellular matrix glycosaminoglycans,69 are entirely 
absent from the Euglena transcriptome. Instead There are members of diverse 
families for hemicellulose biosynthesis, such as GT77 α-galactosyl-, xylosyl- and 
arabinosyl-transferases70 and GT34 α-galactosyl- and xylosyl-transferases,71  
which may be involved in the biosynthesis of extracellular polysaccharides  
(see Section 5.5.8). 
  
 
Figure 5.20: Comparison of glycoside hydrolase family members in Euglena and humans 
There are fewer glycoside hydrolases  in the human genome than in the Euglena transcriptome, and they are in radically different families.  
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5.5.3 Glycoside hydrolases  
There are 30% more glycoside hydrolases in the Euglena transcriptome than are 
found in humans, and their distribution is markedly different (Fig 5.20).  
5.5.3.1 Energy-storage carbohydrates 
Critically, in the Euglena transcriptome there are no members of GH13 or GH77, 
which degrade α-1,4-glucans, but there are members of GH3, GH5, GH17, GH55, 
GH64, GH81, and an expansion of GH30 for β-1,3-glucan degradation (see Section 
5.5.5). This is consistent with the use of β-1,3-glucans as the storage carbohydrate 
in Euglena, as opposed to the α-1,4-glucans used in bacteria, animals and plants. 
5.5.3.2 Mammalian GH families, absent from the Euglena transcriptome 
There do not appear to be any lysozyme family enzymes in Euglena, whereas these 
are prominent families in humans (GH22, GH23 and GH24). Euglena also lacks 
members of GH56, GH79, GH84 or GH89 for degradation of glycosaminoglycans, 
which forms a critical part of the extracellular matrix in animals. Whilst Euglena has 
been noted as containing sialic acid,72 there are no members of the eukaryotic 
(GH33) or the viral (GH34, GH58 and GH83) sialidases, for the removal of this 
sugar (see Section 5.5.7.3).73 
5.5.3.3 Complex polysaccharide hydrolases 
In the Euglena transcriptome there are members of many families likely to be 
involved in the degradation of complex environmental polysaccharides, which are 
not encompassed by the human glycome. These include chitinases (GH19), 
galactosidases (GH56 and GH42), xylosidases (GH43) and rhamnosidases (GH78). 
There is a member of the GH88 family (lm.102467), which has only been 
characterised as hydrolysing unsaturated glucuronic acid, left after the action of a 
polysaccharide lyase. There is no evidence for any polysaccharide lyases in the 
transcriptome, suggesting this enzyme acts upon another sugar. There is also one 
full length member of GH117 (lm.76046), which has so far only been characterised 
as cleaving 3,6-anhydro-α-L-galactose from the non-reducing end of agar 
oligosaccharides.74 
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5.5.4 Carbohydrate binding modules  
Carbohydrate binding modules (CBMs) are domains, normally on the same 
polypeptide as other CAZy domains, which bind to specific carbohydrates.75  
There are just four CBMs encoded in the Euglena transcriptome (Fig 5.21), 
compared to 126 in Arabidopsis and 40 in humans. Trypanosoma and Leishmania, 
the other sequenced Euglenozoa, only contain one CBM each, although these 
organisms live in the sugar rich environment of their animal hosts and thus they do 
not require complicated carbohydrate degradation mechanisms. All three 
sequenced Eugelnozoa contain a protein with a CBM48, which binds to  
α-1,4-glucans, and a protein kinase domain, which together make the AMP-
activated protein kinase β-subunit,76 which is activated upon autophosphorylation.77 
The precise target of this CBM in these organisms remains unclear, as they do not 
themselves use glycogen. There is a transcript in the Euglena transcriptome which 
encodes a GH18 chitinase with a chitin targeting CBM18. Expansins are used by 
plants for the loosening of their cell walls during growth.78 The Euglena 
transcriptome contains a sequence with a possible expansin attached to a cellulose-
binding CBM63, which is probably involved in the degradation of plant material,79 as 
Euglena does not have a cell wall that would require expansin-mediated growth. 
There is also a single member of CBM57 malectin family in the Euglena 
transcriptome, which is thought to bind the Glc residues of the Glc3Man9GlcNAc2   
N-glycans in the endoplasmic reticulum.80 
 
Figure 5.21: Domain architectures of the four CBM containing sequences in 
Euglena 
CBM48 is characterised as binding α-1,4-glucans, and when associated with this 
protein kinase domain (ProtK), as in lm.25689, is the β-subunit of AMP-activated 
protein kinase. lm.29686 contains a chitin-binding CBM18 and a chitin degrading 
GH18. dm.80173 encodes a probable expansin (EXPN) and a cellulose directing 
CBM63. lm.101413 encodes a CBM57 with no other protein domains. 
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5.5.5 Paramylon metabolism 
Paramylon granules are synthesised by the transfer of glucose from UDP-glucose 
by paramylon synthase, a membrane bound  670 kDa complex composed of at 
least seven different proteins as judged by SDS-PAGE.81 Paramylon biosynthesis is 
reported to commence with the glucosylation of a protein,82 in a similar way to 
glycogen biosynthesis. In the Euglena transcriptome there are many members of 
various CAZy families which act on β-glucans, and it is possible to propose the 
enzymes involved in paramylon metabolism (Fig 5.22).  
 
 
 
Figure 5.22: Enzymes proposed to be involved in paramylon metabolism    
The number of members of the CAZy families which contain β-glucan metabolising 
activities encoded in the Euglena transcriptome. 
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5.5.5.1 β-Glucan synthesis 
5.5.5.1.1 GT48 
Plants83 and fungi84 synthesise the β-1,3-glucans in their cell walls using  
membrane-bound members of the GT48 family, which may represent candidate 
paramylon synthases in Euglena. Four sequences could be identified in the Euglena 
transcriptome which encode GT48 domains, three of which are closely related  
(94% identity), and one of which (lm.13336) is a short fragment, missing the first 
1900 amino acids, and is probably not a full length transcript. These longer proteins 
are predicted to be around 300 kDa, much larger than the 16-80 kDa proteins which 
are reported to make up the paramylon synthase complex.81  It is possible that 
these larger proteins undergo proteolytic cleavage to leave the lower molecular 
weight species identified in the purified complexes. Alternatively, these members of 
GT48 may be involved in paramylon biosynthesis but are not associated with these 
complexes or they may be involved in the synthesis of another β-glucan.  
5.5.5.1.2 GT2 
Enzymes of the GT2 family are used in the biosynthesis of β-1,3- and β-1,4-glycans 
such as callose, chitin and cellulose59 and also represent good candidates for 
paramylon synthesis. This family is heavily represented in the Euglena 
transcriptome, with 16 unique members (Fig 5.23). The activities of the 
characterised members of GT2 do not cluster based upon their sequences and the 
Euglena enzymes are spread throughout the family making it impossible to predict 
their functions reliably. Whilst some of the sequences are clearly not full length, 
probably a factor of the sequencing rather than a true reflection of their natural 
characteristics, these proteins are of the expected size for members of the 
paramylon synthase complex.81   
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Figure 5.23: Phylogeny of family GT2 proteins  
Euglena and well characterised GT2 family proteins were aligned. Euglena 
enzymes are spread throughout this family and their specificity cannot be predicted. 
H.s.: Homo sapiens. A.t.: Arabidopsis thaliana. P.t.: Populus trichocarpa.  
C.j.: Campylobacter jejunei. P.m.: Pasteurella multocida. A.n.: Aspergillus nidulans. 
D.m.: Drosophila melanogaster. Ag.t.: Agrobacterium tumefaciens.  
G.a.: Glucanoacetobacter diazotrophicus. S.c.: Saccharomyces cerevisiae.  
HylS: Hyalurone synthase. 1-3/1-4S: β-1,3/1,4-glucan synthase. CellS: Cellulose 
synthase. LamS: Laminarin synthase. ChitS: Chitin synthase. 
 
5.5.5.1.3 GT75 
Two components of the paramylon synthase complex were found to become 
glucosylated during granule biosynthesis.81 A member of family GT75 from  
Zea mays is noted as being capable of self glucosylation, with the formation of  
a β-glucosyl arginine linkage.85 It is conceivable that the two members of this family 
encoded in the Euglena transcriptome (lm.47975 and lm.47982) represent this 
initiator of paramylon granule biogenesis. 
5.5.5.2 β-Glucan degradation 
It is known that in Euglena paramylon is degraded by a series of endo- and  
exo-β-glucosidases to form glucose,86 or by laminarin phosphorylase to form  
α-Glc-1-P (Section 5.5.1).62 There are many glycosyl hydrolases present in the 
Euglena transcriptome that belong to a variety of GH families capable of degrading  
β-1,3-glucans.  
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5.5.5.2.1 GH81 
There are transcripts encoding 17 members of GH81, which are well characterised 
endo-β-1,3-glucan hydrolases predominantly found in fungi, where they are required 
for cell division.87 This family includes the best candidates for the laminarin 
phosphorylase identified by protein purification. 
5.5.5.2.2 GH17 
Three members of GH17, which is used by plants to degrade the cell wall β-glucans  
of pathogenic fungi,88 are present in the Euglena transcriptome.  
5.5.5.2.3 GH64 
Members of GH64 has been found to specifically cleave five residues from the end 
of β-1,3-glucans.89 There is one member of this family in the Euglena transcriptome 
(lm.63754) which is only distantly related to any sequenced organisms.  
5.5.5.2.4 GH1 
Members of families GH1 catalyse the hydrolysis of  β-linked glucose and galactose 
from the non-reducing end of carbohydrates and are relatively non-specific.90  
There are two members of this family in the Euglena transcriptome.   
5.5.5.2.5 GH2 
GH2 includes diverse β-glycosidases, notably the E. coli lacZ gene.91  
Whilst β-glucosidase activity is not known in this family, activity towards GlcNAc and 
glucuronic acid is known and there are 6 members in the transcriptome of Euglena, 
suggesting it could have some involvement in paramylon degradation.  
5.5.5.2.6 GH3 
GH3 β-glycosidases are widely distributed in nature and act in a wide variety of 
roles, including cellulose degradation, cell wall remodelling and pathogen 
response.92 There are 12 members of this family in the Euglena transcriptome and 
they may be involved in the release of storage carbohydrates, as they are known to 
be in barley.93 
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5.5.5.2.7 GH5 and GH30 
GH5 is one of the largest and most complex CAZy families, which cleave a wide 
range of β-linked oligosaccharides.94 There are 12 members of this family in the 
transcriptome of Euglena, although it is difficult to predict their exact substrate 
specificity. Several members of GH5 were transferred into the already extant GH30 
after further sequence analysis,95 to provide this family with β-xylosidase activity,  
as well as β-fucosidase and β-galactosidase activities. β-Glucosidase activity is also 
noted in family GH596 and as such the 13 members in the Euglena transcriptome 
may be good candidate paramylon hydrolases.  
5.5.5.2.8 GH55 
Fungal enzymes with exclusive β-glucosidase activities make up GH55.97  
This makes the single member of GH55 in the Euglena transcriptome the most likely 
candidate hydrolase for the degradation of paramylon, though all the other families 
noted may also be involved. 
  
 
EC # Reaction Protein Transcript # Closest homologue E-value 
5.5.1.4  Inositol-3-phosphate synthase 1 INO1 lm.32631 inositol-3-phosphate synthase 1 [Saccoglossus kowalevskii] 0.00E+00 
3.1.3.25 Myoinositol-1-phosphatase IMPA1 lm.49313 hypothetical protein [Trichoplax adhaerens]  1.00E-60 
2.7.8.11 Phosphatidylinositol synthase PIS1 
lm.37320 phosphatidylinositol synthase [Spathaspora passalidarum] 3.00E-50 
lm.79366 predicted protein [Phaeodactylum tricornutum] 1.00E-47 
2.4.1.198 GPI-GlcNAc transferase 
PIG-A dm.79942 UDP-GlcNAc:PI α-1,6 GlcNAc-transferase [Trypanosoma cruzi] 0.00E+00 
PIG-C none   
PIG-H dm.82217  glycosyltransferase [Ectocarpus siliculosus] 1.00E-16 
PIG-P dm.82867 predicted protein [Populus trichocarpa]  4.00E-24 
PIG-Q dm.48080 hypothetical protein Batrachochytrium dendrobatidis] 5.00E-36 
PIG-Y none   
DPM2 lm.108666 unknown [Picea sitchensis] 6.00E-09 
3.5.1.89 GlcNAc-PI de-N-acetylase 
PIG-L 
  
dm.85635 GlcNAc-PI de-N-acetylase [Leishmania major] 2.00E-52 
dm.27659* hypothetical protein [Paramecium tetraurelia strain d4-2] 3.00E-51 
2.3.-.- Inositol acyltransferase PIG-W lm.93529 uncharacterized protein [Brachypodium distachyon] 2.00E-64 
2.4.1.- α-(1-4)-Mannosyltransferase PIG-M lm.94033 GPI mannosyltransferase 1 [Dicentrarchus labrax] 2.00E-100 
2.7.-.- EtNP transferase PIG-N lm.94615 GPI ethanolamine phosphate transferase 1-like [Brachypodium distachyon] 3.00E-177 
2.4.1.- α-(1-6)-Mannosyltransferase II PIG-V lm.98056 dolichol-p-mannose mannosyltransferase [Selaginella moellendorffii]  4.00E-65 
2.4.1.- α-(1-2)-Mannosyltransferase III PIG-B dm.85690 predicted protein [Physcomitrella patens] 3.00E-86 
2.7.-.- EtNP transferase 
PIG-O lm.48401 hypothetical protein [Trichoplax adhaerens] 1.00E-94 
PIG-F dm.104252 protein kinase [Dictyostelium fasciculatum] 9.00E-09 
 
GPI transamidase 
PIG-K dm.51731 predicted protein [Physcomitrella patens]  3.00E-122 
GAA1 lm.88011 predicted protein [Naegleria gruberi]  4.00E-25 
PIG-S dm.90214 unnamed protein product [Vitis vinifera] 8.00E-21 
PIG-T dm.67348 hypothetical protein [Batrachochytrium dendrobatidis] 8.00E-52 
PIG-U lm.71943 gpi transamidase component [Colletotrichum gloeosporioides] 3.00E-31 
 GPIdeacylase PGAP1 lm.73955 GPI inositol-deacylase [Metarhizium anisopliae] 2.00E-36 
Table 5.4: Annotation of enzymes involved in the biosynthesis of GPI anchors 
Euglena transcripts were identified which encode enzymes involved in GPI anchor biosynthesis by homology with known enzymes.98 
Highlighted in yellow are transcripts only present in the dark cells and highlighted in green are those present only in the light grown cells.  
*Also contains an N-terminal mannosyltransferase domain. 
Chapter 5 – Laminarin phosphorylase – a β-1,3-glucan phosphorylase 
 
~ 148 ~ 
 
5.5.6 Glycolipids 
5.5.6.1 Glycophosphatidylinositol anchor 
Glycophosphatidylinositol (GPI) anchors are glycolipids attached to proteins to 
anchor them to the membranes of cells.99 Their synthesis is well characterised  
(Fig 5.24) and all of the enzymes involved, with the exception of the small accessory 
proteins PIG-Y, PIG-X and PIG-C, are readily identifiable in the Euglena 
transcriptome (Table 5.4).98 The first enzyme in the biosynthesis of the inositol ring 
has been purified from Euglena cells previously,100 but the range of anchored 
proteins and the structure of the carbohydrate remain unclear. The presence of a 
PIG-N homologue suggests the core may have an additional 
phosphatidylethanolamine added to the first mannose of the GPI anchors, as is the 
case with mammalian and yeast cells, though not in Trypanosomes.101 
 
Figure 5.24: Biosynthesis of the glycophosphatidylinositol anchor 
The core GPI anchor is synthesised in an ordered manner. 1. GlcNAc is added to 
the phosphatidylinositol, catalysed by a complex of PIG-A, C, H, P, Q, Y and DPM2. 
2. The GlcNAc acetate is removed by PIG-L, leaving GlcN.  3. An acyl chain is 
attached to the inositol by PIG-W. 4. Man is then transferred on to the GlcN from 
dolichol-phosphate mannose by PIG-M. 5. Another Man is added to the first Man by 
PIG-V. 6. Another Man is added to the second Man by PIG-B.  
7. A phosphatidylethanolamine (PEN) is added to the final Man. 8. A protein is 
attached to the distal PEN by a transamidase composed of PIG-K, S, T, U and 
GAA1. 9. The acyl chain is cleaved from the inositol by PGAP1.  
Zig-zag: acyl chain. P: phosphate. White circle: inositol. Blue square: GlcNAc.  
Diagonal blue square: GlcN. Green circle: Man. Red oval: protein.  
  
 
 
 
 
Figure 5.25: Biosynthesis of plastid glycolipids 
A. Sulfoquinovosyl diacylglycerols (172) are formed by the transfer of SQ from 
UDP-SQ (170) on to diacylglycerol (171) by SQ transferase. Galactolipids β-MGDG 
(174) and αβ-DGDG (175) are formed by the transfer of galactose from UDP-Gal 
(173) on to diacylglycerol (175), by MGDG synthase, and then extended by the 
transfer of another Gal from UDP-Gal or, in the case of ββ-DGDG (176), by transfer 
from MGDG. R1/R2 = acyl chains 
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5.5.6.2 Plastid glycolipids 
The thylakoid membranes of the chloroplasts, including those in Euglena,102 contain 
galactosyl glycerides and sulfolipids,103 which function to keep the membranes 
highly fluid (Fig 5.25). The sulfolipids appear to be present in Euglena cells grown in 
the dark,104 suggesting a role in protoplasts. Sulfolipids are synthesised by the 
transfer of sulfoquinovose (SQ) from UDP-6-deoxy-6-sulfo-glucose on to 
diacylglycerides by SQ transferases, in family GT4.65 There is a sequence for one 
homologue of this enzyme (lm.58009), related to bacterial isoforms, present in both 
the light and the dark transcriptomes. One sulfoquinovosyl transferase transcript 
(lm.20804) is related to the spikemoss enzyme and in the dark the transcript 
encodes the active domain with a 200 amino acids truncation of the N-terminus. The 
other transcript (lm. 33890), related to diatom homologues, is not present in the dark 
cells. 
In plants β-monogalactosyldiacylglycerol (MGDG) is formed by the transfer of 
galactose from UDP-galactose on to diacyl glycerol by MGDG synthase, in family 
GT28.66 αβ-Digalactosyldiacylglycerol (DGDG) is formed by transfer of another 
galactosyl moiety from UDP-galactose, by DGDG synthase (GT4) (Fig 5.24). 
Alternatively, galactose can be transfered from another MGDG, by 
galactolipid:galactolipid galactosyl transferase (GGGT), on to the 6’-OH of a 
molecule of MGDG to form β,β-DGDG.105 Oligogalactosyl glycerides can also be 
formed by a GGGT homologue in Arabidopsis, although this enzyme has not yet 
been specifically identified.66  The galactosyl glycerides are only present in Euglena 
cells that have photosynthetic plastids.106 There is one MGDG synthase (dm.42760) 
in the Euglena transcriptome, but rather surprisingly this is only seen in the dark 
grown cells. There are two isoforms of DGDG synthase (lm84277 and lm.68525), 
the latter of which is only present in the light sequences. 
 
  
 
 
  
Activity EC no. Transcripts 
dolichyldiphosphatase 3.6.1.43 lm.53772 dm.71782  
dolichol kinase 2.7.1.108 lm.96623   
UDP-GlcNAc-adolichol 
phosphate GlcNAc-1-p-
transferase 
2.7.8.15 lm.96341   
beta-1,4-N-acetylglucosaminyl 
transferase 
2.4.1.141 lm.87840   
beta-1,4-mannosyl 
transferase 
2.4.1.142 lm.92144   
alpha-1,3/alpha-1,6-
mannosyltransferase 
2.4.1.132 lm.79157   
alpha-1,2-mannosyltransferase 2.4.1.131 lm.67740   
Flippase 
 
 lm.83408   
alpha-1,3-mannosyltransferase 2.4.1.258 lm.68532   
alpha-1,2-mannosyltransferase 
2.4.1.259/ 
261 
dm.60522 lm.71029 dm.60521 
alpha-1,6-mannosyltransferase 2.4.1.260 lm.71029   
dolichol-phosphate 
mannosyltransferase 
2.4.1.83 lm.31276   
dolichyl-phosphate beta-
glucosyltransferase 
2.4.1.117 lm.48352   
alpha-1,3-glucosyltransferase 2.4.1.267 lm.99883 dm.96080  
alpha-1,3-glucosyltransferase 2.4.1.265 lm.99883 dm.96080  
alpha-1,2-glucosyltransferase 2.4.1.256 lm.100691   
dolichyl-
diphosphooligosaccharide-
protein glycosyltransferase 
2.4.99.18 dm.41728 lm.68366 dm.17756 
Table 5.5:  Annotation of enzymes involved in N-glycan biosynthesis 
Euglena transcripts were identified which encode enzymes involved in  
N-glycan biosynthesis by similarity with known enzymes.107 Highlighted in yellow are 
transcripts only present in the dark grown cells and highlighted in green are those 
present only in the light grown cells. 
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5.5.7 Protein glycosylation 
5.5.7.1 N-Glycans 
Protein glycosylation is one of the hallmarks of eukaryotic cells, but has also been 
found in bacteria, particularly pathogens, such as Campylobacter.108 The 
biosynthesis of asparagine-linked glycans (N-glycans) proceeds by the synthesis of 
a lipid linked oligosaccharide precursor, which is transferred en bloc to proteins in 
the lumen of the endoplasmic reticulum (Fig 5.26.A).109 Euglena is known to make 
the same precursor oligosaccharide as animals and fungi (Glc3Man9GlcNAc2Asn),
110 
whilst the related Trypanosomes have lost the ability to add the distal glucose 
residues to the precursor and Leishmania add two fewer mannose residues  
(Fig 5.26.B).111 In Euglena the flagella-associated glycoproteins are also affected by 
tunicamycin, a known inhibitor of protein glycosylation,112 but the exact structure of 
the glycans and the identity of glycosylated proteins still need to be established. 
Sequences for all of the enzymes required for the synthesis of the full N-glycan 
precursor are present in the Euglena transcriptome (Table 5.5). There are also three 
sequences for the GT66 oligosaccharyl transferases, which in Trypanosomes each 
show defined substrate specificities.113  
 
Figure 5.26: Biosynthesis of dolichol-linked oligosaccharide N-glycan precursor 
A. The oligosaccharide precursor is synthesised on a dolichol pyrophosphate 
precursor. The first steps take place on the cytosolic face of the endoplasmic 
reticulum, using sugar nucleotides as the activated sugar donors. The Man5GlcNAc2 
precursor is flipped into the lumen of the ER and the synthesis proceeds using 
dolichol phosphates as the sugar donors. The entire oligosaccharide is transferred 
en bloc to the protein. B. Euglena makes the full precursor, but the well 
characterised Euglenozoa do not. Trypanosoma does not add the final Glc residues 
and Leishmania does not add the final Man residues either. Black square: GlcNAc. 
White circle: Man. Black triangle: Glc. Dol: dolichol. P: phosphate. Reprinted from 
Essentials of Glycobiology with permission from CSHLP. Copyright (1999).114 
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5.5.7.2 O-GlcNAc 
O-GlcNAc is involved in cell signalling,115 including cross-talk with protein 
phosphorylation.116 There are three putative GT41 O-GlcNAc transferases in the 
transcriptome, (lm.52466, dm.35031 and lm.92993) the latter of which is only 
present in the light grown cells. In humans there is only one transferase, whilst 
plants have two distinct enzymes.117 There are however no homologues for the  
O-GlcNAcase encoded in the Euglena transcriptome, or in plants, which would 
reverse this signal, suggesting a non-canonical hydrolase carries out this reaction. 
5.5.7.3 Sialic acids 
Sialic acids are commonly found in animals at the ends of the glycans, and have 
roles including altering the cell surface charge and in specific cellular recognition.107 
They are also found in a range of pathogenic microorganisms, including parasitic 
protozoa118 and bacteria,119 which can synthesise or appropriate the sialic acid from 
the host.120 Euglena has previously been reported to contain sialic acids, attached to 
glycolipids, based on immunostaining.72 There is one transcript encoding  
N-acetylneuraminate pyruvate-lyase (dm.37271) which can reversibly add pyruvate 
to N-acetyl mannosamine to form N-acetyl neuraminic acid.121 There are no obvious 
transcripts for enzymes which would covert this sialic acid to the usual  
CMP sugar-nucleotide, nor are there any candidate trans-sialidases for scavenging 
sialic acid from glycans in the environment. There are no obvious sialyl transferases 
in the Euglena transcriptome, such as GT12 or GT29. Whilst it is possible that this 
lyase is used in the degradation of exogenous sialic acid, it is also possible that 
Euglena uses a unique route for the addition of sialic acids to its glycans.  
5.5.8 Xylose containing polysaccharides 
It has been reported that Euglena has a xylose-containing protein associated with 
its flagella,122 though neither the carbohydrate structure nor the protein to which it is 
attached have been elucidated. There are many enzymes in CAZy families with 
xylosyltransferase activities, which may represent good candidates for the 
biosynthesis of this flagella glycan.   
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5.5.8.1 GT61 family 
In the Euglena transcriptome there are 19 members of the GT61 family of enzymes, 
for the transfer of α-xylose on to plant glycoproteins,123 extra cellular  
O-GlcNAcylation in animals124 and as probable candidates for arabinosylation of 
cereal xylans,125 though this has yet to be shown biochemically. Many of the 
Euglena transcripts are related to the characterised members of GT61, but their 
precise activity is not clear (Fig 5.27). There are also many sequences which are 
only distantly related to this family and detailed biochemical analysis would be 
needed to either include or reject these enzymes from GT61. 
 
 
Figure 5.27 Phylogeny of family GT61 proteins  
Members of family GT61 from Euglena and well characterised GT61 family proteins 
were aligned. S.o.: Sachharum officinarum. Z.m.: Zea mays. A.t.: Arabidopsis 
thaliana. M.s.: Medicago sativa. P.x: Populus hybrid. O.s.: Oryza sativa.  
T.a.: Triticum aestivum. D.m.: Drosophila melanogaster. GlcNAcT: N-acetyl 
glucosaminyltransferase. XylT: xylosyltransferase. AraT: arabinosyltransferase 
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5.5.8.2 GT77 family 
Family GT77 is characterised as containing α-1,3-xylosyltransferase,70  
β-arabinosyltransferase and α-1,3-galactosyltransferase126 activities. There are  
23 sequences belonging to GT77 encoded in the Euglena transcriptome, which are 
likely to carry out these reactions, though it is not possible to predict their substrate 
specificity (Fig 5.28). 
 
Figure 5.28: Phylogeny of family GT77 proteins  
Members of family GT77 from Euglena and well characterised GT77 family proteins 
were aligned. A.t.: Arabidopsis thaliana. D.d.: Dictyostelium discoideum.  
AraT: arabinosyltransferase. XylT: xylosyltransferase. GalT: galactosyltransferase. 
 
5.5.8.3 Other potential xylosyltransferases 
Only one member of GT90 has been characterised, the xylosyltransferase of the 
Cryptococcus capsule.127 There are two enzymes weakly related to GT90 encoded 
in the Euglena transcriptome, which may be involved in the biosynthesis of the 
surface xylose containing material. There is also an incomplete transcript of a 
member of GT34, predicted to be involved in xylosyl-71 or galactosyl- transfer.128  
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5.5.8.4 Potential xylosyl hydrolases 
There are three members of GH43 in the Euglena transcriptome which may be 
xylosidases129 or arabinases.130 There is also a single member of carbohydrate 
esterase family 3 (CE3), which are characterised as acetyl xylan esterases131 and 
are involved in the degradation of plant cell wall acetylated polysaccharides.132 
Together this suggests Euglena has the capability of synthesising xylan-like material 
and may be able to degrade plant hemicellulose-related xylan. 
5.5.9 Didomain CAZys 
Whilst fusion of CBMs to other CAZYs is relatively common in nature, and contiguity 
of multiple glycoside hydrolase domains in a single protein is well known, it is much 
rarer to find glycosyl transferases as part of a protein containing other domains with 
carbohydrate processing activity.133 Examples include the sea-squirt  
Oikopleura dioica,133 which encodes a cellulose synthase (GT2) and a β-glucan 
hydrolase (GH6), and the O-GlcNAc transferases which are found in most 
eukaryotes and some bacteria, and encode tetratricopeptide repeats in addition to 
the GT41 GlcNAc-transferase domain.134 
Two transcripts were identified in the Euglena transcriptome which encode proteins 
with two carbohydrate-active enzyme domains. The first protein (lm.71174)  
had a putative GT11 fucosyltransferase domain, and a putative GT15 
mannosyltransferase domain (Fig 5.29). The active site of the former does not 
contain the second arginine in the HxRRxD motif,135 whilst the latter contains the 
nucleophile and a zwitterionic ion-binding motif (see Appendix 6).136 It is possible 
that this enzyme this enzyme maybe act to transfer both fucose and mannose to the 
same N-glycan core. Alternatively, this enzyme may transfer mannose on to a 
fucosylated glycan, to which it is directed by the GT11 domain, acting as a 
carbohydrate-binding module.  
A second didomain protein (dm.47703) appears to contain a GT1 sugar transferase, 
most closely related to bacterial sterol β-glucuronic acid transferases, linked to a  
C-terminal GH78 α-rhamnosidase domain (Fig 5.29). Both domains appear to have 
an intact active site, suggesting both activities are viable (see Appendix 6).137,138  
In order to confirm the activity of this enzyme, synthetic gene constructs of the two 
domains were expressed in E. coli. Only the GH78 domain could be expressed 
successfully and was shown to be a rhamnosidase with kinetic parameters 
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consistent with other enzymes of this class (see Appendix 7). This didomain protein 
might conceivably be involved in cleaving rhamnose from a small molecule and 
adding a glucuronic acid moiety, a sugar addition that is known to facilitate  
sub-cellular relocalisation and drug detoxification.139  
 
 
Figure 5.29 Domain architecture of didomain CAZys encoded in the Euglena 
transcriptome 
lm.71174 encodes an N-terminal GT11 and a C-terminal GT15. dm.47703 encodes 
an N-terminal GT1 and a C-terminal GH78. See Appendix 6 for sequence 
alignments with well characterised members of these families. 
 
5.5.1 Conclusions on carbohydrate metabolism in Euglena 
The transcriptome of Euglena encodes a diverse array of carbohydrate active 
enzymes. We can predict the enzymes likely to be involved in synthesis and 
degradation of the β-glucan storage carbohydrate, based on similarity to enzymes 
used in plants and fungi for the synthesis of their cell walls. Validation is required, 
possibly by comparison of the proteins which make up the previously identified 
paramylon synthase complex81 with the transcriptome presented here. 
The Euglena transcriptome also encodes many enzymes involved in the synthesis 
and degradation of complex plant cell wall type carbohydrates, including 
galactosidases, xylosidases and rhamnosidases, suggesting they are capable of 
obtaining sugars from complex plant material. Euglena are not noted as having a 
rigid polysaccharide cell wall, and instead have a flexible proteinaceous coat. 
However, they do have xylan associated with their flagella122  and the transcriptome 
shows that all the machinery for N-glycans and GPI anchored proteins is encoded in 
Euglena. This suggests that the surface of Euglena is coated in carbohydrates. 
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5.6 Conclusions on laminarin phosphorylase  
The sequencing of Euglena gracilis has provided a wealth of information but has not 
yielded any stand-out candidates for the laminarin phosphorylases in the obvious 
CAZy families. However partial purification of the laminarin phosphorylase revealed 
two members of GH81 family endo-β-1,3-glucan hydrolases. Whilst this family is not 
known to contain any phosphorylase activity, work is on-going to characterise the 
activity of these proteins. Laminarin phosphorylases have great potential for 
biotechnology, both for the synthesis of immunomodulating β-glucans, and for the 
synthesis of less accessible glycans, such as β-Glc-gol. It is hoped that identification 
and further characterisation of these enzymes will allow their full potential to be 
realised. 
Euglena are known to have unusual carbohydrate metabolism and the 
transcriptome data presented here provides a starting point for an in-depth study of 
the glycobiology of this class of alga. The complex N-glycan structures need to be 
elucidated but it is possible that this organism could be used to synthesise 
therapeutic human glycoproteins. Understanding the biosynthesis and degradation 
of the unusual storage polysaccharide, paramylon, is also of interest to fundamental 
biology and the carbohydrate active enzymes provides a basis for this research. 
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Chapter 6 – Further details on the Euglena transcriptome 
6.1 Introduction  
6.1.1 Euglena gracilis 
Euglena are common Eukaryotic algae, especially in organic rich freshwaters where 
they can be so populous as to give their characteristic colour to the water, such as 
the verdant green Euglena viridis or blood red Euglena sanguinea. Euglena were 
first recorded1 by van Leeuwenhoek in his 1674 letter to the Royal Society,2 
although Harris is usually credited with the first description.3 They have  
a characteristic shape and size, with a highly flexible cell surface (Fig 6.1). 
 
 
Figure 6.1: Physiology of Euglena gracilis  
 
The Euglenoids are algae related to the pathogenic protozoa Trypanosoma and 
Leishmania (Fig 6.2) and are extremely difficult to classify, even using modern 
molecular techniques.4 Euglena exhibit a highly flexible lifestyle, switching between 
photosynthesis, absorbing nutrients and eating other eukaryotes and bacteria.  
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Figure 6.2: Phylogeny of Euglena gracilis 
Unrooted tree showing Euglena gracilis in relation to sequenced algae and model 
organisms.5 Organisms in green are photosynthetic. 
 
Euglena are readily cultured and have been exploited in diverse fields including as a 
reporter for vitamin B12 production,6 to study the ecotoxicity of zinc oxide 
nanoparticles,7 in a neurocomputer based on their motion in a micro aquarium8 and 
for the intracellular biosynthesis of ferri-hydrite nanoparticles.9 Their behaviour has 
been studied using zero gravity flight10 and the nature of the active gravitaxis 
mechanisms was studied under varying acceleration aboard the space shuttle 
Columbia.11 
Euglena gracilis has been investigated for the biotechnological production of many 
high value compounds, including vitamins A, C, E and essential amino acids.12  
They are a good source of polyunsaturated fatty acids,13 as well as making high 
levels of paramylon.14 In many ways Euglena is a “super food” and is currently sold 
as a nutritional and cosmetic supplement by euglena Co., Ltd 
(http://www.euglena.jp). Under anaerobic conditions some strains of Euglena 
gracilis can form over 50% dry weight wax esters15,16 and are able to produce these 
compounds under adverse conditions encountered in, for example, acid mine 
drains.17 This makes them suitable for use in waste water treatment,18 where they 
can produce these compounds for use in animal feed or as biofuels.  
  
Figure 6.3: Sources of the Euglena genome  
1. The ancestor of all eukaryotic cells formed an endosymbiotic relationship with a 
prokaryote to form the mitochondrion (Mt). 2. Most of the genetic material was 
transferred to the nucleus (Nu) whilst some remained in the mitochondria.  
3. The ancestor of all plant cells subsequently took up a cyanobacterial cell to form 
the chloroplast (Cp) 4. Most of the genetic material was transferred to the nucleus. 
5. The ancestral plant cells diversified to form green algae and plants, golden algae 
and red algae.19 6. A red algal cell was taken up by the ancestor of Euglenids and 
some of the DNA transferred to the nucleus.20 7. The red algae was then lost and 
the ancestor of photosynthetic Euglena formed an endosymbiotic relationship with a 
green algae,21  which has been subsequently lost in several independent Euglenid 
lineages. 8. Nuclear and chloroplast DNA were subsequently transferred from the 
green algae to the nucleus of the Euglenid ancestor. 9. The nucleus and 
mitochondia were lost from the plant cell to leave the final chloroplast.  
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Genome sequencing of Euglena has not been possible to date, due to the large and 
complex genome (approximately 2 Gbp with 80% repetitive sequence – Mark Field, 
private communication), which has arisen from a series of endosymbiotic events 
during its evolution. The genetic material is derived from: the ancestral protozoa;  
the mitochondrion, related to alphaproteobacteria; a red algae endosymbiont which 
has since been lost;20 the primary photosynthetic host, thought to be related to 
green alga;22 and the primary photosynthetic endosymbiont, related to 
cyanobacteria, from the green alga (Fig 6.3). Some genetic material is retained in 
the chloroplast, which has been sequenced,23 and the mitochondrion, which has 
unusually fragmented gene organisation.24 Aside from normal eukaryotic epigenetic 
modification, including DNA methylation and histone acylation, the genome of 
Euglena also contains the modified nucleotide BaseJ (see Section 6.3.3), which is 
found amongst the kinetoplastids.25 Euglena has the ability to extensively process 
mRNA during transcription, including removal of both classical26 and atypical27 
introns as well as transplicing of small leader sequences,28 altering the sequences 
before translation.  
6.1.2 Rationale 
The biochemistry and cellular biology of Euglena have been heavily studied for 
many years but recently the focus on model organisms has led to a reduction  
in research into this alga. The transcriptome sequencing of Euglena (see  
Section 5.4) has allowed us to avoid the difficulties involved in genome sequencing,  
often encountered with algae,29 including large genome size,30 highly repetitive 
sequences31 and a high degree of DNA modification.32 Aside from enzymes 
involved in carbohydrate metabolism (see Section 5.5) the transcriptome revealed 
the complex metabolism available to this highly flexible alga, which has helped us to 
understand the biosynthesis of the many medicinally and biotechnologically 
interesting compounds. 
  
FM lm.32046 dm.18553 
 
   
IFT88 lm.21777 
  
   
IFT52 lm.22088 lm.20473 
 
   
IFT57 dm.22343 lm.26251 
 
   
IFT22 lm.34442 lm.7956 
 
   
IFT140 lm.34442 dm.42150 lm.48576    
IFT172 dm.9347 lm.56041 lm.69878 dm.17483   
RIB72 dm.1605 
 
dm.23873 lm.41593 lm.69421  
RSP3 
   
   
ε-tubulin 
   
   
BBS5 dm.8542 
  
   
AM 
   
   
Drebrin/ABP1 dm.38407 
  
   
Twinfilin lm.40062 dm.58212 
 
   
Filamin dm.96986 
 
lm.55772 dm.66337 dm.22825 lm.54986 
WASH lm.58501 
  
   
Nadrin lm.56666 lm.31604 
 
   
Sphingomyelin synthase related proteins 
   
   
Saposin lm.76724 lm.87578 
 
   
Sphingomyelinase 
 
dm.18553 lm.74949 dm.24189   
Table 6.1: Euglena transcripts encoding key genes associated with flagella motility (FM) or amoeboid motility (AM)33  
Highlighted in yellow are transcripts only present in the dark grown cells.  
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6.2 Movement 
Euglena are extremely active with a rapid swimming movement, propelled by their 
flagella, or by euglenoid movement, based on changes in their cytoskeleton  
(Fig 6.4). The euglenoid movement has unusual kinematics and hydrodynamics,34 
and is of interest to the biomimetic community, inspiring development of active 
envelopes. The key genes which define flagella and amoeboid movement33 are all 
present in the transcriptome with the exceptions of the particular tubulin isoform 
used in flagella, a drebrin homologue involved in microtubule clustering, and the 
saposin activator of sphingomyelin remodelling (Table 6.1). This suggests that 
euglenoid movement, whilst morphologically distinct from amoeboid movement, 
uses similar molecular mechanisms.  
 
Figure 6.4: Euglena movement 
Euglena have a highly flexible cell morphology and can change between long, thin, 
highly motile cells and static, round cells in a few seconds. 
  
  
 
  
 
  
Gene Transcripts 
Spo11 
 
    
Hop1 lm.96881     
Hop2 lm.36457     
Mnd1 lm.38224     
Dmc1 dm.98745     
Rad51 lm.97302 dm.8059 dm.33887   
Msh4,5 lm.100901 
dm.51827 dm.50158 lm.57414 dm.73380 
Msh2,6 
 
Mre11 dm.28705     
Rad50 lm.54833 dm.30793 lm.41294   
Rad52 dm.85580     
Mlh2 
dm.41679 
 
lm.85993 
   
Mlh1 
lm.94725 
dm.89596  
Pms1/2 lm.51341  
Mlh3     
Table 6.2: Euglena transcripts encoding key genes involved in meiosis35  
Several of the proteins have close homology to more than one of the 
Eukaryotic homologues. Highlighted in yellow are transcripts only present in 
the dark grown cells.  
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6.3 Genetic control 
 Eukaryotes use diverse mechanism for genetic control and repair but there remain 
many unresolved issues around the lack of aging in Euglena.36   During symmetric 
cell division all the genetic damage accumulated through the cell cycle must be 
repaired, and epigenetic modifications copied on to the next generation. By studying 
how this is accomplished in the immortal Euglena, greater understanding about 
human aging may lead to advances in medicine. 
6.3.1 Sexual reproduction 
There is no evidence in Euglena for meiosis or sexual reproduction, which 
complicates mutagenesis and genetic transformation, hampering the use of this 
alga in biotechnology. However genome sequencing and direct observation of other 
algae, including Chlorella37 and Ostreococcus,38  has revealed cryptic sexual 
reproduction. The transcriptome of Euglena contains all the genes required for 
meiosis, with the sole exception of the particular isoform of topoisomerase  
(TOPO VI) associated with meiosis (Table 6.2), although this enzyme is not actually 
required for meiosis.39 There are transcripts encoding all four other classes  
of topoisomerase (IA, IB, II and III) which may be able to substitute for this enzyme, 
or homologous recombination may not occur during meiosis. Together this suggests 
that under certain conditions this alga may undergo meiosis and sexual 
reproduction.   
6.3.2 DNA gyrase 
The Euglena transcriptome also encodes one of each subunit of the bacterial 
topoisomerase, DNA gyrase.  In plant cells these are targeted to the chloroplast and 
mitochondrion, where they have a role in controlling DNA topology,40 and would be 
expected to have the same role in Euglena. The fluoroquinolone ofloxacin is a 
specific inhibitor of DNA gyrase and in Euglena is known to disrupt both 
chloroplast41 and mitochondria.42 We have found the fluoroquinolone derivative 
ciprofloxacin to inhibit growth of Euglena cells (IC50 = 8±3 µM) and to lead to 
permanent loss of chlorophyll (Figure 6.5), in a similar way to streptomycin 
treatment of this organism.43 These results support the necessity for DNA gyrase in 
chloroplast growth.  
 
  
 
Protein 
name 
Activity Pathway 
No of 
homologues in 
Euglena  
AGO RNA slicer 
miRNA, S-PTGS, tasi-RNA, 
chromatin 
4 
DCL miRNA synthesis All 4 
RDR 
RNA-dependant 
RNA-polymerase 
S-PTGS, Transitivity, tasi-
RNA, nat-siRNA, Chromatin 
0 
CMT 
Cytosine DNA 
methyltransferase 
Chromatin  2 
K9 MeT 
Histone methyl 
transferase 
Chromatin  5 
NRPD 
DNA-dependant 
RNA-polymerase 
Chromatin, nat-siRNA 8 
HDA6 
Histone 
deacetylase 
Chromatin 8 
SDE3 helicase S-PTGS, Transitivity 8 
HST Exportin miRNA 1 
HYL1 dsRNA binding miRNA 0 
WEX exonuclease S-PTGS 0 
SGS3 unknown 
S-PTGS, Transitivity, 
tasiRNA, nat-siRNA 
0 
HEN1 
sRNA-methyl 
transferase 
All 0 
Table 6.3: Euglena transcripts encoding key genes for RNA silencing  
Number of transcripts for genes involved in gene silencing pathways in the Euglena 
transcriptome.44 tasi: transacting siRNA. S-PTGS: sense posttranscriptional gene 
silencing. IR-PTGS: inverted repeat posttranscriptional gene silencing.  
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Figure 6.5: Ciprofloxacin inhibition of Euglena culture growth 
Cells (104) were inoculated into high nutrient media containing ciprofloxacin and the 
number of cells counted after seven days (30 °C). Ciprofloxacin inhibited growth at 
concentrations above 1 µM, although there have still been around five doublings at 
inhibitor concentrations of 10 mM. The inset images show single cells after 
treatment with 0 mM (top) and 100mM (bottom) antibiotic. Ciprofloxacin causes loss 
of the chloroplasts and therefore chlorophyll, leaving the cells brown in colour.  
6.3.3 Gene silencing 
RNA-mediated gene silencing is a ubiquitous control mechanism found in bacteria,45 
plants46 and animals.47 Three main components make up the machinery  
in Eukaryotes: Dicer like (DCL) which cleave double stranded RNA;48 Argonaute 
(AGO) which targets inactivation of sequences complementary to small RNAs (21-
24nt) as part of the RNA-induced silencing complex (RISC);49 and RNA-dependent 
RNA polymerase (RDRP) which amplifies the silencing.50 Whilst some sequenced 
algae do not have any of the components, most retain some capability.51 Euglena is 
known to possess some capacity for RNA-silencing: successful knockdown 
experiments of a gene involved in vitamin C biosynthesis52 and a photoreceptor 
protein53 have been performed in this organism. The transcriptome encodes four 
DCL proteins and four AGO proteins, along with many of the other components of 
the gene silencing machinery including helicases, histone methylases, histone 
deacetylases, and cytosine methylases (Table 6.3).  There is no RDRP present 
which suggests that Euglena is incapable of producing trans-acting RNAs or utilising 
the aberrant transcript pathway.44 It is possible another enzyme is capable of acting 
to amplify the signal, as is suggested for mammals and insects, which also lack the 
RDRP.50 In Arabidopsis this amplification is involved in development, where the 
original double-stranded RNA might be diluted during growth,54 which is conceivably 
not required in a single celled organism such as Euglena. 
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6.3.4 BaseJ 
BaseJ (179) is a modified nucleotide, formed by hydroxylation and glucosylation of 
thymidine (Fig 6.6), uniquely found amongst the Euglenozoa, including the 
important human pathogens Trypanosoma and Leishmania.55 It prevents RNA 
polymerases passing along the DNA strand, silencing the modified region of the 
genome, and is of key importance to the control of coat expression in 
Trypanosomes.25 In Leishmania some of the BaseJ is not located around the 
telomeres, as it is in Trypanosomes,56 and has been shown to prevent 
transcriptional readthrough, ensuring proper transcriptional termination. BaseJ is 
found throughout the genome of Euglena, where it makes up approximately  
0.2% of the bases.57  
The two proteins involved in the initial hydroxylation of thymidine are well studied in 
Trypanosomes and Leishmania.58 There are matching homologues encoded in the 
Euglena transcriptome, though the JBP1 homologue (dm.72228), essential in 
Leishmania,59 is not found in the transcriptome of the light grown cells. Unlike JBP1, 
JBP2 (dm.12798 in Euglena) does not actually bind BaseJ, but instead appears to 
initiate de novo BaseJ biosynthesis, whilst JBP1 amplifies this signal.60  
The enzymes for addition or removal of the glucose have not, to date, been 
identified in any organism. After removal of the glucose the HOMedU (178) could be 
either dehydroxylated or the base could be excised.  
 
 
Figure 6.6: BaseJ metabolism 
To form Base J (179) a thymidine (177) is hydroxylated by JBPs, to form 
hydroxymethyl-deoxy-uracil (178, HOMedU), and then glucosylated by an 
unidentified glucosyl transfrerase. The glucose is removed by an as yet unidentified 
glucosidase, leaving HOMedU. R1 = 3’ DNA strand, R2= 5’ DNA strand. 
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6.4 Primary metabolism 
6.4.1 Core metabolic enzymes 
Candidate genes were identified in the Euglena transcriptome for all of the enzymes 
in the primary metabolic pathways, including glycolysis and gluconeogenesis, citrate 
cycle, pentose phosphate pathway and fatty acid biosynthesis, based on homology 
to orthologs in the KEGG modules and pathways (see Appendix 8). There are also 
candidates for carotenoid biosynthesis and the Calvin cycle, which are required for 
photosynthesis. The completeness of these pathways confirms that meaningful 
sequencing depth and functional assignments have been achieved. 
The Euglenoid chloroplast is derived from a green algal cell and has had substantial 
genetic rearrangement during evolution.61 This has included the loss of several 
genes from the chloroplast genome to the nucleus, from where they can be 
identified in the Euglena transcriptome, including the protease clpP (lm.95241 and 
lm.15675), the membrane protein cemA (lm.59206) and photosystem 1 component 
ycf3 (lm.46611).  
6.4.2 Lipids 
Under anaerobic conditions Euglena converts pyruvate, produced during glycolysis, 
to acetyl-CoA. This is used to produce diverse final products, including ethanol, 
lactate and fatty acids. Euglena has all four of the enzymes necessary for the 
fermentation of pyruvate62 to acetate in the absence of oxygen (Table 6.4).  
This is then used to make a wide variety of long-chain wax esters, which can reach 
over 50% of the cell dry weight under anaerobic conditions.63  
pyruvate formate lyase dm.62807   
pyruvate-ferredoxin 
oxidoreductase lm.15157 lm.3147  
lactate dehydrogenase lm.11577 dm.18437 lm.9457  
pyruvatedecarboxylase lm.8614   
Table 6.4: Euglena transcripts encoding enzymes for the anaerobic fermentation of 
pyruvate  
Pyruvate formate lyase, highlighted in yellow, is only present in the dark grown cells. 
  
 
Fatty acids (FA) identified by GCMS from Euglena gracilis as methyl esters. 
 
13:0 14:0 15:0 16:4 16:3 16:0 Cyp16 17:0 18:4 18:2 18:3 20:4 20:5 20:3 20:2 22:5 22:6 
 % FA 
4.5 
±0.1 
8.6 
±0.3 
8.3 
±0.5 
0.9 
±1.6 
7.2 
±2.0 
9.1 
±0.8 
5.4 
±0.3 
1.4 
±2.3 
7.5 
±2.3 
1.7 
±3.0 
12.7 
±2.2 
6.1 
±1.6 
7.6 
±2.3 
3.2 
±2.8 
5.8 
±2.5 
2.5 
±2.2 
7.6 
±2.3 
 
Wax esters (WE) identified by GCMS from Euglena gracilis. Isomers cannot be separated and are of the form H(CH2)x-1 COO(CH2)yH. 
x+y= 22 23 24 25 26 27 28 29 30 31 32 33 34 36 
   % WE 
0.2 
±0.01 
0.6 
±0.03 
2.2 
±0.1 
7.7 
±0.1 
17.2 
±0.2 
23.0 
±0.3 
21.4 
±0.2 
12.7 
±0.2 
6.8 
±0.2 
3.5 
±0.1 
1.7 
±0.4 
0.8 
±0.1 
0.4 
±0.4 
0.2 
±0.2 
 
Triglycerides (TG) identified by GCMS from Euglena gracilis. 
Isomers cannot be separated and there are multiple 
desaturation variants. 
CnHxO3 n= 37 38 39 40 41 42 
           
% TG 
12.8 
±2.9 
22.0 
±5.0 
26.6 
±6.2 
21.3 
±5.2 
12.6 
±3.4 
4.6 
±4.0 
Table 6.5: Analysis of the hexane soluble fraction from Euglena 
Most of the isolated fatty acids are multiply desaturated in Euglena. Wax esters make up over 95% of the components of the heptane fractions. 
The triglyceride components also contain phospholipids, after hydrolysis and methyl-esterification. Cyp16 = Cyclopropyl hexadecanoic acid. 
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6.4.2.1 Polyunsaturated fatty acids 
Polyunsaturated fatty acids, which have been credited with a wide variety of health 
benefits,64 make up over 60% of the fatty acids in Euglena (Table 6.5).  In order to 
introduce double bonds into the fatty acids, Euglena requires several desaturase 
enzymes, of which three have previously been sequenced and characterised.65-67  
In the Euglena transcriptome six putative desaturases can be identified  
(lm.37937, lm.17252, dm.49413, lm.14243, dm.2712 and dm.2753). It is difficult to 
predict specific roles for these enzymes, but it is tempting to suggest they each 
perform a specific desaturation on route to docosahexaenoic acid, the most 
unsaturated fatty acid identified in Euglena.13 
6.4.2.2 Cyclopropane fatty acids 
Cyclopropane fatty acids are synthesised by a variety of bacteria,68 plants and 
protozoa, including cotton69 and trypanosomatids.70 They are made by methylation 
of an unsaturated phospholipid68 and inhibit eukaryotic lipid desaturases.71 
Cyclopropane fatty acids are attractive for industry because they have the physical 
properties of unsaturated fatty acids, combined with the oxidative stability of 
saturated hydrocarbons and chemical reactivity from the strained ring.72  
In the transcriptome there is one credible cyclopropane fatty acid synthase 
(lm.28488) related to bacterial enzymes. There is another candidate (dm.16838), 
only present in the dark, which is related to green algal enzymes and encodes an 
extra C-terminal domain of unknown function. 
In order to see if Euglena produces cyclopropane fatty acids the heptane extract 
was compared to an authentic standard. Several fatty acids with odd numbered 
alkyl chains were identified, especially in the triglyceride components. Amongst the 
fatty acids is a compound with the same retention time and fragmentation pattern, in 
GC-MS, as authentic cyclopropyl hexadecanoic acid (180), although this cannot be 
resolved from cis-10-heptadecenoic acid (Table 6.5). This suggests Euglena could 
be explored as a source of this potentially high value compound.73  
  
  
 Figure 6.7: Isoprenoid 
biosynthetic pathway  
Both the MEP and MVA 
pathways are present in 
Euglena. All enzymes 
could be identified in the 
transcriptomes, except 
the final decarboxylase 
of the MEP pathway, 
indicating an alternative 
enzyme must be used in 
Euglena. Listed in blue 
is the closest 
homologue for each 
isoform found in the 
NCBI non-redundant 
protein sequence 
collection, using 
BLASTP. The yellow 
boxes indicate enzymes 
for which sequences 
could only be found in 
the dark grown cells. 
See Appendix 9.1 for 
details of the 
biosynthetic enzymes 
discussed. 
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6.4.3 Isoprenoids 
Isoprenoids are one of the most abundant natural products in algae,74 with functions 
in primary metabolism, including as carotenoids and attached to chlorophyll,  
and as diverse secondary metabolites including polyethers75 and terpenoids.76  
6.4.3.1 Isoprene biosynthesis 
There are two pathways to the formation of the isoprenoid precursor in plants:  
the cytosolic mevalonate (MVA) and the plastidial methylerythritol phosphate  
(MEP) pathways. Both pathways are known in Euglena, though unusually the  
MEP pathway only contributes to carotenoid biosynthesis and is not involved in 
phytol synthesis.77  
All enzymes for both pathways can readily be identified in the transcriptome,  
with the exception of the final decarboxylase of the MVA pathway (Fig 6.7).   
The presence of the rest of the pathway in Euglena implies this last reaction must 
occur, and is catalysed by a non-canonical enzyme. The initial and final enzymes for 
the chloroplast-localised MEP pathway are only apparent in the transcripts from 
dark grown cells. This suggests that, under the conditions utilised in this study, the 
MEP pathway is only active in chloroplasts that are not supplying energy to the 
cells.  
6.4.3.2 Polyprene biosynthesis 
Linear polyprenyl pyrophosphates are formed by condensation of isoprene units, 
which is catalysed by a family of closely related prenyltransferases, and several 
members of this enzyme class are present in the transcriptome.  In order to 
differentiate between the geranyl, farnesyl and geranylgeranyl diphosphate 
synthases structural models of the proteins were built using Swissmodel (Fig 6.8).78 
By comparing the active sites with the geranylgeranyl diphosphate (GGPP) bound 
to the human synthase79 it is possible to propose likely enzyme specificities. 
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The likely geranyl diphosphate synthases (lm.32576 and lm.90469) show some 
interactions with isoprene 2 and 3 of the overlaid GGPP, which suggests they are 
unlikely to accommodate anything longer than geranyl diphosphate in the active site 
(Fig 6.8.A). There are steric clashes between the likely farnesyl diphosphate 
synthases (lm.19578 and dm.26131) with isoprene 4 of the superimposed GGPP, 
which would prevent the formation of GGPP by these enzymes. For the likely  
GGPP synthases (dm.10389 and dm.48870) the active site has the same fold as 
the genuine GGPP synthase, with no steric clashes to the overlaid substrate.  
These models are based on genuine synthases, and so biased towards the 
backbone shape of the template, and biochemical evidence would be required to 
definitively identify the specificity of these enzymes. 
 
Figure 6.8: Polyprene synthase homology models  
Geranylgeranyl diphosphate was overlaid from 2Q8079 and the six prenyl 
transferases found in the Euglena transcriptome were modelled using Swissmodel 
in automated mode.78 These were then aligned and the key amino acids in the 
interacting helix displayed as sticks.  A. Models of likely geranyl diphosphate 
synthases lm.32576 (green) and lm.90469 (cyan). B. Models of likely farnesyl 
diphosphate synthases lm.19578 (green) and dm.26131 (cyan). C. Models of likely 
geranylgeranyl diphosphate synthases dm.10389 (green) and dm.48870 (cyan).  
D. Human GGPP synthase with GGPP bound in the active site (2Q80).  
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6.4.3.3 Carotenoids 
Carotenoids, which play a major role in light absorption during photosynthesis, can 
be obtained at over 70 mg per litre culture from Euglena.12 They are synthesised 
from geranylgeranyl diphosphate by phytoene synthase, followed by a series of 
cyclisations and oxidations. There is one sequence for a phytoene synthase in the 
Euglena transcriptome (lm.32898), present in both the light and the dark grown 
cells, which is related to the chloroplast-localised enzyme from the diatom 
Thalassiosira pseudonana. 
6.4.3.4 Triterpenes 
Triterpenes, including sterols and saponins, are synthesised from two molecules of 
farnesyl diphosphate which are joined by squalene synthase and cyclised by 
triterpene cyclase. Various cycloartenols, including lanosterol80 and ergosterol,81 
have been identified in Euglena. There are sequences for one triterpene cyclase 
(dm.61818) in the Euglena transcriptome, which has a histidine in position to act as 
a base in the reaction (Fig 6.9),82 leading to the prediction that the triterpene formed 
will have a cycloartenol skeleton. This suggests that Euglena is probably not able to 
make any other triterpene skeletons, such as β-amyrin or oxidosqualene.  
Nystatin, which complexes ergosterol, and miconazole, an inhibitor of ergosterol 
biosynthesis, both inhibit growth of Euglena (unpublished data) and ergosterol itself 
is the only sterol detectable, at around 0.1 ± 0.01 % of the total heptane soluble 
compounds, as identified in the lipid analysis (section 6.4.2). This suggests that 
ergosterol is the major, if not the only, sterol formed by Euglena gracilis. 
 
Figure 6.9: Alignment of cycloartenol synthases 
The Euglena triterpene cyclase (dm.61818) was aligned against other triterpene 
synthases. The red box indicates the key residue for determining the scaffold 
produced – a histidine acting as a base in the case of cycloartenol and lanosterol 
synthase.82 LAS: lanosterol synthase. CAS: Cyloartenol synthase.  
BAS: β-amyrin synthase. OSS: Oxidosqualene synthase. 
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6.4.3.5 Vitamin E 
Tocopherols are fat soluble antioxidants produced in photosynthetic cells83 and are 
an essential part of the human diet, as Vitamin E. They are synthesised from 
tyrosine and phytol, and are known to accumulate to over 7 mg per gram in  
E. gracilis.84 In the transcriptome the key genes, dioxygenase and homogentisate 
phytyl transferase, are present, and strong candidates for the rest of the pathway 
are apparent (Fig 6.10). There are many amino transferases in the transcriptome 
which may act on tyrosine and there are many methyltransferases whose substrates 
are difficult to conclusively assign. 
 
 
Figure 6.10: Tocopherol biosynthesis 
Good candidates could be found in the Euglena transcriptome for each gene in the 
biosynthesis of tocopherols. The genus of the closest homologue in the NCBI for 
each isoform is shown in blue. See Appendix 9.2 for details of the biosynthetic 
enzymes discussed. 
 
  
Chapter 6 – Further details on the Euglena transcriptome 
 
~ 186 ~ 
 
6.4.4 Amino acid biosynthesis 
Like plants and other algae, Euglena is capable of synthesising all of the amino 
acids it requires for growth, and can produce high levels of all the essential amino 
acids for the human diet.  
6.4.4.1 Lysine biosynthesis 
Lysine cannot be synthesised by animals and must be obtained in the diet.  
Plants and bacteria utilise the diaminopimelate pathway, whilst the α-aminoadipate 
pathway85 is only found in higher fungi and certain protozoa.86 Biochemical analysis 
has shown that in Euglena lysine biosynthesis is through this  latter pathway.87   
All of the enzymes for the α-aminoadipate pathway88 can readily be identified in the 
transcriptome (Fig 6.11), whilst no homologues of the enzymes for the 
diaminopimelate pathway are present. 
 
Figure 6.11: The α-aminoadipate pathway for biosynthesis of lysine  
All enzymes for the α-aminoadipate pathway can be identified in the Euglena 
transcriptome. The genus of the closest homologue in the NCBI for each isoform is 
shown in blue. See Appendix 9.3 for details of the biosynthetic enzymes discussed. 
  
 
 
Figure 6.12: Arginine and proline biosynthesis  
All of the enzyme for arginine synthesis from glutamate via ornithine are present in 
the transcriptome. The enzymes for proline biosynthesis, both by the reduction of 
pyrroline-5-carboxylate89 and for the cylodeamination of ornithine,90  are present in 
the transcriptome. The genus of the closest homologue in the NCBI for each isoform 
is shown in blue. See Appendix 9.4 for details of the biosynthetic enzymes 
discussed. The transcript for the arginosuccinate synthase is only found in the dark 
grown cells. 
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6.4.4.2 Arginine biosynthesis 
Arginine is synthesised by the sequential transfer of nitrogen on to glutamate 
semialdehyde. All the enzymes required are apparent in the transcriptome from both 
light and dark cells, with the exception of the arginosuccinate synthase which is only 
apparent in the dark grown cells.  
Arginine is used as an efficient nitrogen reservoir in Euglena accumulating to high 
levels, both free and in peptides, when cells are grown in excess nitrogen.91 
Euglena does not possess a urease and degradation is instead via the non-urease 
pathway, with sequential removal of ammonia by the reversible enzymes of arginine 
synthesis (Fig  6.12).92 Nitrogen is rapidly released from arginine by transfer of 
nitrogen, sequentially forming citrulline, ornithine and glutamate semialdehyde, 
efficiently releasing the stored nitrogen. 
6.4.4.3 Proline biosynthesis 
Proline is synthesised in most organisms by the spontaneous cyclisation of 
glutamate semialdehyde followed by reduction.89 In a few cases, such as in 
Clostridium, proline is synthesised from ornithine by cyclisation and deamination.90 
In the transcriptome a bacterial proline reductase and an archaeal ornithine 
cyclodeaminase are present, indicating both pathways probably operate in Euglena.  
  
 
 
Figure 6.13: Threonine 
and branched-chain amino 
acid biosynthesis  
The enzymes for 
threonine biosynthesis 
from aspartate are all 
present in the 
transcriptome except the 
homoserine kinase. For 
valine (R=H) and leucine 
biosynthesis two 
molecules of pyruvate are 
combined by acetolactate 
synthase. For isoleucine 
synthesis (R=Me) 
oxobutanoate, derived 
from threonine, and 
pyruvate are combined by 
acetolactate synthase. 
The genus of the closest 
homologue in the NCBI for 
each isoform is shown in 
blue. See Appendix 9.5 
and 9.6 for details of the 
biosynthetic enzymes 
discussed. 
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6.4.4.4 Threonine biosynthesis 
Threonine is one of the essential amino acids in the human diet. It is synthesised 
from aspartate via a series of phosphorylations and decarboxylations (Fig 6.13).93 
All the enzymes are present in the Euglena transcriptome, with the exception of the 
homoserine kinase, suggesting another enzyme carries out this reaction. 
6.4.4.5 Branched-chain amino acid biosynthesis 
The initial step in branched chain amino acid biosynthesis is the combination of two 
keto acids by acetolactate synthase (Fig 6.13).94 Either, for the synthesis of leucine 
and valine, two molecules of pyruvate or, for isoleucine biosynthesis, one molecule 
of pyruvate and one molecule of 2-oxobutarate are joined. Three homologues  
of threonine dehydratase, which generates the 2-oxobutarate from threonine,  
can be found in the Euglena transcriptome and two have previously been identified 
biochemically in Euglena.95 As only two were found previously it is possible that one 
of the transcripts could encode an enzyme involved in the interconversion of serine 
and pyruvate, and thus not show any activity as a dehydratase. Sequences for the 
other enzymes in the biosynthesis of these amino acids can be found in the Euglena 
transcriptome. The isopropylmalate dehydratase sequences encode contiguous 
large and small subunits, rather than encoding them as separate polypeptides, as is 
the case in most organisms.96  
 
  
Figure 6.14: Aromatic amino acid 
biosynthesis 
In Euglena the five central 
enzymes of the shikimate pathway 
are encoded as a single 
polypeptide, as is seen in fungal 
enzymes. The pathway branches 
at chorismate: towards folate 
biosynthesis, via 4-aminobenzoate, 
catalysed by a bifunctional 
enzyme; towards tryptophan 
biosynthesis, via 2-aminobenzoate; 
or to prephenate via chorismate 
mutase, which is present either as 
a single domain protein or as part 
of a trifunctional protein with 
dehydratase and dehydrogenase 
domains. Aromatic amino acid 
transaminases, for the final step in 
tyrosine and phenylalanine 
synthesis, are present in the 
transcriptome. The biosynthesis of 
tryptophan is carried out by a 
tetrafunctional enzyme. The genus 
of the closest homologue in the 
NCBI for each isoform is shown in 
blue. See Appendix 9.7 for details 
of the biosynthetic enzymes 
discussed. 
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6.4.4.6 Aromatic amino acid biosynthesis 
Chorismate, the precursor to aromatic amino acids, is synthesised by the shikimate 
pathway in seven steps. There are four isoforms of the first committed enzyme in 
the pathway, DHAP synthase, one of which is only apparent in the dark grown cells. 
The next five reactions can be catalysed either by separate enzymes, as in plants,97 
or by a pentafunctional enzyme, as in fungi (Fig 6.14).98 Phylogenetic analysis 
suggests the fusion of these five genes occurred in an ancient eukaryotic ancestor 
and was subsequently rearranged or lost.99 Previously cytosolic and plastid isoforms 
of 5-enolpyruvylshikimate-3-phosphate synthase have been identified in Euglena,100 
which suggested the presence of both types of pathway. The pentafunctional 
enzyme can be identified in the Euglena transcriptome, as can individual shikimate 
synthase and shikimate kinase domains, although no sequences for the other single 
domains are present.  
Chorismate is then converted into tyrosine and phenylalanine, via prephenate. 
Bifunctional chorismate mutase-prephenate dehydratase101 and chorismate mutase-
prephenate dehydrogenase102 are common. However, the trifunctional chorismate 
mutase-prephenate dehydratase-dehydrogenase encoded in the Euglena 
transcriptome, has only been characterised from the hyperthermophile 
Archaeoglobus fulgiduI. In this archaeon it is hypothesised that this domain 
structure protects the labile intermediate under extreme conditions,103  
which is clearly not the situation with Euglena.  
The biosynthesis of tryptophan from chorismate, via anthranilate, is carried out by 
four enzymatic reactions.104 These are normally located on separate chains in 
bacteria, though there is sometimes one gene fusion.105 In Euglena a single 
transcript encodes all four enzymes, which has previously been partially 
sequenced,106 and for which proteomic evidence supports the domain architecture 
(see Appendix 10). The final synthase is  composed of a hetero-tetramer in 
bacteria107 and a homo-dimer in fungi.108 The tetra-functional enzyme encoded in 
the Euglena transcriptome only contains the β-subunit, whilst the α-chain is 
encoded on a separate transcript. This suggests tryptophan biosynthesis is 
catalysed by a hetero-tetramer composed of two copies of the multi-function protein 
and two copies of the α-chain. 
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6.4.4.7 Tetrapyrrole biosynthesis 
Heme, chlorophyll and vitamin B12, all contain a tetrapyrrole which is synthesised 
from δ-aminolevulinic acid (ALA). Heterotrophs tend to synthesize ALA from glycine 
and succinyl-CoA in the Shemin pathway,109 whilst photoautotrophs make ALA from 
glutamate in the C5 pathway.110 Euglena is known to utilise both routes,111 and the 
transcriptome shows a bacterial derived Shemin pathway and a green algae-related 
C5 pathway, presumably obtained with the chloroplast (Fig 6.15). ALA is then 
converted to porphobilinogen by ALA dehydratase, and hydroxymethylbilane 
synthase joins four porphobilinogens to make the core tetrapyrrole. 
 
Figure 6.15: Tetrapyrrole biosynthesis 
Tetrapyrroles are synthesised from δ-aminolevulinic acid. In the Shemin pathway 
this is synthesised from glycine and succinyl-CoA by 5-aminolevulinate synthase 
and from glutamate by reduction and isomerisation, in the C5 pathway. 
The genus of the closest homologue in the NCBI for each isoform is shown in blue. 
See Appendix 9.8 for details of the biosynthetic enzymes discussed. 
6.4.5 Hydrogenase 
Since the 1940s it has been known that certain algae, such as Scendesmus112  and 
Chlamydomonas,113 produce hydrogen under illumination, using an hydrogenase 
containing iron cofactors. One sequence from the Euglena transcriptome 
(dm.82403) encodes a putative hydrogenase candidate, though this alga has not 
previously been noted to produce hydrogen. There are no candidates for the 
accessory proteins,114,115 which are required for organelle-localised hydrogenase, 
and the enzyme does not have a strong signal peptide,116 suggesting this is a 
cytosolic enzyme. Conceivably this enzyme is therefore an accessory protein for the 
correct assembly of cytosolic iron sulphur proteins, which are close homologues to 
the iron only hydrogenases.117 
  
 
 
Figure 6.16: Ascorbic acid 
biosynthesis  
Ascorbic acid is 
synthesised from sugar 
nucleotides. Candidate 
genes are present for 
every reaction in the 
biosynthesis of ascorbate 
but several represent 
weak assignments, 
particularly as prediction 
of sugar based substrates 
is notoriously difficult. The 
genus of the closest 
homologue in the NCBI for 
each isoform is shown in 
blue. See Appendix 9.9 for 
details of the biosynthetic 
enzymes discussed. 
Chapter 6 – Further details on the Euglena transcriptome 
 
~ 195 ~ 
 
6.5 Redox control 
Small molecule antioxidants have a major role in many cellular processes, including 
maintenance of the internal redox balance and xenobiotic detoxification. Whilst the 
major redox modulating thiol is glutathione, many parasites use unusual compounds 
which represent good drug targets.118 These include bacillithiol in certain bacilli,119 
mycothiol in actinobacteria120 and ovothiol and trypanothione in Kinetoplastids.121 
6.4.1 Vitamin C 
Ascorbate is the most important antioxidant in photosynthesising organisms, 
reducing reactive oxygen species formed during photosynthesis.122 This reaction is 
catalysed by ascorbate peroxidase123 which, in Euglena, is localised in the cytosol 
rather than the chloroplast, and has a unique dimeric form.124 Ascorbic acid is 
synthesised either via L-gulonolactone, as in animals,125 or via L-galactonolactone, 
as in plants.126 Radioactive-tracer experiments from the 1970s show Euglena 
possesses both pathways,127 though the L-galactonolactone pathway is apparently 
dominant. More recently the aldonolactonase gene has been identified in Euglena52 
and the galacturonic acid reductase has been characterised,128 but the remaining 
enzymes in the pathway remain to be identified. There are candidate genes present 
in the transcriptome for all enzymes in these pathways (Fig 6.16), although several 
of these are only tentative assignments, based on nearest homologues of several 
similar sequences. There are also transcripts encoding the enzymes for the 
conversion of mannose into ascorbate, as is proposed for higher plants,129 which is 
unprecedented in Euglena. 
  
Figure 6.17: Proposed 
nortrypanothione biosynthetic 
pathway  
Trypanothione is synthesised 
by joining one molecule of 
glutathione to each end of 
spermine. It is proposed that 
nortrypanothione is 
synthesised in the same way, 
attaching glutathione to 
norspermine, synthesised 
from diaminobutyrate. The 
genus of the closest 
homologue in the NCBI for 
each isoform is shown in 
blue. See Appendix 9.10 for 
details of the biosynthetic 
enzymes discussed. 
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6.4.2 Trypanothione 
Independent reductases with exclusive activity towards either glutathione  
or trypanothione, of the tested thiols, have previously been purified from Euglena,130 
but the presence of the trypanothione substrate has not been demonstrated in this 
organism.  
Trypanothione is formed from spermidine with one glutathione moiety at each end 
and can form intra and intermolecular disulphides. The conjugation of glutathione to 
spermidine to form trypanothione can be performed by one or two enzymes.  
In the two enzyme process, such as in Crithidia, glutathione is initially joined to 
spermidine by glutathionylspermidine synthase, followed by addition of another 
glutathione by trypanothione synthase.131 In Trypanosoma a single enzyme 
catalyses the addition of glutathione to both ends of the spermidine.132  
In the Euglena transcriptome the biosynthetic pathways for glutathione and 
polyamines are present, and there are two sequences which more closely match the 
trypanothione, rather than the glutathionylspermidine synthase of Crithidia, although 
they are most closely related to bacterial glutathionyl spermidine synthases  
(Fig 6.17). It is unclear whether these enzymes each carry out a single glutathione 
addition, or perform both conjugations.  
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6.4.3 Ovothiol 
Ovothiols are a group of highly reducing antioxidant mercaptohistidines, which 
accumulate to very high levels in the eggs of certain marine invertebrates, including 
sea urchins, scallops and starfish,133 where they act to scavenge H2O2 released 
during fertilisation.134  They are also found in Trypanosomes and Leishmania121 
where they are involved in the oxidation of trypanothione. The only known enzyme 
for the biosynthesis of ovothiol, OvoA, contains a sulfoxide synthase at the  
N-terminus and an N-methyl transferase at the C-terminus.135 The Euglena 
transcriptome encodes one sequence containing both domains, only found in the 
dark cells, and there are also separate sequences related to the N-terminus and to 
the C-terminus in both light and dark grown cells (Fig 6.18). 
 
Figure 6.18: Ovothiol biosynthetic pathway 
The only known enzyme for the biosynthesis of ovothiol contains a sulfoxide 
synthase and an N-methyl transferase. Sequences for one enzyme of each of these 
domains are present in the Euglena transcriptome, and one sequence containing 
both domains, only found in the dark grown cells. The genus of the closest 
homologue in the NCBI for each isoform is shown in blue. See Appendix 9.11 for 
details of the biosynthetic enzymes discussed. 
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 6.4.4 Thiol analysis 
In order to definitively identify trypanothione as having a physiological role in 
Euglena HPLC analysis was performed on extracts from cells that had been grown 
in high nutrient media with ambient light. The Euglena extracts clearly show the 
ubiquitous glutathione and cysteine peaks. There is a small peak co-eluting with 
trypanothione, suggesting this compound has some physiological relevance  
(Fig 6.19). LC-MS revealed this fraction contained both trypanothione and a 
compound with a molecular weight 14 Da lower (see section 8.5.3). MS2 shows that 
this corresponds to a one carbon shorter spermidine backbone than is usual in 
trypanothione, which we suggest as nortrypanothione. Euglena is known to make 
the norspermine and norspermidine from 1,3-diaminopropane, which is proposed to 
be derived from diaminobutyric acid.136 This would require some flexibility in the 
polyamine chain length in the trypanothione synthase, as is seen in T. cruzi, which 
makes homo-trypanothione, with a one carbon longer spermidine, when 
exogenously supplied with cadavarine.137 
 
Figure 6.19 Analysis of the thiol content of Euglena gracilis  
Thiols were labelled with monobromobimane and analysed by HPLC.  
Cysteine (1) and glutathione (3) can be clearly identified. There is a small peak (4) 
which coelutes with authentic trypanothione and a peak which elutes in the same 
region of the chromatogram as ovothiol (2).121 These were confirmed by MS. 
B: background peaks. 
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6.5 Secondary metabolites 
Only one secondary metabolite, the alkaloid euglenophycin (181), has been isolated 
and characterised from a Euglena (E. sanguinea), based on its toxicity to fish.138  
All four stereoisomers were identified, with one of the cis conformations being the 
major isomer isolated. There is no evidence for the production of this compound by 
E. gracilis (Paul Zimba, private communication) and the biosynthetic pathway 
leading to this compound has not been explored.  
 
6.5.1 Indole alkaloids 
Many plant secondary metabolites are based on the strictosidine skeleton.  
This contains an indole ring, derived from tryptophan by decarboxylation, joined to 
secologanin by strictosidine synthase.139 In the Euglena transcriptome there is one 
sequence for a tryptophan decarboxylase, which may be involved in tryptophan 
degradation. Two potential strictosidine synthases are encoded in the 
transcriptome, though they are only around 20% homologous to the characterised 
Rauvolfia enzyme and appear to have an active site lacking the necessary 
glutamate to be a true synthase (Fig 6.20).140 Instead they are likely to be 
paraoxonases, a highly conserved class of lactonases which act on diverse 
substrates including organophosphates, such as sarin,141 drugs, such as lovastatin, 
and fatty acid lactones, which are their likely natural substrates.142 
 
Figure 6.20: Alignment of candidate Euglena strictosidine synthases to known 
enzymes 
The key glutamate for defining a strictosidine synthase (StrS)140 over a paraoxonase 
(PON) is highlighted and indicates these enzymes may not be strictosidine 
synthases. 
313 413320 330 340 350 360 370 380 390 400(313)
IVAPLSPLLKFLGPPLVRLALAHLSITLDASKYFVKSWGCVLKVSPEGEVLDVLLDPTGRHAATISGVTEHEGRLFLGNLGGDFVSVFDLTR---------light_m.19747(308)
IPTPAPAATKFLVKYRPLRAF--VARLGKAVQPALVPWATIVKVSEAGEVLDCLHDPKGERVTAPSAVKEHGGKLYIGTLRNDFIPVVDLARAA-------dark_m.43252(305)
SSEELDGNMHGRVDPKG------------------------IKFDEFGNILEVIPLPPPFAGEHFEQIQEHDGLLYIGTLFHGSVGILVYDKKGNSFVSSHRauvolfia StrS(246)
CHPNGMKIFFYDSENPPASEV----------------LR-IQNILTEEPKVTQVYAENGTVLQGSTVASVYKGKLLIGTVFHKALYCEL------------Homo PON(284)
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6.5.2 Polyketides 
Polyketides are a wide range of compounds, including tetracycline antibiotics143 and 
toxins such as the ciguatoxin,144 formed by repeated condensation and dehydration 
of carboxylic acids, activated in the form of Coenzyme A thioesters.   
Broadly speaking polyketide synthases (PKSs) can be large multidomain proteins 
(type I) or composed of discreet proteins with individual functions (type II), although 
other architectures are possible.145   
In order to identify polyketide synthases the translated Euglena transcriptome was 
searched for ketosynthase domains, the key catalytic domain, using BLASTP  
(see Appendix 11.1).146 Fourteen potential PKSs were identified as having this 
domain: six sequences encode multidomain proteins indicative of type I PKSs;  
three sequences encode one catalytic domain and an acyl carrier domain; one 
sequence carries two catalytic domains; four sequences only encode individual 
ketosynthase domains. The latter may be true type II PKS modules or fragments of 
type I modules, caused by failure to obtain full length transcripts. They may also be 
enzymes with other functions that this search technique reveals, such as fatty acid 
synthases.  
  
 
 
Figure 6.21: Polyketide synthases encoded in the Euglena transcriptome 
Domain architectures of three candidate polyketide synthases which have multiple domains. Domains were identified using the Conserved 
Domain Database.147 Reactions and partial products of the polyketide synthases were predicted, based on the arrangement of the domain 
architectures. lm.8157 has similar domain architecture to an erythromycin biosynthetic gene module, followed by three modules, which in 
bacillaene biosynthesis are three discrete proteins, which together add one branching methyl group, predicted to give a product similar to 
182.148 Decarboxylative condensation of an amino acid to the polyketide in lm.60697, eliminating the thioester, would leave a free amine to give 
183. Reduction of a ketone, in lm.53854,  can lead to cyclisation and elimination of the thioester, giving rise to a cyclic lactone (184), similar to 
the structure of the band 1 toxins in a fungal pathogen, Alternaria citri (185).149 
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Attempts to predict the structures of the polyketides synthesised by these enzymes, 
based on domain architectures, using the web based prediction programs 
SBSPKS150 and PKS/NRPS Analysis Web-site151 were not successful.  
This is probably due to the evolutionary distance from the bacterial and fungal 
species that these pieces of software were designed to deal with. Analysis of these 
enzymes, using DELTA-BLAST, which searches based on the domain architecture, 
rather than primary sequence, has allowed some product prediction (Fig 6.21).  
The largest polyketide synthase encoded in the Euglena transcriptome (lm.8157) 
contains, aside from a fully reducing PKS module, two enoyl hydratases and an 
HMGCoA synthase. These proteins have been characterised, as single domain 
proteins, in some bacterial gene clusters, such as PksG, H and I in bacillaene 
biosynthesis, to add a β-methyl branch to polyketides (Fig 6.22).148 Whilst the 
association of other components of the complete synthase cannot be predicted, this 
domain architecture suggests the formation of methyl branched alkene, which could 
be part of a polyketide, or alternatively may be included in a fatty acid. 
 
Figure 6.22: Insertion of a β-methyl branch on PksL in the biosynthesis of 
Bacillaene 
The HMGCoA synthase and two enoyl hydratase domains in the Euglena transcript 
lm.8157 match the three domains on PksG, H and I which insert a β-methyl branch 
during Baciallaene biosynthesis. Reprinted from Butcher et. al.148 Copyright (2007) 
National Academy of Sciences, USA. 
One of the Euglena transcripts (lm.60697) encodes a small multidomain PKS 
containing an aminotransferase domain. These domains are found in diverse 
enzymes, including sphingolipid152 and biotin biosynthesis,153 where they catalyse 
decarboxylative condensations, releasing the product. In the Euglena enzyme this 
will add a nitrogen atom to the polyketide, together with the amino acid side chain 
(Fig 6.21). 
  
 
   
Figure 6.23: Nonribosomal peptide synthases encoded in the Euglena 
transcriptome 
A. Domain architectures of three representative candidate non-ribosomal peptide 
synthases from Euglena. Domains were identified using the Conserved Domain 
Database.147 B. Siderophore production by E. gracilis. Siderophore indicator plates 
were made and algae were plated out to get single colonies. The halo around these 
colonies, particularly vivid when viewed with an orange filter, indicates the 
production of a siderophore. 
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The third highlighted polyketide synthase from Euglena (lm.53854) contains a 
dehydratase and no thioesterase domain. If instead cyclisation cleaves the 
thioester, this could lead to a structure related to the toxin produced by the 
phytopathogen Alternaria citri.149  
6.5.3 Nonribosomal peptides 
Nonribosomal peptides synthases (NRPS) are modular multidomain proteins154,155 
which join amino acids to form small molecules with a diversity of function from 
siderophores, such as enterobactin,156 to antibiotics, such as actinomycin,157  
and toxins, such as microcystin.158 No nonribosomal peptides have been isolated 
from Euglenoids to date. The E. gracilis transcriptome was searched for sequences 
encoding adenylation domains (A), which found 19 transcripts, and condensation 
domains (C) which identified 16 transcripts (see Appendix 11.2). Five transcripts 
encode proteins with both A and C domains (Fig 6.23.A), but this search strategy 
also revealed many sequences which are most closely related to enzymes involved 
in fatty acid biosynthesis and two transcripts for L-aminoadipate-semialdehyde 
dehydrogenase, involved in lysine biosynthesis. Notably three adenylation-domain 
encoding transcripts also have ankyrin domains, involved in protein-protein 
interactions,159 which may implicate formation of multi-protein NRPSs. The 
prediction programs, SBSPKS and NRPS/PKS Analysis Web-site, are again 
incapable of dealing with these sequences. In order to obtain iron from the 
environment Euglena produce siderophores (Fig 6.23.B), which may be synthesised 
using NRPSs, analogously with the E. coli siderophore enterobactin.156 
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6.6 Conclusions of Euglena transcriptome sequencing 
Euglena are sometimes considered to be related to both animals and plants.  
In the Euglena transcriptome reported here there are some metabolic pathways that 
are more similar to plants and some that are more similar to animals, and often 
more than one pathway exists for the biosynthesis of the same compound.  
There are many unusual and unique enzyme architectures used by Euglena, 
including many novel gene fusions, which suggest there is some selective pressure 
in this organism, enhancing the acquisition of exotic enzymology. 
No polyketides or non-ribosomal peptides have been found to date in this species, 
but there are transcripts apparent for the complex secondary metabolite synthases 
needed to make such compounds, as has been found from an increasing range of 
algae as genome sequencing data becomes available.160 We have also identified 
sequences for the enzymes necessary to make unusual fatty acids and thiols and 
confirmed the existence of these compounds in this organism.  
This first transcriptome of Euglena has shown that even in relatively well studied 
organisms there are many unexpected and unusual metabolic pathways and 
compounds that may prove useful in biotechnological applications. 
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Chapter 7 – Future directions 
The chemical synthesis of defined oligosaccharides is technically challenging,  
but the use of enzymes can expedite this. Phosphorylases have proved a useful 
class of enzymes for the synthesis of long oligosaccharides from relatively cheap 
starting materials. New product specificities need to be discovered or engineered to 
fully realise the potential of phosphorylases for carbohydrate synthesis.  
7.1 PHS2 
7.1.1 Further crystallography of PHS2 
The crystal structures of PHS2 presented herein have not definitively elucidated the 
active site of this enzyme. The binding of acarbose indicates there are certain 
differences in the active site compared to the other α-1,4-glucan phosphorylase 
structures available. This suggests further studies are required; to produce more 
refined structures for the Glc-1-P binding site and to bind oligosaccharides in the 
active site channel. Of particular interest are the oligosaccharides related to the 
substrate SHG, the structure of which has not been fully elucidated.1 
PHS1 is the plastid localised α-1,4-glucan phosphorylase, and has a role in 
synthesis and degradation of starch granules.2 The sequence is similar to PHS2 
(63%), except for the plastid targeting signal sequence and a large insert in the 
active site which alters the substrate specificity.3 Crystal structures of PHS1 should 
help us to understand the different substrate specificities for these two related 
enzymes and help to understand the role PHS1 plays in plants. 
7.1.2 Engineering of PHS2 
The PHS2 surface glucan-binding site elucidated in this work is unique to this 
protein. In order to understand the relative importance of this to the natural activity 
of this enzyme, mutations of this binding site should be assayed in planta.  
The binding, activity and substrate recognition of this enzyme on glycan arrays 
should also be compared, for wild type and mutants in this site.4 
This class of enzymes is competent to transfer only one molecule of mannose, 
xylose, glucosamine and glucuronic acid onto each acceptor terminus.  
If the efficiency with which these sugars can be transferred can be improved,  
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using mutagenesis and protein engineering, it might be possible to synthesise novel 
polysaccharides. However it is probable that the acceptor site will also need to be 
substantially altered before efficient synthesis of long α-1,4-linked glycans can be 
achieved. These glycans are likely to have interesting properties and may be 
compatible with cyclising enzymes, making modified cyclodextrins and 
cycloamyloses. 
Overall this enzyme has limited use in the synthesis of novel glucans as it requires 
maltotetraose as the minimum acceptor. This is likely because of the requirement 
for binding of a long polymer to overcome the unfavourable binding during the 
reaction. If this unfavourable binding can be reduced, or the relative binding strength 
of the acceptor binding to the -2 position be increased, then shorter glucans may be 
possible. It is proposed that some α-1,4-glucan phosphorylases can use acceptors 
as short as maltose5 and comparison between these enzymes and PHS2 might 
suggest ways to improve the flexibility. 
7.1.3 Starch-like surfaces 
The starch-like surface synthesised with PHS2 is a good analogue of natural starch 
granules which can be probed with a range of enzymes. Proteins which interact with 
the starch granule can be assayed with this surface, in classical SPR experiments, 
to ascertain binding kinetics. For example, Glucan-Water Dikinase, which transfers 
phosphate from ATP onto the surface of starch granules, undergoes 
autophosphorylation, surface binding and phosphate transfer, but it is unclear at 
what stage in the catalytic cycle binding to the surface occurs.6 The surfaces 
developed in this study represent a viable system for the assay of this enzyme and 
working towards this analysis is on-going. 
There are several isoforms of starch synthases7 and the precise role of each is not 
well understood. The binding kinetics, in the presence and absence of substrate, 
and their activity could be analysed on the starch like surface using SPR.  
This will provide substantial insights into the roles each of these isoforms plays and 
enhance our biological understanding of starch metabolism. Enzymes which 
naturally degrade starch granules are normally assayed in solution which is not a 
good analogue of the insoluble granule. This surface should be used as a  
more informative assay to provide data on the inherent degradation of the surface,  
not the release of products.  
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The use of SPR is severely limited by throughput and expense, particularly when 
assaying surface-modifying enzymes. The surface acoustic wave technology  
(SAW instruments GmbH) may allow the direct detection of the rearrangement and 
crystallisation of glucans on the surface, and their disruption by non-hydrolytic 
enzymes. Bio-Layer Interferometry systems, such as the Octet (ForteBio),  
can be used with a higher throughput and removes the risks associated with 
polysaccharide synthesis in a microfluidics device. The synthesis of starch-like 
surfaces will be explored using these systems for the future analysis of starch active 
enzymes. 
These glucan surfaces can also be used as biocompatible coatings and in 
nanotechnology. By combining controlled display of the acceptor and phosphorylase 
catalysed vine-twinning polymerisation around hydrophobic polymers, the controlled 
orientation of insulated polymers, such as carbon nano-tubes,8 may be achieved. 
7.2 Cellodextrin phosphorylase 
7.2.1 Further crystallography of CDP 
The structure of CDP presented in this work is at 2.3 Å resolution and contains extra 
density at the phosphate binding site, which is modelled as a chloride ion. 
Improvements in resolution and alterations in the crystallisation conditions might 
help to resolve phosphate in this site. It has not been possible to achieve structures 
of CDP with substrates bound, but work towards this goal is on-going.  
Without substrate bound structures it is not possible to understand the amino acids 
which give rise to substrate specificity, but comparison with related enzymes can 
help to understand substrate interactions. 
7.2.2 Engineering of CDP 
Family GH94, to which CDP belongs, contains phosphorylases with different 
substrate specificity. Translating the differences between disaccharide 
phosphorylases onto CDP would allow the generation of a novel polymerising 
phosphorylase. For example, the residues which interact with the GlcNAc  
moiety in chitobiose phosphorylase are exactly the same in CDP, with the  
exception of Tyr804, which would clash with the N-acetyl group (Fig 7.1).  
In chitobiose phosphorylase it is replaced with valine and this modification might 
allow the CDP to act upon chitin. CDP has been shown to slowly catalyse the 
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transfer of Xyl, Man and GlcN from their respective phosphates. In order to improve 
this enzyme for the transfer of these sugars, random or site-saturation mutagenesis 
may allow the generation of efficient mannan, xylan and chitosan phosphorylases.  
 
Figure 7.1: Substrate binding site of CDP and chitobiose phosphorylase 
CDP (green) has a tyrosine which overlays with the acetate on the chitobiose in the 
chitobiose phosphorylase structure (cyan, 1V7X). 
7.2.3 Cellulose-like surfaces 
Efficient enzymatic degradation of cellulose is highly valuable for biomass 
conversion but there are limitations with the current analytical tools. CDP is able to 
generate long cellulose polymers in solution, which rapidly precipitate.  
Initial attempts to synthesise these polymers on SPR surfaces, analogously with the 
PHS2 experiments, were unsuccessful. However, it is hoped that by modifying the 
display techniques or using alternative systems, this technology can be explored. 
These surfaces will then be used to analyse cellulose binding and degrading 
enzymes. 
When cellulose is formed in solution it rapidly precipitates to form insoluble material, 
which under the right conditions can form defined structures, such as cellulose 
whiskers9 or enzymatically synthesised spherulites.10 β-lipid glucosides are 
reasonable acceptors for CDP,11 allowing production of novel glycolipids,  
which rapidly precipitate.12 Preliminary data suggest that by carrying out the CDP 
catalysed extension above the critical micelle concentration of the lipid glucans, the 
micelles are coated in a layer of insoluble cellulose forming nanospheres.  
These materials could be used to make biocompatible coatings or to synthesise 
carbohydrate nanoparticles. The CDP catalysed synthesis of insoluble cellulose 
could be used more widely to coat surfaces with a nanoscale, biocompatible and 
insoluble carbohydrate layer. 
Tyr804 
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7.3 Laminarin phosphorylase 
7.3.1 Identification of LDP 
The laminarin phosphorylase from Euglena has been investigated for a number of 
years for the biosynthesis of β-1,3-glucans. The polymerising phosphorylase is a 
highly desirable tool for the synthesis of β-glucans for use in biomedicine and 
nanomaterials. Identification and heterologous expression of the polymerising 
phosphorylase remains a high priority. LDP will be the first phosphorylase identified 
in whichever GH family it belongs to, as there are no known β-phosphorylase 
families encoded in the Euglena transcriptome. From the evidence in this work the 
phosphorylase is most likely to be a member of GH81, though we have been unable 
to confirm this. Once heterologous expression is achieved the enzyme can be 
thoroughly explored for the production of defined β-glycans, including non-glucose 
based polymers. In particular the synthesis of β-glucosyl glycerols should be 
explored in more detail using the purified enzyme. 
7.3.2 Crystallography of LDP 
Since the LDP will be in a novel family, structural studies will be a high priority,  
in order to determine what factors control the phosphorolytic activity.  
There are currently no structures of GH81, the best candidate found in this work, 
and thus elucidation of any structure in this family is valuable. Once structural 
information is available the key residues involved in carbohydrate recognition and 
specificity can be elucidated. This will inform mutagenesis and chimerisation studies 
to enhance substrate promiscuity and help to develop tools for the synthesis of 
defined β-1,3-glycan polymers. 
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7.4 Other phosphorylases 
Phosphorylases are highly versatile enzymes which can readily be used to 
synthesis long polysaccharide chains. However, there are only a limited number 
currently known and re-engineering these to access other polysaccharides has 
limitations. Instead the diversity of activities already present in nature should be fully 
mined before novel activities are artificially developed. 
7.4.1 Identification of the missing glucan phosphorylases 
There are no known phosphorylases for β-trehalose, but this linkage has not so far 
been found in Nature and thus it might not be possible to find a  
β-1,1-phosphorylase. On the other hand α-1,6 and β-1,6-glucans are rather 
common in Nature, produced, for example, by bacteria in dental plaque13 and in the 
yeast cell wall,14 respectively, although no phosphorylases have yet been 
discovered for them. Thus, it is expected that phosphorylases may exist for these 
linkages and could be found by, for example, assaying organisms which can use 
linear dextran as a sole carbon source. Identification of these enzymes would 
complete the suite of phosphorylase linkages.  
7.4.2 Identification of non-glucose phosphorylases 
Most of the phosphorylases so far identified act on homoglucans. These make up 
the major energy storage and structural polysaccharides used by organisms but 
there are numerous other polysaccharides found in nature: fructans are storage 
polymers of fructose found in some plants and algae;15 plant cell walls contain many 
complex polymers including xylans and uronic acid polymers;16 animals cells are 
covered in layers of charged polysaccharides such as chondroitin and heparin;17 
many types of seaweed also have complex and charged polymers in their cell 
wall.18 With the large amount of the compounds produced and degraded it is likely 
there are many more phosphorylases yet to be identified. In order to find them 
microbes which can use these alternative polysaccharides as carbon sources could 
be screened. Since many of these compounds are useful in biotechnology, food and 
medicine the possibility of synthesising defined components, as offered  
by phosphorylases, is highly attractive.  
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7.4.3 Polymerising phosphorylases 
Many of the phosphorylases so far studied act on disaccharides. This limits their 
use in biotechnology and the possibility of converting them into polymerising 
phosphorylases is highly attractive. The comparison between the structures of CDP 
and CBP shows that substantial changes might be necessary to allow 
polymerisation. Initial studies have probed this, opening up the active site of CBP to 
allow anomerically substituted glucose to act as an acceptor19 and increasing the 
length of kojioligosaccharides produced by a GH94 phosphorylase.20  
Comparison of phosphorylases in the same family, but with different acceptor 
lengths, will inform mutations and chimerisations to produce polymerising enzymes. 
Chitobiose phosphorylase could be altered by chimerising with CDP and nigerose 
phosphorylase should be compatible with kojibiose phosphorylase. It is likely that 
disaccharide phosphorylases will continue to yield to biochemical analysis more 
readily than their polymerising counterparts. The ability to convert them into 
polymerising enzymes is highly desirable for polysaccharide synthesis. 
7.4.4 Relationship between hydrolases and phosphorylases 
Most of the phosphorylases are in glycosyl hydrolases families, suggesting they 
have evolved as a more biochemically efficient degradation tool. There are many 
more hydrolases characterised and logic dictates there must be a hydrolase  
(or phosphorylase) for every sugar linkage in nature. If hydrolases can be 
engineered into phosphorylases then every linkage can be readily synthesised from 
simple sugar phosphates suing soluble enzymes.  
To understand the difference between phosphorylases and hydrolases detailed 
structural analysis of closely related enzymes is required. Amylosucrase, sucrose 
hydrolase and sucrose phosphorylase are all members of GH13.  
The phosphorylase structure shows a slight deviation in one active site loop and 
there are notably His234 and Leu341 in the active site, not Ile and Phe, as in the 
hydrolase and transglycosylase structures (Fig 7.2).21 As there is no phosphate 
bound it is not possible to say with confidence the impact of these alterations,  
but it is likely that the histidine is important for the coordination of the phosphate in 
the active site. Further crystallography is required to understand the phosphate 
localisation and exclusion of H2O. Mutagenesis and chimerisaton studies can be 
used to study the interconversion of hydrolases and phosphorylases.  
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There are α-1,6-hydrolases in family GH13 and it might be possible to convert these 
into phosphorylases, based on the principles elucidated. There are however no 
enzymes in this family which act on any other sugars. 
 
Figure 7.2: Family GH13 active site 
Sucrose phosphorylase (1R7A, green)21 has a similar active site to sucrose 
hydrolase (3CZK, magenta)22 and amylosucrase (1G5A, blue).23 However one loop 
has moved and there are two important amino acid changes – His234 and Leu341. 
 
Trehalose phosphorylase and trehalose hydrolase are both present in GH65.  
The structure of the hydrolase is not yet known and comparison of these structures 
may highlight the important structural differences in this family. There are no other 
hydrolases in this family, however, so there is only limited application of the 
principles elucidated for the development of phosphorylases in this family  
There are no other hydrolase families which also contain phosphorylases,  
so the rules developed from families GH13 and 65 would need to then be tested in 
other families. It is likely that the exclusion of water is the most important aspect 
when altering these enzymes and the development of glycosynthases has provided 
some direction for this work.24 
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7.5 Euglena gracilis 
7.5.1 Further sequencing of Euglena 
The de novo transcriptome sequencing of Euglena presented in this work only 
provides a snapshot of metabolism under two conditions. Genome sequence of 
Euglena gracilis is needed to see all the genes in this alga, not just expressed 
transcripts. Additional transcriptome data sets from a variety of conditions, such as 
oxidative stress and anaerobosis, will reveal the strategies used to adapt to these 
conditions. Additional sequencing efforts will be needed for the various strains of 
Euglena gracilis currently under investigation, as it is apparent that individually 
sequenced genes do not match the transcriptome presented in this study.  
There will also be opportunities to build on this sequencing for related Euglenoids, 
such as the toxin producing Euglena sanguinea,25 and non-photosynthetic Astasia.26 
7.5.2 Genetic control mechanisms in Euglena 
The elements for classical gene silencing appear to be present in Euglena, with the 
exception of the RDRP. There is much on-going work in plants and animals on the 
various mechanisms by which RNA silencing occurs and the various genes that are 
targeted. Euglena is not closely related to any of the model organisms and thus 
might reveal novel mechanisms and targets.  
Incorporation of BaseJ into DNA is used in unusual gene silencing routes in 
Trypanosoma and Leishmania. Euglena also utilises this base, but it has not been 
thoroughly investigated. With the transcriptome sequences it is clear that BaseJ 
metabolism is substantially the same in these organisms, but until genome 
sequencing of Euglena has been completed there is limited possibility to study this 
epigenetic modification. Key experiments include immunoprecipitation and 
sequencing of BaseJ containing chromatin, identification of the glycosyltransferases 
and glycoside hydrolases involved in BaseJ metabolism, and down regulation of the 
enzymes involved in BaseJ turnover, possibly by RNAi or mutagenesis. 
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7.5.3 Natural products from Euglena 
It is apparent that Euglena expresses complex natural product synthases. It has not 
been possible to identify any natural products to date, though it is probable that one 
of the nonribosomal peptides is involved in iron sequestration. The role of the other 
complex natural products remains unknown and identification of these products is 
on-going (Fig 7.3).  
 
Figure 7.3: Euglena natural products 
A. MALDI-imaging MS of Euglena cultures from high nutrient media agar revealed a 
peak at m/z = 870.553 only on or close to the colonies. B. Ms/ms fragmentation of 
this ion, after methanol extraction of the colony, does not allow conclusive structure 
solution. 
 
7.5.4 Biotechnological uses of Euglena 
Euglena are highly attractive organisms for biotechnology. They have all the 
attributes of Eukaryotes and are exceptionally easy to cultivate. However, in order to 
fully utilise Euglena in biotechnology, there are a number of hurdles to overcome. 
Euglena have successfully been transformed and there is some evidence for 
homologous recombination.27 This need to be confirmed as it represents a useful 
technique for introducing targeted mutations into the Euglena genome. The 
chloroplast can also be transformed, although there is some complex gene 
processing which may complicate successful expression in this organelle.28 The 
nature of their protein glycosylation and ease of growth makes Euglena ideal for 
expression of therapeutic glycoproteins, once reliable transformation protocols are 
developed. If homologous recombination can be achieved then they can be 
humanised by replacing all the tailoring enzymes with human isoforms. 
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It is possible to mutate genes in Euglena but the procedure is complicated and has 
not been widely used.29 Gene silencing, using electroporation-mediated introduction 
of dsRNA, has been used to deactivate genes and is stable over several 
generations.30 Stable mutants will allow the detailed understanding of all the genes 
involved in various metabolic pathways and the effects of specific perturbations.  
If, as seems likely, Euglena is not haploid then all copies of a gene need to be 
inactivated. In other organisms this is normally achieved by mutation of one copy 
and repeated rounds of sexual recombination in order to achieve homozygotes.  
To accomplish this in Euglena sexual reproduction must be induced. Since all the 
genes necessary appear to be present in the transcriptome (see Section 6.3.1), and 
it is known that under phosphate limited conditions the number of chromosomes is 
halved,31 this seems an achievable aim. 
It has long been recognised that Euglena contains many important metabolic 
pathways with unusual features. The transcriptome provides sequences for all the 
enzymes and will allow their combination into designed pathways in other 
organisms. The unusual protein architectures will facilitate metabolic engineering 
and provide extra tools in the synthetic biology toolbox. 
7.6 Final thoughts 
A great deal of the biology that is currently studied focuses on topics which are 
already well characterised. By concentrating on phosphorylases which have already 
been the subject of research, PHS2, CDP and to a certain extent LDP, I have fallen 
into this trap. The de novo sequencing of the well characterised alga Euglena 
gracilis has revealed an unexpected metabolic capability, including unexpected 
natural product synthases and novel enzyme architectures. All of the analysis has 
focused on <40% of the sequences which match Gene Ontology classifications, 
leaving >60% of the sequences with no functional predictions. This highlights the 
breadth of biology in just this one alga, which has only been partially unveiled, even 
with the power of modern sequencing technology. There are whole worlds to 
explore in every drop of pond water, and we have barely begun to scratch the 
surface. 
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Chapter 8 – Materials and methods 
8.1 General methods 
Unless otherwise noted, all chemicals were purchased form Sigma-Aldrich 
Company Ltd. 
8.1.1 – Molecular biology methods 
8.1.1.1 – Transformation of E. coli 
Chemically competent E. coli were prepared by collecting 5 ml of mid-log phase 
culture by centrifugation (16,000 g), washing and incubating these cells in CaCl2 
(100 mM, 1 ml) for 2 hours at 4 °C.  Cells were diluted into 40% (v/v) glycerol and 
stored at -80 °C until required. After resuspending cells in of CaCl2 (100 mM, 250 μl) 
50 μl aliquots were incubated at 4 °C with approximately 200 ng of plasmid DNA for 
30 min. Cells were then subjected to a 30 s heat shock at 42 °C and immediately 
returned to 4 °C. After 2 min, 500 µl of LB medium was added to the cells. The 
cultures were plated on LB agar immediately, for AmpR selection, or after 1 hour 
incubation at 37 °C for other antibiotic resistances, and incubated for 16 hours at  
37 °C. Single colonies were subsequently grown in 10 ml LB with appropriate 
antibiotic selection and 1 ml of a single successful culture was placed at -80 °C in 
40% (v/v) glycerol for long term storage. Carbenicillin was used at 100 μg/ml and 
chloramphenicol at 35 μg/ml. 
8.1.1.2 – Agarose gel electrophoresis 
Agarose gels (1% w/v), containing 1x SYBR Safe DNA gel stain (Invitrogen), were 
made and run in TBE (58 mM TrisHCl, 89 mM boric acid, 3 mM EDTA). Commercial 
loading buffer (NEB) was added to the samples before loading and the gels were 
run (100 V) until the dyes reached the lower portion of the gels. Gels were 
visualised with a DR88 Dark Reader (Clare Chemical Research) or Gene Genius 
(Syngene) transilluminators. Gel extraction was performed using QiaQuick Gel 
Extraction Kits (Qiagen) 
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8.1.1.3 – PCR, sequencing and alignments 
PCR was performed using Pfusion high fidelity RNA polymerase (Finnzymes) in a 
thermocycler (GStorm). DNA sequencing reactions were performed with BigDye 
v3.1 (Applied Biosystems) according to the manufacturer instructions. The reaction 
products were analysed by Genome Enterprises Limited.  Sequence alignments 
were performed using AlignX (Invitrogen) and ClustalW2 (www.ebi.ac.uk) and 
phylogenies displayed using iTOL web.1 
8.1.2 – Purification and analysis of recombinant proteins from E. coli 
8.1.2.1 – Purification of proteins 
Cell pellets were thawed and resuspended in 50 ml of lysis buffer (50 mM HEPES, 
pH 7.5, 100 mM NaCl, 1x cOmplete, EDTA-free Protease Inhibitor Cocktail Tablet 
(Roche), 0.02 mg/ml DNaseI). Cells were lysed using a cell disruptor (one shot 
mode, 25 kpsi, Constant Systems) and the cell debris removed by centrifugation at 
30,000 g (30 min, 4 °C). Protein was purified at 4 °C using an ÄKTA Xpress FPLC 
system (GE Healthcare). The supernatant was passed through a HiTrap Ni-NTA 
column (5 ml, GE Healthcare), washed with wash buffer (50 mM Tris-HCl, pH 8.0, 
0.5 M NaCl, 0.03 M imidazole) and eluted with elution buffer (50 mM Tris-HCl,  
pH 8.0, 0.5 M NaCl, 0.5 M imidazole (BioUltra)). Further purification was performed 
by gel filtration on a Superdex S75 26/60 column (GE Healthcare) using GF buffer 
(50 mM HEPES, pH 7.5, 100 mM NaCl, 3.2 ml/min) with collection of protein 
containing peaks with A280 over 100 mAU and slope steeper than 100 mAU/min.  
8.1.2.2 Denaturing polyacrylamide gel electrophoresis (SDS-PAGE) 
Polyacrylamide gels were made as a single concentration (8-12%) of acrylamide 
(37.5:1 mono: bis, Severn Biotech) in TrisHCl (0.75 M, pH 8.8, 0.1% SDS), with a 
5% acrylamide stacking gel in TrisHCl (140 mM, pH 6.8, 0.1% SDS), and run in 
SDS Running Buffer (25 mM Tris, 192 mM Glycine, 0.1% SDS). Alternatively 4-20% 
RunBlue precast gels (Expedeon), run in RunBlue Running Buffer (40 mM Tricine, 
60 mM Tris, 0.1% SDS, 2.5 mM Sodium Bisulfite, pH 8.2), were used. Samples 
were loaded in loading buffer (SDS Running Buffer, 10% (v/v) glycerol, 0.1 mg/ml 
bromophenol blue, 0.1 mg/ml β-mercaptoethanol) after incubating at >95 °C for  
5 min and run until the dye reached the end of the gel. Gels were removed from the 
cassettes and stained for protein using InstantBlue (Expedeon). 
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8.1.2.3 – Dynamic light scattering (DyLS) 
Samples of protein (20 µl) were filtered (0.1 µm, Millipore) by centrifugation and 
loaded into a 12 µl quartz cuvette (Wyatt). Measurements were taken over 5 s at  
25 °C in a DynaPro (Wyatt) and averaged over 10 results. 
8.1.3 – Phosphorylase activity assays 
All kinetic analyses were performed in the synthetic direction, measuring release of 
Pi from Glc-1-P. The concentration of released Pi was measured colourimetrically 
using a method modified from De Groeve et al.2 Colour solution (75 μl, 0.1 M HCl, 
13.6 mM sodium ascorbate) was added to the stopped enzyme reaction (25 μl), 
containing ammonium molybdate (200 mM), in a microtitre plate. After incubating for 
5 min at 21 °C stop solution (75 μl, 68 mM sodium citrate, 2 % acetic acid) was 
added and A620 was measured.  pH variation was performed in a mixed buffer  
(0.1 M each Tris, MES, citrate) with pH determined to 0.02 units accuracy at 21 °C. 
Temperature variation was performed in a thermocycler (GStorm).  
8.1.4 – Protein crystallography 
Structure determination using protein crystallography was carried out with the 
assistance of C. Stevenson and D. Lawson (John Innes Centre), and with the 
support of the Diamond Light Source and the assistance of the on-site beam line 
scientists.  
8.1.4.1 – Protein crystallisation screens 
Initial protein crystallisation was performed using the sitting drop vapour diffusion 
method in a 96 well plate format (MRC 96 well crystallization plate, Molecular 
Dimensions). 50 μl of well solutions (AmSO4 and PEG (Qiagen) and JCSG, Classics 
and PACT (Molecular Dimensions) screens) were robotically dispensed (freedom 
evo, Tecan). Drops were made using a robot (OryxNano, Douglas instruments) to 
mix an equal volume (0.3 µl) of well solution and filtered (0.1 µm, Millipore) protein 
solution (10 mg/ml) in GF buffer. Plates were placed in a crystal hotel (CrystalPro, 
TriTek Corp.) at 20 °C and monitored over the course of 4 weeks, when the best 
conditions were selected for further screening in 24-well format using with 1 ml well 
solution and drops, composed of 1 μl protein and 1 μl well solution. 
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8.1.4.2 – Preparation and transport of protein crystals to Diamond Light Source 
(DLS) 
Crystals were soaked with ligands and cryoprotectant as necessary before being 
mounted in CryoLoops (Hampton Research). They were then flash cooled in liquid 
nitrogen to -173 °C and transported to the Diamond Light Source synchrotron 
(Oxford, UK) in Unipuck cassettes. There they were robotically mounted on to the 
goniostats at and maintained at -173 °C with a Cryojet cryocooler  
(Oxford Instruments).  
8.1.4.3 – Data processing 
The resultant data were integrated using either MOSFLM3 or XDS4 and 
subsequently scaled by SCALA.5 All downstream processing was carried out using 
the CCP4 software suit.6 After initial structures were obtained subsequent rounds of 
rebuilding with COOT7 and refinement with REFMAC58  were used to produce the 
final model. 
8.1.5 APTS labelling of sugars 
Sugars were labelled for electrophoresis with 8-aminopyrene-1,3,6-trisulfonic acid 
(APTS) according to the PACE method.9 APTS (0.5 mg, 0.2 M) in aqueous acetic 
acid (5 μl, 30%) was mixed with NaBH3CN (0.5 mg, 0.8 M) in THF (5 μl). Reducing 
carbohydrate (1 mg) was dissolved in the mixture and incubated at 37 °C for 18 hr 
or 70 °C for 2 hr. The sample was then loaded on to a 30% 38:2 mono:bis 
acrylamide (Merck) Tris-borate (100 mM, pH 8.2) gel and separated by 
electrophoresis at 400 V in Tris-borate buffer (100 mM, pH 8.2), water cooled to 
room temperature. The carbohydrate band (upper) was excised and the labelled 
sugar was extracted into purified water by grinding using a ceramic bead in a bead 
mill (Fast Prep FP 120, Thermo) and washing with MQ-H2O (3x 30 ml). The borate 
was removed, either by desalting using a PD-10 column (GE Healthcare) or by 
evaporating three times from methanol, and the product was quantified using APTS 
absorption at 455 nm (17160 1/M/cm).10  
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8.1.6 Capillary electrophoresis with laser induced fluorescence (CE-LIF) 
After enzymatic reactions had been carried out using APTS-labelled carbohydrates, 
samples were placed in boiling water for 5 min and centrifuged for 1 min at  
16,000 g, to inactivate and remove proteins. The samples were made up to at least 
50 μl and loaded on to an N-CHO coated capillary (50.2 cm, 50 μm) in a PA800 
ProteomeLab (Beckman Coulter) by injection at 0.5 psi for 20 s. They were then 
separated in running buffer (25 mM LiOAc, 0.4% polyethylene oxide, pH 4.75,  
20 °C)  at 30 kV for 7 to 45 min and detected using LIF (excitation at 488 nm and 
detection at 520 nm).11 
8.1.7 General chemistry protocols  
8.1.7.1 Nuclear magnetic resonance (NMR) 
 1H NMR was performed at 25 °C (400 MHz, Bruker), referenced to the solvent 
peaks and analysis was performed using TopSpin (Bruker). 
8.1.7.2 Mass spectrometry (MS) 
Unless otherwise noted ESI-MS was performed on a Synapt G2 HDMS (Waters), 
run in MS/sensitivity/positive mode with standard settings. Spectra under the LC 
peak were combined and deconvoluted using the MaxEnt 1 tool in MassLynx 4.1 
(Waters). MALDI-Tof was performed on an Ultraflex Tof/ToF (Bruker) in positive 
mode, using 2,4,6-trihydroxyacetophenone as the matrix and 200 spectra were 
collected and combined. 
8.1.7.3 Thin layer chromatography (TLC) 
TLC was performed on Merck silica gel 60 F254 and visualised by dipping in 
EtOH:H2SO4 3:1 and charring. 
8.1.8 Atomic force microscopy (AFM) 
AFM was performed by A. P. Gunning (Institute of Food Research) on an MFP-3D 
BIO (Asylum Research) using AC160TS cantilevers (Olympus) with a nominal 
spring constant of ~42 N/m oscillated at a frequency 10% below resonance  
(typically around 320 kHz). Images were acquired at a scan rate of 1 Hz in air using 
AC mode.  
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8.1.9 Transmission electron microscopy (TEM) 
8.1.9.1 Microscopy  
TEM was performed with the assistance of K. Findlay (BioImaging, John Innes 
Centre) on a Tecnai20 microscope (FEI), at 200 kV, and imaged using an AMT 
digital camera (Deben UK Ltd.). 
8.1.9.2 Uranyl acetate (UA) staining  
Particles were deposited on TEM Grids (Pd/Cu with plastic/carbon coating) and 
negatively stained with uranyl acetate (UA, 2%, 5 μl) for 5 min before imaging 
8.1.9.3 PATAg staining 
The periodic acid/thiocarbhydrazide/silver (PATAg) staining protocol12 was used in 
order to specifically stain AuNPs for the carbohydrates. Briefly particles were 
deposited on the TEM grids and inverted on to periodic acid (10 mg/ml) for 20 min. 
After washing with MQ-H2O the grids were placed on thiocarbohydrazide  
(2 mg/ml in 20% (v/v) acetic acid) for 2 hours and washed with decreasing aqueous 
acetic acid (20%, 10%, 5%) and finally MQ-H2O. Grids were then floated on silver 
proteinate (10 mg/ml, 8% Ag) for 30 min in the dark and washed with MQ-H2O. 
Grids were kept in the dark before imaging.    
8.1.10 Proteomics 
Proteomic analysis was performed by G. Saalbach (Proteomics Facility, John Innes 
Centre). Proteins for analysis were separated by SDS-PAGE and gel slices excised. 
In-gel digestion with trypsin was performed, after carbamidomethylation of the 
cysteines, and the peptides released were loaded at high flow rate onto a reverse-
phase trapping column (0.3 mm x 1 mm, containing 5 µm C18 100 Å PepMap 
packing, LC Packings) and eluted through a reverse-phase capillary column  
(75 µm x 150 mm column, containing Symmetry C18 300 Å packing, Waters Ltd.) 
directly into the nano-electrospray ion source of a quadrupole time-of-flight mass 
spectrometer (Q-ToF2, Micromass UK Ltd.). Alternatively MALDI-ToF MS was 
performed using α-cyano-4-hydroxycinnamic acid as the matrix. Fragment ion 
spectra were searched using the MASCOT search tool (Matrix Science Ltd.), 
allowing oxidation of methionine.  
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8.2 Specific protocols for PHS2 
8.2.1 Cloning of PHS2 
The PHS2 gene was amplified from Arabidopsis thaliana Col-0 cDNA (kind gift of C. 
Ruzanski) by PCR using the following primers:  
AtPHS2 TOPOF (eurofins MWG):  CACCATGGCAAACGCCAATGGAAAAGC 
AtPHS2 R*(Sigma):   TTAGGGAACAGGACAAGCCTC 
The forward primer contains the TOPO cloning overhang (underlined).  
The band corresponding to 2621 bp, when compared to the marker (Fig 8.1), was 
extracted from the gel and cloned into pET151 using directional TOPO cloning 
(Invitrogen) forming plasmid pET151-PHS2 (Fig 8.2). 
         L cDNA PCR 
 
  
3 kbp 
2 kbp 
Figure 8.1: PCR amplification of PHS2 
PHS2 was amplified by PCR from Arabidopsis cDNA. A 10 µl reaction was run on a 
1% (w/v) agarose gel. The band corresponding to 2621 bp was extracted and the 
other bands, corresponding to non-specific priming, were discarded. L: 1 kb DNA 
Ladder (NEB). cDNA: total cDNA. PCR: total reaction. 
 
2621 bp 
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Figure 8.2: Plasmid map of pET151-PHS2 showing NdeI restriction sites 
The plasmid pET151-PHS2 was transformed from the TOPO reaction mixture (1 μl) 
into OneShot TOP10 chemically competent E. coli (50 μl, Invitrogen), and 
successful transformants were selected for on LB agar using carbenicillin. 
Successful construction of the plasmid was confirmed by growing overnight cultures 
and extracting plasmids from mid log phase E. coli cells (3 ml) using Qiaprep Spin 
Miniprep Kit (Qiagen), eluting with MQ-H2O (50 µl). These were analysed by 
restriction digest using NdeI (NEB) (Fig 8.3), and finally by DNA sequencing 
(Appendix 1).  
 L C1 C2 C3 C4 C5 
 Uncut 
plasmid 
 
 
10kbp 
Cut 
with 
NdeI 
 
1kbp 
Figure 8.3: Restriction digest analysis of pET151-PHS2 plasmid from single clones 
Plasmids were extracted from 5 colonies (C1-5) and either run without digestion or 
after 2 hour digestion with NdeI. Only C3 gave a band at around 1 kb, compared to 
1 kb DNA Ladder (L, NEB), corresponding to 872 bases, though no band 
corresponding to 430 bp is visible.  
PHS2-pET151
8286 bp
Amp(R)
ROP
lacI
AtPHS2
T7 primer
T7 reverse primer
bla promoter
T7 promoter
directional TOPO overhang
pBR322 origin
T7 transcription terminator
NdeI (5664)
NdeI (6094)
NdeI (6966)
pET151-PHS2 
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8.2.2 Optimisation of PHS2 expression 
For protein expression four E. coli strains (BL21, BL21CodonPlus (Agilent), Rosetta-
2 and Rosetta-2 GroEL/ES (Novagen)) were transformed with pET151-PHS2 and 
cultured in Luria-Bertani medium containing carbenicillin and, except for BL21, 
chloramphenicol. Cultures (10 ml) were grown at 37 °C and samples taken from 
uninduced cell and 2 and 4 hours after induction with IPTG (0.5 mM) and analysed 
by SDS-PAGE (Fig 8.4).  
 
 
Figure 8.4: SDS-PAGE analysis of E. coli strains expressing PHS2 
Samples were taken from the four strains of E. coli before, 2 and 4 hours after 
induction with IPTG. M: Broad Range Prestained Ladder (NEB), BL21: BL21, 
BL21C+: BL21 CodonPlus, Ros2: Rosetta-2, Ros2G: Rosetta-2 GroEL/ES. 
 
 
 
 
 M BL21 BL21-C+ Ros2 Ros2G 
0 2 4 0 2 4 0 2 4 0 2 4  
 
175kDa 
80kDa 
99 kDa 
Chapter 8 – Materials and methods 
 
~ 239 ~ 
 
The best expressing strain, as judged by the intensity of the band at 99 kDa, was 
Rosetta-2, which was then selected for expression of PHS2. Cultures of LB  
(8 x 1 litre) were inoculated with these cells and grown at 37 °C until OD600 reached 
0.1 when they were transferred to 16 °C for 1 hour. IPTG was then added to a final 
concentration of 1 mM. After 16 hours the cells were harvested at 7,500 g and 
frozen at -80 °C until required. The cells were lysed and the protein purified using 
the standard protocol (section 8.1.2) to give a total yield of 2.5 mg of purified PHS2 
per litre culture (see section 3.2), which was concentrated to 40 mg/ml with an 
Amicon Ultra-15 50 kDa spin concentrator (Millipore). Protein concentration was 
estimated by absorption at 280 nm (Nanovue, GE Healthcare) using an extinction 
coefficient of 145190 1/M/cm calculated from the amino acid composition.13 Intact 
mass gave a molecular weight of 98943.05 Da (Fig 8.5), in close agreement with 
the calculated mass of the PHS2 monomer with the tag, and with no pyridoxal 
phosphate bound, of 98942.5 Da.  
 
 Figure 8.5: Intact mass of PHS2  
PHS2 (200 pmol) was loaded on to a C4 reverse phase column (BEH300 C4 1.7 
µm, 1 x 50 mm Waters) attached to an Acquity UPLC and eluted with a gradient 
from 10-80% acetonitrile in 0.1% formic acid in 13 min, with ESI-MS analysis. A. 
Spectrum under main peak B. Mass calculated from spectrum. 
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8.2.3 Acceptor length specificity of PHS2 
Assays were performed in triplicate in the range 0.05-3 mM acceptor glucan, using 
10 mM Glc-1-P in 12.5 μl MES buffer (20 mM, pH 6.0) at 21 °C using 8 μg/ml PHS2. 
 
Figure 8.6: Acceptor length specificity of PHS2  
The KM
app for maltooligosaccharides was calculated from the kinetics data 
using GraFit (Erithacus Software Ltd). 
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8.2.4 SPR experiments 
SPR experiments were performed in a BiacoreX instrument (Biacore, GE 
Healthcare) at 25 °C using a continuous flow rate of MES buffer (20 µl/min, 40 mM, 
pH 6.0, degassed under vacuum) and injections were performed only after the 
baseline had stabilised. 
8.2.4.1 Maltoheptaose surface 
(α-1,4-Glc)7 (186, 10 mg, 8 μmol) was reacted with adipic acid dihydrazide  
(187, ADH, 17.4 mg, 100 μmol) in sodium acetate (500 μl, 1 M, pH 4.5), at 37 °C for 
4 hours. The product (188, (α-1,4-Glc)7-ADH) was purified by gel permeation 
chromatography (20 mM NH4HCO3, pH 7.0, 0.5 ml/min, TSK HW40S) on a series 
200 HPLC (Perkin Elmer), equipped with an refractive index detector. The peaks 
were analysed by TLC (iPrOH: H2O, 3:1) and MALDI-ToF. The fractions containing 
product 188 were combined and lyophilised to yield 7.9 mg.  
 
 
Scheme 2: The coupling of maltoheptaose to adipic acid dihydrazide 
The surface was made by reacting 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(68, EDC, 1 μl, 0.2 M) and N-hydroxysuccinimide (69, NHS, 1 μl, 0.05 M) in DMF 
with (1-mercapto-11-undecyl)carboxymethyl hexa(ethylene glycol)  
[HSC11-(EG)6OCH2COOH] (67, SAM linker, 0.25 μmol, neat, Prochimia) at room 
temperature for 30 min and adding (α-1,4-Glc)7-ADH (188, 1 µmol) for 30 min, 
forming (α-1,4-Glc)7-ADH-SAM linker. The sensor surface was prepared by cleaning 
a commercial gold chip (Sensor Chip Au, Biacore BR-1005-42) using 5 μl Piranha 
solution (3:1 H2SO4 (conc): H2O2 (aq., 30%)) and washing exhaustively with purified 
water before drying with compressed air. 
Chapter 8 – Materials and methods 
 
~ 242 ~ 
 
The (α-1,4-Glc)7-ADH-SAM linker solution was then applied to the cleaned gold 
sensor surface and the thiol was left to immobilise for 2 hours and form a self-
assembled monolayer (SAM) on the surface.14  To this surface was added  
(1-mercapto-11-undecyl)tri(ethylene glycol) [HSC11-(EG)3OH]  (72, SAM spacer,  
0.8 µmoles, Assemblon) in DMF (4 μl), ensuring homogeneity of the surface and 
preventing discreet regions forming. The chip was left overnight for the SAM to 
assemble, before washing and loading the surface into the carrier.  
8.2.4.2 Fractionated glucan (FG) 
Glucidex IT12 (Roquette) has 3% branching (as judged by 1H NMR integration of 
the broad peak at δ: 4.90 ppm (α-1,6) compared with the broad peak at δ: 5.33 ppm 
(α-1,4) (Fig 8.6)) and an average molecular weight of 19 kDa (DP ~110). It is known 
to contain low molecular weight maltooligosaccharides,15 which would not act as 
acceptors for PHS2. Fractionated Glucan (FG) was obtained by washing these 
contaminants through a 30 kDa MWCO spin filter (Amicon) by washing with  
MQ-H2O (3x 3 ml, with 0.5 ml retained each time), and lyophilising the retained 
fraction. FG (10 mg) was reacted with adipic acid dihydrazide as above and 
characterised by 1H NMR spectroscopy (Fig 8.7). The reducing terminal anomeric 
signals [δ: 5.14 ppm (d, J1-2=3.7 Hz, H1α) and δ: 4.57 ppm (d, J1-2=8.0 Hz, H1β)] 
disappeared completely and a new signal appeared, corresponding to the glycoside 
anomeric proton in the FG-ADH [δ: 4.03 ppm (d, J=9.3 Hz, H1β)]. 
 
Figure 8.7: 1H NMR of Glucidex IT12 
Glucidex was analysed by 1H NMR in D2O and the integration of the anomeric 
protons shows that about 3% of the non-reducing residues are α-1,6 linked. 
H1α-1,4 
H1α-1,6 H1β H1α 
Chapter 8 – Materials and methods 
 
~ 243 ~ 
 
8.2.4.3 Low FG density SPR surface 
SAM spacer (72, 98 mM) and SAM linker (68, 2 mM) in DMF (10 μl) was placed on 
the gold sensor chip surface and left overnight at 4 °C to assemble into a 
homogenous SAM. EDC (68, 10 μl, 0.2 M) and NHS (69, 10 μl, 0.05 M) in water 
were mixed and added to the surface and incubation was continued at room 
temperature for 30 min. FG-ADH (188, 10 μl, 10 mg/ml) in water was added to the 
surface and incubation was continued for a further 30 min at room temperature. The 
excess liquid was removed and the surface was washed with MQ-H2O before 
inserting into the carrier.  
8.2.4.4 High FG density surface 
The higher sugar density surface, with a higher FG loading, was made in the same 
way as the maltoheptaose surface. Briefly, FG (10 mg) was coupled to the SAM 
linker (67, 0.25 μmol) in solution and then applied to the surface. The SAM spacer 
(72, 0.8 µmol) was added after 2 hours. 
8.2.5 Fractionated glucan gold nanoparticles (FGNPs) 
8.2.5.1 Synthesis of gold nanoparticles 
Gold nanoparticles (AuNPs) were prepared by the method of Turkevich.16 Gold (III) 
chloride (AuCl3·3H2O, 12.5 mg in 100 ml MQ-H2O) was reduced with trisodium 
citrate (Na3C6H5O7· 2H2O, 50 mg in 50 ml MQ-H2O), combined with stirring at 60 °C 
before heating to 85 °C for 150 min. Once the AuNPs had cooled to room 
temperature they were filtered through a disc filter (0.2 µm, Millipore). They were 
confirmed to be uniform in size and shape by TEM and the UV absorption maxima 
(Perkin Elmer Lambda 25 UV/Vis Spectrophotometer) at 524 nm,  
as expected.16  
8.2.5.2 Immobilisation of FG on AuNPs 
Approximately 1 µmole of FG-ADH-SAM linker, as was made for the high FG 
density SPR surface, was added to 10 ml of AuNPs and left to immobilise on the 
surface for 2 hours. 4 µmole of SAM spacer molecule was added and the solution 
was left to assemble overnight at 4 °C to form FGNPs. The FGNPs were purified by 
centrifugation and resuspension with sonication into fresh MQ-H2O six times,  
and stored until ready for use at 5x1012 particles/ml in MQ-H2O at 4 °C.  
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8.2.5.3 Enzymatic reactions on FGNPs 
PHS2 mediated extension was performed by diluting the FGNPs to  
1x1012 particles/ml in a solution containing Glc-1-P (10 mM), PHS2 (10 µg/ml) and 
buffer (MES, 10 mM, pH 6.5) and incubating at 37 °C for 60 min. The reaction was 
stopped by addition of ProteinaseK (20 µg/ml in 20 mM MES, pH 7.5) and 
incubating at 37 °C for 5 min followed by inhibition of the ProteinaseK by addition of 
PMSF (1 mM). 
A fraction of the suspension was diluted two fold in enzyme buffers (0.3 mg/ml PAA 
in 100 mM MES pH 6.5 or 1 mg/ml AG in 100 mM MES, pH 4.5) and incubated for 
60 min at 37 °C. The enzymes were inhibited by addition of acarbose (1 mM),  
a known inhibitor of both enzymes (PPA Ki = 2.1 µM,
17 AG (Aspergillus) Ki = 1 pM
18), 
and the particles were deposited, stained and imaged immediately afterwards. 
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8.3 Specific protocols for cellodextrin phosphorylase 
8.3.1 Optimisation of CDP expression 
8.3.1.1 Initial cloning of CDP 
The plasmid Gs-pET15b-CDP from Genscript was transformed into freshly prepared 
chemically competent E. coli BL21 and plated on to carbenicillin agar plates.  
Eight colonies were picked from these plates and grown in LB cultures (10 ml). 
These were subcultured, grown to OD600 of 0.6 and induced overnight at 30 °C 
using IPTG (1 mM) and the cleared cell lysate was assayed for activity using CE 
(Fig 8.8).  
 
Figure 8.8: Activity assays of initial CDP expression clones 
Cleared E. coli cell lysate (10 μl) from 8 colonies was assayed for CDP activity by 
incubating with Glc-1- P (10 mM) and 0.72 μM APTS-(β-1,4-Glc)6 for 72 hr at 37 °C 
in HEPES (50 mM, pH 7.5), and the products were separated by carbohydrate 
electrophoresis. All samples only showed peaks consistent with the starting material 
APTS-(β-1,4-Glc)6. 
As none of the cultures contained any CDP activity it was concluded that the  
Gs-pET15b-CDP had the gene encoding CDP in the incorrect orientation for 
expression. To rectify this, the gene was excised and religated into the same 
backbone, and the correct orientation screened for by protein expression and CDP 
activity. 
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The plasmid Gs-pET15b-CDP was digested for 4 hr with BamHI (Roche) according 
to the manufacturer instructions. The resulting mixture was separated by 
electrophoresis in a 0.8 % agarose gel (Fig 8.9) and both bands were excised and 
extracted from the gel using QIAquick gel extraction kit (Qiagen). 
HL1 P P P P P P U 
 
Figure 8.9: Restriction digest of pET15b-CDP 
The plasmid Gs-pET15b-CDP (0.8 µg) (Lane U) was digested with BamHI (10 U) in 
Roche buffer B (20 µl) to give two bands (Lane P) corresponding to 5708 bp 
(backbone) and 2968 bp (insert), against Hyper Ladder 1 (Lane HL1) (NEB). 
After extraction, the upper band had the terminal phosphate removed using Calf 
Intestinal Phosphatase (10 U, NEB) according to manufacturer instruction and the 
enzyme was removed using QIAquick PCR cleanup kit (Qiagen). The upper band  
(6 μl) and the lower band (2 μl) were religated using T4 DNA ligase  
(5 U, Fermentas) in T4 DNA ligase buffer. After 15 min the product (1 μl) was 
transformed into freshly prepared chemically competent TOP10 E. coli (50 μl) and 
transferred to LB medium (10 ml) containing carbenicillin. After 16 hours at 37 °C 
the plasmids were extracted using PureYield plasmid miniprep system (Promega). 
The purified plasmid mixture (1 μl) was transformed into freshly prepared chemically 
competent E. coli BL21 (50 μl) and plated on to carbenicillin containing LB agar.  
10 colonies were picked into 10 ml LB and the subcultures were induced, once 
OD600 reached 0.6, with IPTG (1 mM) for 5 hours at 30 °C and analysed for 
expression of CDP by SDS-PAGE (Fig 8.10). 
 
 
2968 bp 
5708 bp 
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 M..    1 2 3 4 5 6 7 8 9 10 -ve 
 
 
150kDa 
100kDa 
Figure 8.10: Trial expression of CDP 
Whole cell lysate of colonies 1-10 (20 μl) were run on SDS-PAGE. M: Kaleidoscope 
protein standards (BioRad). –ve: induced cells not containing a plasmid. 
 
Colony 4 was selected as containing plasmid pET15b-CDP (Fig 8.11), which was 
purified from the cells by mini prep as before.  
  
Figure 8.11: Plasmid map of pET15b-CDP showing BamHI restriction sites. 
pET15b-CDP
8670 bp
LacI
AmpR
CDP
RBS
Thrombin clevage site
T7 R primer
T7 promoter
T7 terminator
Lac operator
His-Tag
pBR322 origin
BamHI (318)
BamHI (3282)
114 
kDa 
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8.3.1.2 Expression of CDP 
An overnight culture of Colony 4 cells (4x 1 ml) was used to inoculate 4x 1 litre 
cultures of LB which were grown at 37 °C, transferred to 30 °C and induced with  
1 mM IPTG. After 4 hours the cells were harvested and frozen at -80 °C until 
required. A total yield of 10 mg/l culture of purified CDP was obtained and 
concentrated to 40 mg/ml with an Amicon Ultra-15 30 kDa spin concentrator 
(Millipore). Protein concentration was estimated at a wavelength of 280 nm using an 
extinction coefficient of 117010 1/M/cm, calculated from the amino acid 
composition,13 and protein quality was analysed by SDS-PAGE.  
8.3.2 Kinetic assays of CDP 
8.3.2.1 Inhibition of CDP 
Molybdate was found to be a good inhibitor of CDP (Fig 8.12) at the concentration 
used in the phosphorylase activity assay. This was carried out in the same way as 
for PHS2.  
  
Figure 8.12: Inhibition of CDP by molybdate 
Using Glc (10 mM) as the acceptor and Glc-1-P (10 mM) as the donor, the inhibition 
of CDP (50 μg/ml) by ammonium molybdate was assayed in the range 0.1-200 mM. 
Plotted using GraFit (Erithacus Software Ltd). 
IC50=3.9 ± 0.94 
mM 
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8.3.2.2 Donor specificity of CDP 
The phosphorylase activity assay was used to measure addition of 
monosaccharides from their respective sugar-1-Ps on to Glc (10 mM) in one hour at 
37 °C (Fig 8.13). There was a high background detected from Gal-1-P in the 
absence of enzyme, indicating release of phosphate due to hydrolysis, and Xyl-1-P 
is known to be a suitable donor for CDP.19 Thus it was concluded that this assay 
was not suitable for measuring the donor specificity of CDP, and CE was used 
instead.  
 
Figure 8.13: Donor specificity of CDP 
Using standard conditions the amount of phosphate released from various sugar 
phosphates was assayed. It appears that only Glc-1-P is a suitable donor, though 
this does not agree with literature. 
 
8.3.2.3 Acceptor specificity of CDP 
The ability for CDP (50 µg/ml) to transfer Glc from Glc-1-P (10 mM) was assayed at 
21 °C for 20 min in HEPES (50 mM, pH 7.5). Various acceptors were assayed over 
a range of concentrations to obtain kinetic parameters (Fig 8.14).  
-0.1
0
0.1
0.2
0.3
0.4
0.5
Glc-1-P Man-1-P Gal-1-P Xyl-1-P bGlc-1-P Fru-1-P GlcN-1-P
A620 
Donor 
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Figure 8.14: Acceptor length specificity of CDP 
The enzyme activity was measured over a range of acceptor concentrations. The 
Km
app was calculated for each using GraFit (Erithacus Software Ltd). 
8.3.2.4 CE assays of CDP 
Standard assays were carried out thereafter using CDP (5 µg/ml) at 40 °C with  
Glc-1-P (10 mM) and APTS-labelled acceptor (2 µM) in HEPES (50 mM, pH 7.5). 
After extended polymerisation the labelled acceptors became insoluble (Fig 8.15). 
  
APTS-(β-1,4-Glc)6 in solution APTS-(β-1,4-Glc)6 extended by  
CDP+Glc-1-P, after 
centrifugation 
Figure 8.15: Insoluble product of CDP catalysed extension of APTS-(β-1,4-Glc)6 
After the CDP reaction on the APTS-(β-1,4-Glc)6 had been terminated the APTS 
fluorescence had become insoluble and associated with the side of the tube,  
as visualised under UV light (254 nm), indicating that the glucans are insoluble. 
  
 
 
 
 
Figure 8.16: X-ray energy scans at the LIII absorption edge for heavy metal 
derivatives of CDP crystals 
A. Thiomersal soaked crystals showed a weak edge at the expected 12290 eV.  
B. Tetrachloroplatinate soaked crystals show a good absorption edge at 11568 eV. 
C. Tetrachloroaurate soaked crystals show a good absorption edge at 11925 eV. 
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8.3.3 X-ray crystallography of CDP 
8.3.3.1 Crystallisation of CDP 
After setting up crystallisation screens hits, the CDP crystallisation solution was 
optimised to contain PEG 3350 (20% (w/v), KCl (300 mM), buffered to pH 7.5 
(HEPES, 100 mM). However, CDP rapidly precipitated when mixed with this 
solution. The protein was pre-precipitated by mixing an equal volume of CDP 
crystallisation solution with CDP (10 mg/ml) in GF buffer and incubating on ice for 
15 min. After centrifugation at 16,000 g for 1 min, crystallisation drops were set up 
by mixing 1 μl of the soluble protein with 1 μl of the crystallisation solution.  
8.3.3.2 Heavy metal derivatisation 
Saturated CDP cryoprotectant solutions (CDP crystallisation solution containing 
20% glycerol) of thiomersal, potassium tetrachloroaurate and potassium 
tetrachloroplatinate were diluted 10x in cryoprotectant and used to soak crystals for 
18 hours. After back soaking in cryoprotectant for 5 min, crystals were flash cooled 
in liquid nitrogen and transported to DLS for data collection. Prior to diffraction data 
collection, fluorescence scans were recorded across the appropriate LIII X-ray 
absorption edges from the heavy atom derivatised crystals; in all cases the 
expected absorption edges were detected (Fig 8.16). Subsequently diffraction data 
were collected on each of these at X-ray energies that were 50 eV above the 
corresponding absorption edges. The resultant data sets were processed to 
resolutions in the range 3.0-4.0 Å, but in every case the anomalous signal was too 
weak to facilitate structure solution.  
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8.3.3.3 Selenomethionine derivative of CDP 
Cells containing plasmid pET15b-CDP were grown in SeMet minimal media20 
(SeMet MM: M9 salts, 0.2% glucose, 2 mM MgSO4, 0.1 mM CaCl2, 10 mg/l 
thiamine, 20 ml of amino acid stock) containing 100 µg/ml carbenicillin. The amino 
acid stock contains Arg, Asp, Glu, Gln, His, Ile, Leu, Lys, Phe, Ser, Thr, Try, Tyr and 
Val (2 mg/ml). An overnight LB culture of cells (5 ml) was collected by centrifugation 
(4000 g) and washed with SeMet MM (3x 5 ml). These cells were then grown in 
SeMet MM (1 litre) at 37 °C until OD600 reached 0.6, when Lys, Phe and Thr  
(100 mg), Ile, Leu and Val (50 mg) and SeMet (60 mg) were added and the 
temperature adjusted to 30 °C. After a further 45 min, cells were induced with IPTG 
(1 mM) and after 16 hours the cells were collected by centrifugation and stored  
at -80 °C until required. The protein was purified using the standard protocol 
(section 8.1.2) to give a final yield of 12 mg of purified protein (Fig 8.17). This 
crystallised under the same conditions as the native protein and produce sufficient 
anomalous diffraction to facilitate structure solution. 
 
 
Figure 8.17: Purification of SeMet derivatised CDP 
A. GF purification of SeMet-CDP after Ni-IMAC shows a single species, eluting at 
120 ml. B. SDS-PAGE of protein purification. Lane 1:  Kaleidoscope protein 
standards (Bio-Rad). Lane 2: total cell extract of uninduced cells. Lane 3: total cell 
extract of induced cells. Lane 4: insoluble cell material. Lane 5: soluble cell lysate. 
Lane 6: purified protein, showing a major band running just over 100 kDa.  
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8.4 Specific protocols for laminarin phosphorylase 
8.4.1 Growth of Euglena 
Euglena gracilis var. saccharophila Klebs was obtained from the culture collection of 
alga and protozoa (http://www.ccap.ac.uk/) (strain 1224/7a).  
High nutrient media. For growth in the dark, cells were grown in the recommended 
1x EG + 1x JM (Euglena gracilis medium plus Jaworski’s Medium, replacing  
“Lab-Lemco” with Tryptone), supplemented with 15 g/l, glucose at 30 °C and shaken 
at 200 rpm in the dark for 7 days between sub-culturing. Dark grown cells were 
harvested by centrifugation at 800 g for 10 min with rapid decantation of the 
supernatant. This yielded over 10 g/l fresh weight cells which were frozen at -80 °C 
until required. 
Low nutrient media. For growing the cells autotrophically the media was adjusted to 
contain no amino acids or sugars as energy sources. The medium consisted of 
CaCl2 (0.1 g/l), NaOAc
.(H2O)3 (1 g/l) and 1x JM.  Cultures were grown at 21 °C 
under ambient light and grew extremely slowly, taking 4 weeks between  
sub-culturing.  
Agar plates were made by supplementing the media with 15 g/l agar (Duchefa) and 
cells were collected from the surface by resuspending in MQ-H2O. 
8.4.2 Euglena lysis 
20 g of Euglena cells, which had been grown in the high nutrient media, were 
resuspended in 40 ml Euglena lysis buffer (10 mM HEPES NaOH, pH 7.0,  
1 tablet cOmplete protease inhibitor cocktail (Roche), 1 mg DNase). Cells were 
broken using a cell disruptor (Constant Systems, 10 kpsi), centrifuged for 20 min at 
30,000 g and the supernatant was filtered through 0.2 μm disc filter (Millipore) and 
frozen as 5 ml aliquots.  
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8.4.3 Synthesis of β-Glc-gol 
8.4.3.1 Enzymatic synthesis of β-Glc-gol 
Cleared Euglena gracilis cell lysate (100 µl) was added to 10 ml of reaction buffer 
(20 mM MES, pH 6.5) containing Glc-1-P (29, 100 mg, 0.38 mmol) and glycerol 
(144, 1 g, 11 mmol) and incubated at 30 °C for 4 days.  Anion exchange 
chromatography was performed on the reaction mixture (DOWEX 1X2-400 OH-). 
This mixture was concentrated in vacuo and dried by co-evaporation with toluene 
(3x 10 ml). The resulting solid, containing products 161-165, was dissolved in 
pyridine (30 ml) and excess Ac2O (10 ml) and the reaction was stirred overnight. 
The excess Ac2O was destroyed by adding MeOH (10 ml) and the solvents were 
evaporated. Residual AcOH was removed by co-evaporation with toluene  
(2 x 10 ml). The residual solid was dissolved in EtOAc and washed with water  
(3 x 20 ml) and aqueous HCl (1 M, 10 ml), neutralised with aqueous NaHCO3  
(sat., 30 ml), washed with aqueous NaCl (sat., 20 ml) and dried over anhydrous 
MgSO4 (1 g). The volatiles were removed by evaporation at reduced pressure. 
MALDI-ToF MS indicated (Glc)n-gol where n=0-5 and (Glc)n where n=1-6,  had been 
formed (Fig 5.8). The products were then separated using automated silica gel 
chromatography (Biotage) with a 25 g silica gel cartridge, using a Hex:EtOAc 
gradient (20-100% over 8 column volumes). The fractions with product were 
identified using TLC (EtOAc:Hex 2:1) and pooled accordingly.   
Fraction 1 Rf = 0.60 ESI-MS: m/z  Calculated [C21H30O14]Na
+: 529.1533  
β-Glc-gol – (150)   Found: 529.1527  
 
Fraction 2 Rf = 0.49 ESI-MS: m/z  calculated [C33H46O22]Na
+: 817.2378  
(β-Glc)2-gol – (151)  Found: 817.2357  
 
Fraction 3 Rf = 0.43 MALDI-ToF MS: m/z 
(β-Glc)3-gol – (152)   Calculated [C45H62O30]Na
+: 1105.3223  
Found: 1105.39,    
Calculated [C45H62O30]K
+: 1121.2963  
Found: 1121.39  
All fractions which only contained products of Rf 0.6 were recombined, evaporated 
to dryness and the chromatography repeated. The purest fraction was then 
analysed by NMR. 1H-NMR (CDCl3) showed more than one compound was present, 
but a significant peak [δ: 4.60(d, J1-2 8 Hz)] matched the spectrum of the synthetic 
product (Fig 5.11). 
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8.4.3.2 Chemical synthesis of β-Glc-gol 
A mixture of peracetylated (2R)-1-, (2S)-1- and 2-O-β-Glc-gol (165-169) was made 
according to Scheme 1 (section 5.2.6).  
8.4.3.2.1 Chemical synthesis of O-2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl 
bromide (189) 
 
33% HBr in AcOH (25 ml, 102.5 mmol) was added to a solution of β-D-glucose 
pentaacetate (159, 10 g, 25.6 mmol, Fluka) in dry DCM (distillation, 10 ml) and the 
mixture was stirred at 0 °C for 3 hours. The mixture was washed with H2O/ice, 
neutralised with aqueous NaHCO3 (sat., 20 ml), washed with water (3 x 20 ml) and 
the organic layer was dried over anhydrous MgSO4 (1 g). The product was 
recrystallised from diethyl ether to afford bromide 189. 1H NMR (400 MHz, CDCl3)  
δ: 6.61 (1H, d, J1,2 = 4.0 Hz, H-1), 5.56 (1H, dd, J2,3 = J3,4 = 9.5 Hz, H-3),  
5.16 (1H,dd, J3,4 = J4,5 = 9.5 Hz, H-4), 4.84 (1H, dd, J1,2 = 4.0 Hz, J2,3 = 9.5 Hz, H-2), 
4.35 – 4.28 (2H, m, H-5, H-6a), 4.13 (1H, m, H-6b), 2.11 (3H, s, OAc),  
2.10 (3H, s, OAc), 2.06 (3H, s, OAc), 2.03 (3H, s, OAc). 
8.4.3.2.2 Chemical synthesis of O-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1→2)-
O-1,3-di-O-acetyl-glycerol (161) and O-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-
(1→1)-O-2,3-di-O-acetyl-glycerol (162)  
 
Glycerol (144, 2.24 g, 24.3 mmol) was dried by co-evaporation with toluene  
(3 x 20 ml) and mixed with dry DCE (distillation, Drierite, 30 ml) to which was added 
HgBr2 (263 mg, 0.73 mmol), Hg(CN)2 (1.474 g, 5.8 mmol)
21 and glucosyl bromide 
189 (2 g, 4.9 mmol). The reaction was refluxed for 2 hours and stirred at room 
temperature for 3 days. The solution was washed with aqueous  
KI (sat., 20 ml) and water (3 x 20 ml), dried over anhydrous MgSO4 (1 g) and the 
volatiles were evaporated under reduced pressure. The crude reaction mixture was 
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dissolved in pyridine (30 ml) and excess Ac2O (10 ml) was added. The mixture was 
stirred overnight at RTP and the excess Ac2O was destroyed by adding MeOH  
(10 ml). The solvents were evaporated and the residual AcOH was removed by  
co-evaporating with toluene (2 x 10 ml). The residue was dissolved in EtOAc and 
washed with water (3 x 20 ml) and aqueous HCl (1 M, 10 ml), neutralised with 
aqueous NaHCO3 (sat., 30 ml), washed with aqueous NaCl (sat., 20 ml) and dried 
over anhydrous MgSO4 (1 g). The volatiles were removed by evaporation at 
reduced pressure. The products were identified as per-acetylated mono-, di- and  
tri- glucosylated glycerol (165-169) by MALDI-ToF MS (Fig 5.10). The products 
were then separated using automated silica gel chromatography (Biotage) with a  
25 g silica gel cartridge, using a Hex:EtOAc gradient (20-100% over 8 column 
volumes).  
1H-NMR (CDCl3) was performed on one fraction with the single product with  
Rf 0.6, showing 6 signals for the anomeric proton which approximately matched 
literature signals for peracetylated (2R/2S)-β-D-glucopyranosyl-1-O-glycerol  
(148, 149) and β-D-glucopyranosyl-2-O-glycerol (147). 
1H NMR (400 MHz, CDCl3) δ: 5.20 – 5.15 (2.6 H, m, H-3’,H2 (148+149)), 5.08 – 
4.96 (3.2 H, m, H-4’, H2’), 4.63 (0.6 H, d, J1,2 = 8 Hz, H1’ (147)), 4.52 (1 H, d, J1,2 = 
8 Hz, H1’ (148+149)), 4.30 – 4.03 (8.8 H, m, H1, H2 (147), H3 (147), H5’, H6’), 3.97 
– 3.91 (1 H, m, H3a (148+149)), 3.72 – 3.65  (2.6 H, m, H5’, H3b (148+149)), 2.07 – 
1.98 (29 H, m, OAc) 
MALDI-ToF-MS: m/z   Calculated [C21H30O14]Na
+: 529.1533  
(147,148,149)   Found: 528.98  
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8.4.4 Laminarin phosphorylase purification 
In order to purify the laminarin phosphorylase a range of purification strategies were 
explored and two multi-step protocols were developed. 
8.4.4.1 Assay for laminarin phosphorylase  
To assay for laminarin phosphorylase 6.25 μl of a 2x assay buffer (200 mM MES, 
pH 7.0, 20 mM Glc, 20 mM Glc-1-P) was incubated with a 6.25 μl assay sample in a 
microtitre plate at 30 °C for 5 min to 16 hours as appropriate and the phosphorylase 
activity assay was then performed. 
The most active fractions were confirmed by reacting 50 μl of purified enzyme in 
100 μl assay mixture (9.2 μM APTS-laminaritriose, 20 mM Glc-1-P, 20 mM MES, pH 
7.0) at 30 °C for appropriate time. After heating to 95 °C in a boiling water bath the 
samples was centrifuged at 16,000 g for 2 min and capillary electrophoresis was 
performed.  
8.4.4.2 Hydrophobic interaction chromatography (HIC) 
Four different 1 ml hydrophobic interaction columns (GE Healthcare) were tested for 
purification of the LDP from the Euglena lysate (Fig 8.18). Euglena cleared cell 
lysate (5 ml) was mixed with (NH4)2SO4 (5 ml, 2 M) and loaded on to the  
HIC columns, pre-equilibrated with (NH4)2SO4 (1 M) in HIC Buffer (5 mM MES,  
pH 6.0) on an AKTA Xplor FPLC (GE healthcare). The protein was eluted  
by decreasing (NH4)2SO4 to 0 M over 20 column volumes and 1 ml fractions were 
collected.  
It was determined that the butyl column gave the best separation of LDP activity 
from total protein and so was used in further purification steps, using a gradient of  
1-0 M (NH4)2SO4 in MES (5 mM, pH 6.0) to elute.  
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Figure 8.18: HIC purification of LDP  
Separation of LDP from Euglena cell lysate on four HIC columns (butyl (A),  
octyl (B), phenyl low FF (C) and phenyl high FF (D)) eluting with a 1-0 M (NH4)2SO4 
gradient in MES (5 mM, pH 6.0).  Conductivity (Cond, measure in mS/cm) indicates 
the reduction in (NH4)2SO4 concentration. The amount of Pi released from the assay 
in 30 min was measured to give an indication of fractions containing LDP activity. 
Blue = protein, measured as A280. Green = activity, measured as Pi released in the 
assay. Red = salt concentration, measured as conductivity. 
 
  
 
 
Figure 8.19: Ion exchange chromatography purification of LDP  
A. CIEX separation of LDP from Euglena cell lysate, on a 1 ml Sepharose SP 
column. The activity in the flow-through (FT) is similar to the activity in the whole cell 
lysate. B. AIEX separation of LDP from Euglena cell lysate, on a 5 ml HiTrap 
Sepharose Q column. The activity separated from the total protein. Blue = protein, 
measured as A280. Green = activity, measured as Pi released in the assay.  
Red = salt concentration, measured as conductivity. 
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8.4.4.3 Ion exchange chromatography  
The suitability of ion exchange chromatography for the purification of the laminarin 
phosphorylase form Euglena lysate was tested.  
8.4.4.3.1 Cation exchange chromatography (CIEX) 
Cleared cell lysate (5 ml) was mixed with an equal volume of CIEX Buffer  
(25 mM MES NaOH, pH 5.8). This was loaded on to a 1 ml HiTrap Sepharose SP  
(GE Healthcare) CIEX column, pre-equilibrated with CIEX Buffer and eluted with a 
gradient of NaCl (0-700 mM) in CIEX Buffer over 20 column volumes, collecting  
0.5 ml fractions (Fig 8.19.A). 
The activity was not retained on the column at all and so no further attempts were 
made to use CIEX to purify LDP. 
8.4.4.3.2 Anion exchange chromatography (AIEX) 
Cleared cell lysate (5 ml) was mixed with an equal volume of AIEX Buffer  
(25 mM TrisHCl, pH 8.5). This was loaded on to a 5 ml HiTrap Sepharose Q  
(GE Healthcare) AIEX column, pre-equilibrated with AIEX Buffer and eluted with a 
gradient of NaCl (0-700 mM) in AIEX Buffer over 20 column volumes, collecting  
2 ml fractions (Fig 8.19.B).  
The activity was retained on the column and eluted as two distinct peaks of activity, 
away from the largest protein peaks. 
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8.4.4.3.3 Optimisation of pH for AIEX 
In order to determine the best pH for separation of LDP activity using AIEX 20 g of 
Euglena cells were lysed into in 50 ml lysis buffer containing 5 mM TrisHCl, pH 8.0. 
Cells were lysed and the lysate cleared, as above (section 8.4.2), and four 10 ml 
aliquots were mixed with equal volumes of TrisHCl (50 mM, pH 7.5, 8.0, 8.5, or 9.0). 
Samples were loaded on to a pre-equilibrated 5 ml Hi Trap SepaharoseQ column 
(GE Healthcare) and eluted with a NaCl gradient (0-700 mM) in 50 mM TrisHCl at 
the appropriate pH (Fig 8.20).  
It was determined that a gradient of 0-700 mM NaCl at pH 8.5 gave the best 
separation of activity (released Pi from the assay) from protein (as measured by 
A280) and this pH was used in further purification. 10% of the fraction volumes of 
HEPES NaOH (1 M, pH 7.0) were added to each collection tube to neutralise the 
fractions as they were collected.  
 
Figure 8.20: AIEX purification of LDP at various pHs 
Separation of LDP from Euglena cell lysate, on a 5 ml HiTrap Sepharose Q column 
(50 mM TrisHCl) at pH 7.5 (A), 8.0 (B), 8.5 (C) and 9.0 (D), eluted with a 0-700 mM 
gradient of NaCl. Blue = protein, measured as A280. Green = activity, measured as 
Pi released in the assay. Red = salt concentration, measured as conductivity. 
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8.4.4.4 Gel filtration (GF) 
40 g of Euglena cleared cell lysate was further clarified by centrifuging at 100,000 g 
for 1 hour and the supernatant was concentrated by spin filtration, with 100 kDa 
cutoff (Millipore), to 8 ml. The whole rententate was applied to a Hi-Load 26/60 
Superdex 200 gel filtration column (GE healthcare), pre-equilibrated in GF buffer 
and eluted at 3.2 ml/min (Fig 8.21). 5 ml fractions were collected between 100 and 
300 ml. The activity eluted with the highest protein concentration, but efficiently 
removed around 75% of the total protein under mild conditions. 
 
 
Figure 8.21: GF purification of LDP  
Separation of LDP from Euglena cell lysate, on a Hi-Load 26/60 Superdex 200 
column, eluted with GF buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 3.2 ml/min). 
Blue = protein, measured as A280. Green = activity, measured as Pi released in the 
assay.  
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8.4.4.5 First purification protocol  
Laminarin phosphorylase was purified by AIEX and fractions 38-40 ml (Eg1.1) and 
60-62 ml (Eg1.2) were separately purified by HIC (Fig 8.22). The fraction at 18 ml 
from each HIC (Eg2.1 and Eg2.2) was precipitated with 50% TCA, run on SDS-
PAGE and proteomic analysis performed on the region 100-150 kDa (Appendix 3). 
 
Figure 8.22: Purification of LDP by the first purification protocol 
A. AIEX, using a 5 ml Sepahrose Q column, in HEPES (50 mM, pH 8.5) eluted with 
a 0-700 mM NaCl gradient. Fractions at 38-40 and 60-62 (Eg1.1 and 1.2) showed 
the highest activity. B. HIC, using a butyl column eluted with a 1-0 M (NH4)2SO4 
gradient in MES (5 mM, pH 6.0), on Eg1.1. The most active fraction was at  
18 ml (Eg 2.1). C. HIC on Eg1.2. The most active fraction was at 18 ml (Eg2.2). 
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8.4.4.6 Second purification protocol  
Laminarin phosphorylase was first purified by GF and the most active fraction was 
at 145-150 ml (EgA) (Fig 8.23). HIC was performed on this fraction and the activity 
eluted at 12-12.5 ml (EgB). Very little activity was detected after AIEX but fractions 
at 19-20 ml and 30-31 ml (EgC and D) were collected, based on previous elution 
profiles, for proteomics (Appendix 3). 
 
Figure 8.23: Purification of LDP by the second purification protocol 
A. Separation of LDP from Euglena cell lysate, on a Hi-Load 26/60 Superdex 200 
column (50 mM HEPES, pH 7.5, 150 mM NaCl). The most active fraction was at 
145-150 ml (EgA). B. HIC, using a butyl column eluted with a 1-0 M (NH4)2SO4 
gradient in MES (5 mM, pH 6.0), on EgA. The most active fraction (EgB), was at  
12-12.5 ml. C. AIEX on EgB, using a 5 ml Sepahrose Q column, in HEPES  
(50 mM, pH 8.5) eluted with a 0-700 mM NaCl gradient. Very little activity was 
detected, but two fractions were collected (EgC and EgD). 
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8.5 Specific protocols for Euglena transcriptome sequencing 
8.5.1 RNA extraction and sequencing 
Transcriptome assembly and automated annotation was performed by M. Trick 
(John Innes Centre). 
Total RNA was isolated from 106 cells grown in: high nutrient media in the dark; and 
low nutrient media agar in ambient light, using RNeasy Minikit (Qiagen) with the 
assiatnce of Tom Turner (JIC), and stored at -80 °C. Purification of the mRNA, 
library preparation and sequencing on an Illumina HiSeq 2000 platform was 
performed by Source Bioscience (Nottingham, UK).  A total of 313,205,944 and 
137,689,062 100 base, paired-end reads were obtained from the light- and dark-
grown samples respectively. The light-grown sequence data was down-sampled to 
100 million pairs of reads, and the entire dataset of 68,844,531 read-pairs from the 
dark-grown sample were used for separate de novo assemblies using Trinity30 
version r2013-02-25, executed in parallel on two 256GB cluster nodes.  233,748 
and 231,176 raw assemblies were generated from light and dark respectively. Likely 
coding sequences were extracted from these using the Perl utility script supplied 
with the Trinity distribution, transcripts_to_best_scoring_ORFs.pl, producing  
45,126 and 47,607 candidate ORFs of lengths greater than 100 amino acids.  
These were combined and then a non-redundant set of 32,128 peptides produced 
using CD-HIT22 (v4.5.4) with an identity threshold of 0.95 and a word length of 5.  
For functional annotation, the set was queried against the UniRef100 protein 
database using BLASTP with an E-value threshold of 10-10. Sequence identifiers of 
the best hits were harvested and used to programmatically collect from databases, 
via SOAP-based web services, GO terms and KEGG pathway objects, and also 
used to enumerate kingdom-level taxonomic classifications for the species of origin. 
Transcript levels for isoforms were estimated from the reads using the  
RSEM wrapper script supplied in the Trinity distribution to implement the RNA-Seq 
by Expectation Maximisation23 methods.  
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8.5.2 Annotation of CAZys 
The annotation of CAZys was performed by B. Henrissat (Centre National de la 
Recherche Scientifique, Marseille, France). Putative carbohydrate-active enzymes 
were identified and classified using the methods used for updating the 
carbohydrate-active enzymes database (CAZy; www.cazy.org) as described 
previously.24 Briefly, the translated protein sequences of Euglena were compared to 
the full-length sequences derived from CAZy using BLAST.25 The sequences that 
gave an E-value <0.1 were then subjected to a second BLAST search against a 
library made with the constitutive modules of  glycoside hydrolases (GH), 
glycosyltransferases (GT), polysaccharide lyases and carbohydrate esterases and 
their associated carbohydrate-binding modules (CBM). In parallel, the sequences 
were subjected to a HMMer search26 using hidden Markov models built for each 
CAZy module family. A protein was considered reliably assigned when it was placed 
in the same family by the two methods. Difficult cases were resolved by manual 
inspection of conserved features such as catalytic residues. 
8.5.4 Fatty acid analysis of Euglena extracts 
Cells grown in the high nutrient media at 21 °C with ambient light (100 mg) were 
vortexed with fatty acid extraction/methylation mixture (500 µL, 
methanol:toluene:2,2-dimethoxypropane:sulphuric acid 33:14:2:1) and heptane  
(250 µL). Samples were heated at 80 °C for 1 hour and 1 µl of the heptane fraction 
was injected on a  7HG-G015-02 GC capillary 30 m x 250 µm (Zebron) with  
1 ml/min helium over a temperature gradient from 140-380 °C in 30 min attached to 
a Network GC (Agilent) and analysed by mass spectrometry (Inert, Agilent). 
Compounds were identified using Chemstation to query the NIST library and by 
manual identification. 
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8.5.3 Identification of thiols in Euglena 
Purification of thiols from Euglena cells was performed by R. Dusi and C. Hamilton 
(University of East Anglia, Norwich, UK). Cells grown in the high nutrient media, at 
21 °C with ambient light (20 mg), were collected by centrifugation at 13,000 g, flash 
cooled in liquid nitrogen and stored at -80 °C until analysis. Cells were extracted into 
50% acetonitrile at 60 °C and the thiols were labelled with monobromobimane27 
(Invitrogen) and separated on a ACE AR C18 4.6 x 250 mm, 5 µm (HiChrom) by 
HPLC (JASCO) with fluorescence detection (JASCO FP2020 Plus) using excitation 
at 385 nm and emission at 460 nm. The gradient used started from 0.225% 
aqueous acetic acid, pH 4.0 to 90%  aqueous methanol over 50 min, held for 2 min, 
reduced to 0% over 2 min and held for 10 min with a flow rate of 1 ml/min.28  
Fluorescent peaks were collected and further analysed by L. Hill (John Ines Centre) 
using LC-MS on a Surveyor HPLC attached to a DecaXPplus ion trap MS (Thermo). 
Separation was on a Kinetex XB-C18 50 x 2.1 mm, 2.6 µm column (Phenomenex) 
running the following gradient of acetonitrile (B) versus 0.1% formic acid in water (A) 
at 300 µl/min and 30 °C: 0 min, 2% B; 10 min, 30% B; 20min, 95% B; 22 min,  
95% B; 22.5 min, 2% B; 26 min, 2% B. Bimane-labelled thiols were detected by  
UV at 390 nm, and positive ESI-MS. MS spectra were collected from m/z 250-2000 
and MS2 spectra of the most abundant ions were collected at an isolation width of 
m/z 4.0 and 35% collision energy. Spray chamber conditions were 50 units sheath 
gas, 5 units aux gas, 350 °C capillary temperature, and a spray voltage of 3.8 kV 
using a steel needle kit. 
8.5.5 Identification of siderophore production by Euglena 
The chrome azurol S (CAS) assay was used to show the production of 
siderophores.29 High nutrient media agar was made containing CAS (60 mg/l), 
hexadecyltrimethylammonium bromide (73 mg/l) and additional FeCl3 (2.7 mg/l) and 
cells were diluted such that approximately 10 cells were plated per petri dish. After 
two weeks a halo, indicating the presence of a siderophore, was clearly visible.  
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Appendices 
Appendix 1 – PHS2 sequencing 
Plasmid pET151-PHS2 was sequenced using the primers detailed below. This gave 
faithful sequence over the full length of the PHS2 insert (5764-8286 bp). 
PHS2 Sequencing primers 
AtPHS2 SEQ F1 ATGGTTTGAGGTACAGACATGG 
AtPHS2 SEQ F2 GGAAATGGTCAGAGTTTCCA 
AtPHS2 SEQ F3 AGGTGGTTACGTTTCTGCAG 
AtPHS2 SEQ F4 AGCGGAGATGCTAATACCCG 
AtPHS2 SEQ R1 AGGCAGATTTAGGGTGGCC 
AtPHS2 SEQ R2 GCTGCCTTCAGTGGTGCTC 
AtPHS2 SEQ R3 TCGAGGTGTGATGCCATTAG 
AtPHS2 SEQ R4 GCTACAGTGACATTGTAGTTTGG 
 
 
PHS2-pET151 CCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAAGCGCTCATGA 5442 
ATPHS2_SEQ_R1                                                  ACAAGCGCTCATGA  
   
PHS2-pET151 GCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAA 5502 
ATPHS2_SEQ_R1 GCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAA  
   
PHS2-pET151 CCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCGTCCGGCGTAGAGGATCGAGATCT 5562 
ATPHS2_SEQ_R1 CCGCACCTGTGGCGCCGGTGATGCCGGCCACGATGCGTCCGGCGTAGAGGATCGAGATCT  
   
PHS2-pET151 CGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCC 5622 
ATPHS2_SEQ_R1 CGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCC  
   
PHS2-pET151 TCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGCATCATCACCATCAC 5682 
ATPHS2_SEQ_R1 TCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATGCATCATCACCATCAC  
   
PHS2-pET151 CATGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACGGAAAACCTGTATTTT 5742 
ATPHS2_SEQ_R1 CATGGTAAGCCTATCCCTAACCCTCTCCTCGGTCTCGATTCTACGGAAAACCTGTATTTT  
  
     
PHS2-pET151 CAGGGAATTGATCCCTTCACCATGGCAAACGCCAATGGAAAAGCTGCGACTAGTTTACCG 5802 
ATPHS2_SEQ_R1 CAGGGAATTGATCCCTTCACCATGGCAAACGCCAATGGAAAAGCTGCGACTAGTTTACCG  
ATPHS2_SEQ_R2 CAGGGAATTGATCCCTTCACCATGGCAAACGCCAATGGAAAAGCTGCGACTAGTTTACCG  
   
PHS2-pET151 GAGAAAATCTCGGCTAAGGCGAATCCGGAGGCCGATGATGCTACGGAGATCGCTGGGAAT 5862 
ATPHS2_SEQ_R1 GAGAAAATCTCGGCTAAGGCGAATCCGGAGGCCGATGATGCTACGGAGATCGCTGGGAAT  
ATPHS2_SEQ_R2 GAGAAAATCTCGGCTAAGGCGAATCCGGAGGCCGATGATGCTACGGAGATCGCTGGGAAT  
   
PHS2-pET151 ATCGTCTACCACGCCAAGTACAGTCCACATTTCTCTCCATTGAAGTTCGGGCCTGAGCAA 5982 
ATPHS2_SEQ_R1 ATCGTCTACCACGCCAAGTACAGTCCACATTTCTCTCCATTGAAGTTCGGGCCTGAGCAA  
ATPHS2_SEQ_R2 ATCGTCTACCACGCCAAGTACAGTCCACATTTCTCTCCATTGAAGTTCGGGCCTGAGCAA  
   
PHS2-pET151 GCTCTCTACGCTACCGCAGAGAGTCTTCGCGATCGTCTCATTCAGCTGTGGAATGAGACT 6042 
ATPHS2_SEQ_R1 GCTCTCTACGCTACCGCAGAGAGTCTTCGCGATCGTCTCATTCAGCTGTGGAATGAGACT  
ATPHS2_SEQ_R2 GCTCTCTACGCTACCGCAGAGAGTCTTCGCGATCGTCTCATTCAGCTGTGGAATGAGACT  
   
PHS2-pET151 TATGTTCATTTTAACAAAGTTGATCCAAAACAAACTTATTACTTGTCAATGGAGTATCTC 6102 
ATPHS2_SEQ_R1 TATGTTCATTTTAACAAAGTTGATCCAAAACAAACTTATTACTTGTCAATGGAGTATCTC  
ATPHS2_SEQ_R2 TATGTTCATTTTAACAAAGTTGATCCAAAACAAACTTATTACTTGTCAATGGAGTATCTC  
   
PHS2-pET151 CAAGGTCGTGCTTTGACCAATGCCATTGGGAATTTGAACCTTCAAGGTCCATATGCTGAT 6162 
ATPHS2_SEQ_R1 CAAGGTCGTGCTTTGACCAATGCCATTGGGAATTTGAACCTTCAAGGTCCATATGCTGAT  
ATPHS2_SEQ_R2 CAAGGTCGTGCTTTGACCAATGCCATTGGGAATTTGAACCTTCAAGGTCCATATGCTGAT  
   
PHS2-pET151 GCACTGCGTACGCTGGGTTATGAGCTTGAGGAGATAGCTGAGCAGGAGAAAGATGCAGCT 6222 
ATPHS2_SEQ_R1 GCACTGCGTACGCTGGGTTATGAGCTTGAGGAGATAGCTGAGCAGGAGAAAGATGCAGCT  
ATPHS2_SEQ_R2 GCACTGCGTACGCTGGGTTATGAGCTTGAGGAGATAGCTGAGCAGGAGAAAGATGCAGCT  
    
PHS2-pET151 CTAGGAAATGGTGGGTTAGGGAGACTTGCCTCGTGTTTCTTGGATTCGATGGCCACCCTA 6282 
ATPHS2_SEQ_R2 CTAGGAAATGGTGGGTTAGGGAGACTTGCCTCGTGTTTCTTGGATTCGATGGCCACCCTA  
   
PHS2-pET151 AATCTGCCTGCTTGGGGTTATGGTTTGAGGTACAGACATGGGTTGTTTAAGCAAATAATC 6342 
ATPHS2_SEQ_R2 AATCTGCCTGCTTGGGGTTATGGTTTGAGGTACAGACATGGGTTGTTTAAGCAAATAATC  
   
PHS2-pET151 ACAAAGAAAGGTCAAGAAGAGATTCCAGAGGACTGGCTTGAGAAATTCAGCCCATGGGAA 6402 
ATPHS2_SEQ_R2 ACAAAGAAAGGTCAAGAAGAGATTCCAGAGGACTGGCTTGAGAAATTCAGCCCATGGGAA  
   
PHS2-pET151 ATTGTGAGGCACGACGTGGTATTCCCTGTCAGATTTTTCGGCAAGGTGCAAGTAAATCCG 6462 
AtPHS2_SEQ_F1 ATTGTGAGGCACGACGTGGTATTCCCTGTCAGATTTTTCGGCAAGGTGCAAGTAAATCCG  
ATPHS2_SEQ_R2 ATTGTGAGGCACGACGTGGTATTCCCTGTCAGATTTTTCGGCAAGGTGCAAGTAAATCCG  
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PHS2-pET151 GATGGATCAAGGAAATGGGTAGATGGTGATGTTGTACAAGCTCTTGCTTATGACGTGCCA 6522 
AtPHS2_SEQ_F1 GATGGATCAAGGAAATGGGTAGATGGTGATGTTGTACAAGCTCTTGCTTATGACGTGCCA  
ATPHS2_SEQ_R2 GATGGATCAAGGAAATGGGTAGATGGTGATGTTGTACAAGCTCTTGCTTATGACGTGCCA  
   
PHS2-pET151 ATCCCGGGATATGGCACAAAGAACACAATCAGTCTCCGTCTCTGGGAAGCAAAAGCTAGA 6582 
AtPHS2_SEQ_F1 ATCCCGGGATATGGCACAAAGAACACAATCAGTCTCCGTCTCTGGGAAGCAAAAGCTAGA  
ATPHS2_SEQ_R2 ATCCCGGGATATGGCACAAAGAACACAATCAGTCTCCGTCTCTGGGAAGCAAAAGCTAGA  
   
PHS2-pET151 GCTGAGGATCTTGATCTTTTTCAGTTCAACGAAGGAGAATATGAATTGGCTGCACAGCTT 6642 
AtPHS2_SEQ_F1 GCTGAGGATCTTGATCTTTTTCAGTTCAACGAAGGAGAATATGAATTGGCTGCACAGCTT  
ATPHS2_SEQ_R2 GCTGAGGATCTTGATCTTTTTCAGTTCAACGAAGGAGAATATGAATTGGCTGCACAGCTT  
   
PHS2-pET151 CATTCTCGAGCTCAACAGATTTGCACTGTTTTATATCCAGGAGATGCTACCGAGAATGGG 6702 
AtPHS2_SEQ_F1 CATTCTCGAGCTCAACAGATTTGCACTGTTTTATATCCAGGAGATGCTACCGAGAATGGG  
ATPHS2_SEQ_R2 CATTCTCGAGCTCAACAGATTTGCACTGTTTTATATCCAGGAGATGCTACCGAGAATGGG  
   
PHS2-pET151 AAGTTATTACGGTTAAAACAGCAGTTCTTTCTCTGCAGTGCTTCGCTTCAGGATATTATA 6762 
AtPHS2_SEQ_F1 AAGTTATTACGGTTAAAACAGCAGTTCTTTCTCTGCAGTGCTTCGCTTCAGGATATTATA  
ATPHS2_SEQ_R4 AAGTTATTACGGTTAAAACAGCAG-TCTTTCTCTGCAAGTGCTCGCTTCAGGATATTATA  
   
PHS2-pET151 TCAAGATTTCACGAGAGGAGCACCACTGAAGGCAGCCGGAAATGGTCAGAGTTTCCAAGT 6822 
AtPHS2_SEQ_F1 TCAAGATTTCACGAGAGGAGCACCACTGAAGGCAGCCGGAAATGGTCAGAGTTTCCAAGT  
ATPHS2_SEQ_R4 TCAAGATTTCACGAGAGGAGCACCACTGAAGGCAGCCGGAAATGGTCAGAGTTTCCAAGT  
   
PHS2-pET151 AAAGTTGCTGTTCAAATGAATGACACACACCCAACTCTTGCAATACCTGAGCTCATGCGA 6882 
AtPHS2_SEQ_F1 AAAGTTGCTGTTCAAATGAATGACACACACCCAACTCTTGCAATACCTGAGCTCATGCGA  
ATPHS2_SEQ_F2                           ACACCCGACTCATGCGATACCTGAGCTCATGCGA  
ATPHS2_SEQ_R4 AAAGTTGCTGTTCAAATGAATGACACACACCCAACTCTTGCAATACCTGAGCTCATGCGA  
   
PHS2-pET151 TTGCTAATGGATGACAATGGACTTGGATGGGATGAGGCTTGGGATGTGACATCAAAGACC 7942 
AtPHS2_SEQ_F1 TTGCTAATGGATGACAATGGACTTGGATGGGATGAGGCTTGGGATGTGACATCAAAGACC  
ATPHS2_SEQ_F2 TTGCTAATGGATGACAATGGACTAGGATGGGATGAGGCTTGGGATGTGACATCAAAGACC  
ATPHS2_SEQ_R4 TTGCTAATGGATGACAATGGACTTGGATGGGATGAGGCTTGGGATGTGACATCAAAGACC  
   
PHS2-pET151 GTTGCTTACACCAATCACACTGTCCTTCCTGAAGCGTTGGAGAAATGGTCACAATCTTTG 7002 
AtPHS2_SEQ_F1 GTTGCTTACACCAATCACACTGTCCTTCCTGAAGCGTTGGAGAAATGGTCACAATCTTTG  
ATPHS2_SEQ_F2 GTTGCTTACACCAATCACACTGTCCTTCCTGAAGCGTTGGAGAAATGGTCACAATCTTTG  
ATPHS2_SEQ_R4 GTTGCTTACACCAATCACACTGTCCTTCCTGAAGCGTTGGAGAAATGGTCACAATCTTTG  
   
PHS2-pET151 ATGTGGAAGCTTCTTCCTCGTCATATGGAAATAATAGAAGAGATTGACAAGAGGTTTGTT 7062 
AtPHS2_SEQ_F1 ATGTGGAAGCTTCTTCCTCGTCATATGGAAATAATAGAAGAGATTGACAAGAGGTTTGTT  
ATPHS2_SEQ_F2 ATGTGGAAGCTTCTTCCTCGTCATATGGAAATAATAGAAGAGATTGACAAGAGGTTTGTT  
ATPHS2_SEQ_R3 ATGTGGAAGCTTCTTCCTCGTCATATGGAAATAATAGAAGAGATTGACAAGAGGTTTGTT  
ATPHS2_SEQ_R4 ATGTGGAAGCTTCTTCCTCGTCATATGGAAATAATAGAAGAGATTGACAAGAGGTTTGTT  
   
PHS2-pET151 CAAACCATTCGCGATACAAGAGTTGATCTGGAGGATAAGATTTCAAGTTTGAGCATCTTA 7122 
AtPHS2_SEQ_F1 CAAACCATTCGCGATACAAGAGTTGATCTGGAGGATAAGATTTCAAGTTTGAGCATCTTA  
ATPHS2_SEQ_F2 CAAACCATTCGCGATACAAGAGTTGATCTGGAGGATAAGATTTCAAGTTTGAGCATCTTA  
ATPHS2_SEQ_R3 CAAACCATTCGCGATACAAGAGTTGATCTGGAGGATAAGATTTCAAGTTTGAGCATCTTA  
ATPHS2_SEQ_R4 CAAACCATTCGCGATACAAGAGTTGATCTGGAGGATAAGATTTCAAGTTTGAGCATCTTA  
   
PHS2-pET151 GATAACAATCCACAAAAGCCTGTGGTGAGAATGGCTAACTTATGTGTTGTATCCTCGCAT 7182 
AtPHS2_SEQ_F1 GATAACAATCCACAAAAGCCTGTGGTGAGAATGGCTAACTTATGTGTTGTATCCTCGCAT  
ATPHS2_SEQ_F2 GATAACAATCCACAAAAGCCTGTGGTGAGAATGGCTAACTTATGTGTTGTATCCTCGCAT  
ATPHS2_SEQ_R3 GATAACAATCCACAAAAGCCTGTGGTGAGAATGGCTAACTTATGTGTTGTATCCTCGCAT  
ATPHS2_SEQ_R4 GATAACAATCCACAAAAGCCTGTGGTGAGAATGGCTAACTTATGTGTTGTATCCTCGCAT  
   
PHS2-pET151 ACGGTGAATGGCGTTGCTCAGTTACACAGTGATATCTTGAAGGCTGAGTTATTCGCAGAC 7242 
AtPHS2_SEQ_F1 ACGGTGAATGGCGTTGCTCAGTTACACAGTGATATCTTGAAGGCTGAGTTATTCGCAGAC  
ATPHS2_SEQ_F2 ACGGTGAATGGCGTTGCTCAGTTACACAGTGATATCTTGAAGGCTGAGTTATTCGCAGAC  
ATPHS2_SEQ_R3 ACGGTGAATGGCGTTGCTCAGTTACACAGTGATATCTTGAAGGCTGAGTTATTCGCAGTC  
ATPHS2_SEQ_R4 ACGGTGAATGGCGTTGCTCAGTTACACAGTGATATCTTGAAGGCTGAGTTATTCGCAGAC  
   
PHS2-pET151 TATGTCTCTATATGGCCAAACAAGTTTCAAAACAAGACTAATGGCATCACACCTCGAAGG 7302 
AtPHS2_SEQ_F1 TATGTCTCTATATGGCCAAACAAGTTTCAAAACAAGACTAATGGCATCACACCTCGAAGG  
ATPHS2_SEQ_F2 TATGTCTCTATATGGCCAAACAAGTTTCAAAACAAGACTAATGGCATCACACCTCGAAGG  
ATPHS2_SEQ_R3 TATGTCTCAATATGGGATTGCAGG  
ATPHS2_SEQ_R4 TATGTCTCTATATGGCCAAACAAGTTTCAAAACAAGACTAATGGCATCACACCTCGAAGG  
   
PHS2-pET151 TGGTTACGTTTCTGCAGCCCTGAGCTCAGTGATATAATCACAAAGTGGTTAAAGACTGAC 7362 
AtPHS2_SEQ_F1 TGGTTACGTTTCTGCAGCCCTGAGCTCAGTGATATAATCACAAAGTG-CTAAAGACTGAC  
ATPHS2_SEQ_F2 TGGTTACGTTTCTGCAGCCCTGAGCTCAGTGATATAATCACAAAGTGGTTAAAGACTGAC  
ATPHS2_SEQ_F3                                                           AC  
ATPHS2_SEQ_R4 TGGTTACGTTTCTGCAGCCCTGAGCTCAGTGATATAATCACAAAGTGGTTAAAGACTGAC  
   
PHS2-pET151 AAATGGATTACCGATCTTGACCTACTTACCGGTCTTCGCCAGTTTGCGGACAATGAAGAA 7422 
AtPHS2_SEQ_F1 AAATGGATTACCGATCTTGACCTACTACCGGTCCTTCGCCAGTTTGCG-ACAATGAAG-A  
ATPHS2_SEQ_F2 AAATGGATTACCGATCTTGACCTACTTACCGGTCTTCGCCAGTTTGCGGACAATGAAGAA  
ATPHS2_SEQ_F3 AAATGGATTACCGATCTTGACCTACTTACCGGTCTTCGCCAGTTTGCGGACAATGAAGAA  
ATPHS2_SEQ_R4 AAATGGATTACCGATCTTGACCTACTTACCGGTCTTCGCCAGTTTGCGGACAATGAAGAA  
   
PHS2-pET151 CTCCAATCTGAATGGGCTTCTGCAAAGACAGCCAATAAGAAACGTTTGGCTCAATATATA 7482 
ATPHS2_SEQ_F2 CTCCAATCTGAATGGGCTTCTGCAAAGACAGCCAATAAGAAACGTTTGGCTCAATATATA  
ATPHS2_SEQ_F3 CTCCAATCTGAATGGGCTTCTGCAAAGACAGCCAATAAGAAACGTTTGGCTCAATATATA  
ATPHS2_SEQ_R4 CTCCAATCTGAATGGGCTTCTGCAAAGACAGCCAATAAGAAACGTTTGGCTCAATATATA  
   
PHS2-pET151 GAGCGTGTGACTGGTGTGAGTATCGATCCAACAAGCTTATTTGACATACAAGTTAAGCGT 7542 
ATPHS2_SEQ_F2 GAGCGTGTGACTGGTGTGAGTATCGATCCAACAAGCTTATTTGACATACAAGTTAAGCGT  
ATPHS2_SEQ_F3 GAGCGTGTGACTGGTGTGAGTATCGATCCAACAAGCTTATTTGACATACAAGTTAAGCGT  
ATPHS2_SEQ_R4 GAGCGTGTGACTGGTGTGAGTATCGATCCAACAAGCTTATTTGACATACAAGTTAAGCGT  
 
PHS2-pET151 ATCCACGAATACAAGAGGCAGCTGATGAACATTCTTGGAGTAGTATACAGATTCAAGAAA 7602 
ATPHS2_SEQ_F2 ATCCACGAATACAAGAGGCAGCTGATGAACATTCTTGGAGTAGTATACAGATTCAAGAAA  
ATPHS2_SEQ_F3 ATCCACGAATACAAGAGGCAGCTGATGAACATTCTTGGAGTAGTATACAGATTCAAGAAA  
ATPHS2_SEQ_F3 ATCCACGAATACAAGAGGCAGCTGATGAACATTCTTGGAGTAGTATACAGATTCAAGAAA  
ATPHS2_SEQ_R4 ATCCACGAATACAAGAGGCAGCTGATGAACATTCTTGGAGTAGTATACAGATTCAAGAAA  
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PHS2-pET151 CTAAAGGAGATGAAGCCTGAGGAGAGGAAGAAAACAGTTCCTCGTACTGTCATGATTGGG 7662 
ATPHS2_SEQ_F2 CTAAAGGAGATGAAGCCTGAGGAGAGGAAGAAAACAGTTCCTCGTACTGTCATGATTGGG  
ATPHS2_SEQ_F3 CTAAAGGAGATGAAGCCTGAGGAGAGGAAGAAAACAGTTCCTCGTACTGTCATGATTGGG  
ATPHS2_SEQ_R4 CTAAAGGAGATGAAGCCTGAGGAGAGGAAGAAAACAGTTCCTCGTACTGTCATGATTGGG  
   
PHS2-pET151 GGTAAAGCATTTGCCACCTATACAAATGCAAAACGGATAGTGAAGCTGGTGAATGATGTT 7722 
ATPHS2_SEQ_F2 GGTAAAGCATTTGCCACCTATACAAATGCAAAACGGATAGTGAAGCTGGTGAATGATGTT  
ATPHS2_SEQ_F3 GGTAAAGCATTTGCCACCTATACAAATGCAAAACGGATAGTGAAGCTGGTGAATGATGTT  
ATPHS2_SEQ_R4 GGTAAAGCATTTGCCACCTATACAAATGCAAAACGGATAGTGAAGCTGGTGAATGATGTT  
   
PHS2-pET151 GGTGATGTTGTTAACAGCGATCCAGAGGTCAACGAATACCTAAAGGTGGTATTTGTTCCA 7782 
ATPHS2_SEQ_F2 GGTGATGTTGTTAACAGCGATCCAGAGTCAACGAATACCTTAAAGGTGGTATTTGTTCCA  
ATPHS2_SEQ_F3 GGTGATGTTGTTAACAGCGATCCAGAGGTCAACGAATACCTAAAGGTGGTATTTGTTCCA  
   
PHS2-pET151 AACTACAATGTCACTGTAGCGGAGATGCTAATACCCGGAAGTGAGCTATCTCAACACATC 7842 
ATPHS2_SEQ_F2 AACTACAATGTCACTGTAGCGGAGATGCTAATACCCGGAAGTGAGCTATCTCAACACATC  
ATPHS2_SEQ_F3 AACTACAATGTCACTGAAGCGGAGATGCTAATACCCGGAAGTGAGCTATCTCAACACATC  
   
PHS2-pET151 AGCACAGCAGGCATGGAGGCAAGTGGTACCAGCAATATGAAATTCGCTCTCAACGGTTGT 7902 
ATPHS2_SEQ_F2 AGCACAGCAG-CATGAAGGCAAGTGGTACCAGCATTATGAAATTCGCTCTCAACGGTTGT  
ATPHS2_SEQ_F3 AACACAACATGCATGGAGGCAAGTGGTACCAGCAATATTAAATTCGCTCTCAACGGTTGT  
   
PHS2-pET151 CTTATTATAGGAACCCTTGATGGGGCTAATGTTGAGATAAGAGAGGAGGTTGGCGAAGAA 7962 
ATPHS2_SEQ_F2 CTTATTATAG-AACCCTTGATGGGGCTATGG-TGAGATAAGAGAGGAGTTTG-CTGAGA  
ATPHS2_SEQ_F3 CTTATTATAGGAACCCTTGATGGGGCTAATGTTGAGATAAGAGAAGAGGTTGGCGACAAA  
ATPHS2_SEQ_F4 CTTATTATAGGAACCCTTGATGGGGCTAATGTTGAGATAAGAGAGGAGGTTGGCGAAGAA  
   
PHS2-pET151 AATTTCTTTCTTTTTGGTGCAACGGCCGATCAGGTCCCTCGACTGCGTAAAGAACGAGAA 8022 
ATPHS2_SEQ_F3 AATTTCTTTCTTTTTGGCGCTACGGCCGATAAAGTCTCTCGACTGCCTAAAGAACGAGAA  
ATPHS2_SEQ_F4 AATTTCTTTCTTTTTGGTGCAACGGCCGATCAGGTCCCTCGACTGCGTAAAGAACGAGAA  
   
PHS2-pET151 GACGGACTGTTCAAACCCGATCCTCGGTTCGAAGAGGCAAAGCAGTTTGTCAAAAGTGGA 8082 
ATPHS2_SEQ_F3 GACGGACTGTT  
ATPHS2_SEQ_F4 GACGGACTGTTCAAACCCGATCCTCGGTTCGAAGAGGCAAAGCAGTTTGTCAAAAGTGGA  
   
PHS2-pET151 GGACGTGGTGATTACTTCCTGGTTGGGTATGACTTCCCCAGCTACATGGACGCTCAGGCC 8142 
ATPHS2_SEQ_F4 GGACGTGGTGATTACTTCCTGGTTGGGTATGACTTCCCCAGCTACATGGACGCTCAGGCC  
   
PHS2-pET151 AAAGTTGACGAAGCTTATAAGGACCGGAAGGGGTGGCTGAAAATGTCGATATTGAGCACA 8202 
ATPHS2_SEQ_F4 AAAGTTGACGAAGCTTATAAGGACCGGAAGGGGTGGCTGAAAATGTCGATATTGAGCACA  
   
PHS2-pET151 GCCGGGTCAGGAAAGTTCAGCAGTGACCGTACAATAGCTCAGTATGCCAAAGAGATTTGG 8262 
ATPHS2_SEQ_F4 GCCGGGTCAGGAAAGTTCAGCAGTGACCGTACAATAGCTCAGTATGCCAAAGAGATTTGG  
           
PHS2-pET151 AACATTGAGGCTTGTCCTGTTCCCTAAAAGGGCGAGCTCAGATCCGGCTGCTAACAAAGC 35 
ATPHS2_SEQ_F4 AACATTGAGGCTTGTCCTGTTCCCTAAAAGGGCGAGCTCAGATCCGGCTGCTAACAAAGC  
   
PHS2-pET151 CCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGG 95 
ATPHS2_SEQ_F4 CCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGG  
   
PHS2-pET151 GGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATATCC 155 
ATPHS2_SEQ_F4 GGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATATCC  
   
PHS2-pET151 CGCAAGAGGCCCGGCAGTACCGGCATAACCAAGCCTATGCCTACAGCATCCAGGGTGACG 215 
ATPHS2_SEQ_F4 CGCAAGAGGCCCGGCAGTACCGGCATAACCAAGCCTATGCCTACAGCATCCAGGGTGACG  
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Appendix 2 – Synthetic gene for CDP 
App2.1 Nucleotide sequence of the E. coli codon optimised CDP  
The gene for CDP from Clostridium thermocellum was codon optimised for 
expression in E. coli and synthesised and cloned into pET15b to form pET15b-CDP 
(BamHI sites underlined). 
GGATCCGATGATTACCAAAGTGACGGCACGCAACAATAAAATTACCCCGGTGGAACTGCTGAACCAAAAATTCGGCAATA 
AAATCAACCTGGGCAACTTTGCAGACGCTGTGTTCACCGATGCGGCCTTTAAAAATGTTGCGGGCATTGCCAACCTGCCG 
ATGAAAGCGCCGGTGATGCAGGTTCTGATGGAAAATTGCATCGTTTCGAAATATCTGAAACAATTTGTCCCGGATCGTAG 
CGTCTGTTTCGTGGAAGAAGGCCAGAAATTTTACATTGTGCTGGAAGACGGTCAAAAAATCGAAGTGCCGGAAGATGTTA 
ACAAAGCACTGAAAGCTACCGTTTCAGATGTCAAACATTGGGCAGGCTATCTGACGGAAGACGGTGAACACGTTATTGAT 
CTGCTGAAACCGGCTCCGGGTCCGCATTTCTACGTCAATCTGCTGATCGGCAACCGTCTGGGTTTTAAACGCACCCTGCA 
GACCACGCCGAAATCTGTGGTTGATCGTTTCGGCCGCGGTTCTTTTCGTAGTCACGCAGCTACCCAGGTTCTGGCAACGC 
GTTTTGACATGCGCCAAGAAGAAAATGGCTTCCCGGCTAACCGCCAGTTTTATCTGTACGAAGATGGTAAACAAATCTTT 
TATAGCGCACTGATTGATGACAATATCGTGGAAGCTACCTGCAAACACTCTTGTAACCGTACCGTTATCAAATACAAAAC 
GGCATGCAATCTGGAAATTACCCGCACGATCTTCCTGGTGCCGCACAAAAAAGGCTTTCCGCTGGCGACCGAACTGCAGC 
GTATTGAAATCAAAAATGCGTCCGATAAAGCCCGCAACCTGTCAATTACCTATACGGGCATGTTCGGCACGGGTGCGGTT 
CATGCCATTTTTGAAGACGTGACCTATACGAATGTTATCATGCAGTCTGCGGCCCTGTACAACGATAAAGGCGAATTTAT 
TGGTATCACCCCGGACTATTACCCGGAAGAATTTAAACAGGATACCCGTTTTGTCACGATGATTGTGCGCAACGGCGATG 
AAAAATCCTTTCCGCAATCATTCTGCACCGATTATAATGACTTTGTGGGCACCGGTACGCTGGAACACCCGGCGGGCGGT 
TGTAATCTGAACAATAAACTGAACCGTAAAGGTCCGGGCTTTTTCGCACTGGGTGCTCCGTTCACCGTCGAACCGGGTAA 
AACGGTGATTATCGATACCTTTACGGGCCTGAGCTCTAGTAAAGACAACGAAAATTATAGCGATGCCGTGATGCTGCGTG 
AACTGGATAATCTGCTGCGCTACTTCGAAAAATCGGAAAGCGTTGAAGAAACCCTGAACGAAATCATCAACTTCCATGAA 
AACTACGGTAAATACTTCCAGTTCAACACGGGCAATAAACTGTTTGATAGTGGTTTCAACCGTAATCTGGCATTCCAGGT 
GCTGTATCAAACCTTCATGTCTCGCAGTTTTGGCCAGACGCAAAAAGGTTACCGTGAAATTGGCTTTCGCGAAATCCAGG 
ACCTGTTCGCCTCCATGTACTACTTCATCAACATCGGCTATCAAGATTTCGTTAAAGAACTGCTGTTTGAATGGACCGCA 
AATGTCTACAAAATGGGTTACGCTAACCATAACTTCTATTGGGTGGGCAAACAGCCGGGTCTGTACTCCGATGACTCACT 
GTGGCTGCTGCAAGCGTATTACCGCTATATTATCTACACCAAAGACACGAGCGTTCTGAACGAAGAAGTCCCGGTGGCGG 
ATGGCAACAATGAAAAACGTGCCGTCCGCGAAACCCTGAAAGCAATTATCCAGTATTCGGCTTGCATTAGCGTGGGTGAC 
CACGGTCTGCCGCTGCTGGATCTGGCCGACTGGAATGATTGTCTGAAAATTGCGTCCAACTCAATCGATGGTGCCACCAA 
AGAAAAACTGTATTACGAACAGCTGAAGAAAACCAACGGCAAATATGGTGACCGTTTCATGAGCGATTACTCGGAAAGCG 
TGATGAATGCGTTTCTGCTGAAACTGGCCATTGATCATCTGGCGGAAATCGCCACCCTGGATAATGACACGCAGCTGGCG 
CAGCAAATGTCGGAACTGAGCAAAGAAGTTACCGATCGCATTCAAAAACACGCATGGAAAGAAAACTTTTTCGCTCGTGT 
CCTGATCAACCGCTATAAAGACGGCTCTTATACCTACCTGGGCGCGAAAGGTGATAAACTGAGTGCCGACCCGAATATTG 
ATGGTGTGTATTTTCTGAACAGTTTCGCGTGGTCTGTTCTGAGTGACGTCGCAACCGATGAACAGATTGCTATCATGGTT 
GATGTCATCAAAAAACATCTGCTGACCCCGTATGGTCTGCGTCTGGTTACGCCGGCCGACCTGAATAAAATCGCAAACGA 
TACCGCTACGGGTCATTACTTTTTCGGCGATCGCGAAAACGGTGCAGTCTTTAAACACGCGTCCATGATGGCCGTGGCAG 
CTCTGATTAAAGCGGCCAAAAAAGTGAAAGACAATGAACTGGCGAAAGAAATGGCACGTATTGCTTATTTCATGATCGAT 
CTGGTCCTGCCGTACAAAAACCTGGAAAATCCGTTTCAGGTGGCCGGCAACCCGCGCATTTGCACCCAATATATCAATAC 
CGATACGGGCGAAAACATTGGTCCGCTGCTGTCCGGCACCGCAACGTGGCTGAACCTGAATCTGATTTCACTGGCCGGCA 
TCGAATATACCCGTGATGGTATTTCGTTCAACCCGATCCTGCGCGAAGAAGAAACCCAGCTGAATTTTACGCTGAAAGCG 
CCGAAATGTTCTTACAAATTCAGTATCACCAAACCGGTGGGCTTTGCCCGCATGGAATCCTCAGAATACGAACTGTTTGT 
TGACGGTCAGAAAATCGATAATACCGTTATTCCGATGTACACCGACGAAAAAGAACATATTGTCACCCTGAAATTCAAAT 
GAGGATCC 
App.2.2. Amino acid sequence encoded in the CDP open reading frame of  
pET15b-CDP  
(Purification tag highlighted in blue). 
MGSSHHHHHHSSGLVPRGSHMLEDPMITKVTARNNKITPVELLNQKFGNKINLGNFADAVFTDAAFKNVAGIANL
PMKAPVMQVLMENCIVSKYLKQFVPDRSVCFVEEGQKFYIVLEDGQKIEVPEDVNKALKATVSDVKHWAGYLTED
GEHVIDLLKPAPGPHFYVNLLIGNRLGFKRTLQTTPKSVVDRFGRGSFRSHAATQVLATRFDMRQEENGFPANRQ
FYLYEDGKQIFYSALIDDNIVEATCKHSCNRTVIKYKTACNLEITRTIFLVPHKKGFPLATELQRIEIKNASDKA
RNLSITYTGMFGTGAVHAIFEDVTYTNVIMQSAALYNDKGEFIGITPDYYPEEFKQDTRFVTMIVRNGDEKSFPQ
SFCTDYNDFVGTGTLEHPAGGCNLNNKLNRKGPGFFALGAPFTVEPGKTVIIDTFTGLSSSKDNENYSDAVMLRE
LDNLLRYFEKSESVEETLNEIINFHENYGKYFQFNTGNKLFDSGFNRNLAFQVLYQTFMSRSFGQTQKGYREIGF
REIQDLFASMYYFINIGYQDFVKELLFEWTANVYKMGYANHNFYWVGKQPGLYSDDSLWLLQAYYRYIIYTKDTS
VLNEEVPVADGNNEKRAVRETLKAIIQYSACISVGDHGLPLLDLADWNDCLKIASNSIDGATKEKLYYEQLKKTN
GKYGDRFMSDYSESVMNAFLLKLAIDHLAEIATLDNDTQLAQQMSELSKEVTDRIQKHAWKENFFARVLINRYKD
GSYTYLGAKGDKLSADPNIDGVYFLNSFAWSVLSDVATDEQIAIMVDVIKKHLLTPYGLRLVTPADLNKIANDTA
TGHYFFGDRENGAVFKHASMMAVAALIKAAKKVKDNELAKEMARIAYFMIDLVLPYKNLENPFQVAGNPRICTQY
INTDTGENIGPLLSGTATWLNLNLISLAGIEYTRDGISFNPILREEETQLNFTLKAPKCSYKFSITKPVGFARME
SSEYELFVDGQKIDNTVIPMYTDEKEHIVTLKFK* 
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App 2.3. Alignment of CDP and CBP from Clostridium thermocellum 
Alignment was performed using ClustalW (EBI). * = identical, := identity score of 8,  
. = identity score of 7. 
 
 
CDP     MITKVTARNNKITPVELLNQKFGNKINLGNFADAVFTDAAFKNVAGIANLPMKAPVMQVL 60 
CBP     ------------------------------------------------------------ 
                                                                            
CDP     MENCIVSKYLKQFVPDRSVCFVEEGQKFYIVLEDGQKIEVPEDVNKALKATVSDVKH-WA 119 
CBP     -----------------------------------MKFGFFDDANKEYVITVPRTPYPWI 25 
                                            *: . :*.**    **. . : *  
CDP     GYLTEDGEHVIDLLKPAPGPHFYVNLLIGNRLGFKRTLQTTPKSVVDRFGRGSFRSHAAT 179 
CBP     NYLGTEN--------------FFS--LISNTAG----------------GYCFYRDARLR 53 
        .**  :.              *:   **.*  *                *   :*.     
CDP     QVLATRFDMRQEENGFPANRQFYLYEDGKQIFYS---ALIDDNIVEATCKHSCNRTVIKY 236 
CBP     RITRYRYNNVPIDMGG---RYFYIYDNGD--FWSPGWSPVKRELESYECRHGLGYTKIAG 108 
        ::   *::    : *    * **:*::*.  *:*   : :. :: .  *:*. . * *   
CDP     KTACNLEITRTIFLVPHKKGFPLATELQRIEIKNASDKARNLSITYTGMFGTGAVHAIFE 296 
CBP     KRNG-IKAEVTFFVPLNYNG-----EVQKLILKNEGQDKKKITLFSFIEFCLWNAYDDMT 162 
        *    ::   *:*:  : :*     *:*:: :** .:. :::::     *    .:  :  
 
CDP     DVTYTNVIMQSAALYNDKGEFIGITPDYYPEEFKQDTRFVTMIVRNGDEKSFPQSFCTDY 356 
CBP     NFQRN----FSTGEVEIEGSVIYHKTEYR--ERRNHYAFYSVNAKISGFDSDRDSFIGLY 216 
        :.  .     *:.  : :*..*  ..:*   * ::.  * :: .: .. .*  :**   * 
CDP     NDFVGTGTLEHPAGGCNLNNKLNRKGPGFFALGAPFTVEPGKTVIIDTFTGLSSSKDNEN 416 
CBP     NGFDAPQAVVNGKS----NNSVADGWAPIASHSIEIELNPGEQKEYVFIIGYVENKDEEK 272 
        *.* .. :: :  .    **.:    . : : .  : ::**:      : *  ..**:*: 
CDP     YS--DAVMLRELDNLLRYFEKSESVEETLNEIINFHENYGKYFQFNTGNKLFDSGFNRNL 474 
CBP     WESKGVINKKKAYEMIEQFNTVEKVDKAFEELKSYWNALLSKYFLESHDEKLNRMVNIWN 332 
        :.  ..:  ::  :::. *:. *.*:::::*: .: :   . : ::: :: ::  .*    
CDP     AFQVLYQTFMSRSFGQTQKGY-REIGFREIQDLFASMYYFINIGYQDFVKELLFEWTANV 533 
CBP     QYQCMVTFNMSRSASYFESGIGRGMGFRDSNQDLLGFVHQI----PERARERLLDLAATQ 388 
         :* :    **** .  :.*  * :***: :: : .: : *     : .:* *:: :*.  
CDP     YKMGYANHNFYWVGKQP-----GLYSDDSLWLLQAYYRYIIYTKDTSVLNEEVPVADGNN 588 
CBP     LEDGSAYHQYQPLTKKGNNEIGSNFNDDPLWLILATAAYIKETGDYSILKEQVPFNNDPS 448 
         : * * *::  : *:      . :.**.***: *   **  * * *:*:*:**. :. . 
CDP     EKRAVRETLKAIIQYSACISVGDHGLPLLDLADWNDCLKIASNSIDGATKEKLYYEQLKK 648 
CBP     KADTMFEHLTRSFYHVVNN-LGPHGLPLIGRADWNDCLNLNCFSTVPD-------ESFQT 500 
        :  :: * *.  : : .   :* *****:. *******:: . *           *.::. 
CDP     TNGKYGDRFMSDYSESVMNAFLLKLAIDHLAEIATLDNDTQLAQQMSELSKEVTDRIQKH 708 
CBP     TTSKDGK-----VAESVMIAGMFVFIGKDYVKLCEYMGLEEEARKAQQHIDAMKEAILKY 555 
        *..* *.      :**** * :: :  .. .::.   .  : *:: .:  . :.: * *: 
CDP     AWKENFFARVLINRYKDGSYTYLGAKGDKLSADPNIDGVYFLNSFAWSVLSDVAT-DEQI 767 
CBP     GYDGEWFLRAYDD------------FGRKVGSKENEEGKIFIESQGFCVMAEIGLEDGKA 603 
        .:. ::* *.  :             * *:.:. * :*  *::* .:.*::::.  * :  
CDP     AIMVDVIKKHLLTPYGLRLVTPADLNKIANDTATGHYFFGDRENGAVFKHASMMAVAALI 827 
CBP     LKALDSVKKYLDTPYGLVLQNPAFTRYYIEYGEISTYPPGYKENAGIFCHNNAWIICAET 663 
           :* :**:* ***** * .**  .   :    . *  * :**..:* * .   :.*   
CDP     KAAKKVKDNELAKEMARIAYFMIDLVLPYKNLENPFQVAGNPRICTQYINTDTGENIGPL 887 
CBP     VVGRGDMAFDYYRKIAPAYIEDVSDIHKLEPYVYAQMVAGKD-------AKRHGEAKNSW 716 
        ..:     :  :::*      :. :   :    .  ***:         .  **  ..  
CDP     LSGTATWLNLNLIS-LAGIEYTRDGISFNPILREEETQLNFTLKAPKCSYKFSITKPVGF 946 
CBP     LTGTAAWNFVAISQWILGVKPDYDGLKIDPCIPKAWDGYKVTRYFRGSTYEITVKNPN-- 774 
        *:***:*  : : . : *::   **:.::* : :     :.*     .:*::::.:*    
CDP     ARMESSEYELFVDGQKIDNTVIPMYTDEKEHIVTLKFK 984 
CBP     -HVSKGVAKITVDGNEISGNILPVFNDGKTHKVEVIMG 811  
   ::...  :: ***::*...::*::.* * * * : : 
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Appendix 3 – Euglena proteins co-purified with laminarin 
phosphorylase activity 
The fractions from the laminarin purification protocols were subject to proteomic 
analysis.  Proteins were identified by peptide mass-fingerprinting against the 
translated transcriptome and searched against the NCBI protein database using 
BLASTP. The closest homologue found for each transcript is listed. Highlighted in 
yellow are GH81 family members. 
Proteins from first purification protocol 
Transcript 
number 
Closest homologue Score 
App.3.1 Euglena proteins identified in Eg2.1 gel slice 
dm.6752 pyruvate carboxylase, gene 1 [Xenopus laevis] 3312 
dm.14567 conserved hypothetical protein [Vibrio harveyi] 3188 
dm.12520 pyridoxal-dependent decarboxylase domain-containing protein 1 
[Gallus gallus] 
3066 
dm.14 malate synthase-isocitrate lyase [Euglena gracilis] 2888 
dm.11270 putative alanyl-tRNA synthetase [Leishmania infantum] 2694 
dm.1790 predicted protein [Physcomitrella patens] 2078 
dm.12625 cullin-associated NEDD8-dissociated protein 1-like [Glycine max] 2062 
dm.44758 ankyrin repeat protein [Paracoccidioides brasiliensis] 1947 
dm.15323 coatomer subunit beta'-1 [Arabidopsis thaliana]  1701 
dm.3707 cell division cycle protein 48-like protein, expressed [Micromonas 
sp]  
1655 
lm.62373 insulin-degrading enzyme [Danio rerio] 1604 
lm.59664 exosome complex exonuclease RRP44-like [Nasonia vitripennis] 1481 
dm.10697 inversin protein alternative isoform [Trichomonas vaginalis] 1431 
dm.16810 WD40 repeat-containing protein [Polysphondylium pallidum] 1385 
dm.501 pyruvate, phosphate dikinase [Caldithrix abyssi]  1372 
dm.9721 coatomer subunit beta-1 [Arabidopsis lyrata] 1306 
dm.33057 tryptophan synthase subunit beta [Planococcus donghaensis] 
See Appendix 10 
1289 
lm.40065 no hits 1288 
lm.41899 ubiquitin-activating enzyme e1, putative [Leishmania donovani] 1090 
lm.55348 alpha-2-macroglobulin domain-containing [Ilumatobacter 
coccineum 
1066 
dm.27248 hypothetical protein Thini_1924 [Thiothrix nivea] 1032 
dm.35794 no hits 1027 
dm.11750 coatomer subunit gamma-2-like [Vitis vinifera] 1010 
dm.8434 hypothetical protein [Rhodanobacter spathiphylli] 922 
dm.22743 hypothetical protein, conserved [Trypanosoma brucei] 902 
dm.17299 ubiquitin activating enzyme [Naegleria gruberi] 899 
dm.468 aconitate hydratase 2 [Methylomicrobium album]  820 
dm.3530 hypothetical protein [Monosiga brevicollis] 788 
dm.12763 hypothetical protein [Monosiga brevicollis] 387 
lm.74157 regulator of chromosome condensation (RCC1)like protein 
putative [Albugo laibachii] 
730 
dm.27489 UV-damaged DNA-binding protein 1A [Arabidopsis lyrata] 678 
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dm.49218 cell division cycle and apoptosis regulator protein 1 [Clonorchis 
sinensis] 
677 
dm.54710 no hits 667 
lm.58565 no hits 539 
dm.7256 heat shock protein, putative [Trypanosoma cruzi] 645 
dm.186 pyruvate: NADP+ oxidoreductase [Euglena gracilis] 579 
lm.73638 no hits 573 
dm.71637 no hits 304 
dm.65801 ubiquitinyl C19 peptidase [Naegleria gruberi] 536 
dm.46 heat shock protein 90 [Euglena gracilis] 471 
dm.39195 hypothetical protein [Trypanosoma cruzi] 465 
dm.10321 carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, 
and dihydroorotase [Danio rerio] 
455 
dm.7071 similar to conserved hypothetical protein [Tribolium castaneum] 450 
dm.7625 cell division cycle and apoptosis regulator protein 1 [Clonorchis 
sinensis] 
449 
dm.28974 Phosphoenolpyruvate carboxylase 1 [Chlamydomonas 
reinhardtii] 
424 
dm.13136 intraflagellar transport protein 122 homolog [Equus caballus] 417 
dm.34328 no hits 414 
dm.30978 ubiquitin-activating enzyme E1 [Salpingoeca sp.] 379 
lm.57406 ring finger protein 123 [Mustela putorius furo] 376 
lm.3583 kinesin [Trypanosoma cruzi] 375 
dm.78696 sec24-like transport protein [Arabidopsis thaliana] 375 
dm.11453 carnosine synthase 1-like [Cavia porcellus] 362 
lm.84438 beta-galactosidase [Psychromonas marina] 343 
lm.8430 hypothetical protein [Dysgonomonas mossii]  343 
lm.9447 hypothetical protein [Dysgonomonas mossii]  60 
dm.322 heat shock protein 60 [Euglena gracilis] 316 
dm.38431 no hits 310 
dm.31243 flagellar associated protein [Chlamydomonas reinhardtii] 309 
dm.7327 carbamoyl-phosphate synthase [ammonia], putative [Phytophora 
infestans] 
268 
dm.3395 heat shock protein [Trypanosoma cruzi] 264 
dm.41656 ubiquitin carboxyl-terminal hydrolase 4 isoform b [Rattus 
norvegicus]  
244 
lm.61306 kinesin K39, putative, partial [Leishmania infantum] 239 
lm.76211 ankyrin repeat protein [Trichomonas vaginalis] 232 
lm.15628 membrane alanyl aminopeptidase [Ectocarpus siliculosus] 211 
dm.13155 membrane alanyl aminopeptidase [Ectocarpus siliculosus] 141 
lm.15629 membrane alanyl aminopeptidase [Ectocarpus siliculosus] 46 
dm.138 elongation factor 1 alpha [Euglena gracilis] 206 
dm.22458 serine/threonine protein kinase [Tetrahymena thermophile] 203 
dm.20564 L-aminoadipate-semialdehyde dehydrogenase [Capsaspora 
owczarzaki] 
196 
dm.24693 no hits 190 
lm.47385 calpain-15 [Gallus gallus] 170 
lm.43993 paraflagellar rod protein 2C [Leishmania mexicana] 170 
lm.58785 conserved hypothetical protein [Leishmania mexicana] 164 
dm.17280 putative acetyl-CoA carboxylase [Leishmania infantum] 156 
lm.27495 hypothetical protein [Phytophthora sojae] 155 
lm.49833 von Willebrand domain-containing protein [Capsaspora 
owczarzaki] 
155 
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dm.21534 no hits 155 
dm.46328 basal body protein [Chlamydomonas reinhardtii] 155 
dm.78615 putative ATP-dependent RNA helicase [Arabidopsis thaliana] 155 
lm.84453 hypothetical protein, variant [Salpingoeca sp. ATCC 5081] 155 
dm.2759 elongation factor EF-3 [Coccomyxa subellipsoidea] 153 
dm.32024 5-oxoprolinase [Azospirillum brasilense]  152 
dm.31760 putative adenylosuccinate synthetase [Leishmania braziliensis] 147 
dm.7644 predicted protein [Physcomitrella patens] 142 
lm.403 unnamed protein product [Tetraodon nigroviridis] 137 
dm.57883 putative protein serine/threonine kinase [Polysphondylium 
pallidum] 
136 
dm.38076 splicing factor 3B subunit 3-like [Oreochromis niloticus] 135 
dm.37350 putative Tyrosine kinase-like (TKL) protein [Neospora caninum] 130 
dm.35236 putative Tyrosine kinase-like (TKL) protein [Neospora caninum] 37 
dm.6466 eukaryotic initiation factor [Coccomyxa subellipsoidea] 128 
dm.51164 predicted protein [Physcomitrella patens]  126 
dm.51828 ubiquitin fusion degradation protein UfdB, putative [Penicilllium 
sp.] 
122 
dm.20604 no hits 118 
dm.6861 GH65 family protein [Thermoanaerobacter wiegelii]  115 
lm.26838 adenylosuccinate synthetase [Trypanosoma cruzi] 109 
lm.80211 dynactin [Coprinopsis cinerea] 106 
dm.30499 gamma-glutamylcysteine synthetase [Laeonereis acuta] 105 
lm.42878 tetratricopeptide repeat protein 21B-like [Xenopus tropicalis] 103 
dm.25799 hypothetical protein [Trypanosoma cruzi] 96 
dm.13040 acetyl-CoA acetyltransferase [Reinekea sp. MED297]  91 
lm.8338 hypothetical protein [Salpingoeca sp. ATCC 5081] 89 
lm.86223 ankyrin 2,3/unc44 [Aedes aegypti] 89 
dm.11294 conserved hypothetical protein [Leishmania Mexicana] 88 
lm.77499 hypothetical protein [Trypanosoma cruzi] 86 
dm.15786 acetyl-CoA carboxylase [Nannochloropsis gaditana] 85 
dm.41655 WD40 repeat-containing protein [Dictyostelium discoideum] 67 
dm.278 DNA-directed RNA polymerase II 135 kDa polypeptide, putative 
[Oryza sativa] 
64 
lm.21412 clathrin interactor 1 [Mustela putorius] 62 
dm.446 RNA-binding region RNP-1 domain-containing protein 
[Polysphondylium pallidum] 
60 
lm.55849 hypothetical protein [Branchiostoma floridae] 59 
lm.24990 flagellar motor protein [Oceanicola granulosus] 58 
dm.21288 predicted protein [Phaeodactylum tricornutum]  58 
lm.57893 ankyrin 2,3/unc44 [Aedes aegypti] 57 
dm.30785 predicted protein [Physcomitrella patens subsp. patens]  55 
dm.61506 Molecular co-chaperone STI1 (ISS) [Ostreococcus tauri] 53 
dm.6921 hypothetical protein [Daphnia pulex] 53 
lm.44496 ankyrin repeat domain-containing protein 50 -like [Amphimedon 
queenslandica] 
50 
lm.41918 maternal embryonic leucine zipper kinase, putative [Ixodes 
scapularis] 
49 
lm.17228 maternal embryonic leucine zipper kinase, putative [Ixodes 
scapularis] 
29 
dm.51076 ccar1, putative [Ixodes scapularis] 46 
lm.67640 putative protein serine/threonine kinase 44 
lm.72440 polyribonucleotide nucleotidyltransferase [Nannochloropsis 43 
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gaditana] 
dm.27702 no hits 41 
lm.51516 proline iminopeptidase [Aeromonas caviae] 40 
lm.66536 epidermal growth factor receptor substrate 15-like 1-like 
[Acyrthosiphon pisum] 
39 
dm.24752 WD repeat-containing protein 19-like [Strongyloides stercoralis] 36 
lm.65316 peptidase C19 family ubiquitinyl hydrolase [Naegleria gruberi]   34 
dm.17922 hypothetical protein [Trypanosoma cruzi] 34 
lm.18544 kinesin family member 12 [Salpingoeca sp.] 34 
lm.50851 HAD superfamily hydrolase [Chlorobium tepidum TLS]  34 
dm.435 ATP-dependent RNA helicase dhh1 [Zea mays]  34 
dm.9754 protein phosphatase 1, regulatory subunit 8 [Xenopus laevis]  34 
lm.25046 hypothetical protein [gamma proteobacterium 34 
lm.73994 viral A-type inclusion protein [Trichomonas vaginalis] 34 
lm.85920 R-SNARE protein, tomsyn-like family [Chlamydomonas 
reinhardtii] 
34 
dm.57166 no hits 34 
dm.11945 adaptor-related protein complex 2 [Dictyostelium fasciculatum] 34 
lm.84772 ubiquitin carboxyl-terminal hydrolase 12 [Vitis vinifera]  34 
dm.30548 hypothetical protein [Gibberella zeae] 33 
dm.11777 ubiquinone/menaquinone biosynthesis methyltransferase 
UbiE/COQ5 [endosymbiont of Tevnia jerichonana]  
32 
dm.3232 vitamin B6 biosynthesis protein [Wallemia sebi] 32 
lm.66673 DEP domain containing 5 isoform 2 [Capsaspora owczarza] 30 
dm.16358 kinesin-like protein KLP6-like [Strongylocentrotus purpuratus] 28 
lm.77341 putative kinesin K39, partial [Leishmania braziliensis] 28 
lm.11279 conserved Plasmodium protein, unknown function [Plasmodium 
falciparum]  
28 
dm.168 RNA-binding region RNP-1 domain-containing protein  28 
lm.32501 hypothetical protein [Trypanosoma cruzi] 28 
dm.1638 heat shock protein 60 [Euglena gracilis] 28 
dm.32489 predicted protein [Physcomitrella patens subsp. patens 28 
lm.83814 PCMT-domain-containing protein [Coccomyxa subellipsoidea] 28 
lm.87063 no hits 28 
lm.71419 ATP-dependent DEAD/H RNA helicase, putative [Trypanosoma 
cruzi] 
28 
dm.14940 putative kinesin [Leishmania braziliensis] 28 
dm.4783  acyl-CoA dehydrogenase FadE [Moraxella catarrhalis] 28 
lm.69342 Rho-associated kinase, putative [Ixodes scapularis] 28 
dm.25565 no hits 28 
dm.70524 Regulator of nonsense transcripts-like protein [Medicago 
trunculata] 
28 
lm.53 beta-tubulin [Euglena gracilis] 27 
dm.4000 UDP-glucose dehydrogenase [Capsaspora owczarzaki] 26 
lm.56904 RNA-binding region RNP-1 domain-containing 
protein [Polysphondylium pallidum] 
25 
dm.3761 DNA polymerase I alpha catalytic subunit, putative 
[Trypanosoma cruzi] 
25 
dm.17952 thymidylate kinase [Modestobacter marinus]  23 
lm.68357 conserved hypothetical protein [Trypanosoma congolense] 22 
dm.47148 presequence protease 2, chloroplastic/mitochondrial-like 
[Glycine max] 
22 
dm.11926 protein transport protein Sec24C, putative [Trypanosoma cruzi] 22 
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lm.64702 no hits 22 
dm.58933 no hits 22 
dm.12424 predicted protein [Naegleria gruberi] 22 
lm.92865 no hits 22 
lm.77127 SAPS-domain-containing protein [Coccomyxa subellipsoidea 16 
dm.3270 caseinolytic peptidase B protein homolog [Pan troglodytes] 14 
dm.484 phosphofructokinase, putative [Toxoplasma gondii] 14 
lm.74092 2,3 cyclic-nucleotide 2-phosphodiesterase [Thermus 
thermophiles] 
14 
lm.85256 RNA polymeraseII elongator complex subunit [Naegleria gruberi]  13 
App.3.2 Euglena proteins identified in Eg2.2 gel slice 
dm.14567 conserved hypothetical protein [Vibrio harveyi] 4833 
dm.14561 hypothetical protein [Shewanella woodyi] 1131 
lm.14 malate synthase-isocitrate lyase [Euglena gracilis] 4127 
dm.42166 malate synthase-isocitrate lyase [Euglena gracilis] 445 
lm.50762 malate synthase-isocitrate lyase [Euglena gracilis] 153 
lm.55348 hypothetical protein [Ilumatobacter coccineum] 2563 
dm.13947 hypothetical protein [Ilumatobacter coccineum] 1318 
dm.6752 pyruvate carboxylase, gene 1 [Xenopus laevis]  2334 
dm.10697 inversin protein alternative isoform [Trichomonas vaginalis]  2088 
dm.10321 carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, 
and dihydroorotase [Danio rerio] 
1710 
dm.17280 putative acetyl-CoA carboxylase [Leishmania infantum] 1642 
dm.8434 hypothetical protein [Rhodanobacter spathiphyllum] 1624 
dm.8064 pyruvate decarboxylase, putative [Perkinsus marinus] 1561 
dm.27248 hypothetical protein Thini_1924 [Thiothrix nivea] 1419 
dm.32024 5-oxoprolinase [Azospirillum brasilense] 1406 
dm.33057 Tryptophan synthase beta chain [Planococcus halocryophilus]  
See Appendix 10 
1198 
lm.20526 phosphoribosylanthranilate isomerase [Thermobaculum 
terrenum]  
202 
dm.20564 protein synthetase, putative [Acanthamoeba castellanii]  993 
dm.25026 aminoadipate-semialdehyde dehydrogenase [Capsaspora 
owczarzaki  
808 
lm.21957 aminoadipate-semialdehyde dehydrogenase [Capsaspora 
owczarzaki  
694 
lm.21099 protein translocase subunit secA, chloroplastic [Coccomyxa 
subellipsoidea C-169] 
775 
dm.13277 Endo-1,3-beta-glucanase, C-terminal fragment, family GH81 
[Ectocarpus siliculosus] 
758 
dm.32489 zinc metalloprotease (insulinase family) [Arabidopsis thaliana] 718 
lm.9201 Hydroxylamine reductase [Opitutaceae bacterium] 678 
dm.7327 carbamoyl-phosphate synthase [ammonia], putative [Phytophora 
infestans] 
669 
lm.8430 von Willebrand factor A [Zunongwangia profunda] 635 
dm.34328 no hits 586 
lm.62373 novel protein similar to H.sapiens IDE, insulin-degrading enzyme 
(IDE, zgc:162603) [Danio rerio] 
555 
dm.17299 ubiquitin activating enzyme [Naegleria gruberi]  512 
dm.322 heat shock protein 60 [Euglena gracilis] 485 
dm.1638 heat shock protein 60 [Euglena gracilis] 65 
dm.11294 conserved hypothetical protein [Leishmania Mexicana] 481 
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lm.13055 hypothetical protein [Mycobacterium sp.] 415 
dm.9720 hypothetical protein [Mycobacterium sp.] 337 
dm.199 acetyl-coa synthetase [Volvox carteri] 395 
dm.22743 hypothetical protein, conserved [Trypanosoma brucei]  361 
dm.17211 exportin-1 [Gallus gallus] 359 
lm.55849 hypothetical protein [Branchiostoma floridae] 340 
dm.54710 predicted protein [Naegleria gruberi] 335 
lm.58565 predicted protein [Naegleria gruberi] 272 
lm.3719 phosphoenolpyruvate carboxykinase [GTP] [Waddlia 
chondrophila] 
305 
dm.1649 phosphoenolpyruvate carboxykinase [GTP] [Waddlia 
chondrophila] 
142 
dm.28607 ubiquitin carboxyl-terminal hydrolase 12 [Arabidopsis thaliana]  301 
dm.37621 hydrogenobyrinic acid a,c-diamide cobaltochelatase, partial 
[Coccomyxa subellipsoidea 
288 
dm.12520 pyridoxal-dependent decarboxylase domain-containing protein 1 
[Gallus gallus] 
277 
lm.52434 dihydropyrimidine dehydrogenase [Polysphondylium pallidum] 274 
lm.19930 fatty acid synthase isoform 2 [Amylomyces rouxii] 259 
lm.15627 membrane alanyl aminopeptidase [Ectocarpus siliculosus] 232 
lm.15621 membrane alanyl aminopeptidase [Ectocarpus siliculosus] 163 
lm.15630 membrane alanyl aminopeptidase [Ectocarpus siliculosus] 128 
dm.462 glutamate synthase-like protein [Chaetomium thermophilum] 232 
dm.3530 hypothetical protein [Monosiga brevicollis] 227 
dm.12763 hypothetical protein [Monosiga brevicollis] 82 
dm.33277 protein transporter SEC23 [Rhizopus oryzae] 226 
dm.51828 ubiquitin fusion degradation protein UfdB, putative [Penicilllium 
sp.] 
200 
dm.11270 putative alanyl-tRNA synthetase [Leishmania infantum]  175 
dm.78696 sec24-like transport protein [Arabidopsis thaliana] 173 
dm.27489 UV-damaged DNA-binding protein 1A [Arabidopsis lyrata] 169 
dm.186 pyruvate: NADP+ oxidoreductase [Euglena gracilis] 159 
lm.90921 ubiquitin activating enzyme [Naegleria gruberi]  159 
lm.29460 hypothetical protein [Phytophthora sojae] 156 
dm.150 glutamine synthetase III [Guillardia theta] 149 
dm.12625 predicted protein [Naegleria gruberi]  145 
lm.95239 putative exoribonuclease 1 [Trypanosoma congolensis] 144 
dm.51164 sec24-like transport protein [Arabidopsis thaliana]  144 
lm.57893 ankyrin 2,3/unc44 [Aedes aegypti]  144 
dm.484 phosphofructokinase, putative [Toxoplasma gondii] 137 
dm.31760 putative adenylosuccinate synthetase [Leishmania braziliensis]  124 
dm.11295 choline/carnitine O-acetyltransferase [Trypanosoma cruzi] 110 
lm.31707 UDP-glucose ceramide glucosyltransferase-like 1, isoform 
CRA_d [Rattus norvegicus] 
95 
dm.33444 dihydropyrimidinase [Dictyostelium purpureum]  91 
lm.23873 WD repeat protein [Methanosaeta harundinacea] 88 
lm.68214 anthranilate/para-aminobenzoate synthase component I 
[uncultured marine group II euryarchaeote] 
87 
dm.13143 isocitrate dehydrogenase [Salpingoeca sp] 86 
lm.59166 ADP-ribosyltransferase 1-like protein [Adineta vaga] 84 
dm.4323 cytosolic fructose-1,6-bisphosphatase [Euglena gracilis] 84 
lm.84438 beta-galactosidase [Psychromonas marina] 81 
dm.96795 hypothetical protein [Volvox carteri]  76 
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dm.13156 aminopeptidase with a membrane alanine aminopeptidase 
domain [Thalassiosira pseudonana] 
75 
lm.53309 ubiquitinyl hydrolase [Coccomyxa subellipsoidea] 73 
lm.91991 NFX1-type zinc finger-containing protein 1-like [Danio rerio] 71 
dm.7515 heat shock protein 70 cytosolic isoform [Rhynchobodo] 70 
lm.32739 rubrerythrin [Geobacter daltonii]  69 
lm.27495 dymeclin hypothetical protein [Phytophthora sojae] 67 
lm.62160 predicted protein [Nematostella vectensis] 64 
dm.21288 predicted protein [Phaeodactylum tricornutum] 61 
lm.87294 proteasome activator complex subunit 4 [Mus musculus] 60 
lm.8338 hypothetical protein [Salpingoeca sp] 56 
lm.47385 similar to predicted protein [Hydra magnipapillata] 52 
dm.21714 short-chain dehydrogenase/reductase SDR [Burkholderia 
oklahomensis] 
49 
lm.51633 putative DNA helicase [uncultured marine group II 
euryarchaeote] 
48 
lm.8553 propionyl-CoA carboxylase beta chain, mitochondrial precursor 
[Phytophthora infestans 
47 
dm.12 aldehyde dehydrogenase [Trichodesmium erythraeum] 47 
dm.1790 predicted protein [Physcomitrella patens] 43 
lm.59664 exosome complex exonuclease RRP44-like [Crassostrea gigas] 43 
dm.30978 ubiquitin-activating enzyme E1 [Salpingoeca sp.] 41 
dm.73610 hypothetical protein [Batrachochytrium dendrobatidis] 40 
dm.3784 Hsc70-interacting protein [Entamoeba histolytica] 38 
dm.61167 peptidase C19 family ubiquitinyl hydrolase [Naegleria gruberi]  35 
lm.84453 hypothetical protein, variant [Salpingoeca sp.] 35 
dm.12386 isoleucyl-tRNA synthetase, cytoplasmic [Equus caballus] 35 
lm.75584 ubiquitin carboxyl-terminal hydrolase [Capsaspora owczarzaki 31 
dm.9303 glucose-6-phosphate 1-dehydrogenase [Condylura cristata] 30 
dm.25799 hypothetical protein [Trypanosoma cruzi] 30 
dm.80676 tetratricopeptide repeat-containing protein [Arabidopsis thaliana] 29 
dm.314 biotin carboxylase [Clostridium sp. BNL1100] 29 
dm.120 heat shock protein HSP70 [Trypanosoma cruzi] 28 
dm.25565 No hits 28 
dm.4304 D-3-phosphoglycerate dehydrogenase [Novosphingobium 
nitrogenifigens] 
27 
dm.24109 kinesin K39, putative, partial [Leishmania infantum] 27 
dm.37941 flavine-containing monoxygenase [Populus trichocarpa] 25 
lm.38812 L-serine dehydratase, iron-sulfur-dependent, single chain form 
[Pseudomonas stutzeri]  
24 
lm.49430 ankyrin repeat protein [Paracoccidioides brasiliensis]  23 
lm.11898 prolyl-tRNA synthetase [Trypanosoma cruzi] 22 
dm.37504 ubiquitin carboxyl-terminal hydrolase 48-like, partial [Anolis 
carolinensis] 
21 
lm.58393 conserved hypothetical protein [Pediculus humanus] 20 
dm.28974 hypothetical protein [Guillardia theta] 19 
lm.11603 magnesium chelatase subunit H [Synechococcus  19 
dm.37470 hypothetical protein [Sulfuricella denitrificans] 19 
dm.16810 WD40 repeat-containing protein [Polysphondylium] 18 
dm.31837 ubiquitin-activating enzyme e1, putative [Leishmania donovani] 18 
dm.49306 No hits 18 
lm.51040 protein serine/threonine kinase [Polysphondylium pallidum] 17 
dm.11778 ubiquinone/menaquinone biosynthesis methyltransferase 17 
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dm.46928 Cytoplasmic dynein 2 heavy chain 1[Tripneustes gratilla] 17 
lm.67640 alpha-type protein kinase [Euglena gracilis] 17 
dm.446 RNA-binding region RNP-1 domain-containing protein 
[Polysphondylium pallidum] 
17 
dm.3232 vitamin B6 biosynthesis protein [Wallemia sebi] 17 
dm.46 heat shock protein 90 [Euglena gracilis] 17 
dm.8303 Saccharopine dehydrogenase [Caldithrix abyssi] 17 
lm.3583 kinesin [Trypanosoma cruzi] 16 
dm.93772 Protein GBF-1, isoform a [Caenorhabditis elegans] 16 
dm.28650 No hits 16 
lm.92865 No hits 15 
lm.50421 Tetratricopeptide TPR_2 repeat protein [Arthrospira maxima] 14 
dm.65397 predicted protein [Micromonas pusilla] 14 
dm.17873 6-phosphogluconate dehydrogenase [Euglena gracilis] 13 
 
 
 
Proteins from second purification protocol 
Transcript 
number 
Closest homologue Score 
App.3.3 Euglena proteins identified in EgC 
dm.14570 hypothetical protein [marine gamma proteobacteria] 557 
lm.36680 hypothetical protein [Kordia algicida] 378 
lm.14 malate synthase-isocitrate lyase [Euglena gracilis] 530 
dm.322 heat shock protein 60 [Euglena gracilis] 146 
dm.3530 hypothetical protein [Monosiga brevicollis] 122 
dm.138 elongation factor 1 alpha [Euglena gracilis] 92 
dm.8145 
propionyl-CoA carboxylase beta chain, mitochondrial precursor 
[Phytophthora infestans ]  
83 
lm.8553 
propionyl-CoA carboxylase beta chain, mitochondrial precursor 
[Phytophthora infestans] 
65 
dm.1598 pyruvate kinase [Takifugu rubripes] 79 
dm.186 pyruvate: NADP+ oxidoreductase [Euglena gracilis] 54 
dm.27598 vacuolar protein 8 [Coniophora puteana  40 
lm.8430 von Willebrand factor A [Zunongwangia profunda] 39 
dm.25642 hypothetical protein [Sorangium cellulosum] 36 
lm.15620 
puromycin-sensitive aminopeptidase-like protein [Salpingoeca 
sp.] 
27 
App.3.4 Euglena proteins identified in EgD 
dm.14570 hypothetical protein [marine gamma proteobacterium] 1117 
lm.36680 hypothetical [Kordia algicida] 663 
lm.14 malate synthase-isocitrate lyase [Euglena gracilis] 951 
dm.138 elongation factor 1 alpha [Euglena gracilis] 202 
dm.3530 hypothetical protein [Monosiga brevicollis] 165 
lm.8550 
propionyl-CoA carboxylase beta chain, mitochondrial precursor 
[Phytophthora infestans]  
153 
dm.186 pyruvate: NADP+ oxidoreductase [Euglena gracilis] 83 
dm.322 heat shock protein 60 [Euglena gracilis] 50 
dm.1598 pyruvate kinase [Takifugu rubripes] 33 
dm.27598 vacuolar protein 8 [Coniophora puteana] 17 
lm.15620 
puromycin-sensitive aminopeptidase-like protein [Salpingoeca 
sp.] 
16 
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Appendix 4 – Carbohydrate-active enzymes in the Euglena 
transcriptome  
Glycosyl Hydrolases Glycosyl Transferases Accessory modules 
Euglena 
transcript # 
CAZy 
module 
Euglena 
transcript # 
CAZy 
module 
Euglena 
transcript # 
CAZy 
module 
lm.80490 GH1 dm.12422 GT1 lm.25689 CBM48 
lm.93530 GH1 dm.19420 GT1 lm.101413 CBM57 
dm.51553 GH2 dm.19717 GT1 dm.80173 EXPN-
CBM63 
dm.56224 GH2 dm.33982 GT1 lm.68827 CE3 
lm.44961 GH2 dm.80517 GT1 dm.66677 CE13 
lm.84438 GH2 dm.90384 GT1 dm.71771 CE13 
lm.98570 GH2 lm.22765 GT1 lm.102226 CE13 
lm.98571 GH2 lm.22766 GT1 lm.102297 CE13 
dm.104047 GH3 lm.34813 GT1 lm.48774 CE13 
dm.80650 GH3 lm.53934 GT1 lm.60242 CE13 
dm.89679 GH3 lm.75841 GT1 lm.90170 CE13 
lm.101242 GH3 lm.75842 GT1 lm.90173 CE13 
lm.72409 GH3 lm.79780 GT1  
lm.81977 GH3 lm.86108 GT1 Distantly related  
lm.89053 GH3 lm.87840 GT1 Glycosyl Transferases 
lm.89054 GH3 dm.47703 GT1-
GH78 
Euglena 
transcript # 
CAZy 
module(s) 
lm.89055 GH3 dm.27722 GT2 lm.72487 GT23 
lm.93078 GH3 dm.27724 GT2 lm.91630 GT23 
lm.95673 GH3 dm.27726 GT2 lm.55165 GT25 
lm.95674 GH3 dm.27728 GT2 lm.94749 GT25 
dm.35835 GH5 dm.27873 GT2 dm.32272 GT32 
dm.35839 GH5 dm.27874 GT2 dm.37769 GT32 
dm.35840 GH5 dm.27876 GT2 dm.39718 GT32 
dm.44807 GH5 dm.42731 GT2 dm.48218 GT32 
dm.69508 GH5 dm.58009 GT2 dm.81916 GT32 
dm.83397 GH5 dm.73971 GT2 lm.13695 GT32 
lm.40866 GH5 dm.96021 GT2 lm.32837 GT32 
lm.40874 GH5 lm.108044 GT2 lm.68834 GT32 
lm.40875 GH5 lm.31276 GT2 dm.30790 GT34 
lm.61020 GH5 lm.31364 GT2 dm.37781 GT34 
lm.71927 GH5 lm.32222 GT2 dm.37782 GT34 
dm.91911 GH117 lm.32223 GT2 dm.37784 GT34 
lm.76046 GH117 lm.32225 GT2 dm.68760 GT34 
lm.76047 GH117 lm.32226 GT2 lm.52552 GT34 
dm.440 GH17 lm.32229 GT2 lm.68129 GT34 
dm.56861 GH17 lm.48352 GT2 lm.83427 GT34 
lm.47728 GH17 lm.56291 GT2 lm.96814 GT4  
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dm.47800 GH18 lm.68894 GT2 dm.87760 GT47 
lm.103637 GH18 lm.81887 GT2 dm.22087 GT61 
dm.34783 GH18-
CBM18 
lm.98495 GT2 dm.33771 GT61 
lm.29686 GH18-
CBM18 
dm.15135 GT4 lm.24531 GT61 
lm.102325 GH19 dm.79942 GT4 lm.24533 GT61 
dm.89574 GH20 dm.81869 GT4 lm.24541 GT61 
lm.88319 GH20 dm.90804 GT4 lm.32128 GT61 
lm.88320 GH20 lm.20804 GT4 lm.32131 GT61 
dm.56632 GH27 lm.21766 GT4 lm.32134 GT61 
dm.63503 GH30 lm.33890 GT4 lm.32135 GT61 
dm.63509 GH30 lm.58009 GT4 lm.70292 GT61 
lm.17784 GH30 lm.62122 GT4 lm.70293 GT61 
lm.17787 GH30 lm.67740 GT4 lm.84274 GT61 
lm.17797 GH30 lm.68525 GT4 lm.90176 GT61 
lm.17800 GH30 lm.68818 GT4 lm.99017 GT61 
lm.17814 GH30 lm.75595 GT4 lm.97192 GT69 
lm.17815 GH30 lm.75596 GT4 dm.12391 GT75 
lm.17825 GH30 lm.76927 GT4 dm.37464 GT90 
lm.17826 GH30 lm.79157 GT4 dm.67893 GT90 
lm.17841 GH30 lm.84277 GT4   
lm.44824 GH30 lm.93157 GT4   
lm.66301 GH30 lm.93215 GT4   
dm.22178 GH31 lm.95961 GT4   
dm.53023 GH31 lm.97615 GT4   
dm.62947 GH31 dm.57564 GT8   
dm.65434 GH31 dm.86901 GT8   
lm.75791 GH31 dm.86904 GT8   
lm.75792 GH31 dm.86905 GT8   
lm.75793 GH31 lm.54268 GT8   
lm.81297 GH31 lm.62538 GT8   
dm.25013 GH36 lm.89703 GT8   
lm.23614 GH36 lm.93668 GT8   
lm.52294 GH36 lm.93674 GT8   
lm.52298 GH36 lm.93676 GT8   
lm.52303 GH36 lm.93679 GT8   
lm.52304 GH36 lm.93682 GT8   
dm.79592 GH38 lm.93685 GT8   
lm.77431 GH38 lm.93697 GT8   
lm.89296 GH38 lm.93704 GT8   
lm.89298 GH38 lm.93705 GT8   
lm.71907 GH42 lm.98440 GT8   
dm.47656 GH43 dm.25919 GT10   
lm.50076 GH43 dm.61080 GT10   
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lm.93323 GH43 dm.72664 GT10   
dm.48562 GH47 dm.78084 GT10   
dm.48567 GH47 dm.78087 GT10   
dm.59995 GH47 dm.78088 GT10   
dm.59996 GH47 lm.67669 GT10   
dm.70793 GH47 lm.78120 GT10   
dm.70795 GH47 lm.89155 GT10   
dm.70799 GH47 lm.90278 GT10   
dm.72005 GH47 lm.91263 GT10   
lm.82143 GH47 lm.91264 GT10   
lm.82528 GH47 lm.92122 GT10   
lm.89589 GH47 lm.71174 GT11-GT15   
dm.30807 GH5 lm.97566 GT13   
dm.22013 GH55 dm.49632 GT15   
lm.96365 GH63 lm.70358 GT15   
lm.97052 GH63 lm.83960 GT15   
lm.63754 GH64 dm.31521 GT17   
dm.92069 GH65 dm.88372 GT17   
lm.12469 GH65 lm.88149 GT17   
lm.41777 GH65 lm.92197 GT17   
lm.50851 GH65 lm.29618 GT20   
lm.95741 GH65 dm.60521 GT22   
lm.71986 GH78 dm.60522 GT22   
dm.20767 GH81 dm.85690 GT22   
dm.25642 GH81 dm.85692 GT22   
dm.31657 GH81 dm.85694 GT22   
dm.31843 GH81 lm.71029 GT22   
dm.31844 GH81 dm.67541 GT23   
dm.66774 GH81 dm.67542 GT23   
dm.82797 GH81 dm.83534 GT23   
lm.26257 GH81 dm.96497 GT23   
lm.28976 GH81 lm.100539 GT23   
lm.28977 GH81 lm.26965 GT23   
lm.39241 GH81 lm.69542 GT23   
lm.39306 GH81 lm.81778 GT23   
lm.39307 GH81 lm.87230 GT23   
lm.4691 GH81 lm.89315 GT23   
lm.80430 GH81 lm.89316 GT23   
lm.84039 GH81 lm.94751 GT23   
lm.90769 GH81 lm.31707 GT24   
lm.91687 GH81 dm.47345 GT25   
lm.94770 GH85 lm.69918 GT25   
lm.94771 GH85 dm.42760 GT28   
lm.94772 GH85 dm.26818 GT31   
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lm.94775 GH85 dm.36833 GT31   
lm.102467 GH88 dm.39545 GT31   
dm.99395 GH99 dm.39554 GT31   
  dm.39555 GT31   
  dm.39557 GT31   
  dm.39558 GT31   
  dm.83370 GT31   
  lm.27958 GT31   
  lm.48152 GT31   
  lm.76406 GT31   
  lm.95852 GT31   
  lm.97727 GT31   
  dm.27659 GT32   
  dm.31546 GT32   
  dm.56081 GT32   
  dm.71099 GT32   
  lm.26881 GT32   
  lm.29288 GT32   
  lm.46212 GT32   
  lm.60500 GT32   
  lm.68996 GT32   
  lm.85050 GT32   
  lm.93810 GT32   
  lm.92144 GT33   
  lm.93348 GT34   
  dm.27721 GT40   
  lm.68449 GT40   
  dm.35031 GT41   
  lm.52466 GT41   
  lm.92993 GT41   
  dm.39277 GT47   
  dm.39390 GT47   
  dm.39998 GT47   
  dm.40001 GT47   
  dm.66841 GT47   
  dm.76900 GT47   
  lm.68145 GT47   
  lm.85331 GT47   
  lm.87611 GT47   
  lm.88157 GT47   
  lm.89017 GT47   
  lm.89707 GT47   
  lm.90869 GT47   
  lm.92839 GT47   
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  lm.92840 GT47   
  dm.22210 GT48   
  lm.13240 GT48   
  lm.13249 GT48   
  lm.13336 GT48   
  dm.58200 GT49   
  dm.64067 GT49   
  lm.94033 GT50   
  dm.96080 GT57   
  lm.99883 GT57   
  lm.68532 GT58   
  lm.100691 GT59   
  dm.33780 GT61   
  dm.33783 GT61   
  dm.33784 GT61   
  dm.47644 GT61   
  dm.56369 GT61   
  dm.74359 GT61   
  lm.32130 GT61   
  lm.32132 GT61   
  lm.32133 GT61   
  lm.32136 GT61   
  lm.47661 GT61   
  lm.70294 GT61   
  lm.70295 GT61   
  lm.79988 GT61   
  lm.86157 GT61   
  lm.95124 GT61   
  dm.17756 GT66   
  dm.41728 GT66   
  lm.68366 GT66   
  dm.60061 GT69   
  dm.60062 GT69   
  lm.47975 GT75   
  lm.47982 GT75   
  dm.100639 GT76   
  lm.98056 GT76   
  dm.20225 GT77   
  dm.26143 GT77   
  dm.26148 GT77   
  dm.46237 GT77   
  dm.46238 GT77   
  dm.48743 GT77   
  dm.57100 GT77   
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  dm.57112 GT77   
  dm.64325 GT77   
  dm.70621 GT77   
  lm.28466 GT77   
  lm.43281 GT77   
  lm.43282 GT77   
  lm.43283 GT77   
  lm.43284 GT77   
  lm.43910 GT77   
  lm.52104 GT77   
  lm.56292 GT77   
  lm.57291 GT77   
  lm.90263 GT77   
  lm.90264 GT77   
  lm.90266 GT77   
  lm.90271 GT77   
  lm.90272 GT77   
  lm.92804 GT77   
 
  
Appendices 
~ 290 ~ 
 
Appendix 5 – Numbers of CAZys annotated in the database for 
various species.1-3 
 
#GH #GT #CBM 
Fungi 
   Ascomycota 
   Aspergillus 251 92 43 
Botryotinia 242 106 65 
Leptosphaeria 216 100 54 
Magnaporthe 232 94 71 
Penicillium 219 103 50 
Myceliophthora 194 88 46 
Neurospora 174 78 27 
Basidiomycota 
   Cryptococcus 85 68 1 
Malassezia  25 41 1 
Piriformospora 200 73 101 
Sporisorium 103 66 7 
Yeasts 
   Ashbya 45 58 9 
Candida 56 69 10 
Kluyveromyces 48 63 11 
Saccharomyces 51 66 12 
Yarrowia 54 69 6 
Oomycetes 
   Albugo 88 68 10 
Phytophora 279 157 40 
Plant 
   Arabidopsis 400 562 126 
Oryza 428 607 119 
Bathycoccus 49 171 25 
Micromonas 41 86 30 
Osterococcus 30 70 22 
Red algae 
   Cyanidioschyzon 21 54 13 
Porphyridium 31 83 40 
Glaucophytes 
   Cyanophora 84 128 24 
Cryptophytes 
   Guillardaria 53 257 29 
Chlorarachinophytes 
  Bigelowiella 112 109 7 
Animals 
   Homo 98 235 40 
Caenorhabditis 111 270 80 
Drosophila 103 150 279 
Euglenozoa 
   Euglena 127 228 4 
Leishmania 12 41 1 
Trypanosoma 19 36 1 
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Appendix 6 – Alignments of didomain CAZys (lm.71174 and 
dm.47703) with well characterised single domain proteins  
Alignments were performed using AlignX (Invitrogen) and confirmed by modelling 
proteins using SWISS-MODEL in automated mode.4 The key catalytic residues are 
highlighted in red boxes.  
App.6.1 Alignment of lm.71174 with GT11s5  
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App.6.2 Alignment of lm.71174 with GT15s6 
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App.6.3 Alignment of dm.47703 with GT1s7  
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App.6.4 Alignment of dm.47703 with GH78s8 
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Appendix 7 – Rhamnosidase from Euglena transcript dm.44703 
C-terminus (EgRase) 
App.7.1 Synthetic gene for EgRase 
The synthetic gene for the C-terminus of dm.44703 was ordered from Genescript 
(www.genescript.com), codon optimised for expression in Nicotiana tabacum  
(Fig App.7.1), in case E. coli expression was no possible, sub-cloned into 
expression vector pET15b, to form pET15b-dm.47703-CTerm (Fig App.7.2). 
A: 
CATATGCCCGGGAAGCTTCTCATGGATAGATTAGATTACAGGTTAAGAGCAGGACTTTGTCTCGCAGCATCATTTTTGAAGAGGG
TGCCTTACAGATTAGCAGGTGCTCAAGCTGCACCACTCTCATTTACTGGAGCACCTACTACAGCTCTTTTGGGTTTACCAGCTGA
TGGAACTAGAGATGGTAGGAATACAGCATTGAGAGCTACACCAACTCCTTACAGGACTGGACAATCATATTTTAGATTCGATGGA
GGTGCAAGGGAAGAGTTAGTGCTCCCAGCTACACTTAGTGGAGTTGGTTACGTTATCGTGGATTTCGGAGCTATGAGAAGGGGTA
GAGTTCAGTTGAGTGTGGAATGTTCTTCACCTGCTGTTGTGTGTATTGGACTCTGCGAGAGACTTAAGGGTTGGACTGTGGGAGG
TGATAGGCTTACATCCACTGTTACATCTGGAGCTTTGCAAGCTCCTGCAATTATAAGATTAGATGGAGGTTCTAGGACTACAGTT
AGTTCCGGAGCTGGTACATTTAGATATGTTGTGGTTTCAGCTAAAGCAGGTGCTTTCGCACTCCATGCTGCAGATGTGACTAGTA
CACTTACTCCAGCTGTTCCTCATGGACACCCATACCCTGGTAATTTTAGATGTTCATGCCCACAGCTTACTAGGGTTTGGTATGC
TGGAGCAAACACACTTGAATTGTGCACTGGAGGTACACCTTCAGTTTTTCTTGATGGTAGTAAGAGAGATAGGTGGGTGTGGACT
GGTGATCTCTTCGTTGAACATCTTGTTGCATACGTGTCTAATGGAGATGTTGCTTCAGCACTTAACAGTTTGGCTATTTTAGCTG
AGGCACAGGATCCAGATGGTTATGTTACACACCTTTCCCCACCTAAGGATGATCCTCTCAGAAACCTTTCTATGATCTTTGCAAA
AGAATTGTATTTCACTGAGTACTGTGCTTGGTATGTTGTTGTGACATGGTTGCATTACTTACACACTGGTGATGATACATTTGCT
AGAGAATTCGAGCCAGTTATTGATAGGGCAATGGGATGGCTCTGCGGTCTTGTGGCTGATGATGGATTACTCAAGGTTGGTCCTG
AAACTGCATCTACATGGCATGTTCCAGAGGTTGTGCTTGGAGCTCCTACTGATTTGAATTGTTTAATGGCTCACGCATTTAGATG
CGCTAACGCATTGAGGGCTGCAGTTGGTAAACCACCTTCAACAAGATGGGATGAATTGAGAAGTAGGATGGTTGAGGCAGTGAAC
GCTAGGTTATGGGATGAATCCTTGGGAGTTTACCTCAACTCCGATAACGAGGATTCTATTCCAACTCAAGATTCTACTACAACTG
CAGTTTGGACTGAAGTGGCTCCTCTTGATAGAGCAACAAGGGCTCTCGATTACCTTGAAAGAGAGCATGGAGTTAGGTTTGGTGT
GCTTACTGCTAAAGAGCATCACCCATCTATGACATCATATTTGAGTCCTTTTGCATCCTTCAGACATCTTTTGGCTTTCGGAAGG
ATGGGTGATGCTGCAGGTGCATTAAGACTCATAAGGAAGTTGTGGGTTCACATGGCTGAAACTGATCCAGAGGATGTGTTTTGGG
AAAAAGTTTCAAGAGATGGAGAAATCGAGCCATATTGGCAGCTTGGAATGTGTCCTACATTCACTTCCACATGTCATGGATGGTC
TGCAGGTCCAACATACGCTTTGACAACTATGTTACTCGGAGTTACTCCAGTGACACCTGGTTATGCAGATGTTGCTGTGAGACCT
GCTTTGGCAGATTTAAGATGGGCTGAAGGAGTTGTGCCAACTCCTCACGGAGGTATCGCTGTTGCATGGGAAACATTTGGTCCAG
CTGAGTGTCTTTTGAGAGTTGCAGTGCCTGCTGGAGTTAGAGCAACTGTGAGGTTCCCAGTTGCTGGTGTTCCTGTGAGAAGGCT
TGGAGGTGCAGAAGATGATGAGCCAGCTGTTGTGGCTGATGCAGAGGCTATACCTTTGGTTGGTCCTGCTACTGCTGCTTGGGCA
ACACTTTCCTGTCCTTCTGATTTCTCCTTTGAATGACTCGAG 
 
B: 
MGSSHHHHHHSSVLPPRGSHMPGKLLMDRLDYRLRAGLCLAASFLKRVPYRLAGAQAAPLSFTGAPTTALLGLPADGTRDGRNTA
LRATPTPYRTGQSYFRFDGGAREELVLPATLSGVGYVIVDFGAMRRGRVQLSVECSSPAVVCIGLCERLKGWTVGGDRLTSTVTS
GALQAPAIIRLDGGSRTTVSSGAGTFRYVVVSAKAGAFALHAADVTSTLTPAVPHGHPYPGNFRCSCPQLTRVWYAGANTLELCT
GGTPSVFLDGSKRDRWVWTGDLFVEHLVAYVSNGDVASALNSLAILAEAQDPDGYVTHLSPPKDDPLRNLSMIFAKELYFTEYCA
WYVVVTWLHYLHTGDDTFAREFEPVIDRAMGWLCGLVADDGLLKVGPETASTWHVPEVVLGAPTDLNCLMAHAFRCANALRAAVG
KPPSTRWDELRSRMVEAVNARLWDESLGVYLNSDNEDSIPTQDSTTTAVWTEVAPLDRATRALDYLEREHGVRFGVLTAKEHHPS
MTSYLSPFASFRHLLAFGRMGDAAGALRLIRKLWVHMAETDPEDVFWEKVSRDGEIEPYWQLGMCPTFTSTCHGWSAGPTYALTT
MLLGVTPVTPGYADVAVRPALADLRWAEGVVPTPHGGIAVAWETFGPAECLLRVAVPAGVRATVRFPVAGVPVRRLGGAEDDEPA
VVADAEAIPLVGPATAAWATLSCPSDFSFE* 
 
Figure App.7.1: The sequence of EgRase 
A: The DNA sequence of the ordered EgRase gene, including the tags (blue) 
added, encoding NdeI, XmaI and HindIII restriction sites at the start and XhoI at the 
end, to facilitate cloning. B: The protein sequence of the expressed EgRase with the 
tag (blue) added during cloning and from the pET15b, encoding a hexahistidine tag 
to facilitate purification. 
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Figure App.7.2: Plasmid map of pET15b-dm.47703-CTerm 
 
App.7.2 Expression and purification of EgRase 
pET15b-dm.47703-CTerm was transformed into E. coli strain BL21 and selected on 
carbenicillin. EgRase was expressed in these cells, grown in AIM at 37 °C until 
OD600 reached 0.1 when the temperature was reduced to 18 °C. After culturing 
overnight the cells were collected, lysed and the protein purified using the normal 
protocol (see Section 8.1.2) to yield approximately 0.5 mg per litre cell culture of 
>95% pure protein, as judged by SDS-PAGE (Fig App.7.3). 
pET15b-dm.47703-CTerm
7778 bp
AmpR
LacI
His Tag
tet1191-576
Thrombin clev age
RBS
Lac operator
dm.47703-CTerm
T7R
T7 Promoter
pBR322origin
T7 terminator
NdeI (5376)
XhoI (7451)
XmaI (5381)
HindIII (5387)
HindIII (7746)
Appendices 
~ 297 ~ 
 
 
Figure App.7.3: Purification of EgRase 
EgRase was purified from E. coli using Ni-IMAC and GF (A) to give one peak of 
pure protein (fractions A6, B6, B5), some partially degraded protein fractions  
(B4-B2) and one peak of UV absorbent small molecules (B1). B. The pure protein 
were combined and run on SDS-PAGE. Lane 1: Kaleidoscope ladder (BioRad).   
Lane 2: cells containing pET15b-dm.47703-CTerm, but grown in LB. Lane 3: cells 
expressing the protein. Lane 4: insoluble cell fraction. Lane 5: soluble cell fraction. 
Lane 6: combined fractions A6, B6, B5. 
 
 App.7.3 Activity of EgRase 
The hydrolysis of PNP-α-L-Rhamnose (PNP-Rha) by the EgRase was measured 
under standard reaction conditions (20 mM MES, pH 7.5, 10% DMSO, 1.75 μg/ml 
EgRase containing 10 % GF buffer) in the range 0-10 mM substrate and incubated 
at 37 °C. After 3 hours, to allow significant turnover at this very low enzyme 
concentration, an equal volume (100 μl) of Na2CO3 (2 M) was added and the 
released PNP was measured by absorption at 415 nm, with comparison to 
standards (Fig App.8.4). This gave a KM of 400 ± 65 μM and a specific activity of 
106 ± 4 μmol/min/mg protein, giving a turnover of 136 per second, in good 
agreement with the well characterised, and crystallised Bacillus homologue  
(KM = 280 μM, kcat = 140 per second).
8 
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Figure App.7.4: Activity assay of EgRase 
The activity assay was performed in duplicate and the average shown. The data 
was processed using GraFit (Erithacus Software Ltd.) to calculate the Vmax and KM. 
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Appendix 8 – Euglena transcripts for core metabolic enzymes 
(Only the first Euglena homologue for each enzyme is detailed) 
E.C. Activity Transcript Nearest homologue Evalue 
App.8.1 Glycolysis/gluconeogenesis 
5.4.2.2 phosphoglucomutase lm.27422 phosphoglucomutase [Phytophthora infestans T30-4] 6.00E-120 
5.3.1.9 
Glucose-6-phosphate 
isomerase 
lm.56040 Glucose-6-phosphate isomerase [Crassostrea gigas] 0.00E+00 
3.1.3.11 fructose-bisphosphatase dm.3989 fructose-1,6-bisphosphatase [Guillardia theta] 5.00E-165 
2.7.1.11 6-phosphofructokinase lm.19925 putative 6-phospho-1-fructokinase [Leishmania mexicana]  9.00E-145 
2.7.1.90 
diphosphate-fructose-6-
phosphate 1-
phosphotransferase 
lm.13041 
Pyrophosphate--fructose 6-phosphate 1-phosphotransferase subunit beta 
[Ectocarpus siliculosus] 
0.00E+00 
4.1.2.13 
Fructose-bisphosphate 
aldolase 
dm.182 fructose-bisphosphate aldolase, class I [Galdieria sulphuraria] 7.00E-153 
5.3.1.1 
Triose-phosphate 
isomerase 
dm.3382 triosephosphate isomerase (TIM) [Galdieria sulphuraria] 3.00E-107 
1.2.1.12 
glyceraldehyde-3-
phosphate 
dehydrogenase 
lm.52 glyceraldehyde 3-phosphate dehydrogenase [Bodo saltans] 0.00E+00 
2.7.2.3 phosphoglycerate kinase light 6737 hypothetical protein [Guillardia theta] 0.00E+00 
5.4.2.1 phosphoglycerate mutase lm.11257 phosphoglycerate mutase [Thalassiosira pseudonana]] 9.00E-108 
4.2.1.11 
phosphopyruvate 
hydratase 
dm.588 phosphopyruvate hydratase [Candidatus Accumulibacter phosphatis]  0.00E+00 
2.7.1.40 pyruvate kinase dm.39974 pyruvate kinase [Galdieria sulphuraria] 3.00E-162 
 
 
 
  
App.8.2 Citrate cycle 
2.3.3.1 citrate synthase lm.23523 citrate synthase I [Rhodospirillum centenum SW]  5.00E-180 
4.2.1.3 aconitate hydratase lm.27090 hypothetical protein [Selaginella moellendorffii]  0.00E+00 
1.1.1.41 isocitrate dehydrogenase lm.56820 isocitrate dehydrogenase [Salpingoeca sp.]  2.00E-166 
6.2.1.4 succinate-CoA ligase lm.9621 succinate-CoA ligase [Polysphondylium pallidum] 3.00E-137 
1.3.5.1 succinate dehydrogenase dm.59812 predicted protein [Ostreococcus lucimarinus]  0.00E+00 
4.2.1.2 fumarate hydratase lm.18575  hypothetical protein [Saccoglossus kowalevskii] 0.00E+00 
1.1.1.37 malate dehydrogenase lm.15162 malate dehydrogenase, mitochondrial precursor [Phytophthora infestans]  2.00E-147 
 
App.8.3 Pentose phosphate pathway 
1.1.1.47 glucose 1-dehydrogenase dm.50276 GDH/6PGL endoplasmic bifunctional protein isoform X1 [Ficedula albicollis]  0.00E+00 
3.1.1.17 gluconolactonase dm.27330 hypothetical protein [Paenibacillus sp.] 1.00E-50 
2.7.1.12 gluconokinase lm.34185 gluconokinase [Rhizobium leguminosarum] 1.00E-57 
1.1.1.44 
phosphogluconate 
dehydrogenase  
lm.22792 6-phosphogluconate dehydrogenase putative [Albugo laibachii] 0.00E+00 
5.3.1.6 
Ribose-5-phosphate 
isomerase 
lm.10968 predicted protein [Bathycoccus prasinos] 4.00E-82 
2.7.6.1 
ribose-phosphate 
diphosphokinase 
lm.72623 ribose-phosphate pyrophosphokinase 2 isoform X1 [Echinops telfairi] 3.00E-84 
5.1.3.1 
ribulose-phosphate 3-
epimerase 
dm.6906 ribulosephosphate 3epimerase putative [Albugo laibachii] 8.00E-106 
2.2.1.1 transketolase lm.12767 transketolase [Chthoniobacter flavus]  0.00E+00 
2.2.1.2 transaldolase lm.15850 transaldolase [Rattus norvegicus]  2.00E-145 
4.1.2.13 
Fructose-bisphosphate 
aldolase 
lm.11373 hypothetical protein [Monosiga brevicollis]  6.00E-176 
2.7.1.11 6-phosphofructokinase lm.15159 putative 6-phospho-1-fructokinase [Leishmania mexicana]  2.00E-139 
3.1.3.11 fructose-bisphosphatase lm.38478 inositol phosphatase/fructose-1,6-bisphosphatase [Nitrosococcus 3.00E-163 
  
halophilus] 
2.7.6.1 
ribose-phosphate 
diphosphokinase 
lm.72623 
PREDICTED: ribose-phosphate pyrophosphokinase 2 isoform X1 [Echinops 
telfairi] 
3.00E-84 
3.1.1.31 
6-
phosphogluconolactonase 
lm.67599 6-phosphogluconolactonase, putative [Phytophthora infestans] 2.00E-78 
 
 App.8.4 Fatty acid biosynthesis 
6.4.1.2 acetyl-CoA carboxylase lm.45716 putative acetyl-CoA carboxylase [Leishmania infantum]  0.00E+00 
2.3.1.86 fatty-acyl-CoA synthase lm.76569 fatty acid synthase [Wickerhamomyces ciferrii] 6.00E-54 
3.1.2.14 
oleoyl-[acyl-carrier-
protein] hydrolase 
lm.47166 hypothetical protein [Streptomyces scabrisporus] 2.00E-24 
     
Carotenoid biosynthesis. 
  
2.5.1.32 phytoene synthase lm.32898 predicted protein [Thalassiosira pseudonana]  4.00E-108 
1.3.5.5 phytoene desaturase lm.43440 phytoene dehydrogenase [Phaeodactylum tricornutum]  0.00E+00 
5.2.1.12  carotene isomerase dm.32619 hypothetical protein [Guillardia theta] 9.00E-140 
 
App.8.5 Calvin cycle 
4.1.1.39 
Ribulose-bisphosphate 
carboxylase 
lm.3071 
ribulose-bisphosphate carboxylase small chain precursor [Chlamydomonas 
sp.] 
1.00E-60 
1.2.1.13 
glyceraldehyde-3-
phosphate 
dehydrogenase  
lm.3559 glyceraldehyde-3-phosphate dehydrogenase [Pyrocystis lunula] 0.00E+00 
3.1.3.37 
sedoheptulose-
bisphosphatase 
lm.14721 sedoheptulose-1,7-biphosphatase [Volvox carteri f. nagariensis]  2.00E-156 
2.7.1.19 phosphoribulokinase dm.49223 predicted protein [Micromonas sp.]  5.00E-166 
 
  
Appendix 9 – Euglena transcripts for biosynthetic enzymes  
(Only the first two Euglena homologues for each enzyme are detailed) 
E.C. Activity Transcript Nearest homologue Evalue Transcript Nearest homologue Evalue 
App 9.1 Isoprenoid biosynthesis 
2.3.1.9 
acetyl-CoA C-
acetyltransfera
se lm.23285 
acetyl-CoA acetyltransferase 
[Reinekea blandensis] 
4.00E-
150 lm.46227 
hypothetical protein[uncultured 
bacterium] 
4.00E-
155 
2.3.3.10 
hydroxymethyl
glutaryl-CoA 
synthase lm.98584 
hydroxymethylglutaryl-CoA 
synthase 1-like 
[Acyrthosiphon pisum] 4.00E-83 lm.20443 
hypothetical protein 
[Trypanosoma cruzi] 
3.00E-
174 
1.1.1.34 
hydroxymethyl
glutaryl-CoA 
reductase 
(NADPH)  lm.36658 
putative 3-hydroxy-3-
methylglutaryl-CoA reductase 
[Leishmania braziliensis]  
4.00E-
170 
   
2.7.1.36 
mevalonate 
kinase  lm.47203 
mevalonate kinase 
[Pyrococcus sp.] 5.00E-39 
   
2.7.4.2 
phosphomeval
onate kinase  dm.76890 
predicted protein [Naegleria 
gruberi] 2.00E-82 
   
4.1.1.33 
diphosphomev
alonate 
decarboxylase none 
     
2.2.1.7 
1-deoxy-D-
xylulose-5-
phosphate 
synthase dm.12516 
1-deoxy-D-xylulose 5-
phosphate synthase, 
chloroplast precursor 
[Ectocarpus siliculosus] 
0.00E+0
0 
   
1.1.1.267 
1-deoxy-D-
xylulose-5- lm.41205 
putative plastid 1-deoxy-D-
xylulose 5-phosphate 
0.00E+0
0 
   
  
phosphate 
reductoisomer
ase 
reductoisomerase precursor 
[Pyropia yezoensis] 
2.7.7.60 
2-C-methyl-D-
erythritol 4-
phosphate 
cytidylyltransfe
rase  lm.51784 
4-diphosphocytidyl-2C-
methyl-D-erythritol synthase 
[Chlamydomonas reinhardtii]  
3.00E-
104 
   
2.7.1.14
8 
4-
diphosphocytid
yl-2-C-methyl-
D-erythritol 
kinase  lm.83522 
4-diphosphocytidyl-2c-
methyl-d-erythritol kinase 
[Thalassiosira pseudonana] 
1.00E-
100 
   
4.6.1.12 
2-C-methyl-D-
erythritol 2,4-
cyclodiphosph
ate synthase  dm.50045 
putative plastid 2-C-methyl-
D-erythritol 2,4-
cyclodiphosphate synthase 
precursor [Guillardia theta] 5.00E-77 
   
1.17.7.1 
(E)-4-hydroxy-
3-methylbut-2-
enyl-
diphosphate 
synthase lm.27792  
hypothetical protein [Volvox 
carteri]  
0.00E+0
0 
   
1.17.1.2 
4-hydroxy-3-
methylbut-2-
enyl 
diphosphate 
reductase dm.13897 
hypothetical protein [Chlorella 
variabilis] 
0.00E+0
0 
   
2.5.1.1 
geranyl 
diphosphate 
synthase lm.32576 
geranylgeranyl 
pyrophosphate synthase 
[Oscillatoria acuminate] 
1.00E-
122 lm.90469 
geranylgeranyl diphosphate 
synthase [Synechococcus sp.] 
2.00E-
71 
2.5.1.10 
farnesyl 
diphosphate lm.19578  
predicted protein 
[Phaeodactylum tricornutum]  2.00E-71 dm.26131 
hypothetical protein 
[Phytophthora sojae] 
4.00E-
79 
  
synthase  
2.5.1.29 
geranylgeranyl 
diphosphate 
synthase dm.48870 
predicted protein 
[Nematostella vectensis] 9.00E-45 dm.10389 
predicted protein 
[Physcomitrella patens]  
1.00E-
143 
2.5.1.32 
Phytoene 
synthase lm.32898 
predicted protein 
[Thalassiosira pseudonana ] 
3.00E-
108 
   
2.5.1.21 
Squalene 
synthase lm.22898 
farnesyltransferase 
[Trypanosoma cruzi] 
1.00E-
112 
   
5.4.9.88 
cycloartenol 
synthase dm.6181 
cycloartenol synthase;-2,3-
epoxysqualene mutase-like 
protein [Thalassiosira 
pseudonana] 0 
   
 App.9.2 Vitamin E biosynthesis 
1.13.11.
27 
4-
hydroxyphenyl
pyruvate 
dioxygenase lm.13577 
4-hydroxyphenylpyruvate 
dioxygenase [Oxytricha 
trifallax] 
3.00E-
157 dm.13964 
4-hydroxyphenylpyruvic acid 
dioxgenase [Capsaspora 
owczarzaki] 
1.00E-
155 
2.5.1.- 
homogenitisat
e 
phytyltransfera
se lm.60507 
hypothetical protein 
[Selaginella moellendorffii] 
8.00E-
122 lm.48543 
predicted protein 
[Phaeodactylum tricornutum] 
3.00E-
91 
2.1.1.- 
tocopherol 
cyclase dm.38942 
predicted protein 
[Thalassiosira pseudonana] 9.00E-64 
   
2.1.1.95 
tocopherol O-
methyltransfer
ase lm.59814 
hypothetical protein 
[Selaginella moellendorffii]  7.00E-86 dm.3700 
hypothetical protein [Volvox 
carteri]  
1.00E-
153 
 
 
 
 
  
App.9.3 Lysine biosynthesis 
4.1.3.21 
homocitrate 
synthase dm.16450 
2-isopropylmalate synthase 
[Phytophthora infestans] 
0.00E+0
0 lm.48249 
2-isopropylmalate 
synthase/homocitrate synthase 
[Phycisphaera mikurensis] 
2.00E-
178 
4.2.1.26 
homoaconitas
e lm.36101 
homoaconitase [Melioribacter 
roseus] 
0.00E+0
0 lm.11199 
Isopropylmalate dehydratase 
[Guillardia theta] 
0.00E+
00 
1.1.1.87 
homoisocitrate 
dehydrogenas
e lm.15833 
isocitrate/isopropylmalate 
dehydrogenase 
[Aciduliprofundum boonei] 
8.00E-
170 lm.80792 
isocitrate/isopropylmalate 
dehydrogenase family protein 
[Caldilinea aerophila] 
1.00E-
90 
2.6.1.39 
aminoadipate 
aminotransfera
se dm.43146 
kynurenine/alpha-
aminoadipate 
aminotransferase 
[acanthomeba castellani] 
6.00E-
144 lm.82932 
aminotransferase [Deinococcus 
radiodurans] 
4.00E-
87 
1.2.1.31 
aminoadipate 
reductase 
lm.21957 
aminoadipate-semialdehyde 
dehydrogenase [Capsaspora 
owczarzaki] 0 
lm.23118 protein synthetase, putative 
[Acanthamoeba castellanii] 
0.00E+
00 
1.5.1.10 
saccharopine 
dehydrogenas
e  lm.12750 
saccharopine dehydrogenase 
[Acanthamoeba castellanii] 
1.00E-
133 
   
1.5.1.17 
saccharopine 
dehydrogenas
e  lm.14473 
lysine ketoglutarate 
reductase [Caldithrix abyssi] 
    
 App.9.4 Arginine and proline biosynthesis 
2.7.2.11 
Glutamate 
kinase lm.12713  
predicted protein 
[Nematostella vectensis]  3.00E-71 dm.21434 
glutamate 5-kinase 
[Halobacteroides halobius] 
7.00E-
75 
1.2.1.41 
Gamma-
glutamyl 
phosphate 
reductase lm.12713  
predicted protein 
[Nematostella vectensis] 3.00E-71 dm.21435 
glutamate 5-kinase 
[Halobacteroides halobius]  
7.00E-
75 
2.6.1.13 ornithine-∆- dm.2778 Ornithine aminotransferase, 0 lm.13761 predicted protein [Naegleria 4.00E-
  
aminotransfera
se 
mitochondrial [Dicentrarchus 
labrax] 
gruberi]  159 
2.1.3.3 
ornithine 
carbamoyltran
sferase lm.57420 
predicted protein 
[Physcomitrella patens] 
9.00E-
108 dm.3271 
ornithine carbamoyltransferase 
family protein [Trichomonas 
vaginalis]  
3.00E-
134 
6.3.4.5 
argininosuccin
ate synthase dm.3269 
Argininosuccinate synthase 
[Plesiocystis pacifica]  0 
   
4.3.2.1 
argininosuccin
ate lyase dm.26272 
argininosuccinate lyase 
[Thermobaculum terrenum]  
1.00E-
119 
   
3.5.3.6 
arginine 
deiminase lm.85339 
probable arginine deiminase 
[Cyanidioschyzon merolae] 7.00E-93 
   
4.3.1.12 
ornithine 
cyclodeaminas
e dm.78705 
ornithine cyclodeaminase 
[Candidatus Korarchaeum 
cryptofilum] 
5.00E-
100 
   
1.5.1.2 
pyrroline-5-
carboxylate 
reductase dm.52519  
pyrroline-5-carboxylate 
reductase [Anaerolinea 
thermophile] 4.00E-94 
   
1.5.99.8 
proline 
dehydrogenas
e dm.3408 
proline oxidase [Capsaspora 
owczarzaki] 
5.00E-
128 
lm.30651 
proline oxidase, putative 
[Phytophthora infestans]  
2.00E-
59 
 
App.9.5 Threonine biosynthesis 
2.7.2.4 aspartokinase lm.48603 
aspartate kinase [Fibrisoma 
limi] 
7.00E-
173 
   
1.2.1.11 
aspartate-
semialdehyde 
dehydrogenas
e  lm.25814 
aspartate-semialdehyde 
dehydrogenase [Bermanella 
marisrubri] 
2.00E-
175 
   
1.1.1.3 
homoserine 
dehydrogenas
e lm.48604 
aspartate kinase [Fibrisoma 
limi] 
7.00E-
173 
lm.20768 hypothetical protein [Selaginella 
moellendorffii]  
2.00E-
104 
  
2.7.1.39 
homoserine 
kinase none 
     
4.2.3.1 
threonine 
synthase lm.36284 
threonine synthase 
[Geobacter metallireducens]  
2.00E-
172 
   
 App.9.6 Branched-chain amino acid biosynthesis 
4.3.1.19 
Threonine 
dehydratase lm.62724 
threonine 
dehydratase[Batrachochytriu
m dendrobatidis] 
7.00E-
164 lm.15790 
threonine dehydratase, medium 
form [Polaromonas sp.CF318] 
0.00E+
00 
2.2.1.6 
acetolactate 
synthase I/III  lm.11204 
pyruvate decarboxylase, 
putative [Perkinsus marinus] 
0.00E+0
0 
   
1.1.1.86 
ketol-acid 
reductoisomeras
e  dm.442  
ketol-acid reductoisomerase 
[Gemmata obscuriglobus] 
2.00E-
164 lm.36809 
ketol-acid reductoisomerase 
[SAR324 cluster bacterium] 
4.00E-
54 
4.2.1.9 
dihydroxy-acid 
dehydratase  lm.22604 
dihydroxy-acid dehydratase 
[Beggiatoa alba] 
0.00E+0
0 lm.48541 
dihydroxy-acid dehydratase 2-
like [Nematostella vectensis] 
0.00E+
00 
2.6.1.42 
Branched chain 
amino acid 
amino 
transferase lm.13579 
Glu/Leu/Phe/Val 
dehydrogenase family protein 
[Microscilla marina] 
0.00E+0
0 
   
2.3.3.13 
2-
isopropylmalate 
synthase lm.48249  
2-isopropylmalate 
synthase/homocitrate 
synthase [Phycisphaera 
mikurensis] 
2.00E-
178 
dark_m.16
450 
hypothetical protein 
[Phytophthora sojae] 0 
4.2.1.33 
3-
isopropylmalate 
dehydratase  lm.11199 
Isopropylmalate dehydratase 
[Guillardia theta] 0 lm.36101 
homoaconitase [Melioribacter 
roseus] 0 
1.1.1.85 
3-
isopropylmalate 
dehydrogenase lm.13576 
3-isopropylmalate 
dehydrogenase 
[Planctomyces limnophilus]  
2.00E-
136 
lm.15833 
isocitrate/isopropylmalate 
dehydrogenase 
[Thermoplasmatales archaeon]  
3.00E-
174 
 
  
App.9.7 Aromatic amino acid biosynthesis 
2.5.1.54 
3-deoxy-7-
phosphoheptul
onate 
synthase lm.61463 
probable 3-deoxy-D-arabino-
heptulosonate 7-phosphate 
(DAHP) synthase isoenzyme 
[Ustilago hordei] 
8.00E-
152 lm.32049 
phospho-2-dehydro-3-
deoxyheptonate aldolase 
[Dickeya zea] 
6.00E-
149 
4.2.3.4 
3-
dehydroquinat
e synthase lm.52098 
hypothetical protein 
[Batrachochytrium 
dendrobatidis] 
0.00E+0
0 
   
4.2.1.10 
3-
dehydroquinat
e dehydratase lm.52099 
hypothetical protein 
[Batrachochytrium 
dendrobatidis] 
0.00E+0
0 
   
1.1.1.25 
Shikimate 
dehydrogenas
e lm.52100 
hypothetical protein 
[Batrachochytrium 
dendrobatidis JAM81] 
0.00E+0
0 lm.97034 
shikimate 5-dehydrogenase 
[Achromobacter xylosoxidans] 
2.00E-
70 
2.7.1.71 
Shikimate 
kinase lm.52101 
hypothetical protein 
[Batrachochytrium 
dendrobatidis] 
0.00E+0
0 lm.64084 
Shikimate kinase (ISS) 
[Ostreococcus tauri] 
1.00E-
24 
2.5.1.19 
EPSP 
synthase lm.52102 
hypothetical protein 
[Batrachochytrium 
dendrobatidis] 
0.00E+0
0 
   
4.2.3.5 
Chorismate 
synthase dm.12955 
chorismate synthase 
[Desulfotalea psychrophila] 
2.00E-
151 
   
4.1.3.27 
anthralinate 
synthase lm.68214 
anthranilate/para-
aminobenzoate synthase 
component I [uncultured 
euryarchaeote] 
2.00E-
136 dm.24194 
phenazine biosynthesis protein 
PhzE [Streptomyces sviceus] 
8.00E-
139 
5.4.99.5 
chorismate 
mutase lm.67331 
hypothetical protein 
[Phytophthora sojae] 6.00E-98 lm.43560 
tyrosine biosynthesis 
bifunctional enzyme 
[Phytophthora sojae] 
1.00E-
161 
4.2.1.51 
prephenate 
dehydratase lm.67331 
hypothetical protein 
[Phytophthora sojae] 6.00E-98 lm.43561 
tyrosine biosynthesis 
bifunctional enzyme 
1.00E-
161 
  
[Phytophthora sojae] 
1.3.1.12 
prephenate 
dehydrogenas
e lm.67331 
hypothetical protein 
[Phytophthora sojae] 6.00E-98 
   
2.6.1.57 
aromatic 
amino acid 
transaminase lm.50263 
aromatic amino acid 
aminotransferase [Rubrivivax 
benzoatilyticus]  7.00E-19 
   
2.6.1.85 
aminodeoxych
orismate 
synthetase dm.24194 
phenazine biosynthesis 
protein PhzE [Streptomyces 
sviceus] 
8.00E-
139 
   
4.1.3.38 
aminodeoxych
orismate lyase lm.32069 
hypothetical protein 
[Selaginella moellendorffii]  
7.00E-
167 
   
2.4.2.18 
Anthralinate 
phosphoribosyl
transferase dm.33057 
tryptophan synthase subunit 
beta [Planococcus 
antarcticus]  
2.00E-
163 
   
5.3.1.24 
Phosphoribosy
lanthralinate 
isomerase dm.33057 
tryptophan synthase subunit 
beta [Planococcus 
antarcticus]  
2.00E-
163 
   
4.1.1.48 
Indoyl-3-
glycerol 
phosphate 
synthase dm.33057 
tryptophan synthase subunit 
beta [Planococcus 
antarcticus DSM 14505]  
2.00E-
163 
   
4.2.1.20 
Tryptophan 
synthase B 
subunit dm.33057 
tryptophan synthase subunit 
beta [Planococcus 
antarcticus] 
2.00E-
163 
   
4.2.1.20 
Tryptophan 
synthase A 
subunit lm.34856  
Tryptophan synthase (alpha / 
beta chains) [Ectocarpus 
siliculosus] 8.00E-42 
    
 
 
  
App.9.8 Tetrapyrrole biosynthesis 
2.3.1.37 
5-
aminolevulinat
e synthase  lm.11190 
5-aminolevulinate synthase 
[Oceanibaculum indicum] 
7.00E-
160 
   
1.2.1.7 
glutamyl-tRNA 
reductase lm.12397 
Glutamyl tRNA reductase 
[Volvox carteri] 
7.00E-
175 
   
5.4.3.8 
glutamate-1-
semialdehyde 
2,1-
aminomutase  dm.2724 
glutamate-1-semialdehyde 
aminotransferase/glutamate-
1-semialdehyde 21-
aminomutase 
[Nannochloropsis gaditana] 
0.00E+0
0 lm.7162 
predicted protein [Micromonas 
sp.]  
3.00E-
174 
4.2.1.24 
aminolevulinat
e dehydratase lm.37481 
MGC84775 protein-like 
[Saccoglossus kowalevskii] 
5.00E-
122 dm.7076 
hypothetical protein 
Thalassiosira oceanica] 
3.00E-
153 
2.5.1.61 
hydroxymethyl
bilane 
synthase lm.59777 
hydroxymethylbilane 
synthase [Oscillatoria nigro-
viridis] 6.00E-95 
    
App.9.9 Ascorbate biosynthesis 
1.1.1.22 
UDP-Glc 
dehydrogenas
e lm.8509 
UDP-glucose dehydrogenase 
[Capsaspora owczarzak] 
0.00E+0
0 
   
5.1.3.2 
UDP-Glc 4-
epimerase dm.42120 
UDP-glucose 4-epimerase 
[Nannochloropsis gaditana]  
3.00E-
144 dm.18834 
UDP-glucose 4-epimerase 
[Nannochloropsis gaditana] 
4.00E-
149 
2.7.7.64 
UDP-sugar 
pyrophosphory
lase lm.84866 
predicted protein 
[Micromonas sp.] 
8.00E-
163 lm.77285 
predicted protein [Micromonas 
sp.] 
1.00E-
148 
2.7.1.43 
glucuronokinas
e lm.74877 
predicted protein 
[Nematostella vectensis] 
6.00E-
160 
   
1.1.1.19 
GlcUA 
reductase lm.70407 
Mannitol dehydrogenase 
rossman domain family 
[Ectocarpus siliculosus]  
1.00E-
140 dm.24690 
mannitol-1-phosphate 5-
dehydrogenase [Providencia 
sneebia]  
2.00E-
123 
  
3.1.1.17 
aldonolactonas
e dm.27330 
Gluconolactonase 
[Crocosphaera watsonii] 8.00E-48 
Already 
known 
  
1.1.3.8/1
.3.2.3 
L-
gulonolactone 
oxidase dm.53576 
FAD/FMN-containing 
dehydrogenase [Moorea 
producens] 2.00E-13 lm.29571 
Putative actin interacting protein 
[Polysphondylium pallidum] 
0.00E+
00 
2.7.7.69 
GDP-L-
galactose 
phosphorylase lm.98124 
Hypothetical protein, partial 
[Rhipicephalus pulchellus] 3.00E-62 
   
3.1.3.- Aldoase lm.49313 
hypothetical protein 
[Trichoplax adhaerens]  1.00E-60 lm.96714 
inositol monophosphatase 
[Burkholderia ambifaria]  
4.00E-
74 
1.1.1.12
2 
D-threo-aldose 
1-
dehydrogenas
e dm.6726 
aldo/keto reductase 
[Alicyclobacillus 
acidocaldarius subsp. 
acidocaldarius]  5.00E-75 lm.28331 
predicted protein [Micromonas 
sp.] 
7.00E-
81 
1.3.2.3 
L-galactono-
1,4-lactone 
dehydrogenas
e dm.53576 
FAD/FMN-containing 
dehydrogenase [Moorea 
producens] 2.00E-13 
   
5.1.3.18 
GDP-D-
mannose 3', 
5'-epimerase lm.30913  
NAD-dependent 
epimerase/dehydratase 
[Planococcus donghaensis]  
1.00E-
146 lm.21407 
NAD-dependent 
epimerase/dehydratase 
[Pedosphaera parvula] 
1.00E-
121 
2.7.1.6  galactokinase lm.57669 
hypothetical protein 
[Monosiga brevicollis] 
5.00E-
158 
   
1.1.1.- 
Galuronic acid 
reductase lm.15162 
malate dehydrogenase, 
mitochondrial precursor 
[Phytophthora infestans] 
2.00E-
147 lm.86647 
malate dehydrogenase, 
mitochondrial precursor 
[Phytophthora infestans]  
5.00E-
41 
2.7.7.10 
UDP-hexose 
pyrophosphata
se lm.20758 
galactose-1-phosphate 
uridylyltransferase 
[Planctomycete limnophilus] 1.00E-36 light only 
   
 
  
App.9.10 Trypanothione biosynthesis 
4.1.1.18 
Lysine 
decarboxylase lm.45128 
decarboxylase [Microlunatus 
phosphovorus] 0 lm.75103 
putative arginine/lysine/ornithine 
decarboxylase [Sulfitobacter sp.]  
2.00E-
166 
4.1.1.17 
Ornithine 
decarboxylase none 
     
2.6.1.76 
Diaminobutyrat
e-2-
oxoglutarate 
transaminase lm.13761 
predicted protein [Naegleria 
gruberi] 
4.00E-
159 lm.27919 
aminotransferase class-III 
[Dictyostelium purpureum] 
7.00E-
166 
4.1.1.86 
L-2,4-
diaminobutyrat
e 
decarboxylase lm.51975 
cysteine synthetase/pyridoxal 
dependent decarboxylase 
[Micromonas pusilla]  
1.00E-
140 
   
2.5.1.16 
Spermidine 
synthase lm.8151 
spermidine synthase 
[Rhizopus delemar] 
8.00E-
106 dm.16659 
predicted protein [Micromonas 
sp.] 
7.00E-
99 
6.3.2.3 
Glutathione 
synthase lm.34786 
hypothetical protein 
[Dictyostelium purpureum] 3.00E-97 
   
6.3.2.2 
Glutathamate 
cysteine ligase lm.43917 
glutamate-cysteine ligase, 
catalytic subunit [Taeniopygia 
guttata] 
0.00E+0
0 
   
4.1.1.50 
S-
adenosylmethi
onine 
decarboxylase dm.44803 
S-adenosylmethionine 
decarboxylase [Leishmania 
donovani] 3.00E-91 
   
6.3.1.9 
Glutathionylsp
ermidine 
synthase lm.36171 
bifunctional 
glutathionylspermidine 
amidase/glutathionylspermidi
ne synthetase [Simiduia 
agarivorans]  4.00E-98 lm.20283 
hypothetical protein 
[Plasmodiophora brassicae] 
3.00E-
48 
3.5.1.78 
Glutathionylsp
ermidine lm.36172 
bifunctional 
glutathionylspermidine 
1.00E+0
0 lm.20284 
hypothetical protein 
[Plasmodiophora brassicae] 
3.00E-
48 
  
amidase amidase/glutathionylspermidi
ne synthetase [Simiduia 
agarivorans]  
1.8.1.12 
Trypanothione 
reductase dm.46314 
trypanothione reductase, 
putative [Trypanosoma cruzi 
marinkellei] 
0.00E+0
0 
    
App.9.11 Ovothiol biosynthesis 
NA 
5-
histidylcysteine 
sulfoxide 
synthase dm.8268 
generic methyltransferase 
[Salpingoeca sp.] 
0.00E+0
0 lm.33343 
hypothetical protein [Rhizopus 
delemar] 
6.00E-
171 
NA 
5-
histidylcysteine 
sulfoxide N-
mehtyl 
transferase dm.8269 
generic methyltransferase 
[Salpingoeca sp.] 
0.00E+0
0 lm.51716 
hypothetical protein  [Trichoplax 
adhaerens]  
2.00E-
89 
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Appendix 10 – Proteomic analysis of dm.33057 
The protein encoded on the Euglena transcript dm.33057 was co-purified with the 
laminarin phosphorylase activity and identified by proteomic analysis. This transcript 
encodes four domains, which are normally found on separate polypetides, for the 
biosynthesis of tryptophan. Peptides were found that match 31% of its sequence, 
evenly spread throughout, except in the region before the first domain. This sample 
had been purified by AIEX, HIC and has a mass in the range 100-150 kDa on 
denaturing PAGE indicating that all four domains are translated as a single 
polypeptide (Fig App.10.1). 
1 GALAPPLATL SGGPAGMGLV AFDGAAAVVT DLTADRQALM AGINALAVGD 
51 GGPTHLAAAL DAGVAAFGDS EPRRARFLEV LTDRLGDDGR WALERAAAHK 
101 AAGVVVLVVG VGPAPEAGPL QVLASDPAEE HWMRLGALPA VPAVADIVGS 
151 GGDGQNTWNV STPAAIVAAG AGIRMAKHGN RSASSNSGSA DLLEQFGAYL 
201 PVSPTVVPEL VDRTNFSFLY APAFHPALRN VAKVRQDLGT KTVFNFLGPL 
251 LNPAAPQYNV VGVSDRAMAE VMARCLSRRP GVQALVVHSE DGMDKISPVR 
301 NTHSWRVEGG KEPVYQLLRP EDFGLVSDPA KDCGAGGGSP AHNAAALLRV 
351 LQGTSPDPLL ADFVLLQAAA LAHLAGKAAS YAEGMALMRE TVASGRALAA 
401 LNEYVRLSTR LSRDSNRAIL QTIVRRRQVD VALAQQLVPE AELRALPHFS 
451 RPCVDLAAAL KGSTTPVAVM AEIKRASPSE GDINPSLDVA AIAGQYTEGG 
501 AVALSVLTEP TWFKGSLQDL TTAREVVEKA GAQRPAVLRK EFVFTKYQIT 
551 EAKAHGADTV LLIAAIEPAM REAGESLQSL LDYSRSLGME PLVEVVTEDE 
601 VDAAIGCGAK VIGINNRDLT TFRVDLGRTE TLTRYAEFAY PEKAGEVVWV 
651 SLSGVNDNAD IHILQKLSPR VRTVLVGTSL MRAADPAALL RTFTSGVVSP 
701 ADLAKIKAPP KARPLVKICG LKTPEQVISA LRDGVDFVGL MFYPKSHRYI 
751 ADPATARRMV ELTHQCALPG HPVWGQLPLA VGVFMQESLE RINELSRAVG 
801 FDAVQLYGYR PGDIDLAQLK KADGSPLPVI WACSVTTAED VAAVAYPPGI 
851 AALCLDRKAG GALGGTGQAF DWGLLKGFAA PVPVWLAGGI DEGNAPQAAE 
901 VPGIATIDLS SGVETDKVKD FWKIRTVTRL IKNRLPAYFG PFGGQFVPEI 
951 LMPALIDLEK QYLRVFRNPD FWREVKWYWA NYAGRPTLLY KATKQTEDIR 
1001 KTCAPGMGAQ IWYKREDLLH TGAHKVNNAL GQALMAKWLG KRRMIAETGA 
1051 GQHGVATATV CALFGLECIV YMGALDTVRQ KLNVLRMEAL GAKVVAVEAG 
1101 QKTLNDAVNE ALRDWATTSH YSHYMIGSCV GPHPFPTMVR DFQSIISREA 
1151 RVQCLEQLGR LPDKVFACTG GGSNAIGTFD AFVQDAGVQI FGVEAGGDGH 
1201 DLNSATLSKG SIGFVHGART YLLQDEESGQ VKPTHSVSAG LDYPGVGPEH 
1251 SYLKSMGRVQ YINASDKAAL DAFQHLARTE GILAALESSH AVAATIEASR 
1301 NSPQEMNLVC CMSGRGDKDM NTIEEWLRGD GVPHH 
 
Figure App.10.1: Proteomic analysis of dm.33057 
The peptides identified with mascot (red) matched throughout the sequence, 
including the TrpD (amino acids 130-408, yellow), TrpC (419-693, green), TrpF 
(713-933, cyan) and TrpB (935-1332, grey) domains. 
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Appendix 11 – Natural product synthases encoded in the 
Euglena transcriptome  
Transcripts were identified using BLASTP to search for keto synthase (for PKSs), 
condensation, and adenylation (for NRPSs) domains. There is a high degree of 
uncertainty using this technique. 
A – Amino acid adenylation. AA-syn – Amino acid synthesis. ANK – Ankyrin 
domain. AT – Acyl transfer. C – Condensation. CoAL – Acyl-CoA ligase.  
DH – Dehydratase. AmT – Aspartate amino transferase. EH – Enoyl CoA hydratase 
ER – Enoyl reductase. HCS – HMGCoA synthase. KR – keto reductase.  
KS – Polyketide synthase. TE – thioesterase. 
App.11.1 Polyketide synthases 
 
Transcript Role Domains 
1 lm.8157 PKS 
KS-AT-DH-ER-KR-ACP-
EH-EH-TE-HCS 
2 lm.60697 PKS DH-KS-ACP-AmT 
3 lm.53854 PKS KS-AT-KR-ACP-KS 
4 lm.82030 PKS KR-ACP-KS 
5 lm.42557 PKS KR-ACP-KS-DH-KR 
6 lm.91532 PKS A-ACP-KS 
7 lm.95952 PKS ACP-KS 
8 lm.88225 PKS KS-AT 
9 lm.23151 PKS KS 
10 lm.94376 PKS C-ACP 
11 lm.88941 PKS KS 
12 lm.110121 PKS KS 
13 lm.102218 PKS KS 
14 lm.97081 PKS ACP-KS 
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App.11.2 Nonribosomal peptide synthases 
 
Transcript Activity  
1 lm.66007 NRPS C-A-ACP 
2 lm.9669 NRPS C-C-A-ACP-TE 
3 lm.32232 NRPS C-C-A-ACP-C-A 
4 lm.96272 NRPS C-A-A 
5 lm.21957 AA-syn C-A-ACP-TE 
6 lm.23118 AA-syn A-ACP-TE 
7 lm.78138 A A-ANK 
8 lm.54590 A A-ANK 
9 lm.87820 A A-ACP-TE 
10 lm.77877 A A-ACP-ANK 
11 lm.98982 A A 
12 lm.89785 A A-ACP 
13 lm.47668 A A 
14 lm.94698 A A 
15 lm.44795 A A 
16 lm.44327 A CoAL 
17 lm.11010 A CoAL 
18 lm.81072 A CoAL 
19 lm.97175 C CoAL 
20 lm.26470 C CoAL 
21 lm.22119 C CoAL 
22 lm.37810 C CoAL 
23 lm.3119 C CoAL 
24 lm.28443 C CoAL 
25 lm.9400 C CoAL 
26 lm.26875 C CoAL 
27 lm.12406 C CoAL 
28 lm.3346 C CoAL 
29 lm.44112 C CoAL 
30 lm.17087 C CoAL 
 
 
Appendices 
~ 317 ~ 
 
References 
1 Cantarel, B. L. et al. The Carbohydrate-Active EnZymes database (CAZy): 
an expert resource for glycogenomics. Nucleic Acids Res. 37, D233-D238 
(2009). 
2 Curtis, B. A. et al. Algal genomes reveal evolutionary mosaicism and the fate 
of nucleomorphs. Nature 492, 59-65 (2012). 
3 Bhattacharya, D. et al. Genome of the red alga Porphyridium purpureum. 
Nat. Commun. 4, 1941-1941 (2013). 
4 Arnold, K., Bordoli, L., Kopp, J. & Schwede, T. The SWISS-MODEL 
workspace: a web-based environment for protein structure homology 
modelling. Bioinformatics 22, 195-201 (2006). 
5 Takahashi, T. et al. A sequence motif involved in the donor substrate binding 
by α-1,6-fucosyltransferase: the role of the conserved arginine residues. 
Glycobiology 10, 503-510 (2000). 
6 Lobsanov, Y. D. et al. Structure of Kre2p/Mnt1p: a yeast  
α-1,2-mannosyltransferase involved in mannoprotein biosynthesis. J. Biol. 
Chem. 279, 17921-17931 (2004). 
7 Mulichak, A. M., Lu, W., Losey, H. C., Walsh, C. T. & Garavito, R. M. Crystal 
atructure of vancosaminyltransferase GtfD from the vancomycin biosynthetic 
pathway: interactions with acceptor and nucleotide ligands. Biochemistry  
43, 5170-5180 (2004). 
8 Cui, Z., Maruyama, Y., Mikami, B., Hashimoto, W. & Murata, K. Crystal 
structure of glycoside hydrolase family 78 α-L-rhamnosidase from Bacillus 
sp. GL1. J. Mol. Biol. 374, 384-398 (2007). 
 
 
